<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://myelomabeacon.org/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.8.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.9" -->
<!-- generated-on="December 9, 2020 6:34 pm" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>https://myelomabeacon.org/</loc>
		<lastmod>2020-11-26T00:19:57+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/11/25/myeloma-on-the-high-plains-the-its-all-relative-blues/</loc>
		<lastmod>2020-11-26T00:19:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/11/20/northern-lights-how-my-husband-helps-me-deal-with-my-multiple-myeloma/</loc>
		<lastmod>2020-11-20T23:47:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/11/13/us-fda-approves-generic-pomalidomide/</loc>
		<lastmod>2020-11-20T13:29:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/11/17/us-fda-lifts-clinical-hold-on-melani-01-trial/</loc>
		<lastmod>2020-11-20T09:52:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/11/12/darzalex-faspro-pomalyst-dex-approval-filings-usa-europe/</loc>
		<lastmod>2020-11-13T22:45:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/11/06/myeloma-on-the-high-plains-surviving-2/</loc>
		<lastmod>2020-11-06T22:34:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/21/darzalex-maintenance-therapy-cassiopeia-initial-results/</loc>
		<lastmod>2020-11-06T12:04:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/11/04/cellprotect-receives-us-orphan-drug-designation/</loc>
		<lastmod>2020-11-06T11:50:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/15/cellprotect-orphan-drug-designation-europe/</loc>
		<lastmod>2020-11-06T11:42:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/11/02/sanofi-kiadis-agree-to-acquisition-offer/</loc>
		<lastmod>2020-11-06T10:39:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/08/kiadis-sanofi-cd38-knock-out-nk-cell-licensing-agreement/</loc>
		<lastmod>2020-11-06T10:27:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/19/motixafortide-bl-8040-phase-3-trial-interim-analysis-planned/</loc>
		<lastmod>2020-10-31T13:12:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/30/genesis-trial-bl-8040-motixafortide-interim-analysis-results/</loc>
		<lastmod>2020-10-30T22:17:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/07/bl-8040-positive-results-lead-in-period-phase-3-genesis-trial/</loc>
		<lastmod>2020-10-30T22:02:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/10/21/my-myelomaverse-feeling-dazed-and-confused/</loc>
		<lastmod>2020-10-21T23:14:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/12/oncopeptides-to-seek-conditional-approval-melflufen-europe/</loc>
		<lastmod>2020-10-20T23:16:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/12/us-fda-grants-onkord-orphan-drug-designation-multiple-myeloma/</loc>
		<lastmod>2020-10-20T23:04:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/19/opd5-ind-submitted-to-us-fda/</loc>
		<lastmod>2020-10-20T22:06:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/15/oncopep-mana-therapeutics-licensing-agreement/</loc>
		<lastmod>2020-10-20T21:39:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/10/09/myeloma-party-of-two-legacies/</loc>
		<lastmod>2020-10-10T11:32:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/05/nirogacestat-pf-06863135-collaboration-springworks-pfizer/</loc>
		<lastmod>2020-10-10T11:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/06/nexi-002-multiple-myeloma-trial-first-patient-dosed/</loc>
		<lastmod>2020-10-09T16:32:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/08/cytovia-inserm-car-nk-cd38-licensing-agreement/</loc>
		<lastmod>2020-10-09T12:50:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/10/01/melflufen-us-expanded-access-program-now-open/</loc>
		<lastmod>2020-10-01T11:09:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/2020-fundraising-goals-updates/</loc>
		<lastmod>2020-10-01T11:03:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/09/30/myeloma-on-the-high-plains-can-i-do-this/</loc>
		<lastmod>2020-09-30T22:26:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/30/prt1419-trial-relapsed-hematologic-malignancies-first-patient-dosed/</loc>
		<lastmod>2020-09-30T11:51:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/09/25/northern-lights-managing-fear/</loc>
		<lastmod>2020-09-25T22:04:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/24/kyan-therapeutics-georgetown-hdac-inhibitors-licensing/</loc>
		<lastmod>2020-09-24T11:37:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/22/idecabtagene-vicleucel-ide-cel-bb2121-accepted-priority-review-us-fda/</loc>
		<lastmod>2020-09-22T11:55:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/21/pbcar269a-nirogacestat-collaboration-agreement/</loc>
		<lastmod>2020-09-21T11:43:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/09/17/my-myelomaverse-hygge-houseplants-and-well-being-oh-my/</loc>
		<lastmod>2020-09-17T22:11:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/23/phosplatin-therapeutics-us-patent-pt-112-bone-blood-cancers/</loc>
		<lastmod>2020-09-17T16:34:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/17/bristol-myers-squibb-dr-reddys-revlimid-patent-litigation-settlement/</loc>
		<lastmod>2020-09-17T16:34:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/08/kp1237-orphan-drug-designation-us-fda/</loc>
		<lastmod>2020-09-16T22:02:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/02/cynk-001-us-fda-ind-clearance-covid-19-clinical-trial/</loc>
		<lastmod>2020-09-15T02:00:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/08/cynk-001-covid-19-clinical-trial-first-patient-dosed/</loc>
		<lastmod>2020-09-14T22:08:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/25/ipsc-derived-nk-cells-provisional-us-patent-filing/</loc>
		<lastmod>2020-09-14T21:19:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/08/tti-622-and-tti-621-updated-dose-escalation-trial-results/</loc>
		<lastmod>2020-09-14T18:59:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/14/nirogacestat-teclistamab-collaboration-springworks-janssen/</loc>
		<lastmod>2020-09-14T12:28:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/04/melflufen-ocean-clinical-trial-extended-enrollment-completed/</loc>
		<lastmod>2020-09-12T16:19:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/09/pbcar269a-fast-track-designation-us-fda/</loc>
		<lastmod>2020-09-11T22:17:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/09/ninlaro-tourmaline-mm2-clinical-trial-more-detailed-results/</loc>
		<lastmod>2020-09-11T22:00:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/09/09/clover-1-phase-2-clinical-trial-overall-response-60-mci-dose/</loc>
		<lastmod>2020-09-11T19:22:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/19/clr-131-multiple-myeloma-phase-1-clinical-trial-complete/</loc>
		<lastmod>2020-09-10T22:08:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/08/29/myeloma-on-the-high-plains-time-flies/</loc>
		<lastmod>2020-08-29T17:32:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/20/melflufen-phase-ii-trial-multiple-myeloma/</loc>
		<lastmod>2020-08-29T12:10:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/24/melflufen-ocean-clinical-trial-delay-completion-of-patient-recruitment/</loc>
		<lastmod>2020-08-29T12:10:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/20/melflufen-accelerated-approval-application-preparation-initiated/</loc>
		<lastmod>2020-08-29T12:10:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/26/melflufen-horizon-clinical-trial-recruitment-completed/</loc>
		<lastmod>2020-08-29T12:10:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/26/melflufen-overall-response-rate-triple-class-refractory-multiple-myeloma/</loc>
		<lastmod>2020-08-29T12:10:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/22/ocean-phase-3-myeloma-clinical-trial-enrollment-completed/</loc>
		<lastmod>2020-08-29T12:10:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/01/melflufen-ocean-phase-3-trial-to-continue-recruiting-patients/</loc>
		<lastmod>2020-08-29T12:09:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/30/melflufen-new-drug-application-submitted-us-fda/</loc>
		<lastmod>2020-08-29T12:09:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/04/start-port-study-melflufen-peripheral-vs-central-administration/</loc>
		<lastmod>2020-08-29T12:08:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/29/melflufen-priority-review-us-fda/</loc>
		<lastmod>2020-08-29T12:07:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/26/blenrep-european-approval-belantamab-mafodotin/</loc>
		<lastmod>2020-08-26T21:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/08/21/northern-lights-myeloma-treatments-and-tolerability-2/</loc>
		<lastmod>2020-08-22T10:46:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/20/us-fda-approves-new-darzalex-combination-regimen-for-relapsed-multiple-myeloma/</loc>
		<lastmod>2020-08-21T21:34:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/20/darzalex-kyprolis-dexamethasone-relapsed-multiple-myeloma-us-fda-approval/</loc>
		<lastmod>2020-08-20T21:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/21/janssen-legend-biotech-lcar-b38m-agreement/</loc>
		<lastmod>2020-08-06T17:10:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/30/fda-clearance-ind-phase-1b-2-lcar-b38m-jnj-68284528/</loc>
		<lastmod>2020-08-06T17:10:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/30/start-phase-1b-2-development-jnj-68284528-bcma-car-t-cell/</loc>
		<lastmod>2020-08-06T17:10:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/04/jnj-68284528-granted-prime-designation-by-ema/</loc>
		<lastmod>2020-08-06T17:10:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/05/cilta-cel-breakthrough-therapy-designation-recommendation-china/</loc>
		<lastmod>2020-08-06T17:10:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/06/jnj-4528-breakthrough-therapy-designation-us-fda/</loc>
		<lastmod>2020-08-06T15:16:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/21/legend-biotech-janssen-global-collaboration-lcar-b38m/</loc>
		<lastmod>2020-08-06T15:16:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/29/ide-cell-bb2121-bla-resubmission-us-fda/</loc>
		<lastmod>2020-08-06T05:11:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/05/fda-approves-blenrep-belantamab-mafodotin-multiple-myeloma/</loc>
		<lastmod>2020-08-06T03:50:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/02/gsk2857916-breakthrough-therapy-designation-multiple-myeloma/</loc>
		<lastmod>2020-08-06T03:43:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/27/springworks-glaxosmithkline-collaboration-nirogacestat-belantamab-mafodotin-multiple-myeloma/</loc>
		<lastmod>2020-08-06T03:43:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/08/23/belantamab-mafodotin-dreamm-2-headline-results/</loc>
		<lastmod>2020-08-06T03:43:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/09/23/retreatment-multiple-myeloma-bcma-targeted-therapies/</loc>
		<lastmod>2020-08-06T03:43:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/16/belantamab-mafodotin-dreamm-2-trial-trial-update-and-fda-approval-application/</loc>
		<lastmod>2020-08-06T03:43:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/01/21/belantamab-mafodotin-priority-review-us-fda/</loc>
		<lastmod>2020-08-06T03:43:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/03/belantamab-mafodotin-european-medicines-agency-acceptance-marketing-authorisation-application/</loc>
		<lastmod>2020-08-06T03:43:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/19/belantamab-mafodotin-gsk2857916-us-fda-odac-meeting-scheduled/</loc>
		<lastmod>2020-08-06T03:43:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/22/first-patient-dosed-nirogacestat-belantamab-mafodotin-clinical-trial/</loc>
		<lastmod>2020-08-06T03:43:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/14/belantamab-mafodotin-fda-odac-advisory-committee-positive-vote/</loc>
		<lastmod>2020-08-06T03:43:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/24/chmp-positive-opinion-belantamab-mafodotin-gsk2857916-multiple-myeloma/</loc>
		<lastmod>2020-08-06T03:43:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/08/05/my-myelomaverse-hold-up-wait-a-minute/</loc>
		<lastmod>2020-08-05T23:26:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/25/topline-results-phase-3-trial-subcutaneous-daratumumab/</loc>
		<lastmod>2020-08-04T14:40:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/12/subcutaneous-darzalex-forumulation-fda-application-submitted/</loc>
		<lastmod>2020-08-04T14:40:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/12/subcutaneous-forumulation-darzlex-approval-application-us-fda-submitted/</loc>
		<lastmod>2020-08-04T14:40:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/19/application-submitted-european-approval-subcutaneous-darzalex/</loc>
		<lastmod>2020-08-04T14:40:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/19/ema-approval-sought-subcutaneous-darzalex/</loc>
		<lastmod>2020-08-04T14:40:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/19/extension-application-ema-subcutaneous-darzalex/</loc>
		<lastmod>2020-08-04T14:40:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/26/subcutaneous-darzalex-new-drug-application-japan/</loc>
		<lastmod>2020-08-04T14:40:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/30/chmp-positive-opinion-darzalex-subcutaneous-formulation/</loc>
		<lastmod>2020-08-04T14:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/01/us-fda-approval-darzalex-faspro-genmab-announcement/</loc>
		<lastmod>2020-08-04T14:39:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/04/subcutaneous-darzalex-european-approval/</loc>
		<lastmod>2020-08-04T14:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/04/european-approval-subcutaneous-darzalex/</loc>
		<lastmod>2020-08-04T14:39:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/31/topline-results-apollo-clinical-trial-darzalax-pomalyst-multiple-myeloma/</loc>
		<lastmod>2020-08-04T14:39:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/04/darzalex-sc-approval-canada/</loc>
		<lastmod>2020-08-04T14:39:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/13/candor-clinical-trial-topline-results/</loc>
		<lastmod>2020-08-03T16:49:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/08/03/first-patient-dosed-tasquinimod-multiple-myeloma-clinical-trial/</loc>
		<lastmod>2020-08-03T12:03:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/07/30/myeloma-party-of-two-risky-business/</loc>
		<lastmod>2020-07-30T22:16:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/02/07/fda-grants-pt-112-orphan-drug-designation-multiple-myeloma/</loc>
		<lastmod>2020-07-28T16:40:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/20/xpovio-second-line-therapy-supplemental-nda-accepted-for-filing/</loc>
		<lastmod>2020-07-20T11:50:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/06/08/bb2121-continues-to-impress-potential-multiple-myeloma-therapy-asco-2018/</loc>
		<lastmod>2020-07-15T14:51:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/08/13/number-stem-cell-transplants-multiple-myeloma-by-cancer-center/</loc>
		<lastmod>2020-07-15T14:50:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/10/15/multiple-myeloma-testosterone-levels/</loc>
		<lastmod>2020-07-15T14:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/07/15/myeloma-on-the-high-plains-hitting-the-curve/</loc>
		<lastmod>2020-07-15T14:46:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/14/cyad-211-ind-clearance-us-fda/</loc>
		<lastmod>2020-07-14T12:14:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/01/05/nkg2d-30-day-safety-follow-up-cohort-two/</loc>
		<lastmod>2020-07-14T12:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/02/25/nkg2d-cohort-two-follow-up-complete/</loc>
		<lastmod>2020-07-14T12:03:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/08/sarclisa-isatuximab-now-available-in-canada/</loc>
		<lastmod>2020-07-08T15:08:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/07/07/my-myelomaverse-time-to-tell/</loc>
		<lastmod>2020-07-07T22:47:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/15/imw-2009-physicians-discuss-new-drugs-for-relapsedrefractory-patients/</loc>
		<lastmod>2020-07-07T11:39:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/04/elotuzumab-in-combination-with-revlimid-and-dexamethasone-shows-encouraging-results-in-multiple-myeloma-ash-2009/</loc>
		<lastmod>2020-07-07T11:39:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/14/beacon-newsflashes-january-14-2010/</loc>
		<lastmod>2020-07-07T11:39:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/23/the-top-myeloma-research-of-2009/</loc>
		<lastmod>2020-07-07T11:39:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/06/asco-2010-multiple-myeloma-update-day-two/</loc>
		<lastmod>2020-07-07T11:39:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/07/asco-2010-multiple-myeloma-updateday-two/</loc>
		<lastmod>2020-07-07T11:39:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/21/elotuzumab-combinations-show-encouraging-results-in-multiple-myeloma-asco-2010/</loc>
		<lastmod>2020-07-07T11:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/05/ash-2010-multiple-myeloma-update-day-one/</loc>
		<lastmod>2020-07-07T11:38:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/09/ash-2010-multiple-myeloma-update-day-four/</loc>
		<lastmod>2020-07-07T11:38:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/15/elotuzumab-combinations-show-encouraging-results-in-relapsedrefractory-multiple-myeloma-ash-2010/</loc>
		<lastmod>2020-07-07T11:38:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/28/thought-leader-perspective-dr-kenneth-anderson-on-the-future-of-multiple-myeloma-treatment/</loc>
		<lastmod>2020-07-07T11:38:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/15/promising-new-drugs-for-multiple-myeloma-will-the-future-come-soon-enough-by-dr-vincent-rajkumar/</loc>
		<lastmod>2020-07-07T11:38:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/09/imw-2011-multiple-myeloma-update-day-three-part-1/</loc>
		<lastmod>2020-07-07T11:37:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/25/myeloma-research-to-be-presented-at-the-american-society-of-clinical-oncologys-47th-annual-meeting-asco-2011/</loc>
		<lastmod>2020-07-07T11:37:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/06/asco-2011-multiple-myeloma-update-day-three-part-one/</loc>
		<lastmod>2020-07-07T11:37:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/08/asco-2011-multiple-myeloma-update-day-four/</loc>
		<lastmod>2020-07-07T11:37:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/10/elotuzumab-combination-is-effective-for-relapsed-myeloma-asco-2011/</loc>
		<lastmod>2020-07-07T11:37:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/19/experts-review-current-and-future-research-into-new-multiple-myeloma-treatments/</loc>
		<lastmod>2020-07-07T11:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/11/ash-2011-multiple-myeloma-update-day-one/</loc>
		<lastmod>2020-07-07T11:37:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/14/elotuzumab-combination-effective-for-relapsed-refractory-multiple-myeloma-ash-2011/</loc>
		<lastmod>2020-07-07T11:37:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/13/ash-2011-multiple-myeloma-update-day-three-morning-new-therapies/</loc>
		<lastmod>2020-07-07T11:37:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/23/ash-2011-initial-thoughts-key-multiple-myeloma-related-findings/</loc>
		<lastmod>2020-07-07T11:37:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/09/the-top-multiple-myeloma-research-of-2011/</loc>
		<lastmod>2020-07-07T11:37:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/16/multiple-myeloma-research-american-society-of-clinical-oncology-48th-annual-meeting-asco-2012/</loc>
		<lastmod>2020-07-07T11:37:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/04/asco-2012-multiple-myeloma-update-day-four-immunotherapy-for-myeloma/</loc>
		<lastmod>2020-07-07T11:37:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/04/asco-2012-multiple-myeloma-update-day-four-poster-presentations-on-new-myeloma-treatments/</loc>
		<lastmod>2020-07-07T11:37:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/13/elotuzumab-combination-continues-to-show-promise-as-treatment-for-multiple-myeloma-asco-2012/</loc>
		<lastmod>2020-07-07T11:37:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/26/new-agents-in-combination-with-revlimid-lenalidomide-relapsed-refractory-multiple-myeloma/</loc>
		<lastmod>2020-07-07T11:37:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/10/ash-2012-multiple-myeloma-update-day-two-late-afternoon-oral-session/</loc>
		<lastmod>2020-07-07T11:37:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/21/multiple-myeloma-ash-2012-meeting-taking-stock-and-tagging-highlights/</loc>
		<lastmod>2020-07-07T11:37:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/22/the-top-multiple-myeloma-research-of-2012/</loc>
		<lastmod>2020-07-07T11:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/08/beacon-newsflashes-april-8-2013/</loc>
		<lastmod>2020-07-07T11:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/06/05/myeloma-party-of-two-the-cave-view/</loc>
		<lastmod>2020-07-07T11:34:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/08/cid-103-clinical-trial-application-submitted/</loc>
		<lastmod>2020-07-07T11:34:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/08/pbcar269a-clinical-trial-multiple-myeloma-first-patient-dosed/</loc>
		<lastmod>2020-07-07T11:34:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/10/menarini-group-completes-stemline-therapeutics-acquisition/</loc>
		<lastmod>2020-07-07T11:34:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/06/10/the-final-mile-the-numbers-game/</loc>
		<lastmod>2020-07-07T11:34:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/11/cellectar-granted-european-patent-for-phospholipid-ether-analogs-for-cancer-therapy/</loc>
		<lastmod>2020-07-07T11:34:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/11/avm-biotechnology-receives-nci-sbir-phase-1-grant-avm0703/</loc>
		<lastmod>2020-07-07T11:33:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/06/15/myeloma-on-the-high-plains-old-dogs/</loc>
		<lastmod>2020-07-07T11:33:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/16/dexamethasone-reduces-risk-of-death-in-hospitalized-covid-19-patients/</loc>
		<lastmod>2020-07-07T11:33:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/06/19/my-myelomaverse-the-waiting-is-the-hardest-part/</loc>
		<lastmod>2020-07-07T11:33:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/06/24/laughter/</loc>
		<lastmod>2020-07-07T11:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/07/01/northern-lights-learning-about-others/</loc>
		<lastmod>2020-07-07T11:33:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/07/06/ucartcs1a-melani-01-clinical-trial-hold/</loc>
		<lastmod>2020-07-07T11:30:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/23/beyond-kyprolis-and-pomalyst-what-is-on-the-horizon-for-multiple-myeloma/</loc>
		<lastmod>2020-07-07T11:28:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/20/multiple-myeloma-research-american-society-of-clinical-oncology-annual-meeting-asco-2013/</loc>
		<lastmod>2020-07-07T11:28:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/24/future-multiple-myeloma-treatment/</loc>
		<lastmod>2020-07-07T11:28:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/06/asco-2013-multiple-myeloma-update-day-four-poster-presentations/</loc>
		<lastmod>2020-07-07T11:28:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/11/asco-2013-multiple-myeloma-highlights/</loc>
		<lastmod>2020-07-07T11:28:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/06/15/elotuzumab-pfs-data-eha-2013/</loc>
		<lastmod>2020-07-07T11:28:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/05/19/elotuzumab-breakthrough-therapy-designation-fda/</loc>
		<lastmod>2020-07-07T11:28:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/05/19/elotuzumab-breakthrough-therapy-designation-multiple-myeloma/</loc>
		<lastmod>2020-07-07T11:28:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/10/01/lirilumab-elotuzumab-multiple-myeloma-phase-1-trial/</loc>
		<lastmod>2020-07-07T11:28:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/12/05/ash-2014-multiple-myeloma-new-treatments-preview/</loc>
		<lastmod>2020-07-07T11:28:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/12/08/ash-2014-multiple-myeloma-update-day-one-poster-session/</loc>
		<lastmod>2020-07-07T11:28:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/01/30/myeloma-quiz-january-2015/</loc>
		<lastmod>2020-07-07T11:28:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/05/29/multiple-myeloma-asco-2015-overview/</loc>
		<lastmod>2020-07-07T11:28:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/06/07/asco-2015-posters-new-multiple-myeloma-therapies/</loc>
		<lastmod>2020-07-07T11:28:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/06/25/2015-asco-eha-imwg-summit-multiple-myeloma-highlights/</loc>
		<lastmod>2020-07-07T11:28:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/07/27/empliciti-elotuzumab-marketing-authorization-application/</loc>
		<lastmod>2020-07-07T11:28:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/07/30/elotuzumab-eloquent-2-closer-look/</loc>
		<lastmod>2020-07-07T11:28:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/01/empliciti-elotuzumab-fda-priority-review/</loc>
		<lastmod>2020-07-07T11:28:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/30/fda-approves-empliciti/</loc>
		<lastmod>2020-07-07T11:28:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/30/elotuzumab-2/</loc>
		<lastmod>2020-07-07T11:28:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/30/bms-abbvie-receive-fda-approval-empliciti-elotuzumab/</loc>
		<lastmod>2020-07-07T11:27:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/12/01/empliciti-elotuzumab-fda-approval-multiple-myeloma/</loc>
		<lastmod>2020-07-07T11:27:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/05/longer-term-empliciti-data-ash-2015/</loc>
		<lastmod>2020-07-07T11:27:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/01/29/empliciti-europe-positive-chmp-opinion/</loc>
		<lastmod>2020-07-07T11:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/01/31/myeloma-quiz-january-2016/</loc>
		<lastmod>2020-07-07T11:27:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/02/myeloma-dispatches-empliciti/</loc>
		<lastmod>2020-07-07T11:27:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/19/myeloma-morning-empliciti-velcade-dexamethasone-treanda/</loc>
		<lastmod>2020-07-07T11:27:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/11/empliciti-elotuzumab-european-approval/</loc>
		<lastmod>2020-07-07T11:27:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/12/empliciti-elotuzumab-europe-approval/</loc>
		<lastmod>2020-07-07T11:27:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/05/23/empliciti-elotuzumab-europa-zulassung/</loc>
		<lastmod>2020-07-07T11:27:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/06/15/asco-2016-multiple-myeloma-update-poster-presentations-current-myeloma-therapies-smoldering-myeloma/</loc>
		<lastmod>2020-07-07T11:27:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/23/empliciti-pomalyst-dexamethasone-fda-application-accepted/</loc>
		<lastmod>2020-07-07T11:27:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/09/18/ema-validates-empliciti-pomalyst-dexamethasone-application/</loc>
		<lastmod>2020-07-07T11:27:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/06/us-fda-approves-empliciti-pomalyst-dexamethasone-for-relapsed-multiple-myeloma/</loc>
		<lastmod>2020-07-07T11:27:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/26/empliciti-pomalyst-dexamethasone-positive-chmp-opinion/</loc>
		<lastmod>2020-07-07T11:27:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/08/06/myeloma-party-of-two-moonshots/</loc>
		<lastmod>2020-07-07T11:27:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/08/27/european-approval-empliciti-pomalyst-imnovid-dexamethasone-relapsed-multiple-myeloma/</loc>
		<lastmod>2020-07-07T11:27:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/09/eloquent-1-clinical-trial-erd-vs-rd-topline-results/</loc>
		<lastmod>2020-07-07T11:27:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/02/us-fda-approves-ucartcs1-clinical-trial-multiple-myeloma/</loc>
		<lastmod>2020-07-07T11:26:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/04/05/allogeneic-car-t-cell-therapy-multiple-myeloma-clinical-trial/</loc>
		<lastmod>2020-07-07T11:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/29/first-patient-dosed-ucartcs1-multiple-myeloma-clinical-trial/</loc>
		<lastmod>2020-07-07T11:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/15/clr-131-cohort-6-phase-1-trial-50-percent-overall-response/</loc>
		<lastmod>2020-06-11T18:57:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/08/11/ind-submission-i-131-clr1404-multiple-myeloma/</loc>
		<lastmod>2020-06-11T18:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/09/04/i-131-clr1404-ind-multiple-myeloma-accepted/</loc>
		<lastmod>2020-06-11T18:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/04/15/i-131-clr1404-multiple-myeloma-trial/</loc>
		<lastmod>2020-06-11T18:57:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/01/05/clr131-multiple-myeloma-phase-1-data/</loc>
		<lastmod>2020-06-11T18:57:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/08/08/clr131-overall-survival-multiple-myeloma/</loc>
		<lastmod>2020-06-11T18:57:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/03/27/cellectar-granted-us-patent-for-phospholipid-ether-analogs-for-cancer-therapy/</loc>
		<lastmod>2020-06-11T18:57:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/04/03/clr131-granted-patent-covering-use-in-multiple-myeloma/</loc>
		<lastmod>2020-06-11T18:57:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/09/24/clr131-update-on-fda-import-alert/</loc>
		<lastmod>2020-06-11T18:57:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/02/clr131-overall-survival-phase-1b-trial/</loc>
		<lastmod>2020-06-11T18:57:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/12/clr131-import-alert-exemption-granted-by-fda/</loc>
		<lastmod>2020-06-11T18:57:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/11/clr131-patient-protection-japan/</loc>
		<lastmod>2020-06-11T18:57:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/07/update-results-clr-131-trial-relapsed-multiple-myeloma/</loc>
		<lastmod>2020-06-11T18:57:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/13/clr131-fast-track-designation-us-fda/</loc>
		<lastmod>2020-06-11T18:57:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/24/clr-131-orphan-drug-designation-multiple-myeloma-europe/</loc>
		<lastmod>2020-06-11T18:57:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/16/clr-131-results-25-mci-m2-bolus-dose-clover-1-clinical-trial/</loc>
		<lastmod>2020-06-11T18:57:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/14/clr-131-patent-granted-europe/</loc>
		<lastmod>2020-06-11T18:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/05/20/sl-401-preclinical-data-multiple-myeloma-asco/</loc>
		<lastmod>2020-06-10T16:07:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/03/asco-2013-multiple-myeloma-update-day-three-poster-presentations/</loc>
		<lastmod>2020-06-10T16:06:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/20/bristol-myers-squibb-completes-acquisition-of-celgene/</loc>
		<lastmod>2020-06-10T16:02:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/04/menarini-group-to-acquire-stemline-therapeutics/</loc>
		<lastmod>2020-06-10T15:31:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/04/12/fda-grants-tasquinimod-orphan-drug-designation-multiple-myeloma/</loc>
		<lastmod>2020-06-09T02:10:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/03/active-biotech-status-update-portfolio-projects/</loc>
		<lastmod>2020-06-09T02:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/23/tasquinimod-multiple-myeloma/</loc>
		<lastmod>2020-06-09T01:57:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/05/22/northern-lights-a-different-spring/</loc>
		<lastmod>2020-06-05T20:53:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/06/02/letters-from-cancerland-labyrinth/</loc>
		<lastmod>2020-06-02T21:57:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/22/beacon-newsflashes-april-22-2013/</loc>
		<lastmod>2020-06-02T15:49:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/12/beacon-newsflashes-august-12-2013/</loc>
		<lastmod>2020-06-02T15:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/10/melflufen-additional-u-s-patent-protection-until-2033/</loc>
		<lastmod>2020-06-02T15:49:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/06/02/sarclisa-isatuximab-european-approval/</loc>
		<lastmod>2020-06-02T15:01:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/08/selinexor-european-approval-application/</loc>
		<lastmod>2020-05-22T19:26:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/02/iaso-bio-bcma-car-t-cell-ct053a-ind-clearance-nmpa/</loc>
		<lastmod>2020-05-22T15:38:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/03/arcellx-series-b-financing-results/</loc>
		<lastmod>2020-05-22T15:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/28/ct053-granted-rmat-designation-us-fda/</loc>
		<lastmod>2020-05-22T15:31:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/28/arcellx-bcma-t-cell-therapy-first-patient-dosed/</loc>
		<lastmod>2020-05-22T15:29:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/12/cart-ddbcma-orphan-drug-designation-us-fda/</loc>
		<lastmod>2020-05-22T15:29:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/27/ct053-orphan-drug-designation-ema-positive-opinion/</loc>
		<lastmod>2020-05-22T15:27:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/06/bluebird-bio-presents-pre-clinical-and-manufacturing-data-from-car-t-oncology-programs-at-ash-annual-meeting/</loc>
		<lastmod>2020-05-22T15:26:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/02/17/bb2121-crb401-clinical-trial-first-patient/</loc>
		<lastmod>2020-05-22T15:26:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/16/bb2121-breakthrough-therapy-designation-multiple-myeloma/</loc>
		<lastmod>2020-05-22T15:26:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/03/28/bluebird-bio-celgene-bb2121-co-development-co-promotion-usa/</loc>
		<lastmod>2020-05-22T15:26:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/06/04/asco-2018-multiple-myeloma-oral-presentations-expert-perspectives/</loc>
		<lastmod>2020-05-22T15:26:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/06/07/asco-2018-expertenperspektiven-vortrage-multiples-myelom/</loc>
		<lastmod>2020-05-22T15:26:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/27/karmma-clinical-trial-completes-enrollment/</loc>
		<lastmod>2020-05-22T15:26:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/06/bb2121-ide-cel-karmma-trial-topline-results/</loc>
		<lastmod>2020-05-22T15:26:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/31/ide-cell-bb2121-bla-submission-us-fda/</loc>
		<lastmod>2020-05-22T15:26:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/11/bluebird-bio-bristol-myers-squibb-amend-car-t-cell-therapy-agreement-collaboration-agreement/</loc>
		<lastmod>2020-05-22T15:26:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/13/ide-cel-bb2121-fda-approval-application-must-be-resubmitted/</loc>
		<lastmod>2020-05-22T15:26:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/22/european-medicines-agency-validates-idecabtagene-vicleucel-ide-cel-bb2121-cc-486-applications/</loc>
		<lastmod>2020-05-22T11:50:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/20/us-fda-application-xpovio-second-line-therapy/</loc>
		<lastmod>2020-05-21T17:14:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/21/kleo-celularity-collaboration-allogeneic-nk-cell-therapies-covid-19-multiple-myeloma/</loc>
		<lastmod>2020-05-21T16:09:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/01/13/allogene-springworks-allo-715-nirogacestat-clinical-collaboration-agreement/</loc>
		<lastmod>2020-05-21T16:02:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/04/allo-715-ind-clearance-us-fda/</loc>
		<lastmod>2020-05-21T16:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/01/cellectis-lonza-car-t-cell-manufacturing-agreement/</loc>
		<lastmod>2020-05-21T16:02:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/05/introducing-notch-therapeutics/</loc>
		<lastmod>2020-05-21T16:01:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/05/allogene-notch-collaboration-agreement/</loc>
		<lastmod>2020-05-21T16:01:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/12/editas-medicine-celgene-amend-t-cell-therapy-collaboration/</loc>
		<lastmod>2020-05-21T16:01:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/01/13/pbcar269a-ind-accepted-us-fda/</loc>
		<lastmod>2020-05-21T16:00:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/06/us-fda-clears-ft516-ind/</loc>
		<lastmod>2020-05-21T15:17:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/04/nantkwest-promab-biotechnologies-license-agreement-natural-killer-cell-therapies/</loc>
		<lastmod>2020-05-21T15:14:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/05/md-anderson-takeda-nk-cell-collaboration/</loc>
		<lastmod>2020-05-21T15:13:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/20/us-fda-clears-ft538-ind/</loc>
		<lastmod>2020-05-21T15:13:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/05/18/myeloma-on-the-high-plains-no-matter-what/</loc>
		<lastmod>2020-05-18T21:57:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/19/tj202-mor202-pivotal-phase-2-clinical-trial/</loc>
		<lastmod>2020-05-15T17:18:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/07/tj202-mor202-ind-submission-china/</loc>
		<lastmod>2020-05-15T17:16:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/30/first-patient-dosed-phase-3-clinical-trial-tj202-mor202/</loc>
		<lastmod>2020-05-15T17:16:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/27/first-patient-dosed-tj202-mor202-phase-3-clinical-triali-mab-and-morphosys-announce-first-patient-dosed-in-phase-3-clinical-trial-china/</loc>
		<lastmod>2020-05-15T17:15:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/05/antengene-karyopharm-expand-asia-pacific-collaboration/</loc>
		<lastmod>2020-05-15T16:46:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/24/karyopharm-antengene-license-agreement-china-asia/</loc>
		<lastmod>2020-05-15T16:22:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/20/selinexor-covid-19-clinical-trial-first-patient-dosed/</loc>
		<lastmod>2020-05-15T12:25:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/30/patent-application-filing-continuous-delivery-lenalidomide-and-other-immunomodulatory-agents/</loc>
		<lastmod>2020-05-14T19:19:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/27/transdermal-lenalidomide-proof-of-concept-study-completed/</loc>
		<lastmod>2020-05-14T19:10:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/05/13/the-final-mile-crash-and-comeback/</loc>
		<lastmod>2020-05-13T22:01:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/05/kyprolis-carfilzomib-patents-upheld-against-generic-manufacturer/</loc>
		<lastmod>2020-05-12T20:18:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/05/12/sarclisa-meets-primary-endpoint-ikema-clinical-trial/</loc>
		<lastmod>2020-05-12T19:39:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/240/</loc>
		<lastmod>2020-05-06T14:22:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4612/</loc>
		<lastmod>2020-05-06T14:22:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3264/</loc>
		<lastmod>2020-05-06T14:22:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/686-2/</loc>
		<lastmod>2020-05-06T14:22:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4522/</loc>
		<lastmod>2020-05-06T14:22:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4052/</loc>
		<lastmod>2020-05-06T14:22:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/538-2/</loc>
		<lastmod>2020-05-06T14:22:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4631/</loc>
		<lastmod>2020-05-06T14:22:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2352/</loc>
		<lastmod>2020-05-06T14:22:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4513/</loc>
		<lastmod>2020-05-06T14:22:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4469/</loc>
		<lastmod>2020-05-06T14:22:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4504-2/</loc>
		<lastmod>2020-05-06T14:22:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2120/</loc>
		<lastmod>2020-05-06T14:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3320-2/</loc>
		<lastmod>2020-05-06T14:21:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/244/</loc>
		<lastmod>2020-05-06T14:21:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3333/</loc>
		<lastmod>2020-05-06T14:21:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4473/</loc>
		<lastmod>2020-05-06T14:21:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/241/</loc>
		<lastmod>2020-05-06T14:21:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4466/</loc>
		<lastmod>2020-05-06T14:21:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2417/</loc>
		<lastmod>2020-05-06T14:21:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3318/</loc>
		<lastmod>2020-05-06T14:21:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2267/</loc>
		<lastmod>2020-05-06T14:21:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/484/</loc>
		<lastmod>2020-05-06T14:21:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3303/</loc>
		<lastmod>2020-05-06T14:21:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3248/</loc>
		<lastmod>2020-05-06T14:21:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/487/</loc>
		<lastmod>2020-05-06T14:21:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4613/</loc>
		<lastmod>2020-05-06T14:21:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/392-2/</loc>
		<lastmod>2020-05-06T14:21:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2115-3/</loc>
		<lastmod>2020-05-06T14:21:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3262/</loc>
		<lastmod>2020-05-06T14:21:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2176/</loc>
		<lastmod>2020-05-06T14:21:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/119-2/</loc>
		<lastmod>2020-05-06T14:21:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4516-2/</loc>
		<lastmod>2020-05-06T14:21:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2102/</loc>
		<lastmod>2020-05-06T14:21:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4463/</loc>
		<lastmod>2020-05-06T14:21:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4505/</loc>
		<lastmod>2020-05-06T14:21:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4464/</loc>
		<lastmod>2020-05-06T14:21:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2271/</loc>
		<lastmod>2020-05-06T14:21:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4498-2/</loc>
		<lastmod>2020-05-06T14:21:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3302/</loc>
		<lastmod>2020-05-06T14:21:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/05/05/my-myelomaverse-living-in-the-universe-of-the-vast-unknown/</loc>
		<lastmod>2020-05-05T20:58:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/27/hpn217-trial-multiple-myeloma-first-patient-dosed/</loc>
		<lastmod>2020-05-04T18:35:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/04/16/living-for-lamingtons-life-on-hold/</loc>
		<lastmod>2020-04-16T22:23:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/04/11/northern-lights-an-update-on-my-treatment-with-darzalex-revlimid-and-dexamethasone/</loc>
		<lastmod>2020-04-11T20:37:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/04/07/myeloma-on-the-high-plains-to-the-saints-in-our-lives/</loc>
		<lastmod>2020-04-07T21:50:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/07/xpovio-selinexor-coronavirus-covid-19-clinical-trial/</loc>
		<lastmod>2020-04-07T12:37:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/04/02/kite-teneobio-antibody-license-collaboration-agreement/</loc>
		<lastmod>2020-04-02T16:20:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/04/01/myeloma-party-of-two-tough-choices/</loc>
		<lastmod>2020-04-01T22:04:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/27/sarclisa-isatuximab-irfc-chmp-opinion/</loc>
		<lastmod>2020-03-31T20:57:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/18/nirogacestat-new-composition-of-matter-patent-us/</loc>
		<lastmod>2020-03-18T15:06:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/03/14/northern-lights-how-i-am-dealing-with-covid-19-as-a-multiple-myeloma-patient/</loc>
		<lastmod>2020-03-14T20:48:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/03/11/the-final-mile-rappin-it-out/</loc>
		<lastmod>2020-03-11T22:04:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/07/topline-results-phase-3-tourmaline-mm4-trial-ninlaro-maintenance/</loc>
		<lastmod>2020-03-10T21:21:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/10/tourmaline-mm2-clinical-trial-initial-results/</loc>
		<lastmod>2020-03-10T14:11:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/03/03/myeloma-on-the-high-plains-partial-information/</loc>
		<lastmod>2020-03-03T23:23:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/01/beacon-newsflashes-july-1-2010/</loc>
		<lastmod>2020-03-02T21:32:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/14/beacon-newsflashes-january-14-2013/</loc>
		<lastmod>2020-03-02T21:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/15/ash-2013-preview-newest-treatments-on-the-horizon/</loc>
		<lastmod>2020-03-02T21:31:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/13/ash-2013-multiple-myeloma-update-day-three-morning-oral-sessions/</loc>
		<lastmod>2020-03-02T21:31:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/17/sar650984-multiple-myeloma-ash-2013/</loc>
		<lastmod>2020-03-02T21:31:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/01/top-myeloma-research-2013/</loc>
		<lastmod>2020-03-02T21:31:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/05/15/multiple-myeloma-asco-2014-overview/</loc>
		<lastmod>2020-03-02T21:31:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/05/31/asco-2014-multiple-myeloma-update-day-one/</loc>
		<lastmod>2020-03-02T21:31:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/06/04/asco-2014-multiple-myeloma-update-day-four-oral-presentations/</loc>
		<lastmod>2020-03-02T21:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/07/23/myeloma-quiz-july-2014/</loc>
		<lastmod>2020-03-02T21:31:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/12/10/ash-2014-multiple-myeloma-update-day-two-education-session-midday-oral-session/</loc>
		<lastmod>2020-03-02T21:31:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/21/myeloma-morning-asco-2016-multiple-myeloma-oral-presentation-titles/</loc>
		<lastmod>2020-03-02T21:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/06/06/asco-2016-multiple-myeloma-update-days-one-two-three/</loc>
		<lastmod>2020-03-02T21:31:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/06/09/asco-2016-multiple-myeloma-update-days-four-five-potential-new-myeloma-therapies/</loc>
		<lastmod>2020-03-02T21:31:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/06/15/asco-2016-multiples-myelom-update-tag-eins-zwei-drei/</loc>
		<lastmod>2020-03-02T21:31:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/05/isatuximab-prolongs-progression-free-survival-relapsed-multiple-myeloma/</loc>
		<lastmod>2020-03-02T21:31:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/10/us-fda-accepts-approval-application-isatuximab/</loc>
		<lastmod>2020-03-02T21:31:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/02/fda-approves-sarclisa-isatuximab-irfc-for-previously-treated-multiple-myeloma/</loc>
		<lastmod>2020-03-02T21:30:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/02/fda-approves-sarclisa-isatuximab-irfc-multiple-myeloma/</loc>
		<lastmod>2020-03-02T21:30:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/03/02/xpovio-meets-primary-endpoint-boston-clinical-trial/</loc>
		<lastmod>2020-03-02T13:32:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/19/first-patient-dosed-tak-169-phase-1-clinical-trial/</loc>
		<lastmod>2020-02-19T16:36:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/02/19/letters-from-cancerland-it-is-a-ponderous-chain/</loc>
		<lastmod>2020-02-19T13:52:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/11/karyopharm-promedico-xpovio-selinexor-distribution-agreement-israel/</loc>
		<lastmod>2020-02-14T01:15:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/10/darzalex-kyprolis-dexamethasone-relapsed-myeloma-approval-application-us-fda/</loc>
		<lastmod>2020-02-11T13:01:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/02/10/myeloma-party-of-two-zero-point-seven/</loc>
		<lastmod>2020-02-10T23:47:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/05/active-biotech-new-direction/</loc>
		<lastmod>2020-02-10T21:40:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/23/myeloma-morning-nexavar-mig-spinal-damage-mangos/</loc>
		<lastmod>2020-02-10T21:38:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/05/windmil-university-pennsylvania-mil-collaboration/</loc>
		<lastmod>2020-02-07T04:19:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/01/03/tj2020-mor202-first-patient-dosed-clinical-trial-mainland-china/</loc>
		<lastmod>2020-02-06T22:53:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/02/06/kp1237-ind-accepted-us-fda/</loc>
		<lastmod>2020-02-06T22:53:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/02/04/myeloma-on-the-high-plains-consent-to-decisions/</loc>
		<lastmod>2020-02-04T12:03:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/donate/</loc>
		<lastmod>2020-02-04T11:38:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/2019-fundraising-goals-updates/</loc>
		<lastmod>2020-02-04T11:37:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/01/20/darzalex-vtd-approval-europe-transplant-eligible-ndmm/</loc>
		<lastmod>2020-02-04T06:53:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2020/01/27/gdc-0560-ningbo-newbay-medical-technology-genentech-license-agreement/</loc>
		<lastmod>2020-02-04T06:36:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/27/mp0250-orphan-drug-designation-multiple-myeloma-us-fda/</loc>
		<lastmod>2020-02-04T06:28:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2020/01/09/myeloma-on-the-high-plains-time-now/</loc>
		<lastmod>2020-01-09T23:21:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/12/25/happy-holidays-2019/</loc>
		<lastmod>2019-12-25T15:22:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/11/21/myeloma-on-the-high-plains-surviving/</loc>
		<lastmod>2019-12-24T00:06:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/13/chmp-positive-opinion-darzalex-vtd-transplant-eligible-ndmm/</loc>
		<lastmod>2019-12-23T23:58:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/12/23/myeloma-on-the-high-plains-my-eyes-have-been-opened/</loc>
		<lastmod>2019-12-23T20:59:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/13/darzalex-vtd-chmp-positive-opinion-transplant-eligible-ndmm/</loc>
		<lastmod>2019-12-23T18:37:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/19/nexi-002-us-fda-ind-clearance-phase-1-2-clinical-trial/</loc>
		<lastmod>2019-12-23T17:21:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/12/20/telo-genomics-mayo-clinic-collaboration/</loc>
		<lastmod>2019-12-23T07:10:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/12/02/myeloma-party-of-two-ringing-the-bell/</loc>
		<lastmod>2019-12-02T22:43:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/22/celgene-settles-revlimid-patent-litigation/</loc>
		<lastmod>2019-11-21T13:31:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/04/04/morphosys-sues-janssen-and-genmab-patent-infringement/</loc>
		<lastmod>2019-11-21T13:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/05/myeloma-morning-morphosys-darzalex-patent-lawsuit-cudc-907/</loc>
		<lastmod>2019-11-21T13:30:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/02/15/second-patent-added-morphosys-janssen-genmab-lawsuit/</loc>
		<lastmod>2019-11-21T13:30:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/22/composition-of-matter-patent-for-bion-1301/</loc>
		<lastmod>2019-11-21T13:30:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/26/morphosys-patents-ruled-invalid/</loc>
		<lastmod>2019-11-21T13:30:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/26/patents-asserted-against-darzalex-declared-invalid/</loc>
		<lastmod>2019-11-21T13:29:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/31/darzalex-patent-infringement-lawsuit-is-over/</loc>
		<lastmod>2019-11-21T13:29:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/31/settlement-in-morphosys-janssen-genmab-lawsuit/</loc>
		<lastmod>2019-11-21T13:29:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/13/poseida-therapeutics-notice-of-allowance-new-patents/</loc>
		<lastmod>2019-11-21T13:29:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/29/natco-kyprolis-patent-settlement-usa/</loc>
		<lastmod>2019-11-21T13:29:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/20/cellectis-wins-patent-challenge-in-europe-for-a-method-using-crispr-cas9-for-gene-editing-in-t-cells/</loc>
		<lastmod>2019-11-21T13:28:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/21/harpoon-therapeutics-abbvie-hpn217-licensing-agreement/</loc>
		<lastmod>2019-11-21T12:09:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/19/darzalex-revlimid-dexamethasone-european-approval-transplant-ineligible-ndmm/</loc>
		<lastmod>2019-11-20T03:37:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/19/european-approval-darzalex-revlimid-dexamethasone-transplant-ineligible-ndmm/</loc>
		<lastmod>2019-11-19T21:55:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/11/14/northern-lights-my-first-six-weeks-on-darzalex-revlimid-dexamethasone/</loc>
		<lastmod>2019-11-14T22:57:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/11/04/age-and-importance-of-factors-affecting-multiple-myeloma-survival/</loc>
		<lastmod>2019-11-13T16:11:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/11/13/alter-bedeutung-von-faktoren-ueberleben-multiples-myelom/</loc>
		<lastmod>2019-11-13T16:10:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/11/07/the-final-mile-the-decision/</loc>
		<lastmod>2019-11-07T23:36:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/11/06/tnb-383b-orphan-drug-designation-us-fda/</loc>
		<lastmod>2019-11-06T14:19:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/10/10/darzalex-impact-on-immunoglobulin-levels/</loc>
		<lastmod>2019-11-04T19:41:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/31/amgen-beigene-global-collaboration-agreement/</loc>
		<lastmod>2019-10-31T22:11:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/31/beigene-amgen-global-collaboration-agreement/</loc>
		<lastmod>2019-10-31T21:36:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/30/canada-approval-darzalex-revlimid-dexamethasone-transplant-ineligible-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-10-30T13:35:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/10/28/living-for-lamingtons-managing-risk/</loc>
		<lastmod>2019-10-28T21:51:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/10/22/darzalex-einfluss-immunglobuline/</loc>
		<lastmod>2019-10-22T15:27:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/18/chmp-positive-opinion-darzalex-revlimid-dexamethasone-newly-diagnosed-transplant-ineligible-multiple-myeloma/</loc>
		<lastmod>2019-10-21T14:43:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/10/18/myeloma-on-the-high-plains-living-with-cancer/</loc>
		<lastmod>2019-10-18T18:47:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/18/chmp-positive-opinion-darzalex-revlimid-dexamethasone-front-line-multiple-myeloma/</loc>
		<lastmod>2019-10-18T11:48:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/05/31/myeloma-party-of-two-may-i-have-another/</loc>
		<lastmod>2019-10-17T20:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/06/19/myeloma-party-of-two-accentuate-the-positive/</loc>
		<lastmod>2019-10-17T20:36:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/10/04/myeloma-party-of-two-dealing-with-shingles/</loc>
		<lastmod>2019-10-17T20:36:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/05/07/myeloma-party-of-two-ptsd/</loc>
		<lastmod>2019-10-17T20:34:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/17/teneobio-and-selexis-expand-relationship-three-commercial-license-agreements/</loc>
		<lastmod>2019-10-17T14:42:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/16/nktr-255-first-clinical-trial-start/</loc>
		<lastmod>2019-10-16T14:37:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/15/glenmark-spinoff-ichnos-sciences-launches/</loc>
		<lastmod>2019-10-15T20:02:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/15/cyteir-series-b-round-closing-first-patient-dosed-cyt-0851-phase-1-2-trial/</loc>
		<lastmod>2019-10-15T19:41:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/14/mor202-tj202-gains-ind-clearance-trial-expansion-to-mainland-china/</loc>
		<lastmod>2019-10-15T19:15:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/10/14/tj202-mor202-in-clearance-mainland-china-trial-expansion/</loc>
		<lastmod>2019-10-15T19:14:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/10/12/northern-lights-starting-treatment-with-darzalex/</loc>
		<lastmod>2019-10-12T19:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/10/08/tiragolumab-multiples-myelom/</loc>
		<lastmod>2019-10-08T19:30:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/10/02/tiragolumab-for-multiple-myeloma/</loc>
		<lastmod>2019-10-08T19:30:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/05/02/the-faucet-and-tub-model-of-multiple-myeloma/</loc>
		<lastmod>2019-10-04T16:24:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/10/03/nelfinavir-revlimid-resistenzen-multiples-myelom/</loc>
		<lastmod>2019-10-03T19:27:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/09/25/nelfinavir-revlimid-resistance-multiple-myeloma/</loc>
		<lastmod>2019-10-03T15:15:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/08/29/tnb-383b-for-multiple-myeloma/</loc>
		<lastmod>2019-10-02T14:56:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/07/keytruda-revlimid-dex-multiple-myeloma/</loc>
		<lastmod>2019-10-01T20:50:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/10/01/erneute-behandlung-bmca-gerichtete-therapien-multiples-myelom/</loc>
		<lastmod>2019-10-01T15:47:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/01/22/celgene-to-acquire-juno/</loc>
		<lastmod>2019-09-30T18:26:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/08/04/juno-memorial-sloan-kettering-eureka-license-agreement/</loc>
		<lastmod>2019-09-30T16:40:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/06/juno-oncotracker-fred-hutchinson-gamma-secretase-inhibitor-bcma-car-t-licensing-agreements/</loc>
		<lastmod>2019-09-30T16:40:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/26/us-fda-approves-darzalex-vtd-transplant-eligible-multiple-myeloma/</loc>
		<lastmod>2019-09-27T14:02:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/09/26/letters-from-cancerland-the-electronic-invasion/</loc>
		<lastmod>2019-09-26T23:52:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/26/darzalex-vtd-us-fda-approval-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-09-26T20:12:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/23/ct053-granted-prime-eligibility-by-ema/</loc>
		<lastmod>2019-09-23T12:16:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/09/18/living-for-lamingtons-learning-about-depression-in-unexpected-ways/</loc>
		<lastmod>2019-09-18T19:05:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/13/candor-study-kyprolis-darzalex-meets-primary-endpoint-progression-free-survival/</loc>
		<lastmod>2019-09-17T15:19:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/16/gbr-1342-orphan-drug-designation-multiple-myeloma-us-fda/</loc>
		<lastmod>2019-09-16T14:32:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/09/10/ccs1477-multiple-myeloma-clinical-trial-dosing-starts/</loc>
		<lastmod>2019-09-10T14:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/09/04/tnb-383b-multiples-myelom/</loc>
		<lastmod>2019-09-04T19:07:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/08/30/ct053-orphan-drug-designation-us-fda/</loc>
		<lastmod>2019-08-31T11:06:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/email-subscription/</loc>
		<lastmod>2019-08-29T11:42:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/08/28/northern-lights-preparing-for-what-may-lie-ahead/</loc>
		<lastmod>2019-08-28T16:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2010/04/15/aeterna-zentaris-scientific-advice-ema-perifosine/</loc>
		<lastmod>2019-08-24T20:41:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/04/perifosine-advances-to-phase-3-multiple-myeloma-clinical-trial/</loc>
		<lastmod>2019-08-24T20:25:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/30/generic-velcade-bortezomib-launch-canada-teva/</loc>
		<lastmod>2019-08-24T20:10:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/04/17/darzalex-revlimid-velcade-dexamethasone-relapsed-multiple-myeloma-approval-canada/</loc>
		<lastmod>2019-08-24T16:17:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/02/11/pomalyst-pomalidomide-multiple-myeloma-canada-approval/</loc>
		<lastmod>2019-08-24T11:59:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/17/darzalex-vmp-approval-newly-diagnosed-patients-canada/</loc>
		<lastmod>2019-08-24T11:48:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/08/12/evomela-launched-in-china/</loc>
		<lastmod>2019-08-22T19:11:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/08/22/darzalex-approval-frontline-multiple-myeloma-japan/</loc>
		<lastmod>2019-08-22T18:53:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/09/23/selective-digestive-decontamination-autologous-stem-cell-transplants/</loc>
		<lastmod>2019-08-22T18:29:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/08/22/selektive-dekontamination-verdauungstrakt-infektionsrisiko-multiples-myelom-stammzelltransplantation/</loc>
		<lastmod>2019-08-22T18:28:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/08/12/ligand-partner-casi-launches-evomela-in-china/</loc>
		<lastmod>2019-08-22T16:43:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/08/20/living-for-lamingtons-pedaling-my-way-back/</loc>
		<lastmod>2019-08-20T22:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/stem-cell-transplants-multiple-myeloma-treatment-centers-usa/</loc>
		<lastmod>2019-08-16T12:15:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/08/15/a-northwest-lens-on-myeloma-anniversary-and-decision-point/</loc>
		<lastmod>2019-08-15T20:59:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/contact-us/</loc>
		<lastmod>2019-07-30T20:18:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/07/25/letters-from-cancerland-i-can-swim/</loc>
		<lastmod>2019-07-25T15:46:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/10/health-canada-approves-pomalyst-velcade-dexamethasone-triplet/</loc>
		<lastmod>2019-07-16T19:51:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/07/15/northern-lights-celebrating-a-decade-since-diagnosis/</loc>
		<lastmod>2019-07-15T22:55:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/15/first-patient-dosed-clinical-trial-tnb-383b-multiple-myeloma/</loc>
		<lastmod>2019-07-15T20:39:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/12/genmab-blink-biomedical-commercial-license-agreement/</loc>
		<lastmod>2019-07-15T19:01:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/08/topline-results-griffin-study-darzalex-plus-rvd-vs-rvd/</loc>
		<lastmod>2019-07-10T13:03:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/03/us-fda-approves-xpovio-selinexor-multiple-myeloma/</loc>
		<lastmod>2019-07-03T20:51:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/06/13/selinexor-multiple-myeloma-eha-2014/</loc>
		<lastmod>2019-07-03T18:10:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/03/10/fda-partial-hold-selinexor-clinical-trials/</loc>
		<lastmod>2019-07-03T18:10:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/03/30/fda-lifts-partial-clinical-hold-selinexor-clinical-trials/</loc>
		<lastmod>2019-07-03T18:10:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/04/10/selinexor-fda-fast-track-designation/</loc>
		<lastmod>2019-07-03T18:10:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/04/30/selinexor-phase2b-storm-top-line-data-and-regulatory-filing-plans/</loc>
		<lastmod>2019-07-03T18:10:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/05/09/new-selinexor-myeloma-trial-results-fda-application-timeline/</loc>
		<lastmod>2019-07-03T18:10:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/05/15/neue-studienergebnisse-selinexor-multiples-myelom-antrag-zulassung/</loc>
		<lastmod>2019-07-03T18:10:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/07/18/selinexor-rolling-submission-fda-new-drug-application-started/</loc>
		<lastmod>2019-07-03T18:10:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/06/selinexor-rolling-submission-new-drug-application-completed/</loc>
		<lastmod>2019-07-03T18:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/05/fda-accepts-selinexor-nda-grants-priority-review/</loc>
		<lastmod>2019-07-03T18:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/07/fda-advisory-committee-meeting-scheduled-to-review-selinexor/</loc>
		<lastmod>2019-07-03T18:10:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/26/outcome-of-fda-advisory-committee-reviewing-selinexor/</loc>
		<lastmod>2019-07-03T18:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/14/fda-extends-pdufa-date-selinexor-nda-decision/</loc>
		<lastmod>2019-07-03T18:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/07/03/us-fda-approves-xpovio-selinexor-relapsed-multiple-myeloma/</loc>
		<lastmod>2019-07-03T18:10:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/06/27/living-for-lamingtons-its-nobodys-fault/</loc>
		<lastmod>2019-06-27T23:14:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/27/us-fda-approval-darzalex-revlimid-dexamethasone-transplant-ineligible-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-06-27T20:41:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/09/05/update-phase-1-trial-p-bcma-101-car-t-cell-therapy/</loc>
		<lastmod>2019-06-25T02:21:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/05/p-bcma-101-rmat-designation-us-fda/</loc>
		<lastmod>2019-06-25T02:21:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/14/sea-bcma-dosing-begins-phase-1-clinical-trial-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:21:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/08/cellular-biomedicine-group-clinical-trial-bcma-car-t-cell-therapy/</loc>
		<lastmod>2019-06-25T02:21:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/01/carsgen-bcma-car-t-cell-ct053-ind-clearance-nmpa/</loc>
		<lastmod>2019-06-25T02:21:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/06/beacon-newsflashes-january-6-2011/</loc>
		<lastmod>2019-06-25T02:18:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/23/new-multiple-myeloma-treatments-on-the-horizon-asco-2012/</loc>
		<lastmod>2019-06-25T02:18:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/07/daratumumab-shows-promise-as-treatment-for-relapsed-refractory-multiple-myeloma-asco-2012/</loc>
		<lastmod>2019-06-25T02:18:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2012/08/30/janssen-global-license-development-agreement-daratumumab/</loc>
		<lastmod>2019-06-25T02:18:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/17/beacon-newsflashes-september-17-2012/</loc>
		<lastmod>2019-06-25T02:18:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/19/new-multiple-myeloma-treatments-on-the-horizon-ash-2012/</loc>
		<lastmod>2019-06-25T02:18:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/09/ash-2012-multiple-myeloma-update-day-two-early-afternoon-oral-session/</loc>
		<lastmod>2019-06-25T02:18:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/09/daratumumab-for-relapsed-refractory-myeloma-patients-ash-2012/</loc>
		<lastmod>2019-06-25T02:18:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/06/beacon-newsflashes-may-6-2013/</loc>
		<lastmod>2019-06-25T02:18:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/05/asco-2013-multiple-myeloma-update-day-four-oral-presentations/</loc>
		<lastmod>2019-06-25T02:18:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/13/european-hematology-associations-eha-2013-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:18:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/10/new-daratumumab-multiple-myeloma-trial/</loc>
		<lastmod>2019-06-25T02:18:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/20/ash-2013-preview-treatments-in-mid-to-late-stage-clinical-development-for-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:18:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/08/ash-2013-multiple-myeloma-update-day-one/</loc>
		<lastmod>2019-06-25T02:18:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/03/05/daratumumab-phase-iii-study/</loc>
		<lastmod>2019-06-25T02:18:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/11/24/daratumumab-smoldering-multiple-myeloma-trial/</loc>
		<lastmod>2019-06-25T02:17:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/05/30/daratumumab-multiple-myeloma-asco-2015/</loc>
		<lastmod>2019-06-25T02:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/06/05/daratumumab-starts-rolling-fda-submission/</loc>
		<lastmod>2019-06-25T02:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/06/05/daratumumab-rolling-submission-fda/</loc>
		<lastmod>2019-06-25T02:17:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/06/05/daratumumab-multiples-myelom-asco-2015/</loc>
		<lastmod>2019-06-25T02:17:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/06/05/daratumumab-fda-application-review/</loc>
		<lastmod>2019-06-25T02:17:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/07/07/daratumumab-expanded-access-program/</loc>
		<lastmod>2019-06-25T02:17:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/07/09/daratumumab-rolling-bla-submission-to-fda-completed/</loc>
		<lastmod>2019-06-25T02:17:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/07/30/myeloma-quiz-july-2015/</loc>
		<lastmod>2019-06-25T02:17:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/04/fda-grants-daratumumab-priority-review/</loc>
		<lastmod>2019-06-25T02:17:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/04/daratumumab-fda-priority-review/</loc>
		<lastmod>2019-06-25T02:17:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/09/daratumumab-european-marketing-authorization-application/</loc>
		<lastmod>2019-06-25T02:17:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/25/daratumumab-accelerated-assessment-europe/</loc>
		<lastmod>2019-06-25T02:17:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/25/chmp-grants-daratumumab-accelerated-assessment/</loc>
		<lastmod>2019-06-25T02:17:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/16/fda-approves-darzalex-daratumumab-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:17:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/16/genmab-us-approval-darzalex-daratumumab/</loc>
		<lastmod>2019-06-25T02:17:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/11/17/darzalex-daratumumab-fda-approval-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:17:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/16/darzalex-daratumumab-approved-by-us-fda/</loc>
		<lastmod>2019-06-25T02:17:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/18/daratumumab-new-drug-submission-canada/</loc>
		<lastmod>2019-06-25T02:17:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/11/24/darzalex-daratumumab-fda-zulassung-multiples-myelom-usa/</loc>
		<lastmod>2019-06-25T02:17:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/06/daratumumab-multiple-myeloma-ash-2015/</loc>
		<lastmod>2019-06-25T02:17:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/01/07/darzalex-sirius-mmy2002-results-the-lancet/</loc>
		<lastmod>2019-06-25T02:17:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/21/darzalex-atezolizumab-clinical-trials/</loc>
		<lastmod>2019-06-25T02:17:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/21/darzalex-atezolizumab-solid-tumor-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:17:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/30/darzalex-velcade-dex-clinical-trial-endpoint/</loc>
		<lastmod>2019-06-25T02:17:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/31/myeloma-morning-positive-darzalex-aplidin-trial-results-defitelio-fda-approval/</loc>
		<lastmod>2019-06-25T02:17:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/04/01/darzalex-chmp-positive-opinion/</loc>
		<lastmod>2019-06-25T02:17:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/01/myeloma-morning-darzalex-europe-approval-allogeneic-transplants/</loc>
		<lastmod>2019-06-25T02:17:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/04/20/genmab-announces-daratumumab-asco-2016-data/</loc>
		<lastmod>2019-06-25T02:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/23/myeloma-morning-darzalex-castor-results-treanda-transplantation/</loc>
		<lastmod>2019-06-25T02:16:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/04/29/myeloma-morning-darzalex-castor-treanda-stammzelltransplantation/</loc>
		<lastmod>2019-06-25T02:16:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/18/darzalex-top-line-pollux-results/</loc>
		<lastmod>2019-06-25T02:16:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/20/myeloma-morning-important-transplantation-and-darzalex-trial-results/</loc>
		<lastmod>2019-06-25T02:16:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/23/darzalex-marketing-authorization-europe/</loc>
		<lastmod>2019-06-25T02:16:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/23/single-agent-darzalex-approved-in-europe/</loc>
		<lastmod>2019-06-25T02:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/24/darzalex-daratumumab-europe-approval/</loc>
		<lastmod>2019-06-25T02:16:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/06/30/darzalex-approved-by-health-canada/</loc>
		<lastmod>2019-06-25T02:16:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/07/01/myeloma-morning-darzalex-ym155-sendai-virus-argonaut-2-multiples-myelom/</loc>
		<lastmod>2019-06-25T02:16:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/07/25/darzalex-combinations-breakthrough-therapy-designation-fda-relapsed-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/07/25/darzalex-with-revlimid-or-velcade-breakthrough-therapy-designation/</loc>
		<lastmod>2019-06-25T02:15:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/08/17/darzalex-fda-supplemental-biologics-application-revlimid-velcade/</loc>
		<lastmod>2019-06-25T02:15:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/08/17/darzalex-sbla-fda-relapsed-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/08/23/darzalex-marketing-application-europe-relapsed-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/10/07/priority-review-darzalex-revlimid-velcade-dexamethasone/</loc>
		<lastmod>2019-06-25T02:15:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/08/23/darzalex-revlimid-velcade-combinations-approval-application-submitted-europe/</loc>
		<lastmod>2019-06-25T02:15:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/31/myeloma-dispatches-unexpected-gifts/</loc>
		<lastmod>2019-06-25T02:15:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/10/genmab-announces-darzalex-kyprolis-phase-3-trial/</loc>
		<lastmod>2019-06-25T02:15:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/10/amgen-janssen-collaboration-kyprolis-darzalex-trials/</loc>
		<lastmod>2019-06-25T02:15:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/10/janssen-amgen-collaboration-darzalex-kyprolis-trials/</loc>
		<lastmod>2019-06-25T02:15:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/21/fda-approves-darzalex-revlimid-velcade-dexamethasone-relapsed-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/22/fda-approves-expanded-label-darzalex-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/01/05/janssen-bristol-myers-squibb-darzalex-opdivo-collaboration/</loc>
		<lastmod>2019-06-25T02:15:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/01/05/genmab-announces-darzalex-opdivo-clinical-trials-solid-tumors-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/02/24/darzalex-first-relapse-revlimid-velcade-chmp-positive-opinion/</loc>
		<lastmod>2019-06-25T02:15:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/04/28/european-commission-extends-darzalex-multiple-myeloma-approval/</loc>
		<lastmod>2019-06-25T02:15:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/06/16/fda-approval-darzalex-pomalyst-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/21/darzalex-european-regulatory-submission-darzalex-front-line-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/21/darzalex-vmp-fda-application-submitted-genmab/</loc>
		<lastmod>2019-06-25T02:15:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/21/darzalex-ema-application-newly-diagnosed-myeloma/</loc>
		<lastmod>2019-06-25T02:15:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/21/darzalex-fda-application-approval-use-in-transplant-ineligible/</loc>
		<lastmod>2019-06-25T02:15:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/01/19/darzalex-fda-priority-review-front-line-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/04/30/shorter-darzalex-infusion-times/</loc>
		<lastmod>2019-06-25T02:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/07/darzalex-vmp-fda-approval/</loc>
		<lastmod>2019-06-25T02:15:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/07/darzalex-vmp-fda-approval-janssen/</loc>
		<lastmod>2019-06-25T02:15:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/26/darzalex-tecentriq-jnj63723283-clinical-trials-halted/</loc>
		<lastmod>2019-06-25T02:15:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/05/29/two-darzalex-clinical-trials-halted/</loc>
		<lastmod>2019-06-25T02:15:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/05/31/zwei-darzalex-studien-gestoppt-multiples-myelom/</loc>
		<lastmod>2019-06-25T02:15:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/07/27/chmp-positive-opinion-darzalex-front-line-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/07/27/darzalex-velcade-melphalan-prednisone-chmp-positive-opinion-1/</loc>
		<lastmod>2019-06-25T02:15:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/08/darzalex-split-dosing-regimen-us-european-applications-2/</loc>
		<lastmod>2019-06-25T02:15:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/08/darzalex-split-dosing-regimen-us-european-applications/</loc>
		<lastmod>2019-06-25T02:15:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/31/darzalex-daratumumab-european-marketing-authorization-frontline-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/09/03/european-approval-darzalex-daratumumab-frontline-treatment-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:15:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/21/cassiopeia-study-darzalex-vtd-topline-results/</loc>
		<lastmod>2019-06-25T02:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/29/initial-results-darzalex-rd-vs-rd-phase-3-trial/</loc>
		<lastmod>2019-06-25T02:15:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/19/darzalex-split-dosing-chmp-positive-opinion/</loc>
		<lastmod>2019-06-25T02:14:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/13/darzalex-snda-japan-frontline-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:14:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/20/darzalex-split-dosing-approval-european-commission/</loc>
		<lastmod>2019-06-25T02:14:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/20/european-commission-approval-darzalex-split-dosing-regimen/</loc>
		<lastmod>2019-06-25T02:14:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/22/fda-submission-darzalex-transplant-ineligible-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:14:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/12/u-s-fda-approves-darzalex-split-dosing-regimen/</loc>
		<lastmod>2019-06-25T02:14:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/12/us-fda-approval-darzalex-split-dosing-regimen/</loc>
		<lastmod>2019-06-25T02:14:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/12/darzalex-application-us-fda-approval-newly-diagnosed-multiple-myeloma-transplant-ineligible/</loc>
		<lastmod>2019-06-25T02:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/22/darzalex-revlimid-dexamethasone-newly-diagnosed-multiple-myeloma-europe-approval-application/</loc>
		<lastmod>2019-06-25T02:14:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/22/european-approval-application-darzalex-revlimid-dexamethasone-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:14:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/26/us-fda-approval-application-darzalex-vtd-transplant-eligible-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/26/darzalex-vtd-transplant-eligible-newly-diagnosed-multiple-myeloma-us-fda-approval-application/</loc>
		<lastmod>2019-06-25T02:14:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/05/darzalex-supplemental-new-drug-application-frontline-multiple-myeloma-japan/</loc>
		<lastmod>2019-06-25T02:14:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/30/us-fda-priority-review-darzalex-velcade-thalidomide-dex-ndmm/</loc>
		<lastmod>2019-06-25T02:14:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/17/casi-acquires-tsk011010-exclusive-worldwide-rights-from-black-belt-therapeutics/</loc>
		<lastmod>2019-06-25T02:12:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/29/tnb-383b-ind-multiple-myeloma-cleared-by-us-fda/</loc>
		<lastmod>2019-06-25T02:12:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/13/p-bcma-101-orphan-drug-designation-us-fda/</loc>
		<lastmod>2019-06-25T02:11:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/11/genmab-janssen-hexabody-cd38-license-agreement/</loc>
		<lastmod>2019-06-25T02:10:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/17/tak-169-ind-accepted-by-us-fda/</loc>
		<lastmod>2019-06-25T02:10:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/18/kleo-cd38-antibody-recruiting-molecule-multiple-myeloma/</loc>
		<lastmod>2019-06-25T02:10:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/19/carsgen-bcma-car-t-cell-ct053-ind-clearance-us-fda/</loc>
		<lastmod>2019-06-25T02:10:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/06/24/us-fda-lifts-partial-clinical-hold-phase-3-trial-venclexta-multiple-myeloma-t-11-14/</loc>
		<lastmod>2019-06-25T02:07:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/06/for46-receives-ind-clearance-from-us-fda/</loc>
		<lastmod>2019-06-20T20:56:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/12/stro-001-receives-fda-orphan-drug-designation-for-multiple-myeloma/</loc>
		<lastmod>2019-06-20T20:47:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/09/19/molecular-templates-takeda-agreement-multiple-myeloma-therapy/</loc>
		<lastmod>2019-06-19T20:12:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/06/14/northern-lights-sunshine-and-shadow/</loc>
		<lastmod>2019-06-14T15:22:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/05/16/a-northwest-lens-on-myeloma-you-look-great/</loc>
		<lastmod>2019-06-05T23:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/06/05/letters-from-cancerland-lasts/</loc>
		<lastmod>2019-06-05T22:42:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/05/09/generic-pomalidomide-launches-in-india/</loc>
		<lastmod>2019-05-31T17:38:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/08/05/dr-reddys-amgen-kyprolis-distribution-agreement-india/</loc>
		<lastmod>2019-05-31T16:28:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/05/23/chalazia-blepharitis-velcade-case-series-recommendations/</loc>
		<lastmod>2019-05-30T15:01:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/05/30/chalazia-blepharitis-fallserie-velcade-empfehlungen/</loc>
		<lastmod>2019-05-30T14:59:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/05/29/a-northwest-lens-on-myeloma-the-pendulum-throws-2/</loc>
		<lastmod>2019-05-29T17:35:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/10/myeloma-morning-velcade-eyelid-inflammation-styes-imaging-race-weight/</loc>
		<lastmod>2019-05-23T21:44:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/05/17/northern-lights-having-a-pet-ct-scan/</loc>
		<lastmod>2019-05-17T15:22:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/12/study-compares-mri-and-pet-ct-scans-for-evaluation-of-multiple-myeloma/</loc>
		<lastmod>2019-05-17T15:09:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/12/study-favors-pet-ct-scans-over-whole-body-mri-in-determining-response-to-multiple-myeloma-treatment/</loc>
		<lastmod>2019-05-17T15:09:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/09/myeloma-morning-kyprolis-immunotherapy-targets-pet-ct/</loc>
		<lastmod>2019-05-17T15:09:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/05/02/imaging-techniques-for-multiple-myeloma/</loc>
		<lastmod>2019-05-17T15:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/16/european-commission-approval-revlimid-imnovid-pomalyst-triplet-regimens/</loc>
		<lastmod>2019-05-17T13:23:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/15/bion-1301-multiple-myeloma-development-halted/</loc>
		<lastmod>2019-05-16T18:48:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/05/06/early-radiation-therapy-and-multiple-myeloma-survival/</loc>
		<lastmod>2019-05-15T20:23:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2019/05/15/fruher-einsatz-strahlentherapie-uberleben-multiples-myelom/</loc>
		<lastmod>2019-05-15T20:22:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/05/14/predicting-heart-related-side-effects-of-kyprolis/</loc>
		<lastmod>2019-05-14T18:52:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/08/myeloma-in-paradise-things-my-mom-taught-me/</loc>
		<lastmod>2019-05-12T23:36:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/10/seans-burgundy-thread-myeloma-and-mothers-day/</loc>
		<lastmod>2019-05-12T10:59:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/05/08/cs1-car-t-cell-therapy-clinical-trial-enrollment-opens/</loc>
		<lastmod>2019-05-08T21:34:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/26/first-patient-dosed-mdg1011-blood-cancer-trial/</loc>
		<lastmod>2019-05-08T20:13:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/04/24/living-for-lamingtons-nasty-neuropathy/</loc>
		<lastmod>2019-05-01T16:13:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/2018-fundraising-goals-updates/</loc>
		<lastmod>2019-04-30T18:53:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2019/04/29/ect-001-granted-rmat-designation/</loc>
		<lastmod>2019-04-30T01:45:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/07/doxorubicin-cytori-pre-submission-request-for-new-drug-application-europe/</loc>
		<lastmod>2019-04-26T18:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/23/transdermal-lenalidomide-program-initiation/</loc>
		<lastmod>2019-04-25T20:54:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/04/23/ect-001-receives-fda-regenerative-medicine-advanced-therapy-rmat-designation/</loc>
		<lastmod>2019-04-25T19:55:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/01/27/myeloma-rocket-scientist-happy-birthday-dear-immune-system/</loc>
		<lastmod>2019-04-24T14:41:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/08/30/myeloma-rocket-scientist-teaching-an-old-dog-new-tricks/</loc>
		<lastmod>2019-04-24T14:41:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/09/myeloma-lessons-some-risks-are-not-worth-taking/</loc>
		<lastmod>2019-04-24T14:38:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/11/18/myeloma-lessons-am-i-a-dope/</loc>
		<lastmod>2019-04-24T14:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/04/23/speed-of-response-and-multiple-myeloma-survival/</loc>
		<lastmod>2019-04-24T14:33:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/22/pats-cracked-cup-healing-water/</loc>
		<lastmod>2019-04-24T13:32:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/27/pats-cracked-cup-the-perils-and-humor-of-dating-while-living-with-multiple-myeloma/</loc>
		<lastmod>2019-04-24T13:32:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/28/a-northwest-lens-on-myeloma-putting-risk-in-perspective/</loc>
		<lastmod>2019-04-24T13:25:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/06/15/letters-from-cancerland-my-hipaa-release/</loc>
		<lastmod>2019-04-24T13:19:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/07/06/a-northwest-lens-on-myeloma-how-did-all-this-become-normal/</loc>
		<lastmod>2019-04-24T13:19:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/05/15/light-chain-mgus-progression-disappearance-overall-survival/</loc>
		<lastmod>2019-04-24T13:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/06/13/roxithromycin-antibiotic-multiple-myeloma/</loc>
		<lastmod>2019-04-24T13:15:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/10/01/nelfinavir-velcade-combination-very-active-in-advanced-multiple-myeloma/</loc>
		<lastmod>2019-04-24T13:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/29/chmp-positive-opinions-revlimid-imnovid-pomalyst-triplet-regimens/</loc>
		<lastmod>2019-04-22T13:59:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/05/tinostamustine-enters-expansion-stage-phase-1-2-clinical-trial/</loc>
		<lastmod>2019-04-18T19:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/12/secura-bio-acquires-farydak-global-rights/</loc>
		<lastmod>2019-04-13T02:49:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/20/fda-approves-ninlaro-ixazomib/</loc>
		<lastmod>2019-04-12T21:54:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/08/31/fda-data-halting-keytruda-multiple-myeloma-clinical-trials/</loc>
		<lastmod>2019-04-12T21:51:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/30/fda-commissioner-statement-signing-of-right-to-try-act/</loc>
		<lastmod>2019-04-12T21:50:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/09/28/fda-approves-clonoseq-mrd-test-all-and-multiple-myeloma/</loc>
		<lastmod>2019-04-12T21:49:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/05/31/arrow-trial-once-weekly-kyprolis/</loc>
		<lastmod>2019-04-12T21:46:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/06/30/onyx-unsolicited-amgen-offer/</loc>
		<lastmod>2019-04-12T21:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/06/28/chmp-positive-opinion-velcade-retreatment-and-thalidomide-combination/</loc>
		<lastmod>2019-04-12T21:39:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/08/velcade-bortezomib-europe-approval-frontline-before-transplant/</loc>
		<lastmod>2019-04-12T21:39:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/03/siltuximab-submitted-fda-ema-castleman-disease/</loc>
		<lastmod>2019-04-12T21:38:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/03/21/bluebird-bio-celgene-form-global-collaboration-gene-therapies-oncology/</loc>
		<lastmod>2019-04-12T20:41:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/12/09/updated-mln9708-data-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-04-12T20:28:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/07/27/ixazomib-marketing-authorization-application/</loc>
		<lastmod>2019-04-12T20:26:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/04/27/phase-3-ninlaro-results-nejm-new-england-journal-medicine/</loc>
		<lastmod>2019-04-12T20:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/24/ninlaro-approved-in-europe-for-multiple-myeloma/</loc>
		<lastmod>2019-04-12T20:24:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/07/11/ninlaro-phase-3-maintenance-therapy-trial-initial-results/</loc>
		<lastmod>2019-04-12T20:23:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/12/07/ixazomib-maintenance-ash-2014/</loc>
		<lastmod>2019-04-12T20:22:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/02/10/ixazomib-interim-phase-3-results/</loc>
		<lastmod>2019-04-12T20:22:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/07/14/ixazomib-new-drug-application/</loc>
		<lastmod>2019-04-12T20:21:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/09/ixazomib-priority-review-fda/</loc>
		<lastmod>2019-04-12T20:21:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/20/fda-approves-takedas-ninlaro-ixazomib/</loc>
		<lastmod>2019-04-12T20:20:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/06/ninlaro-tourmaline-mm1-results-ash-2015/</loc>
		<lastmod>2019-04-12T20:20:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/02/16/ixazomib-canada-new-drug-submission/</loc>
		<lastmod>2019-04-12T20:19:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/08/08/ninlaro-approval-canada/</loc>
		<lastmod>2019-04-12T20:17:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/09/16/ninlaro-positive-chmp-opinion-conditional-approval/</loc>
		<lastmod>2019-04-12T20:16:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/06/26/morphosys-celgene-alliance-mor202-multiple-myeloma/</loc>
		<lastmod>2019-04-12T16:00:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/26/morphosys-celgene-end-mor202-collaboration/</loc>
		<lastmod>2019-04-12T15:59:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/04/15/cellectar-announces-pricing-of-public-offering/</loc>
		<lastmod>2019-04-12T15:52:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/07/11/revlimid-lenalidomide-mm-020-ifm-07-01/</loc>
		<lastmod>2019-04-12T15:45:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/01/revlimid-lenalidomide-smoldering-myeloma-new-england-journal-medicine/</loc>
		<lastmod>2019-04-12T15:45:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/09/pomalidomide-imnovid-pomalyst-approval-europe-multiple-myeloma/</loc>
		<lastmod>2019-04-12T15:44:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/05/pomalidomide-low-dose-dexamethasone-phase-3-results/</loc>
		<lastmod>2019-04-12T15:43:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/25/kyprolis-blincyto-chmp-positive-opinion/</loc>
		<lastmod>2019-04-12T15:41:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/07/initial-results-first-trial-mm-020-ifm-0701-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-04-12T15:39:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/02/18/fda-approval-expanded-revlimid-indication/</loc>
		<lastmod>2019-04-12T15:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/02/20/eu-revlimid-approval-previously-untreated-multiple-myeloma/</loc>
		<lastmod>2019-04-12T15:37:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/04/23/fda-approves-pomalyst-prescribing-information-update/</loc>
		<lastmod>2019-04-12T15:36:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/05/swog-velcade-revlimid-dexamethasone-ash-2015/</loc>
		<lastmod>2019-04-12T15:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/21/revlimid-approval-japan-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2019-04-12T15:33:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/01/24/revlimid-approval-canada-first-line-use/</loc>
		<lastmod>2019-04-12T15:33:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/02/22/fda-approves-revlimid-as-maintenance-therapy/</loc>
		<lastmod>2019-04-12T15:32:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/02/24/european-approval-revlimid-as-maintenance-therapy/</loc>
		<lastmod>2019-04-12T15:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/23/revlimid-smoldering-myeloma-trial-progression-free-survival-results/</loc>
		<lastmod>2019-04-12T15:30:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/12/19/revlimid-multiple-myeloma-chmp-opinion/</loc>
		<lastmod>2019-04-12T15:29:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/01/27/revlimid-maintenance-post-asct-chmp-positive-opinion/</loc>
		<lastmod>2019-04-12T15:28:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/09/07/durvalumab-clinical-trials-multiple-myeloma-clinical-hold/</loc>
		<lastmod>2019-04-12T15:28:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/01/kyprolis-velcade-phase-3-endeavor-interim-analysis/</loc>
		<lastmod>2019-04-12T15:22:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/07/24/kyprolis-fda-approval-new-indication/</loc>
		<lastmod>2019-04-12T15:21:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/19/kyrpolis-carfilzomib-european-approval/</loc>
		<lastmod>2019-04-12T15:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/05/kyprolis-multiple-myeloma-ash-2015/</loc>
		<lastmod>2019-04-12T15:19:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/05/endeavor-lancet-oncology-kyprolis-vs-velcade/</loc>
		<lastmod>2019-04-12T15:19:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/01/21/fda-approves-new-kyprolis-combination-therapy/</loc>
		<lastmod>2019-04-12T15:18:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/01/05/fda-approves-xgeva-for-multiple-myeloma-patients/</loc>
		<lastmod>2019-04-12T15:16:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/25/amgen-to-acquire-onyx/</loc>
		<lastmod>2019-04-12T15:14:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/10/01/amgen-completes-onyx-tender-offer/</loc>
		<lastmod>2019-04-12T15:14:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/07/amgen-only-data-presentations-ash-meeting/</loc>
		<lastmod>2019-04-12T15:13:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/08/04/kyprolis-aspire-trial-results-interim-analysis/</loc>
		<lastmod>2019-04-12T15:12:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/08/13/kyprolis-focus-phase-3-trial-top-line-results/</loc>
		<lastmod>2019-04-12T15:09:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/02/26/kyprolis-european-marketing-application-acceptance/</loc>
		<lastmod>2019-04-12T15:08:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/27/kyprolis-chmp-opinion-indication-extension/</loc>
		<lastmod>2019-04-12T15:04:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/09/01/amgen-acquires-amg-420-bi-836908-development-and-commercial-rights-from-boehringer-ingelheim/</loc>
		<lastmod>2019-04-12T15:03:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/09/27/clarion-trial-kyprolis-velcade-melphalan-prednisone/</loc>
		<lastmod>2019-04-12T15:02:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/10/20/xgeva-vs-zometa-phase-3-multiple-myeloma-trial-top-line-results/</loc>
		<lastmod>2019-04-12T15:02:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/01/19/kpt-8602-multiple-myeloma-clinical-trial/</loc>
		<lastmod>2019-04-12T14:58:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/06/01/fda-lifts-partial-clinical-hold-opdivo-pomalyst-multiple-myeloma-trial/</loc>
		<lastmod>2019-04-12T14:51:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/06/imbruvica-combination-multiple-myeloma-ash-2015/</loc>
		<lastmod>2019-04-11T23:05:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/04/abbvie-to-acquire-pharmacyclics/</loc>
		<lastmod>2019-04-11T20:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/04/11/a-northwest-lens-on-myeloma-whats-next/</loc>
		<lastmod>2019-04-11T14:50:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/09/14/a-northwest-lens-on-myeloma-treading-water/</loc>
		<lastmod>2019-04-11T14:29:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/12/cs3003-receives-china-ind-approval/</loc>
		<lastmod>2019-04-11T03:21:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/04/04/xgeva-indication-expansion-multiple-myeloma-us-europe-applications-filed/</loc>
		<lastmod>2019-04-10T21:49:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/06/19/fda-accepts-xgeva-application-indication-expansion-multiple-myeloma/</loc>
		<lastmod>2019-04-10T21:48:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/09/06/opdivo-clinical-trials-multiple-myeloma-partial-clinical-hold/</loc>
		<lastmod>2019-04-10T21:47:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/30/morphosys-i-mab-regional-license-agreement-mor202/</loc>
		<lastmod>2019-04-10T21:47:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/05/fda-lifts-partial-clinical-hold-opdivo-multiple-myeloma-trials/</loc>
		<lastmod>2019-04-10T21:46:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/06/11/fda-approves-adding-aspire-overall-survival-data-to-kyprolis-label/</loc>
		<lastmod>2019-04-10T21:44:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/01/fda-approves-once-weekly-kyprolis/</loc>
		<lastmod>2019-04-10T21:43:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/05/kyprolis-expanded-approval-europe/</loc>
		<lastmod>2019-04-10T21:40:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/01/27/kyprolis-applications-us-europe-relapsed-myeloma/</loc>
		<lastmod>2019-04-10T21:39:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/18/kyprolis-supplemental-nda-gets-priority-review/</loc>
		<lastmod>2019-04-10T21:38:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/30/fda-priority-review-kyprolis-carfilzomib-supplemental-new-drug-application-relapsed-multiple-myeloma/</loc>
		<lastmod>2019-04-10T21:37:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/07/23/amgen-submits-supplemental-new-drug-application-for-kyprolis-carfilzomib-in-relapsed-multiple-myeloma/</loc>
		<lastmod>2019-04-10T21:36:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/08/27/kyprolis-once-weekly-dosing-fda-application-filed/</loc>
		<lastmod>2019-04-10T21:35:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/01/03/bristol-myers-squibb-to-acquire-celgene/</loc>
		<lastmod>2019-04-10T21:33:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/02/11/abbvie-teneobio-tnb-383b-agreement/</loc>
		<lastmod>2019-04-10T21:07:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/19/us-fda-partial-clinical-hold-venclexta-multiple-myeloma-clinical-trials/</loc>
		<lastmod>2019-04-10T19:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2019/03/20/authorization-received-for-phase-1-2-clinical-trial-car-t-cd44v60-cell-therapy-aml-multiple-myeloma/</loc>
		<lastmod>2019-04-10T19:47:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/10/03/clarification-announcement/</loc>
		<lastmod>2019-04-10T01:31:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/06/04/car-t-cell-therapy-multiple-myeloma/</loc>
		<lastmod>2019-04-05T20:17:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/ct/NCT03891914/</loc>
		<lastmod>2019-04-02T15:22:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/ct/NCT03890614/</loc>
		<lastmod>2019-04-02T15:22:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/ct/NCT03875495/</loc>
		<lastmod>2019-04-02T15:04:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/ct/NCT03896737/</loc>
		<lastmod>2019-04-02T15:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/03/31/letters-from-cancerland-so-maybe/</loc>
		<lastmod>2019-04-01T03:54:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/07/01/lls-johns-hopkins-immunotherapy-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:34:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/07/01/ctca-stem-cell-transplant-center-philadelphia/</loc>
		<lastmod>2019-03-24T11:34:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/10/07/myprs-positive-coverage-decision-arkansas-blue-cross-blue-shield/</loc>
		<lastmod>2019-03-24T11:33:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/10/08/doxil-doxorubicin-hydrochloride-liposome-injection-availability/</loc>
		<lastmod>2019-03-24T11:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/10/08/lannett-update-on-generic-thalidomide/</loc>
		<lastmod>2019-03-24T11:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/10/24/stem-cell-transplant-sexual-side-effects/</loc>
		<lastmod>2019-03-24T11:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/10/30/completion-enrollment-pivotal-trial-captisol-enabled-melphalan/</loc>
		<lastmod>2019-03-24T11:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/05/velcade-bortezomib-peripheral-neuropathy-clinical-trial-natural-medicine/</loc>
		<lastmod>2019-03-24T11:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/06/fda-grants-pat-sm6-orphan-drug-status/</loc>
		<lastmod>2019-03-24T11:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/07/array-biopharma-arry-520-arry-614-ash-meeting/</loc>
		<lastmod>2019-03-24T11:33:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/07/threshold-announces-th-302-data-ash/</loc>
		<lastmod>2019-03-24T11:33:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/07/quest-pharmatech-anti-muc1-ige-technology/</loc>
		<lastmod>2019-03-24T11:33:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/11/pat-sm6-carfilzomib-clinical-trial/</loc>
		<lastmod>2019-03-24T11:33:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/25/acetylon-pharmaceuticals-hdac-inhibitors-ash-2013/</loc>
		<lastmod>2019-03-24T11:33:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/12/06/panobinostat-lbh589-extends-progression-free-survival/</loc>
		<lastmod>2019-03-24T11:33:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/11/28/how-thalidomide-like-drugs-fight-cancer/</loc>
		<lastmod>2019-03-24T11:33:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/12/09/rocilinostat-acy-1215-multiple-myeloma-ash-meeting/</loc>
		<lastmod>2019-03-24T11:33:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/12/10/genomic-alterations-multiple-myeloma-identified-foundationone-heme/</loc>
		<lastmod>2019-03-24T11:33:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/07/18/revlimid-lenalidomide-origin-cll-trial-halted/</loc>
		<lastmod>2019-03-24T11:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/07/22/myprs-update/</loc>
		<lastmod>2019-03-24T11:33:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/07/29/acetylon-celgene-collaboration/</loc>
		<lastmod>2019-03-24T11:33:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/07/29/array-biopharma-celgene-collaboration/</loc>
		<lastmod>2019-03-24T11:33:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/18/aging-gene-link-to-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:33:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/20/myeloma-uk-fifth-trial-open-to-recruitment/</loc>
		<lastmod>2019-03-24T11:33:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/08/29/survey-reveals-knowledge-gap-about-blood-cancers/</loc>
		<lastmod>2019-03-24T11:33:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/05/asc-101-trial-fda-clearance/</loc>
		<lastmod>2019-03-24T11:33:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/09/researchers-discover-root-cause-multiple-myeloma-relapse/</loc>
		<lastmod>2019-03-24T11:33:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/11/university-alabama-birmingham-multiple-myeloma-clinic/</loc>
		<lastmod>2019-03-24T11:33:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/12/pat-sm6-orphan-drug-designation-multiple-myeloma-europe/</loc>
		<lastmod>2019-03-24T11:33:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/09/18/root-cause-multiple-myeloma-relapse-2/</loc>
		<lastmod>2019-03-24T11:33:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/09/18/lbh589-panobinostat-lancet-oncology/</loc>
		<lastmod>2019-03-24T11:32:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/11/25/fda-extends-panobinostat-farydak-review/</loc>
		<lastmod>2019-03-24T11:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/12/06/ash-2014-advances-lymphoma-multiple-myeloma-treatment/</loc>
		<lastmod>2019-03-24T11:32:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/12/26/captisol-enabled-melphalan-nda/</loc>
		<lastmod>2019-03-24T11:32:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/02/23/fda-approves-farydak-panobinostat-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:32:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/02/23/novartis-receives-fda-approval-farydak-panobinostat/</loc>
		<lastmod>2019-03-24T11:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/02/24/fda-approval-panobinostat/</loc>
		<lastmod>2019-03-24T11:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/09/fda-accepts-ce-melphalan-nda/</loc>
		<lastmod>2019-03-24T11:32:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/10/halozyme-janssen-subcutaneous-daratumumab/</loc>
		<lastmod>2019-03-24T11:32:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2013/12/19/actinium-technology-transfer-iomab-b/</loc>
		<lastmod>2019-03-24T11:32:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/02/27/marizomib-fda-orphan-drug-designation/</loc>
		<lastmod>2019-03-24T11:32:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/03/14/nice-better-information-needed-on-revlimid-lenalidomide/</loc>
		<lastmod>2019-03-24T11:32:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/03/26/pat-sm6-final-data-phase-i-iia-trial/</loc>
		<lastmod>2019-03-24T11:32:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/04/22/nice-recommends-velcade-bortezomib/</loc>
		<lastmod>2019-03-24T11:32:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/04/22/uams-mirt-gareth-morgan-director/</loc>
		<lastmod>2019-03-24T11:32:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/04/23/captisol-enabled-melphalan-phase-2-endpoint/</loc>
		<lastmod>2019-03-24T11:32:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/05/14/mayo-clinic-measles-virus-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:32:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/06/02/asco-2014-panobinostat-lbh589-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:32:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/08/08/fda-approval-velcade-retreatment-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:32:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2014/09/04/cb-5083-phase-1-trial-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:32:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/19/bi-505-phase-2a-trial-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/03/16/immucin-eu-orphan-drug-designation/</loc>
		<lastmod>2019-03-24T11:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/06/01/aplidin-phase-3-trial-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/06/22/immucin-fda-orpha-drug-designation/</loc>
		<lastmod>2019-03-24T11:31:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/06/26/farydak-recommended-for-eu-approval/</loc>
		<lastmod>2019-03-24T11:31:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/04/farydak-panobinostat-approval-europe/</loc>
		<lastmod>2019-03-24T11:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/09/ctl019-multiple-myeloma-complete-response/</loc>
		<lastmod>2019-03-24T11:31:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/24/atara-wilms-tumor-1-imw-results/</loc>
		<lastmod>2019-03-24T11:31:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/25/reolysin-kyprolis-pilot-study-results/</loc>
		<lastmod>2019-03-24T11:31:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/09/26/marizomib-pomalidomide-dexamethasone-imw/</loc>
		<lastmod>2019-03-24T11:31:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/10/23/spectrum-evomela-captisol-melphalan-complete-response-letter/</loc>
		<lastmod>2019-03-24T11:31:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/11/20/ixazomib/</loc>
		<lastmod>2019-03-24T11:31:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/05/triple-drug-combination-beats-standard-treatment/</loc>
		<lastmod>2019-03-24T11:30:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/08/reolysin-kyprolis-multiple-myeloma-ash-2015/</loc>
		<lastmod>2019-03-24T11:30:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/07/acetylon-presents-data-on-the-use-of-hdac-6-inhibitors-ricolinostat-acy-1215-and-acy-241-in-combination-with-pomalidomide-for-the-treatment-of-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:30:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2015/12/16/bioinvent-update-clinical-preclinical-drug-programs/</loc>
		<lastmod>2019-03-24T11:30:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/01/12/preliminary-wt1-results-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:30:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/02/09/nice-guidance-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:30:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/07/on123300-cdk4-ark5-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:29:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/10/apo010-screening-trial-first-patient/</loc>
		<lastmod>2019-03-24T11:29:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/10/sting-agonists-b-cell-blood-cancers/</loc>
		<lastmod>2019-03-24T11:29:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/15/fda-approval-evomela-captisol-enabled-melphalan/</loc>
		<lastmod>2019-03-24T11:29:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/18/omnis-pharma-magnis-therapeutics-merge-to-form-vyriad/</loc>
		<lastmod>2019-03-24T11:29:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/21/molmed-genenta-agreement-gene-therapy-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:29:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/30/defitelio-defibrotide-sodium-fda-approval/</loc>
		<lastmod>2019-03-24T11:29:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/30/fda-approves-defitelio/</loc>
		<lastmod>2019-03-24T11:29:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/03/31/aplidin-positive-phase-iii-trial-results/</loc>
		<lastmod>2019-03-24T11:29:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/04/18/bi-505-phase-2-clinical-trial-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:29:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/25/iceni-pharmaceuticals-launches-as-new-company/</loc>
		<lastmod>2019-03-24T11:29:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/27/ninlaro-ixazomib-chmp-negative-opinion/</loc>
		<lastmod>2019-03-24T11:29:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/05/31/edo-s101-first-clinical-trial/</loc>
		<lastmod>2019-03-24T11:29:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/09/22/aplidin-european-approval-submission/</loc>
		<lastmod>2019-03-24T11:27:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/10/13/wt1-galinpepimut-s-phase-2-high-risk-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:27:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/10/27/adaptimmune-merck-collaboration-ny-eso-spear-keytruda/</loc>
		<lastmod>2019-03-24T11:27:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/10/28/ema-accepts-aplidin-marketing-authorization-application-for-review/</loc>
		<lastmod>2019-03-24T11:27:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/08/bi-505-phase-2-trial-clinical-hold/</loc>
		<lastmod>2019-03-24T11:27:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/11/17/celgene-acquires-marizomib-from-triphase/</loc>
		<lastmod>2019-03-24T11:27:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2016/12/09/bioinvent-terminates-bi-505-phase-ii-study/</loc>
		<lastmod>2019-03-24T11:27:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/02/06/green-tea-light-chain-amyloidosis/</loc>
		<lastmod>2019-03-24T11:27:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/02/07/actinium-actimab-m-phase-1-multiple-myeloma-trial/</loc>
		<lastmod>2019-03-24T11:27:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/06/12/keytruda-multiple-myeloma-trials-paused-due-to-deaths/</loc>
		<lastmod>2019-03-24T11:27:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/07/05/fda-clinical-hold-keytruda-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:26:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/09/15/tecentriq-clinical-trials-multiple-myeloma-partial-hold/</loc>
		<lastmod>2019-03-24T11:26:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/11/08/pharmamar-expects-negative-chmp-opinion-aplidin-plitidepsin-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:26:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/05/fda-lifts-partial-clinical-hold-tecentriq-myeloma-lymphoma-trials/</loc>
		<lastmod>2019-03-24T11:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/15/chmp-negative-opinion-aplidin-plitidepsin/</loc>
		<lastmod>2019-03-24T11:26:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/13/egyptian-mummies-oldest-cases-breast-cancer-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:26:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2017/12/28/kyprolis-cardiovascular-toxicity/</loc>
		<lastmod>2019-03-24T11:26:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/01/03/ema-reexamining-aplidin-plitidepsin/</loc>
		<lastmod>2019-03-24T11:26:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/01/12/generic-velcade-for-intravenous-infusion-launched-in-us/</loc>
		<lastmod>2019-03-24T11:26:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/03/21/chmp-confirms-previous-negative-opinion-aplidin-plitidepsin/</loc>
		<lastmod>2019-03-24T11:26:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/03/23/aplidin-plitidepsin-refusal-of-marketing-authorisation/</loc>
		<lastmod>2019-03-24T11:26:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/04/05/sorrento-and-celularity-anti-cd38-car-t-therapy-trial-multiple-myeloma/</loc>
		<lastmod>2019-03-24T11:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/05/09/galinpepimut-s-orphan-drug-designation-fda/</loc>
		<lastmod>2019-03-24T11:26:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/06/27/tinostamustine-completes-first-clinical-trial/</loc>
		<lastmod>2019-03-24T11:25:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/07/20/galinpepimut-s-receives-fast-track-designation-from-fda/</loc>
		<lastmod>2019-03-24T11:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/07/24/gsk3377794-ny-eso-spear-t-cell-program-transfer-adaptimmune-to-gsk-complete/</loc>
		<lastmod>2019-03-24T11:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/07/30/srf231-receives-orphan-drug-designation-from-fda/</loc>
		<lastmod>2019-03-24T11:25:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/09/13/galinpepimut-s-orphan-designation-multiple-myeloma-europe/</loc>
		<lastmod>2019-03-24T11:21:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/11/01/dosing-initiation-clinical-trial-anti-cd38-car-t-cell-therapy/</loc>
		<lastmod>2019-03-24T11:21:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/11/aplidin-approval-australia/</loc>
		<lastmod>2019-03-24T11:20:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/12/pelareorep-kyprolis-opdivo-clinical-trial-first-patient/</loc>
		<lastmod>2019-03-24T11:20:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/2018/12/20/ayala-novartis-al102-development-commercialization-agreement/</loc>
		<lastmod>2019-03-24T11:20:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/03/23/northern-lights-my-real-and-imaginary-menagerie/</loc>
		<lastmod>2019-03-23T20:40:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/03/13/myeloma-party-of-two-switching-roles/</loc>
		<lastmod>2019-03-13T21:49:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/03/04/living-for-lamingtons-do-i-have-to-be-relentlessly-positive-to-live-with-multiple-myeloma/</loc>
		<lastmod>2019-03-04T23:00:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/07/19/living-for-lamingtons-walking-with-the-samburu/</loc>
		<lastmod>2019-03-04T21:31:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/242/</loc>
		<lastmod>2019-02-23T14:43:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/02/19/a-northwest-lens-on-myeloma-learning-to-be-forgetful/</loc>
		<lastmod>2019-02-21T12:47:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/02/06/northern-lights-being-an-efficient-patient/</loc>
		<lastmod>2019-02-06T22:38:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/01/23/letters-from-cancerland-dress-rehearsal/</loc>
		<lastmod>2019-01-24T01:11:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/01/17/myeloma-party-of-two-resolutions/</loc>
		<lastmod>2019-01-17T22:50:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2019/01/10/a-northwest-lens-on-myeloma-i-am-resolved/</loc>
		<lastmod>2019-01-10T22:17:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/12/14/northern-lights-coping-with-treatment-again/</loc>
		<lastmod>2018-12-14T23:51:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/16/beacon-newsflashes-may-16-2011/</loc>
		<lastmod>2018-12-13T02:05:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/12/07/a-northwest-lens-on-myeloma-memories-are-made-of-this/</loc>
		<lastmod>2018-12-07T23:24:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/terms-of-service/</loc>
		<lastmod>2018-12-03T22:25:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/11/30/living-for-lamingtons-the-illness-scale/</loc>
		<lastmod>2018-11-30T17:49:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/11/27/diet-risk-of-mgus-progression-to-multiple-myeloma/</loc>
		<lastmod>2018-11-29T20:09:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/11/29/ernaehrung-mgus-progressionsrisiko-multiples-myelom/</loc>
		<lastmod>2018-11-29T20:08:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/11/28/revlimid-velcade-dexamethason-initialtherapie-stammzelltransplantation-remissionen-gesamtuberleben-multiples-myelom/</loc>
		<lastmod>2018-11-28T20:11:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/11/21/rvd-vrd-induction-plus-transplantation-responses-survival/</loc>
		<lastmod>2018-11-28T20:10:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/11/24/letters-from-cancerland-no-bones-about-it/</loc>
		<lastmod>2018-11-24T18:38:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/11/14/myeloma-party-of-two-little-traumas/</loc>
		<lastmod>2018-11-14T23:25:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/11/12/nachhaltige-komplette-remission-erstbehandlung-gesamtuberleben-multiples-myelom/</loc>
		<lastmod>2018-11-14T15:56:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/11/06/overall-survival-benefit-sustained-complete-response/</loc>
		<lastmod>2018-11-12T17:22:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/11/08/a-northwest-lens-on-myeloma-lies-damned-lies-and-statistics/</loc>
		<lastmod>2018-11-09T16:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/20/multiple-myeloma-study-determines-complete-response-to-treatment-is-generally-correlated-with-survival/</loc>
		<lastmod>2018-11-06T23:47:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/11/02/northern-lights-my-history-with-multiple-myeloma-and-how-things-have-changed/</loc>
		<lastmod>2018-11-02T18:15:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/03/04/phase-3-ixazomib-studie-erste-ergebnisse-multiples-myelom/</loc>
		<lastmod>2018-10-30T14:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/11/22/ninlaro-ixazomib-fda-approval-multiple-myeloma/</loc>
		<lastmod>2018-10-30T14:23:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/22/myeloma-morning-asco-2016-multiple-myeloma-poster-presentation-titles/</loc>
		<lastmod>2018-10-30T14:23:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/28/ninlaro-tourmaline-mm1-results-new-england-journal-nejm/</loc>
		<lastmod>2018-10-30T14:22:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/04/myeloma-morning-bence-jones-smoldering-plasma-cell-percentage-tjp1/</loc>
		<lastmod>2018-10-30T14:22:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/27/myeloma-morning-early-relapse-survival-ninlaro-kyprolis-europe/</loc>
		<lastmod>2018-10-30T14:22:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/06/revlimid-lenalidomide-dexamethasone-relapsed-refractory-myeloma/</loc>
		<lastmod>2018-10-30T11:38:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/10/study-confirms-survival-benefit-of-revlimid-lenalidomide-dexamethasone-decadron-combo-in-elderly-relapsed-refractory-multiple-myeloma-patients/</loc>
		<lastmod>2018-10-30T11:38:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/31/velcade-doxorubicin-dexamethasone-ipad-relapsed-refractory-myeloma/</loc>
		<lastmod>2018-10-30T11:37:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/11/ash-2013-multiple-myeloma-update-day-three-afternoon-oral-sessions/</loc>
		<lastmod>2018-10-30T11:37:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/20/kyprolis-carfilzomib-revlimid-lenalidomide-dexamethasone-relapsed-multiple-myeloma-2/</loc>
		<lastmod>2018-10-30T11:36:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/10/26/myeloma-party-of-two-unicorns/</loc>
		<lastmod>2018-10-26T17:35:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/10/24/christoph-driessen-nelfinavir-treatment-multiple-myeloma/</loc>
		<lastmod>2018-10-24T16:46:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/10/18/stem-cell-transplantation-multiple-myeloma-patients-in-their-80s/</loc>
		<lastmod>2018-10-19T19:50:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/10/19/stammzelltransplantation-multiples-myelom-ueber-80/</loc>
		<lastmod>2018-10-19T19:49:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/10/19/multiples-myelom-testosteronspiegel/</loc>
		<lastmod>2018-10-19T15:42:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/10/16/craig-hofmeister-testosterone-multiple-myeloma/</loc>
		<lastmod>2018-10-16T22:49:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/10/11/living-for-lamingtons-rules-for-remission/</loc>
		<lastmod>2018-10-11T12:19:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/10/09/risk-of-mgus-in-close-relatives-of-multiple-myeloma-patients/</loc>
		<lastmod>2018-10-09T23:27:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/27/multiple-myeloma-patient-relatives-twice-as-likely-to-have-mgus/</loc>
		<lastmod>2018-10-09T18:51:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/10/07/kyprolis-once-weekly-dosing-fda-approval/</loc>
		<lastmod>2018-10-07T21:30:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/09/25/adding-clarithromycin-to-vcd-efficacy-side-effects/</loc>
		<lastmod>2018-10-05T15:25:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/10/05/zugabe-clarithromycin-zu-vcd-wirksamkeit-nebenwirkungen/</loc>
		<lastmod>2018-10-05T15:24:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/10/04/nelfinavir-velcade-kombination-sehr-aktiv-fortgeschrittenem-velcade-resistentem-multiplen-myelom/</loc>
		<lastmod>2018-10-04T16:35:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/10/03/northern-lights-trying-to-make-plans-in-advance/</loc>
		<lastmod>2018-10-03T23:02:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/05/green-tea-blocks-effectiveness-of-velcade-treatment/</loc>
		<lastmod>2018-10-02T10:50:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/31/gene-therapy-to-treat-leukemia-and-multiple-myeloma-update/</loc>
		<lastmod>2018-09-30T02:15:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/12/gene-therapy-advance-in-leukemia-suggests-new-treatment-options-for-multiple-myeloma/</loc>
		<lastmod>2018-09-30T02:15:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/09/29/letters-from-cancerland-this/</loc>
		<lastmod>2018-09-29T19:18:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/09/07/northern-lights-returning-to-cycling/</loc>
		<lastmod>2018-09-07T21:49:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/08/31/letters-from-cancerland-new-occasions-new-duties/</loc>
		<lastmod>2018-08-31T16:35:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/08/23/living-for-lamingtons-balancing-worry-and-pleasure/</loc>
		<lastmod>2018-08-23T22:54:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/08/16/a-northwest-lens-on-myeloma-time-marches-on/</loc>
		<lastmod>2018-08-16T21:30:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/08/10/northern-lights-stitching-summer-sunflowers/</loc>
		<lastmod>2018-08-10T21:07:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/07/26/myeloma-party-of-two-pitfalls/</loc>
		<lastmod>2018-07-26T22:21:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/07/13/northern-lights-a-case-of-missing-immunities/</loc>
		<lastmod>2018-07-13T18:20:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/06/27/myeloma-party-of-two-whats-behind-door-4/</loc>
		<lastmod>2018-06-27T23:39:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/06/22/northern-lights-mental-changes-with-multiple-myeloma/</loc>
		<lastmod>2018-06-27T17:49:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/12/ash-2013-multiple-myeloma-abstracts/</loc>
		<lastmod>2018-06-27T16:35:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/06/22/einmal-wochentliches-kyprolis-liefert-tieferes-ansprechen-und-langere-remissionen-als-zweimal-wochentliches-kyprolis-asco-eha-2018/</loc>
		<lastmod>2018-06-22T15:35:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/06/20/once-weekly-kyprolis-arrow-trial-results-asco-eha-2018/</loc>
		<lastmod>2018-06-22T13:58:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/27/myeloma-morning-new-proteasome-inhibitors-mgus-smoldering-progression/</loc>
		<lastmod>2018-06-21T02:01:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/06/14/antibiotikum-roxithromycin-multiples-myelom/</loc>
		<lastmod>2018-06-19T04:00:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/20/letters-from-cancerland-the-wheatgrass-juice-chronicles/</loc>
		<lastmod>2018-06-18T23:12:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/04/20/subcutaneous-velcade-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2018-06-18T23:06:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/03/myeloma-morning-minimal-residual-disease-bcma-april-in-multiple-myeloma/</loc>
		<lastmod>2018-06-18T23:06:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/04/17/key-u-s-multiple-myeloma-survival-rate-unchanged-in-annual-cancer-statistics-update/</loc>
		<lastmod>2018-06-18T23:05:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2018-multiple-myeloma-abstracts-oral-presentations/</loc>
		<lastmod>2018-06-17T03:04:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2018-multiple-myeloma-abstracts-posters-june-16/</loc>
		<lastmod>2018-06-17T02:17:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2018-multiple-myeloma-abstracts-e-posters/</loc>
		<lastmod>2018-06-16T20:27:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2018-multiple-myeloma-abstracts-posters-june-15/</loc>
		<lastmod>2018-06-16T20:22:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/04/25/letters-from-cancerland-whose-hipaa-is-it-anyway/</loc>
		<lastmod>2018-06-16T01:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/24/filanesib-arry-520-heavily-pretreated-multiple-myeloma-ash-2013/</loc>
		<lastmod>2018-06-14T12:18:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/06/13/bb2121-beeindruckt-weiterhin-potenzielle-neue-myelomtherapie-asco-2018/</loc>
		<lastmod>2018-06-13T14:38:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2018-multiple-myeloma-oral-presentations/</loc>
		<lastmod>2018-06-09T12:21:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/06/05/living-for-lamingtons-what-are-we-waiting-for/</loc>
		<lastmod>2018-06-05T22:15:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2018-multiple-myeloma-poster-presentations/</loc>
		<lastmod>2018-06-05T04:38:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2018-multiple-myeloma-eabstracts/</loc>
		<lastmod>2018-06-05T02:27:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/06/01/new-path-same-destination-for-the-myeloma-beacon/</loc>
		<lastmod>2018-06-01T17:18:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2018-multiple-myeloma-education-presentations/</loc>
		<lastmod>2018-06-01T11:18:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/16/mln9708-son-of-velcade-shows-promising-initial-results-in-multiple-myeloma-ash-2011/</loc>
		<lastmod>2018-05-30T16:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/20/ash-2011-multiple-myeloma-update-day-three-afternoon-other-new-therapies/</loc>
		<lastmod>2018-05-30T16:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/02/asco-2012-multiple-myeloma-update-day-two-poster-session/</loc>
		<lastmod>2018-05-30T16:34:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/03/asco-2012-multiple-myeloma-update-day-three-new-myeloma-treatments/</loc>
		<lastmod>2018-05-30T16:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/15/mln9708-ixazomib-shows-encouraging-results-for-the-treatment-of-multiple-myeloma-asco-2012/</loc>
		<lastmod>2018-05-30T16:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/04/beacon-newsflashes-july-4-2012/</loc>
		<lastmod>2018-05-30T16:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/31/beacon-newsflashes-may-31-2013/</loc>
		<lastmod>2018-05-30T16:34:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/14/multiple-myeloma-poster-presentations-eha-2013/</loc>
		<lastmod>2018-05-30T16:34:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/02/11/initial-ixazomib-phase-3-trial-results/</loc>
		<lastmod>2018-05-30T16:34:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/17/ash-2008-carfilzomib-reduces-peripheral-neuropath/</loc>
		<lastmod>2018-05-30T16:33:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/17/ash-2008-ongoing-phase-ii-clinical-trials-for-carfilzomib-show-promising-results/</loc>
		<lastmod>2018-05-30T16:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/06/04/carfilzomib/</loc>
		<lastmod>2018-05-30T16:33:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/08/carfilzomib-is-highly-active-in-relapsed-myeloma-patients/</loc>
		<lastmod>2018-05-30T16:33:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/14/onyx-pharmaceuticals-acquires-proteolix-manufacturer-of-carfilzomib/</loc>
		<lastmod>2018-05-30T16:33:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/03/carfilzomib-is-effective-for-multiple-myeloma-part-1-as-a-single-agent-or-in-a-combination-therapy-ash-2009/</loc>
		<lastmod>2018-05-30T16:33:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/04/carfilzomib-is-effective-for-multiple-myeloma-part-2-treatment-of-specific-patient-groups-ash-2009/</loc>
		<lastmod>2018-05-30T16:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/05/beacon-newsflashes-february-5-2010/</loc>
		<lastmod>2018-05-30T16:32:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/04/carfilzomib-in-combination-with-revlimid-and-dexamethasone-is-well-tolerated-in-multiple-myeloma-patients-including-long-term-therapy-asco-2010/</loc>
		<lastmod>2018-05-30T16:32:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/05/asco-2010-multiple-myeloma-update-day-one/</loc>
		<lastmod>2018-05-30T16:32:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/14/carfilzomib-may-benefit-relapsed-and-refractory-multiple-myeloma-patients-asco-2010/</loc>
		<lastmod>2018-05-30T16:32:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/23/beacon-newsflashes-july-23-2010/</loc>
		<lastmod>2018-05-30T16:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/27/single-agent-carfilzomib-continues-to-show-promise-for-relapsed-and-refractory-multiple-myeloma/</loc>
		<lastmod>2018-05-30T16:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/07/carfilzomib-application-for-fda-approval-delayed/</loc>
		<lastmod>2018-05-30T16:32:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/05/carfilzomib-continues-to-show-promising-results-for-multiple-myeloma-ash-2010/</loc>
		<lastmod>2018-05-30T16:32:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/08/ash-2010-multiple-myeloma-update-day-three-afternoon-and-evening/</loc>
		<lastmod>2018-05-30T16:32:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/20/carfilzomib-shows-promise-in-both-newly-diagnosed-and-relapsed-refractory-multiple-myeloma-patients-ash-2010/</loc>
		<lastmod>2018-05-30T16:32:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/07/beacon-newsflashes-february-7-2011/</loc>
		<lastmod>2018-05-30T16:32:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/04/beacon-newsflashes-april-4-2011/</loc>
		<lastmod>2018-05-30T16:32:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/04/asco-2011-multiple-myeloma-update-days-1-and-2/</loc>
		<lastmod>2018-05-30T16:32:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/04/beacon-newsflashes-july-4-2011/</loc>
		<lastmod>2018-05-30T16:32:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/08/beacon-newsflashes-august-8-2011/</loc>
		<lastmod>2018-05-30T16:32:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/15/beacon-newsflashes-august-15-2011/</loc>
		<lastmod>2018-05-30T16:32:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/05/beacon-newsflashes-september-5-2011/</loc>
		<lastmod>2018-05-30T16:32:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/28/beacon-breakingnews-onyx-submits-carfilzomib-for-fda-approval/</loc>
		<lastmod>2018-05-30T16:32:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/29/beacon-breaking-news-fda-accepts-carfilzomib-new-drug-application/</loc>
		<lastmod>2018-05-30T16:32:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/11/beacon-breaking-news-carfilzomib-to-get-standard-not-priority-fda-review/</loc>
		<lastmod>2018-05-30T16:32:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/19/ash-2011-multiple-myeloma-update-day-three-afternoon-carfilzomib-and-pomalidomide/</loc>
		<lastmod>2018-05-30T16:32:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/31/birds-in-spring-waiting-on-carfilzomib/</loc>
		<lastmod>2018-05-30T16:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/22/onyx-no-news-about-carfilzomib-and-the-fda/</loc>
		<lastmod>2018-05-30T16:31:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/26/fda-sets-date-for-carfilzomib-advisory-board-meeting/</loc>
		<lastmod>2018-05-30T16:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/30/kyprolis-carfilzomib-is-proposed-brand-name/</loc>
		<lastmod>2018-05-30T16:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/15/me-vs-mm-agent-d/</loc>
		<lastmod>2018-05-30T16:31:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/03/asco-2012-multiple-myeloma-update-day-three-carfilzomib-and-pomalidomide/</loc>
		<lastmod>2018-05-30T16:30:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/08/extensive-carfilzomib-clinical-trial-results-presented-asco-2012/</loc>
		<lastmod>2018-05-30T16:30:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/15/carfilzomib-kyprolis-to-face-critical-fda-advisory-committee-meeting-next-week/</loc>
		<lastmod>2018-05-30T16:30:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/18/fda-releases-key-documents-related-to-carfilzomib-kyprolis-advisory-committee-odac-meeting/</loc>
		<lastmod>2018-05-30T16:30:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/18/fda-very-concerned-about-carfilzomib-kyprolis-safety/</loc>
		<lastmod>2018-05-30T16:30:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/20/liveblog-of-carfilzomib-kyprolis-odac-fda-advisory-committee-meeting/</loc>
		<lastmod>2018-05-30T16:30:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/20/carfilzomib-kyprolis-earns-strong-positive-vote-from-fda-advisory-committee-odac/</loc>
		<lastmod>2018-05-30T16:30:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/20/fda-approves-kyprolis-carfilzomib-for-relapsed-and-refractory-multiple-myeloma/</loc>
		<lastmod>2018-05-30T16:30:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/25/questions-and-answers-about-the-fdas-approval-of-kyprolis-carfilzomib/</loc>
		<lastmod>2018-05-30T16:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/26/beacon-newsflashes-july-26-2012/</loc>
		<lastmod>2018-05-30T16:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/01/beacon-newsflashes-august-1-2012/</loc>
		<lastmod>2018-05-30T16:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/06/researchers-publish-final-results-of-kyprolis-carfilzomib-study-that-led-to-fda-approval/</loc>
		<lastmod>2018-05-30T16:30:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/17/kyprolis-carfilzomib-which-multiple-myeloma-patients-will-physicians-treat-with-it/</loc>
		<lastmod>2018-05-30T16:30:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/21/revlimid-lenalidomide-maintenance-therapy-gets-nccn-vote-of-confidence/</loc>
		<lastmod>2018-05-30T16:30:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/10/ash-2012-multiple-myeloma-update-day-three-early-morning-oral-session/</loc>
		<lastmod>2018-05-30T16:30:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/11/ash-2012-multiple-myeloma-update-day-three-late-morning-oral-session/</loc>
		<lastmod>2018-05-30T16:30:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/11/ash-2012-multiple-myeloma-update-day-three-late-afternoon-oral-session/</loc>
		<lastmod>2018-05-30T16:29:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/13/ash-2012-multiple-myeloma-update-day-four-oral-session/</loc>
		<lastmod>2018-05-30T16:29:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/14/arry-520-encouraging-early-results-relapsed-refractory-multiple-myeloma-ash-2012/</loc>
		<lastmod>2018-05-30T16:29:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/18/kyprolis-carfilzomib-multiple-myeloma-kidney-damage/</loc>
		<lastmod>2018-05-30T16:29:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/08/kyprolis-carfilzomib-revlimid-lenalidomide-dexamethasone-relapsed-multiple-myeloma/</loc>
		<lastmod>2018-05-30T16:29:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/19/kyprolis-carfilzomib-nccn-multiple-myeloma-guidelines/</loc>
		<lastmod>2018-05-30T16:29:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/09/kyprolis-revlimid-dexamethasone-high-risk-smoldering-myeloma-imw-2013/</loc>
		<lastmod>2018-05-30T16:29:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/17/kyprolis-carfilzomib-revlimid-lenalidomide-dexamethasone-elderly-newly-diagnosed-multiple-myeloma-imw-2013/</loc>
		<lastmod>2018-05-30T16:29:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/22/kyprolis-relapsed-high-risk-multiple-myeloma/</loc>
		<lastmod>2018-05-30T16:29:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/26/amgen-onyx-acquisition-impact-myeloma-community/</loc>
		<lastmod>2018-05-30T16:29:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/04/kyprolis-carfilzomib-pomalyst-pomalidomide-dual-refractory-myeloma/</loc>
		<lastmod>2018-05-30T16:28:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/09/ash-2013-multiple-myeloma-update-day-two/</loc>
		<lastmod>2018-05-30T16:28:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/01/28/kyprolis-carfilzomib-ash-2013/</loc>
		<lastmod>2018-05-30T16:28:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/06/14/asco-2014-multiple-myeloma-update-day-four-poster-presentations/</loc>
		<lastmod>2018-05-30T16:28:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/08/04/kyprolis-initial-aspire-trial-results/</loc>
		<lastmod>2018-05-30T16:28:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/08/17/kyprolis-focus-trial-top-line-results/</loc>
		<lastmod>2018-05-30T16:28:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/12/07/ash-2014-multiple-myeloma-update-day-one-oral-sessions/</loc>
		<lastmod>2018-05-30T16:28:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/03/03/kyprolis-velcade-endeavor-trial-initial-results/</loc>
		<lastmod>2018-05-30T16:28:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/04/07/kyprolis-farydak-relapsed-multiple-myeloma/</loc>
		<lastmod>2018-05-30T16:28:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/11/29/kyprolis-carfilzomib-europa-zulassung/</loc>
		<lastmod>2018-05-30T16:25:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/06/01/asco-2015-multiple-myeloma-update-poster-presentations-1/</loc>
		<lastmod>2018-05-30T16:24:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/11/20/kyprolis-carfilzomib-europe-approval/</loc>
		<lastmod>2018-05-30T16:24:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/28/myeloma-morning-kyprolis-thombotic-microangiopathy-roneparstat-spry2/</loc>
		<lastmod>2018-05-30T16:24:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/30/myeloma-morning-cometriq-kyprolis-thrombotic-microangiopathy/</loc>
		<lastmod>2018-05-30T16:24:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/17/myeloma-morning-survival-age-once-weekly-kyprolis-revlimid-neutropenia/</loc>
		<lastmod>2018-05-30T16:24:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/about-us/</loc>
		<lastmod>2018-05-25T03:41:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2016-multiple-myeloma-education-presentations/</loc>
		<lastmod>2018-05-24T17:35:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2018/05/24/asco-2018-multiple-myeloma-abstracts/</loc>
		<lastmod>2018-05-24T17:29:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/15/mohrs-myeloma-musings-myeloma-hypochondria/</loc>
		<lastmod>2018-05-17T18:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/01/myeloma-lessons-a-dirty-little-story/</loc>
		<lastmod>2018-05-17T18:41:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/07/20/birds-in-spring-i-just-want-my-old-carefree-life-back/</loc>
		<lastmod>2018-05-17T18:38:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/06/27/mohrs-myeloma-musings-defined-by-multiple-myeloma/</loc>
		<lastmod>2018-05-17T18:35:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/24/myeloma-mom-what-i-learned-from-bogie-and-bacall/</loc>
		<lastmod>2018-05-17T17:49:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/10/14/revlimid-diarrhea-bile-acid/</loc>
		<lastmod>2018-05-17T17:48:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/10/05/a-northwest-lens-on-myeloma-little-reminders/</loc>
		<lastmod>2018-05-17T03:30:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/02/01/living-for-lamingtons-dont-look-back/</loc>
		<lastmod>2018-05-17T03:29:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/05/16/leichtketten-mgus-progress-ueberleben/</loc>
		<lastmod>2018-05-16T19:56:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/privacy-policy/</loc>
		<lastmod>2018-05-14T14:55:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/05/10/northern-lights-a-second-myeloma-spring/</loc>
		<lastmod>2018-05-11T03:48:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/05/02/living-for-lamingtons-the-big-things-and-the-small-things/</loc>
		<lastmod>2018-05-02T20:31:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2018/05/02/langsames-ansprechen-prognose-ueberleben-multiples-myelom/</loc>
		<lastmod>2018-05-02T17:54:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/04/19/northern-lights-staying-grounded-with-my-myeloma/</loc>
		<lastmod>2018-04-19T16:56:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/31/multiple-myeloma-survival-race-age/</loc>
		<lastmod>2018-04-17T22:42:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/04/11/myeloma-party-of-two-room-with-a-view/</loc>
		<lastmod>2018-04-11T20:29:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/04/06/a-northwest-lens-on-myeloma-an-unexpected-foe/</loc>
		<lastmod>2018-04-06T22:29:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/26/rvd-consolidation-maintenance-high-risk-multiple-myeloma/</loc>
		<lastmod>2018-04-05T17:53:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/03/21/northern-lights-my-habits-for-staying-healthy/</loc>
		<lastmod>2018-03-21T21:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/03/14/living-for-lamingtons-the-effect-we-have-on-other-people/</loc>
		<lastmod>2018-03-14T20:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/03/07/letters-from-cancerland-standing-on-my-own-two-feet/</loc>
		<lastmod>2018-03-07T21:18:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/02/28/myeloma-party-of-two-community/</loc>
		<lastmod>2018-02-28T21:38:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/02/22/a-northwest-lens-on-myeloma-capturing-the-moment/</loc>
		<lastmod>2018-02-22T19:29:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/02/15/northern-lights-turning-tables/</loc>
		<lastmod>2018-02-16T18:02:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/02/08/myeloma-rocket-scientist-total-eclipses-and-myeloma/</loc>
		<lastmod>2018-02-08T21:28:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/01/24/letters-from-cancerland-breathe-in-breathe-out/</loc>
		<lastmod>2018-01-24T18:40:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/01/19/a-northwest-lens-on-myeloma-a-treatment-day-in-my-life/</loc>
		<lastmod>2018-01-19T20:42:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/01/15/northern-lights-a-good-start-to-the-new-year-healthwise/</loc>
		<lastmod>2018-01-15T22:23:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2018/01/04/myeloma-party-of-two-looking-forward/</loc>
		<lastmod>2018-01-04T20:56:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/10/myeloma-in-paradise-how-much-caregiving-is-too-much/</loc>
		<lastmod>2017-12-25T16:14:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/17/personal-perspective-survivor-overcomes-multiple-myeloma-and-amyloidosis/</loc>
		<lastmod>2017-12-25T16:02:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/28/once-weekly-velcade-is-equally-effective-but-better-tolerated-in-elderly-multiple-myeloma-patients/</loc>
		<lastmod>2017-12-25T16:02:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/13/personal-perspective-the-struggle-of-treating-multiple-myeloma-in-turkeys-centralized-health-care-system/</loc>
		<lastmod>2017-12-25T16:02:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/27/prolia-may-delay-the-onset-of-bone-complications-more-effectively-than-zometa-in-multiple-myeloma-patients/</loc>
		<lastmod>2017-12-25T16:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/15/new-fda-warning-about-bisphosphonates-does-not-apply-to-multiple-myeloma/</loc>
		<lastmod>2017-12-25T16:01:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/11/02/seans-burgundy-thread-my-adventures-through-total-therapy/</loc>
		<lastmod>2017-12-25T16:01:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/05/experts-publish-treatment-recommendations-for-multiple-myeloma-patients-with-kidney-impairment/</loc>
		<lastmod>2017-12-25T16:01:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/08/multiple-myeloma-vaccine-shows-promise-in-phase-1-clinical-trial/</loc>
		<lastmod>2017-12-25T16:01:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/12/beacon-siteupdate-myeloma-beacon-launches-opinion-section/</loc>
		<lastmod>2017-12-25T16:01:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/19/xgeva-denosumab-prolia-receives-fda-approval-for-bone-disease-in-solid-tumors-but-not-multiple-myeloma/</loc>
		<lastmod>2017-12-25T16:01:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/11/30/pats-cracked-cup-introducing-my-multiple-myeloma-column-and-my-experiment/</loc>
		<lastmod>2017-12-25T16:01:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/03/risk-adapted-therapy-for-multiple-myeloma-by-dr-vincent-rajkumar/</loc>
		<lastmod>2017-12-25T16:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/10/studies-support-revlimid-lenalidomide-maintenance-therapy-for-multiple-myeloma-patients-ash-2010/</loc>
		<lastmod>2017-12-25T16:00:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/13/velcade-subcutaneous-injections-show-similar-activity-but-fewer-side-effects-compared-to-iv-injections-in-multiple-myeloma-patients-ash-2010/</loc>
		<lastmod>2017-12-25T16:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/03/treanda-shows-promising-activity-in-relapsedrefractory-multiple-myeloma-patients-ash-2010-meeting/</loc>
		<lastmod>2017-12-25T16:00:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/10/revlimid-and-pomalidomide-elicit-high-response-rates-in-multiple-myeloma-patients-who-relapsed-after-thalidomide-or-revlimid-ash-2010/</loc>
		<lastmod>2017-12-25T16:00:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/15/multiple-myeloma-associated-amyloidosis-what-every-patient-should-know/</loc>
		<lastmod>2017-12-25T16:00:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/14/long-term-study-shows-thalidomide-delays-disease-progression-in-smoldering-multiple-myeloma-but-causes-significant-side-effects/</loc>
		<lastmod>2017-12-25T16:00:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/27/guide-to-nutrition-in-multiple-myeloma-part-1-an-introduction/</loc>
		<lastmod>2017-12-25T16:00:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/24/personal-perspective-tips-for-how-every-myeloma-patient-can-be-their-own-advocate/</loc>
		<lastmod>2017-12-25T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/18/mgus-and-smoldering-multiple-myeloma-experts-identify-risk-factors-for-disease-progression-and-establish-monitoring-guidelines-part-2-smoldering-myeloma/</loc>
		<lastmod>2017-12-25T15:59:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/16/mgus-and-smoldering-multiple-myeloma-experts-identify-risk-factors-for-disease-progression-and-establish-monitoring-guidelines-part-1-mgus/</loc>
		<lastmod>2017-12-25T15:59:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/09/personal-perspective-myeloma-patient-pays-it-forward-by-creating-a-myeloma-support-group/</loc>
		<lastmod>2017-12-25T15:59:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/28/higher-quality-response-to-revlimid-dexamethasone-combination-yields-better-prognosis-for-relapsed-and-refractory-multiple-myeloma-patients/</loc>
		<lastmod>2017-12-25T15:59:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/12/study-reveals-common-features-of-long-term-surviving-multiple-myeloma-patients-eha-2010/</loc>
		<lastmod>2017-12-25T15:59:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/07/pomalidomide-dexamethasone-combination-has-therapeutic-benefit-for-heavily-pre-treated-multiple-myeloma-patients-asco-2010/</loc>
		<lastmod>2017-12-25T15:38:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/06/01/seans-burgundy-thread-introducing-my-monthly-myeloma-column/</loc>
		<lastmod>2017-12-25T15:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/14/guide-to-clinical-trials-for-myeloma-patients-part-1-learning-about-clinical-trials/</loc>
		<lastmod>2017-12-25T15:37:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/17/curcumin-and-multiple-myeloma-preclinical-and-early-clinical-studies-are-promising-still-awaiting-more-clinical-evidence/</loc>
		<lastmod>2017-12-25T15:37:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/14/physician-perspective-dr-robert-kyle-on-treating-multiple-myeloma/</loc>
		<lastmod>2017-12-25T15:37:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/11/papayas-papain-and-multiple-myeloma-a-potential-adjunct-therapy-that-requires-further-evaluation/</loc>
		<lastmod>2017-12-25T15:37:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/28/npi-0052-shows-promise-in-treating-relapsedrefractory-multiple-myeloma-ash-2009/</loc>
		<lastmod>2017-12-25T15:37:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/23/preemptive-treatment-benefits-high-risk-smoldering-myeloma-patients-study-finds-ash-2009/</loc>
		<lastmod>2017-12-25T15:36:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/17/perifosine-combination-therapy-is-promising-for-relapsed-and-refractory-multiple-myeloma-ash-2009/</loc>
		<lastmod>2017-12-25T15:36:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/09/survival-greater-than-10-years-in-multiple-myeloma-is-related-to-a-longer-treatment-duration-ash-2009/</loc>
		<lastmod>2017-12-25T15:36:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/05/velcade-dexamethasone-combination-regimen-increases-survival-in-newly-diagnosed-high-risk-myeloma-patients-ash-2009/</loc>
		<lastmod>2017-12-25T15:36:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/23/single-agent-actimid-and-combination-actimid-dexamethasone-regimens-are-promising-treatments-for-relapsed-multiple-myeloma-ash-2009/</loc>
		<lastmod>2017-12-25T15:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/10/the-h1n1-swine-flu-vaccine-and-multiple-myeloma-a-comprehensive-review/</loc>
		<lastmod>2017-12-25T15:36:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/27/study-shows-higher-survival-with-revlimid-and-low-dose-dexamethasone-than-revlimid-and-high-dose-dexamethasone-in-multiple-myeloma-patients/</loc>
		<lastmod>2017-12-25T15:36:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/26/phase-2-clinical-trial-offers-positive-results-for-a-steroid-free-multiple-myeloma-treatment/</loc>
		<lastmod>2017-12-25T15:36:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/17/myeloma-patients-are-at-increased-risk-for-blood-clots-particularly-patients-using-revlimid-or-thalidomide/</loc>
		<lastmod>2017-12-25T15:36:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/08/03/seans-burgundy-thread-new-multiple-myeloma-patients-are-put-to-the-test/</loc>
		<lastmod>2017-12-25T15:31:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/15/seasonal-influenza-and-h1n1-swine-flu-vaccinations-recommended-for-multiple-myeloma-patients/</loc>
		<lastmod>2017-12-25T15:27:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/11/red-wine-resveratrol-and-multiple-myeloma-the-evidence-is-promising-but-needs-further-study/</loc>
		<lastmod>2017-12-25T15:27:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/diagnosis/</loc>
		<lastmod>2017-12-25T15:27:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/28/patient-perspective-engineer-with-myeloma-finds-hope-through-cancer-support-group-and-blogs/</loc>
		<lastmod>2017-12-25T15:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/22/patient-perspective-the-adventures-of-cancer-girl/</loc>
		<lastmod>2017-12-25T15:25:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/10/31/a-new-beacon-for-the-multiple-myeloma-community/</loc>
		<lastmod>2017-12-25T15:25:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/treatment/</loc>
		<lastmod>2017-12-25T15:25:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/velcade/</loc>
		<lastmod>2017-12-25T15:25:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/31/a-northwest-lens-on-myeloma-sky-of-fullness/</loc>
		<lastmod>2017-12-25T15:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/12/25/happy-holidays-7/</loc>
		<lastmod>2017-12-25T15:08:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/12/21/northern-lights-when-the-holiday-season-is-not-so-jolly/</loc>
		<lastmod>2017-12-21T21:41:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/12/15/living-for-lamingtons-from-green-juices-to-pink-bubbles/</loc>
		<lastmod>2017-12-15T20:52:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/12/07/a-northwest-lens-on-myeloma-being-the-good-patient/</loc>
		<lastmod>2017-12-07T22:56:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/11/30/northern-lights-my-favorite-four-legged-friend/</loc>
		<lastmod>2017-11-30T16:56:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/11/22/letters-from-cancerland-tired-fatigued-none-of-the-above/</loc>
		<lastmod>2017-11-22T22:39:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/11/15/myeloma-rocket-scientist-a-rose-by-any-other-acronym-would-smell-as-sweet/</loc>
		<lastmod>2017-11-15T21:02:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/11/09/a-northwest-lens-on-myeloma-hope-and-intellect/</loc>
		<lastmod>2017-11-09T18:55:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/11/03/myeloma-party-of-two-on-myelomas-ice/</loc>
		<lastmod>2017-11-03T20:09:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/10/28/living-for-lamingtons-lets-talk-maintenance/</loc>
		<lastmod>2017-10-28T21:43:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/10/20/northern-lights-staying-positive/</loc>
		<lastmod>2017-10-20T17:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/10/12/letters-from-cancerland-what-the-view-looks-like-from-here/</loc>
		<lastmod>2017-10-12T21:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/09/28/myeloma-party-of-two-fragile/</loc>
		<lastmod>2017-09-28T20:27:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/09/20/letters-from-cancerland-the-four-questions-revisited/</loc>
		<lastmod>2017-09-20T22:03:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/09/15/northern-lights-watching-patiently-month-by-month/</loc>
		<lastmod>2017-09-15T22:02:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/09/11/a-northwest-lens-on-myeloma-building-for-the-future/</loc>
		<lastmod>2017-09-11T21:03:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/09/05/myeloma-rocket-scientist-clinical-trials-and-tribulations/</loc>
		<lastmod>2017-09-05T20:38:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/08/30/living-for-lamingtons-waiting/</loc>
		<lastmod>2017-08-30T23:50:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/08/25/northern-lights-trying-not-to-be-a-perfectionist/</loc>
		<lastmod>2017-08-25T17:02:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/08/16/myeloma-dispatches-cues-for-courage/</loc>
		<lastmod>2017-08-16T22:43:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/08/11/letters-from-cancerland-through-rose-colored-glasses/</loc>
		<lastmod>2017-08-11T21:33:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/08/04/a-northwest-lens-on-myeloma-celebrating-my-new-birthday/</loc>
		<lastmod>2017-08-04T18:59:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/07/31/myeloma-party-of-two-the-myeloma-door/</loc>
		<lastmod>2017-07-31T18:00:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/07/26/northern-lights-physical-changes-during-my-myeloma-journey/</loc>
		<lastmod>2017-07-26T13:37:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/07/13/myeloma-dispatches-season-of-change/</loc>
		<lastmod>2017-07-14T00:33:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/07/06/living-for-lamingtons-a-room-with-a-view/</loc>
		<lastmod>2017-07-06T22:46:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/06/30/myeloma-rocket-scientist-predictions-are-tough/</loc>
		<lastmod>2017-06-30T19:34:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/06/27/northern-lights-summer-reading-suggestions/</loc>
		<lastmod>2017-06-27T22:32:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/06/20/letters-from-cancerland-small-acts/</loc>
		<lastmod>2017-06-20T22:20:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/06/14/myeloma-dispatches-dealing-with-denial/</loc>
		<lastmod>2017-06-14T22:36:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/06/10/a-northwest-lens-on-myeloma-whats-in-a-number/</loc>
		<lastmod>2017-06-10T11:09:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/06/06/myeloma-party-of-two-guidance-from-estelle-the-caregiver/</loc>
		<lastmod>2017-06-06T22:38:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/05/31/living-for-lamingtons-myeloma-days/</loc>
		<lastmod>2017-05-31T20:12:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/05/25/myeloma-rocket-scientist-randomness-in-multiple-myeloma/</loc>
		<lastmod>2017-05-25T17:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/03/13/myeloma-rocket-scientist-note-to-self-multiple-myeloma-is-not-mainstream/</loc>
		<lastmod>2017-05-25T17:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/05/17/northern-lights-meshing-two-diagnoses/</loc>
		<lastmod>2017-05-17T10:05:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/05/09/myeloma-dispatches-observing-peonies/</loc>
		<lastmod>2017-05-09T20:10:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/05/03/a-northwest-lens-on-myeloma-making-room-to-grow/</loc>
		<lastmod>2017-05-03T21:06:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/04/26/letters-from-cancerland-treading-water/</loc>
		<lastmod>2017-04-26T22:48:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/04/21/living-for-lamingtons-im-very-fortunate/</loc>
		<lastmod>2017-04-21T18:53:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/04/14/northern-lights-spring-thaw/</loc>
		<lastmod>2017-04-14T22:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/04/07/myeloma-dispatches-lost-days/</loc>
		<lastmod>2017-04-07T21:25:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/04/04/a-northwest-lens-on-myeloma-two-years-and-many-new-beginnings/</loc>
		<lastmod>2017-04-04T17:31:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/03/30/myeloma-party-of-two-as-slow-as-you-can/</loc>
		<lastmod>2017-03-30T18:47:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/24/letters-from-cancerland-puzzles/</loc>
		<lastmod>2017-03-23T17:02:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/03/23/letters-from-cancerland-comprehensive-cancer-care/</loc>
		<lastmod>2017-03-23T15:14:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/03/18/living-for-lamingtons-engraftment-ups-and-downs/</loc>
		<lastmod>2017-03-18T20:14:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/03/08/northern-lights-enjoying-life-without-treatment/</loc>
		<lastmod>2017-03-08T22:23:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/18/myeloma-morning-personalizing-multiple-myeloma-therapy-lansoprazole/</loc>
		<lastmod>2017-03-05T11:40:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/03/02/myeloma-dispatches-gifts-from-the-desert/</loc>
		<lastmod>2017-03-02T22:27:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/05/myeloma-dispatches-its-only-temporary/</loc>
		<lastmod>2017-03-02T14:40:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/23/myeloma-party-of-two-outsiders/</loc>
		<lastmod>2017-02-23T21:09:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/28/letters-from-cancerland-its-not-easy-being-green/</loc>
		<lastmod>2017-02-22T10:13:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/21/letters-from-cancerland-locomotives/</loc>
		<lastmod>2017-02-21T18:36:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/16/mohrs-myeloma-musings-change-of-game-plan/</loc>
		<lastmod>2017-02-16T21:12:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/04/seans-burgundy-thread-im-just-wild-about-hairy/</loc>
		<lastmod>2017-02-14T16:40:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/14/northern-lights-losing-my-hair/</loc>
		<lastmod>2017-02-14T16:38:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/14/living-for-lamingtons-hair-and-hats/</loc>
		<lastmod>2017-02-14T16:37:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/22/myeloma-party-of-two-trudging-through-winter/</loc>
		<lastmod>2017-02-14T15:54:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/10/northern-lights-our-myeloma-journeys-involve-change/</loc>
		<lastmod>2017-02-10T21:04:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/08/myeloma-lessons-breathing-freely-again-for-the-time-being/</loc>
		<lastmod>2017-02-08T20:50:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/02/02/myeloma-dispatches-caregiving-as-an-art/</loc>
		<lastmod>2017-02-02T20:16:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/04/study-finds-no-link-between-hair-dyes-and-myeloma/</loc>
		<lastmod>2017-02-01T04:07:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/27/myeloma-party-of-two-evolution/</loc>
		<lastmod>2017-01-27T18:05:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/17/living-for-lamingtons-unexpected-outcomes/</loc>
		<lastmod>2017-01-17T20:07:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/11/15/living-for-lamingtons-journey-to-and-through-induction/</loc>
		<lastmod>2017-01-17T18:27:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/14/myeloma-morning-early-mortality-very-short-survival/</loc>
		<lastmod>2017-01-13T13:48:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/16/mohrs-myeloma-musings-four-memories-and-four-lessons-in-four-years/</loc>
		<lastmod>2017-01-13T13:48:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/16/myeloma-morning-multiple-myeloma-prevalence-mgus-survival-dopamine/</loc>
		<lastmod>2017-01-13T13:48:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/20/letters-from-cancerland-big-books/</loc>
		<lastmod>2017-01-13T13:47:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/23/myeloma-rocket-scientist-dex-cant-live-with-it-cant-live-without-it/</loc>
		<lastmod>2017-01-13T13:47:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/30/myeloma-morning-allogeneic-stem-cell-transplantation-multiple-myeloma-europe/</loc>
		<lastmod>2017-01-13T13:47:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/04/seans-burgundy-thread-let-me-count-the-myeloma-ways/</loc>
		<lastmod>2017-01-13T13:47:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/07/northern-lights-staying-healthy-by-exercising-2/</loc>
		<lastmod>2017-01-13T13:46:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/11/myeloma-in-paradise-taking-a-vacation-from-multiple-myeloma/</loc>
		<lastmod>2017-01-13T13:46:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/14/myeloma-morning-translocation-11-14-subcutaneous-fat/</loc>
		<lastmod>2017-01-13T13:46:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/15/myeloma-lessons-the-most-important-lesson-yet/</loc>
		<lastmod>2017-01-13T13:46:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/18/letters-from-cancerland-winding-down/</loc>
		<lastmod>2017-01-13T13:45:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/11/northern-lights-a-new-diagnosis/</loc>
		<lastmod>2017-01-13T13:44:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/15/myeloma-morning-multiple-myeloma-survival-data-pomalyst-mgus/</loc>
		<lastmod>2017-01-13T13:44:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/07/myeloma-morning-tumoral-cells-stem-cell-reinfusions-cyclophosphamide-mobilization/</loc>
		<lastmod>2017-01-13T13:44:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/09/myeloma-lessons-taking-the-plunge/</loc>
		<lastmod>2017-01-13T13:44:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/29/myeloma-party-of-two-the-smoldering/</loc>
		<lastmod>2017-01-13T13:42:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/13/northern-lights-experiences-with-radiation/</loc>
		<lastmod>2017-01-13T13:30:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/07/14/myeloma-in-paradise-a-tale-of-two-toms/</loc>
		<lastmod>2017-01-10T15:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/06/myeloma-dispatches-mirror-mirror-on-the-wall/</loc>
		<lastmod>2017-01-06T13:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/03/a-northwest-lens-on-myeloma-accepting-reality/</loc>
		<lastmod>2017-01-06T13:01:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/08/12/myeloma-in-paradise-lessons-on-living-with-multiple-myeloma/</loc>
		<lastmod>2017-01-06T13:00:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2017/01/03/a-northwest-lens-on-myeloma-lessons-from-my-stem-cell-transplant/</loc>
		<lastmod>2017-01-04T01:00:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/01/a-northwest-lens-on-myeloma-giving-thanks/</loc>
		<lastmod>2017-01-04T00:33:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/30/myeloma-lessons-holding-my-breath/</loc>
		<lastmod>2016-12-30T17:58:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/09/10/letters-from-cancerland-still/</loc>
		<lastmod>2016-12-28T18:26:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/25/happy-holidays-6/</loc>
		<lastmod>2016-12-25T12:15:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/24/seans-burgundy-thread-youre-a-mean-one-mr-m/</loc>
		<lastmod>2016-12-24T15:14:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/22/myeloma-rocket-scientist-a-christmas-carol/</loc>
		<lastmod>2016-12-22T15:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/16/living-for-lamingtons-stem-cell-collection-and-recollection/</loc>
		<lastmod>2016-12-16T14:21:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4517/</loc>
		<lastmod>2016-12-14T03:41:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4414/</loc>
		<lastmod>2016-12-14T03:38:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3327-3/</loc>
		<lastmod>2016-12-14T03:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/488/</loc>
		<lastmod>2016-12-14T03:30:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/13/northern-lights-keeping-it-simple-during-the-holiday-season/</loc>
		<lastmod>2016-12-13T23:12:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3313/</loc>
		<lastmod>2016-12-13T20:29:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1151/</loc>
		<lastmod>2016-12-13T20:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1149/</loc>
		<lastmod>2016-12-13T20:25:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/381/</loc>
		<lastmod>2016-12-13T18:22:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/194/</loc>
		<lastmod>2016-12-13T18:16:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3316-2/</loc>
		<lastmod>2016-12-13T18:07:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3308/</loc>
		<lastmod>2016-12-13T16:55:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1150/</loc>
		<lastmod>2016-12-13T16:44:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/489/</loc>
		<lastmod>2016-12-13T02:32:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3311-2/</loc>
		<lastmod>2016-12-12T23:45:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/10/myeloma-in-paradise-a-trip-to-the-school-of-life-and-death/</loc>
		<lastmod>2016-12-10T21:30:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2133/</loc>
		<lastmod>2016-12-09T00:04:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2123/</loc>
		<lastmod>2016-12-08T20:14:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2090-2/</loc>
		<lastmod>2016-12-08T17:32:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4530/</loc>
		<lastmod>2016-12-08T16:56:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2129-2/</loc>
		<lastmod>2016-12-08T16:49:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4520-2/</loc>
		<lastmod>2016-12-08T16:34:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3319/</loc>
		<lastmod>2016-12-08T16:28:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2142/</loc>
		<lastmod>2016-12-08T16:25:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4415/</loc>
		<lastmod>2016-12-08T14:59:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2122/</loc>
		<lastmod>2016-12-07T19:23:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/675/</loc>
		<lastmod>2016-12-06T17:31:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2124/</loc>
		<lastmod>2016-12-06T17:13:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/492/</loc>
		<lastmod>2016-12-06T17:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/12/06/myeloma-party-of-two-what-i-know-about-the-holidays/</loc>
		<lastmod>2016-12-06T16:22:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4630/</loc>
		<lastmod>2016-12-06T03:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4774/</loc>
		<lastmod>2016-12-06T03:50:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3278/</loc>
		<lastmod>2016-12-06T02:58:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2094/</loc>
		<lastmod>2016-12-06T02:36:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/ash-2016-multiple-myeloma-gateway/</loc>
		<lastmod>2016-12-04T03:56:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/115-2/</loc>
		<lastmod>2016-12-03T15:39:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4794/</loc>
		<lastmod>2016-12-02T22:57:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4784/</loc>
		<lastmod>2016-12-02T22:54:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4781/</loc>
		<lastmod>2016-12-02T22:53:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4777/</loc>
		<lastmod>2016-12-02T22:51:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4726/</loc>
		<lastmod>2016-12-02T22:49:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4722/</loc>
		<lastmod>2016-12-02T22:48:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4644/</loc>
		<lastmod>2016-12-02T22:45:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4635/</loc>
		<lastmod>2016-12-02T22:40:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4633/</loc>
		<lastmod>2016-12-02T22:39:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4632/</loc>
		<lastmod>2016-12-02T22:38:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4626/</loc>
		<lastmod>2016-12-02T22:37:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4585/</loc>
		<lastmod>2016-12-02T22:32:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4532/</loc>
		<lastmod>2016-12-02T22:30:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4531/</loc>
		<lastmod>2016-12-02T22:30:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4529/</loc>
		<lastmod>2016-12-02T22:28:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4527/</loc>
		<lastmod>2016-12-02T22:28:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4521-3/</loc>
		<lastmod>2016-12-02T22:25:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4518/</loc>
		<lastmod>2016-12-02T22:23:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4512/</loc>
		<lastmod>2016-12-02T22:20:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4510/</loc>
		<lastmod>2016-12-02T22:19:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4507-2/</loc>
		<lastmod>2016-12-02T21:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4506-2/</loc>
		<lastmod>2016-12-02T21:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4499/</loc>
		<lastmod>2016-12-02T21:53:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4491/</loc>
		<lastmod>2016-12-02T21:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4485-2/</loc>
		<lastmod>2016-12-02T21:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4480/</loc>
		<lastmod>2016-12-02T21:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4474/</loc>
		<lastmod>2016-12-02T21:47:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4462/</loc>
		<lastmod>2016-12-02T21:44:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4453-2/</loc>
		<lastmod>2016-12-02T21:43:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4455-2/</loc>
		<lastmod>2016-12-02T21:42:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4451-2/</loc>
		<lastmod>2016-12-02T21:41:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4445-2/</loc>
		<lastmod>2016-12-02T21:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4436-3/</loc>
		<lastmod>2016-12-02T21:31:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4432-3/</loc>
		<lastmod>2016-12-02T21:30:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4431-2/</loc>
		<lastmod>2016-12-02T21:30:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4428-2/</loc>
		<lastmod>2016-12-02T21:29:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4425/</loc>
		<lastmod>2016-12-02T21:28:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4424/</loc>
		<lastmod>2016-12-02T21:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4417/</loc>
		<lastmod>2016-12-02T21:24:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4412/</loc>
		<lastmod>2016-12-02T21:22:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4409/</loc>
		<lastmod>2016-12-02T17:00:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4408/</loc>
		<lastmod>2016-12-02T17:00:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4407/</loc>
		<lastmod>2016-12-02T16:59:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4406/</loc>
		<lastmod>2016-12-02T16:59:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3698/</loc>
		<lastmod>2016-12-02T16:55:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3607/</loc>
		<lastmod>2016-12-02T16:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3606/</loc>
		<lastmod>2016-12-02T16:53:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3570/</loc>
		<lastmod>2016-12-02T16:50:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3563/</loc>
		<lastmod>2016-12-02T16:48:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3475/</loc>
		<lastmod>2016-12-02T16:47:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3558/</loc>
		<lastmod>2016-12-02T16:42:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3555/</loc>
		<lastmod>2016-12-02T16:41:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3546/</loc>
		<lastmod>2016-12-02T16:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3544/</loc>
		<lastmod>2016-12-02T16:40:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3542/</loc>
		<lastmod>2016-12-02T16:39:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3463/</loc>
		<lastmod>2016-12-02T15:50:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3457/</loc>
		<lastmod>2016-12-02T15:49:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3456/</loc>
		<lastmod>2016-12-02T15:48:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3454/</loc>
		<lastmod>2016-12-02T15:48:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3453/</loc>
		<lastmod>2016-12-02T15:47:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3452/</loc>
		<lastmod>2016-12-02T15:46:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3449/</loc>
		<lastmod>2016-12-02T15:45:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3381/</loc>
		<lastmod>2016-12-02T14:48:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3339/</loc>
		<lastmod>2016-12-02T14:41:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3337/</loc>
		<lastmod>2016-12-02T14:41:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3336/</loc>
		<lastmod>2016-12-02T14:40:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3332-2/</loc>
		<lastmod>2016-12-02T14:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3331/</loc>
		<lastmod>2016-12-02T14:33:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3329-2/</loc>
		<lastmod>2016-12-02T14:32:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3326/</loc>
		<lastmod>2016-12-02T14:30:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3322/</loc>
		<lastmod>2016-12-02T14:29:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3321-2/</loc>
		<lastmod>2016-12-02T14:29:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3315-2/</loc>
		<lastmod>2016-12-02T14:27:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3312-3/</loc>
		<lastmod>2016-12-02T14:25:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3309-2/</loc>
		<lastmod>2016-12-02T14:24:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3306-2/</loc>
		<lastmod>2016-12-02T14:16:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3305/</loc>
		<lastmod>2016-12-02T14:16:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3296/</loc>
		<lastmod>2016-12-02T14:13:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3295/</loc>
		<lastmod>2016-12-02T14:13:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3286/</loc>
		<lastmod>2016-12-02T14:11:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3285/</loc>
		<lastmod>2016-12-02T14:11:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3283/</loc>
		<lastmod>2016-12-02T14:09:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3282/</loc>
		<lastmod>2016-12-02T14:08:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3281/</loc>
		<lastmod>2016-12-02T14:08:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3275/</loc>
		<lastmod>2016-12-02T14:06:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3274/</loc>
		<lastmod>2016-12-02T14:05:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3270/</loc>
		<lastmod>2016-12-02T14:04:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3257-2/</loc>
		<lastmod>2016-12-02T14:00:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3255/</loc>
		<lastmod>2016-12-02T13:59:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3254/</loc>
		<lastmod>2016-12-02T13:59:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3251-2/</loc>
		<lastmod>2016-12-02T13:58:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2624/</loc>
		<lastmod>2016-12-02T13:55:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2418/</loc>
		<lastmod>2016-12-02T13:54:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2403/</loc>
		<lastmod>2016-12-02T13:52:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/308/</loc>
		<lastmod>2016-12-02T05:15:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/376-2/</loc>
		<lastmod>2016-12-02T05:13:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4465/</loc>
		<lastmod>2016-12-02T05:13:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4646/</loc>
		<lastmod>2016-12-02T05:12:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4479/</loc>
		<lastmod>2016-12-02T05:11:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3247-2/</loc>
		<lastmod>2016-12-02T05:09:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2086-2/</loc>
		<lastmod>2016-12-02T05:08:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2759/</loc>
		<lastmod>2016-12-02T05:08:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3569/</loc>
		<lastmod>2016-12-02T05:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4484/</loc>
		<lastmod>2016-12-02T05:03:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2134/</loc>
		<lastmod>2016-12-02T05:03:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3297-2/</loc>
		<lastmod>2016-12-02T05:01:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2138/</loc>
		<lastmod>2016-12-02T05:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4475/</loc>
		<lastmod>2016-12-02T04:42:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2127/</loc>
		<lastmod>2016-12-02T04:41:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4482/</loc>
		<lastmod>2016-12-02T04:38:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4684/</loc>
		<lastmod>2016-12-02T04:37:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4427-2/</loc>
		<lastmod>2016-12-02T04:31:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2104/</loc>
		<lastmod>2016-12-02T04:29:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4457/</loc>
		<lastmod>2016-12-02T04:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4461/</loc>
		<lastmod>2016-12-02T04:08:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/239/</loc>
		<lastmod>2016-12-02T04:08:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2065/</loc>
		<lastmod>2016-12-02T04:07:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3277/</loc>
		<lastmod>2016-12-02T04:06:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1592/</loc>
		<lastmod>2016-12-02T04:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4470/</loc>
		<lastmod>2016-12-02T04:02:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2388/</loc>
		<lastmod>2016-12-02T03:36:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2379/</loc>
		<lastmod>2016-12-02T03:35:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2367/</loc>
		<lastmod>2016-12-02T03:33:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2364/</loc>
		<lastmod>2016-12-02T03:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2363/</loc>
		<lastmod>2016-12-02T03:32:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2362/</loc>
		<lastmod>2016-12-02T03:31:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2351/</loc>
		<lastmod>2016-12-02T03:28:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2350/</loc>
		<lastmod>2016-12-02T03:24:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2349/</loc>
		<lastmod>2016-12-02T03:20:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2348/</loc>
		<lastmod>2016-12-02T03:14:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2320/</loc>
		<lastmod>2016-12-02T03:14:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2306/</loc>
		<lastmod>2016-12-02T03:13:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2302/</loc>
		<lastmod>2016-12-02T03:12:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2069/</loc>
		<lastmod>2016-12-02T03:12:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2274/</loc>
		<lastmod>2016-12-02T03:10:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2269/</loc>
		<lastmod>2016-12-02T03:08:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2261/</loc>
		<lastmod>2016-12-02T03:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/236/</loc>
		<lastmod>2016-12-02T03:05:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2260/</loc>
		<lastmod>2016-12-02T03:04:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4203-2/</loc>
		<lastmod>2016-12-02T03:04:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4418/</loc>
		<lastmod>2016-12-02T03:04:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/183/</loc>
		<lastmod>2016-12-02T03:03:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/235/</loc>
		<lastmod>2016-12-02T03:02:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2208/</loc>
		<lastmod>2016-12-02T03:01:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3601/</loc>
		<lastmod>2016-12-02T03:00:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2184/</loc>
		<lastmod>2016-12-02T03:00:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3334/</loc>
		<lastmod>2016-12-02T02:59:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3271/</loc>
		<lastmod>2016-12-02T02:59:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2402-2/</loc>
		<lastmod>2016-12-02T02:58:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2144/</loc>
		<lastmod>2016-12-02T02:57:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4416/</loc>
		<lastmod>2016-12-02T02:54:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2137/</loc>
		<lastmod>2016-12-02T02:54:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/833/</loc>
		<lastmod>2016-12-02T02:38:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2112/</loc>
		<lastmod>2016-12-02T02:38:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2089-2/</loc>
		<lastmod>2016-12-02T02:35:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/373-2/</loc>
		<lastmod>2016-12-02T02:33:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4446-2/</loc>
		<lastmod>2016-12-02T02:31:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2125/</loc>
		<lastmod>2016-12-02T02:31:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2126-2/</loc>
		<lastmod>2016-12-02T02:30:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2079/</loc>
		<lastmod>2016-12-02T02:30:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/801/</loc>
		<lastmod>2016-12-02T02:29:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/537-2/</loc>
		<lastmod>2016-12-02T02:24:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2111/</loc>
		<lastmod>2016-12-02T02:24:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3325-2/</loc>
		<lastmod>2016-12-02T02:24:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2109/</loc>
		<lastmod>2016-12-02T02:24:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1190/</loc>
		<lastmod>2016-12-02T02:24:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4488/</loc>
		<lastmod>2016-12-02T02:22:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/673/</loc>
		<lastmod>2016-12-02T02:21:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2100-2/</loc>
		<lastmod>2016-12-02T02:21:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3301/</loc>
		<lastmod>2016-12-02T02:20:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4508-2/</loc>
		<lastmod>2016-12-02T02:20:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/803/</loc>
		<lastmod>2016-12-02T02:19:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/540-2/</loc>
		<lastmod>2016-12-02T02:18:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4650/</loc>
		<lastmod>2016-12-02T02:17:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/481/</loc>
		<lastmod>2016-12-02T02:17:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4434-2/</loc>
		<lastmod>2016-12-02T02:16:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/374-2/</loc>
		<lastmod>2016-12-02T02:13:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1194/</loc>
		<lastmod>2016-12-02T02:12:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/243/</loc>
		<lastmod>2016-12-02T02:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4452-2/</loc>
		<lastmod>2016-12-02T02:11:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1862-2/</loc>
		<lastmod>2016-12-02T02:09:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2058/</loc>
		<lastmod>2016-12-02T02:05:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/516-2/</loc>
		<lastmod>2016-12-02T02:01:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/310/</loc>
		<lastmod>2016-12-02T01:58:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3280/</loc>
		<lastmod>2016-12-02T01:56:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2087-2/</loc>
		<lastmod>2016-12-02T01:53:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2103-2/</loc>
		<lastmod>2016-12-02T01:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2062/</loc>
		<lastmod>2016-12-02T01:48:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4421/</loc>
		<lastmod>2016-12-02T01:47:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4509/</loc>
		<lastmod>2016-12-02T01:47:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3294-2/</loc>
		<lastmod>2016-12-02T01:46:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2055/</loc>
		<lastmod>2016-12-02T01:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2081/</loc>
		<lastmod>2016-12-02T01:43:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1142/</loc>
		<lastmod>2016-12-02T01:42:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1843-3/</loc>
		<lastmod>2016-12-02T01:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2056/</loc>
		<lastmod>2016-12-02T01:41:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1241/</loc>
		<lastmod>2016-12-01T23:59:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1238/</loc>
		<lastmod>2016-12-01T23:58:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1236/</loc>
		<lastmod>2016-12-01T23:57:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1192/</loc>
		<lastmod>2016-12-01T23:54:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1191/</loc>
		<lastmod>2016-12-01T23:53:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1184/</loc>
		<lastmod>2016-12-01T23:51:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1146/</loc>
		<lastmod>2016-12-01T23:48:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/996/</loc>
		<lastmod>2016-12-01T23:43:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/994/</loc>
		<lastmod>2016-12-01T23:42:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/993/</loc>
		<lastmod>2016-12-01T23:41:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1591/</loc>
		<lastmod>2016-12-01T23:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/246/</loc>
		<lastmod>2016-12-01T23:24:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3266/</loc>
		<lastmod>2016-12-01T23:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3298/</loc>
		<lastmod>2016-12-01T23:23:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2119/</loc>
		<lastmod>2016-12-01T23:22:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/978/</loc>
		<lastmod>2016-12-01T23:21:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/974/</loc>
		<lastmod>2016-12-01T23:21:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4476/</loc>
		<lastmod>2016-12-01T23:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/360/</loc>
		<lastmod>2016-12-01T23:16:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4492/</loc>
		<lastmod>2016-12-01T23:13:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/846/</loc>
		<lastmod>2016-12-01T23:12:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2293/</loc>
		<lastmod>2016-12-01T23:12:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/843/</loc>
		<lastmod>2016-12-01T23:09:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4519-2/</loc>
		<lastmod>2016-12-01T23:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/812/</loc>
		<lastmod>2016-12-01T23:06:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4433-2/</loc>
		<lastmod>2016-12-01T23:06:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/245/</loc>
		<lastmod>2016-12-01T23:05:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/973/</loc>
		<lastmod>2016-12-01T23:03:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/677/</loc>
		<lastmod>2016-12-01T23:03:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3299/</loc>
		<lastmod>2016-12-01T23:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/689-2/</loc>
		<lastmod>2016-12-01T23:01:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3521/</loc>
		<lastmod>2016-12-01T23:01:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/678/</loc>
		<lastmod>2016-12-01T23:00:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3330/</loc>
		<lastmod>2016-12-01T22:59:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/676/</loc>
		<lastmod>2016-12-01T22:58:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4501-2/</loc>
		<lastmod>2016-12-01T22:56:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/534-2/</loc>
		<lastmod>2016-12-01T22:55:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4552/</loc>
		<lastmod>2016-12-01T22:55:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4458/</loc>
		<lastmod>2016-12-01T22:47:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4410/</loc>
		<lastmod>2016-12-01T22:46:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3253/</loc>
		<lastmod>2016-12-01T22:43:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2075/</loc>
		<lastmod>2016-12-01T22:43:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2057/</loc>
		<lastmod>2016-12-01T22:43:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3288-2/</loc>
		<lastmod>2016-12-01T22:42:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/359/</loc>
		<lastmod>2016-12-01T22:41:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4429-2/</loc>
		<lastmod>2016-12-01T22:41:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1342/</loc>
		<lastmod>2016-12-01T22:41:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/116-2/</loc>
		<lastmod>2016-12-01T22:38:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2096/</loc>
		<lastmod>2016-12-01T22:36:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/312/</loc>
		<lastmod>2016-12-01T22:33:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3377/</loc>
		<lastmod>2016-12-01T22:31:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4550/</loc>
		<lastmod>2016-12-01T22:29:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1340/</loc>
		<lastmod>2016-12-01T22:27:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/377-2/</loc>
		<lastmod>2016-12-01T22:26:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/118-2/</loc>
		<lastmod>2016-12-01T22:26:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/991/</loc>
		<lastmod>2016-12-01T22:26:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4495-2/</loc>
		<lastmod>2016-12-01T22:24:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/384/</loc>
		<lastmod>2016-12-01T22:22:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/274-2/</loc>
		<lastmod>2016-12-01T22:09:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/193/</loc>
		<lastmod>2016-12-01T21:40:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/120-2/</loc>
		<lastmod>2016-12-01T21:38:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2067/</loc>
		<lastmod>2016-12-01T20:18:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4456/</loc>
		<lastmod>2016-12-01T20:18:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3314/</loc>
		<lastmod>2016-12-01T20:18:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4649/</loc>
		<lastmod>2016-12-01T20:17:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2292/</loc>
		<lastmod>2016-12-01T20:16:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2063/</loc>
		<lastmod>2016-12-01T20:16:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3290/</loc>
		<lastmod>2016-12-01T20:15:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2085-2/</loc>
		<lastmod>2016-12-01T20:14:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4486/</loc>
		<lastmod>2016-12-01T20:14:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3323/</loc>
		<lastmod>2016-12-01T20:13:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3289/</loc>
		<lastmod>2016-12-01T20:13:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4494/</loc>
		<lastmod>2016-12-01T20:13:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3304-2/</loc>
		<lastmod>2016-12-01T20:11:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2121/</loc>
		<lastmod>2016-12-01T20:10:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1148/</loc>
		<lastmod>2016-12-01T20:05:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2105-2/</loc>
		<lastmod>2016-12-01T20:05:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1141/</loc>
		<lastmod>2016-12-01T20:04:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4472/</loc>
		<lastmod>2016-12-01T20:03:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2106/</loc>
		<lastmod>2016-12-01T19:54:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4441-2/</loc>
		<lastmod>2016-12-01T19:53:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2774/</loc>
		<lastmod>2016-12-01T19:53:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/802/</loc>
		<lastmod>2016-12-01T19:53:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/382/</loc>
		<lastmod>2016-12-01T19:52:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3252/</loc>
		<lastmod>2016-12-01T19:50:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/674/</loc>
		<lastmod>2016-12-01T19:49:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2114-2/</loc>
		<lastmod>2016-12-01T19:48:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3598/</loc>
		<lastmod>2016-12-01T19:44:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/804/</loc>
		<lastmod>2016-12-01T19:43:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4619/</loc>
		<lastmod>2016-12-01T19:42:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3287/</loc>
		<lastmod>2016-12-01T19:42:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2128-2/</loc>
		<lastmod>2016-12-01T17:39:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/656/</loc>
		<lastmod>2016-12-01T17:13:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1144/</loc>
		<lastmod>2016-12-01T17:12:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/26/beacon-newsflashes-june-26-2012/</loc>
		<lastmod>2016-11-30T21:56:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/11/29/myeloma-dispatches-report-from-the-battlefield/</loc>
		<lastmod>2016-11-29T21:48:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/11/24/seans-burgundy-thread-my-first-multiple-myeloma-thanksgiving/</loc>
		<lastmod>2016-11-24T18:07:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/11/22/myeloma-rocket-scientist-a-man-with-two-watches/</loc>
		<lastmod>2016-11-22T16:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/11/08/northern-lights-in-between-myeloma-treatments/</loc>
		<lastmod>2016-11-09T00:38:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/11/03/a-northwest-lens-on-myeloma-recapturing-my-passion/</loc>
		<lastmod>2016-11-03T18:03:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2098/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4426/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4528/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/844/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/975/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4636/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4478/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/483/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3373/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3469/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3245/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2239/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4489-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2141/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3263/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1136/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3689/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2097/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4413/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3307-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/117-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4490/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4468/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2073/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2928/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4411/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/383/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/976/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3421/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3284/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4497-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4493/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3250-3/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3276-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/482/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1135/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2083/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2078/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/379/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3436/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2130/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2117/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/485/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/799/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1137/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/195/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/237/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/197/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4483/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1147/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/311/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4526/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2263/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4477/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3465/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1143/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1145/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3256/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/992/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2107/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2116-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2419-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2088/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/490/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3259/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4459/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4637/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2118/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2143-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4548/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2221/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4610/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4502-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3265/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3260/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2093-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4419/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3328/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4420/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/375-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4776/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/380/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1139/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4642/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2095/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3300/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4647-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2389/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/307/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3448/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/491/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2066/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2206/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2060-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4422/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3460/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2074-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1138/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2266/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/977/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3267/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/378-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2064/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2135/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3279/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4423/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/358/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2113/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2091-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2068/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3335/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2059/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/309/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4449-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4515-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2080/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/198/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4471/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1140/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4430-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1062/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3340/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/1152/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2077/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/357/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/196/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/355/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3437/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2084-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3960/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2071/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2092/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2070/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3958/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/356/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/486/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4438-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4439-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4440-3/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2061/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3461/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2099/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2358/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/238/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/800/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4442-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3292-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4524/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4467/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2076/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2420-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/4450-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2373/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2360/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3293/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/2108/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3582/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/3324-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/lba-1-2/</loc>
		<lastmod>2016-11-01T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/07/06/myeloma-dispatches-chasing-numbers/</loc>
		<lastmod>2016-10-31T16:55:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/28/myeloma-party-of-two-the-caregivers-club/</loc>
		<lastmod>2016-10-28T19:54:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/15/beacon-newsflashes-october-15-2012/</loc>
		<lastmod>2016-10-28T17:34:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/24/living-for-lamingtons-making-rules-to-cope/</loc>
		<lastmod>2016-10-24T18:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/19/mohrs-myeloma-musings-practicing-gratitude/</loc>
		<lastmod>2016-10-19T17:44:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/09/27/mohrs-myeloma-musings-momentum/</loc>
		<lastmod>2016-10-18T16:01:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/14/myeloma-in-paradise-who-do-you-tell/</loc>
		<lastmod>2016-10-14T13:21:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/06/02/pomalyst-stratus-mm010-trial-results/</loc>
		<lastmod>2016-10-10T19:30:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/08/myeloma-lessons-checking-in-at-the-six-month-mark/</loc>
		<lastmod>2016-10-08T12:54:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/10/01/myeloma-rocket-scientist-superstitions-in-multiple-myeloma-and-spaceflight/</loc>
		<lastmod>2016-10-01T13:00:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/09/29/myeloma-party-of-two-unwanted-visitors/</loc>
		<lastmod>2016-09-29T17:36:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/09/22/northern-lights-sandcastles-and-dexamethasone/</loc>
		<lastmod>2016-09-22T15:07:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/09/18/seans-burgundy-thread-walk-on/</loc>
		<lastmod>2016-09-18T21:08:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/09/15/myeloma-lessons-hey-hey-im-a-mentor/</loc>
		<lastmod>2016-09-15T23:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/09/07/myeloma-in-paradise-our-evolution/</loc>
		<lastmod>2016-09-07T23:30:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/08/24/myeloma-party-of-two-first-responders/</loc>
		<lastmod>2016-08-24T21:32:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/08/22/mohrs-myeloma-musings-just-livin-the-dream/</loc>
		<lastmod>2016-08-22T21:15:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/08/16/myeloma-dispatches-the-gift-of-blood/</loc>
		<lastmod>2016-08-16T21:14:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/08/08/seans-burgundy-thread-multiple-myelathon/</loc>
		<lastmod>2016-08-08T20:35:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/08/02/myeloma-rocket-scientist-reflections-on-harold-macmillan-and-multiple-myeloma/</loc>
		<lastmod>2016-08-02T20:17:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/07/28/myeloma-party-of-two-the-easy-button/</loc>
		<lastmod>2016-07-29T00:14:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/07/25/northern-lights-changing-circumstances-changing-plans/</loc>
		<lastmod>2016-07-25T17:46:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/07/21/mohrs-myeloma-musings-you-aint-so-bad/</loc>
		<lastmod>2016-07-21T20:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/07/14/asco-2016-multiples-myelom-update-posterprasentationen-aktuelle-myelomtherapien-schwelendes-myelom/</loc>
		<lastmod>2016-07-14T19:04:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/06/22/asco-2016-multiples-myelom-update-tage-vier-funf-potenzielle-neue-myelomtherapien/</loc>
		<lastmod>2016-07-13T20:17:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/07/12/myeloma-lessons-time/</loc>
		<lastmod>2016-07-12T17:50:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/06/03/myeloma-dispatches-questions-and-answers/</loc>
		<lastmod>2016-07-06T15:28:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/07/02/myeloma-rocket-scientist-conditional-luck/</loc>
		<lastmod>2016-07-02T17:07:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/06/myeloma-morning-darzalex-ym155-sendai-virus-argonaute2/</loc>
		<lastmod>2016-07-01T21:45:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/06/29/myeloma-party-of-two-dichotomy/</loc>
		<lastmod>2016-06-29T22:01:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/21/mohrs-myeloma-musings-a-family-affair/</loc>
		<lastmod>2016-06-27T21:13:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/06/21/letters-from-cancerland-a-different-n-of-1/</loc>
		<lastmod>2016-06-21T17:37:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/06/18/myeloma-in-paradise-planning/</loc>
		<lastmod>2016-06-18T16:37:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/13/myeloma-in-paradise-when-to-get-a-stem-cell-transplant/</loc>
		<lastmod>2016-06-18T16:20:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/06/16/northern-lights-dreamcatchers/</loc>
		<lastmod>2016-06-16T19:01:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2016-multiple-myeloma-oral-presentations/</loc>
		<lastmod>2016-06-15T15:11:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/06/10/seans-burgundy-thread-bad-blood-and-redbuds/</loc>
		<lastmod>2016-06-10T17:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2016-multiple-myeloma-poster-presentations/</loc>
		<lastmod>2016-06-10T02:38:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2016-multiple-myeloma-satellite-symposia/</loc>
		<lastmod>2016-06-09T06:42:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2016-multiple-myeloma-eabstracts/</loc>
		<lastmod>2016-06-03T16:23:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/06/02/pomalyst-compassionate-use-umbilical-cord-blood-transplants/</loc>
		<lastmod>2016-06-02T21:54:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/09/arnies-rebounding-world-the-one-thing-i-wont-do/</loc>
		<lastmod>2016-06-02T14:35:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1834/</loc>
		<lastmod>2016-06-02T06:34:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/30/myeloma-party-of-two-the-real-must-see-tv/</loc>
		<lastmod>2016-05-30T18:53:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/05/26/darzalex-daratumumab-europa-zulassung/</loc>
		<lastmod>2016-05-26T15:25:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/29/serum-albumin-levels-indicate-severity-of-multiple-myeloma/</loc>
		<lastmod>2016-05-26T01:41:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/05/25/myeloma-rocket-scientist-of-trees-and-reset-buttons/</loc>
		<lastmod>2016-05-25T18:36:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/09/pomalidomide-imnovid-pomalyst-europe-ema-approval-multiple-myeloma/</loc>
		<lastmod>2016-05-24T21:36:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/05/23/myeloma-morning-transplants-kidney-impairment-older-patients/</loc>
		<lastmod>2016-05-23T15:44:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/05/16/myeloma-morning-allogene-stammzelltransplantantion-europa-multiples-myelom/</loc>
		<lastmod>2016-05-16T20:47:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/29/myeloma-morning-marizomib-osteoblast-osteoclast-precursors/</loc>
		<lastmod>2016-04-30T03:07:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/27/myeloma-party-of-two-mea-culpa/</loc>
		<lastmod>2016-04-27T16:59:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/26/myeloma-morning-mmset-igf-spep-ebmt-2016/</loc>
		<lastmod>2016-04-27T04:03:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/25/myeloma-morning-monoclonal-gammopathy-renal-significance-mgrs/</loc>
		<lastmod>2016-04-26T00:44:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/24/myeloma-morning-abscopal-effect-demographics-clinical-trial-participants/</loc>
		<lastmod>2016-04-25T01:29:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/04/22/myeloma-morning-uberlebensdaten-multiples-myeloma-pomalyst-imnovid-mgus/</loc>
		<lastmod>2016-04-22T20:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/04/19/myeloma-morning-myelomzellen-stammzellreinfusionen-cytoxan-mobilisierung/</loc>
		<lastmod>2016-04-19T18:59:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/17/myeloma-morning-lansoprazole-prevacid-saracatinib-bone-disease/</loc>
		<lastmod>2016-04-17T21:50:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/13/myeloma-morning-ccf642-pdi-inhibition/</loc>
		<lastmod>2016-04-13T22:37:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/13/northern-lights-spring-break-in-reykjavik/</loc>
		<lastmod>2016-04-13T08:53:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/12/myeloma-morning-post-transplant-outcomes-soliris-tma-ccf642/</loc>
		<lastmod>2016-04-12T21:12:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/04/myeloma-morning-b-cells-multiple-myeloma-gep-translation/</loc>
		<lastmod>2016-04-12T02:25:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/02/myeloma-morning-treating-relapse-second-primary-malignancies/</loc>
		<lastmod>2016-04-12T02:25:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/29/myeloma-morning-pomalyst-kidney-impairment-treatment-heavy-light-levels/</loc>
		<lastmod>2016-04-12T02:23:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/26/myeloma-morning-mgus-smoldering-progression-dialysis-independence/</loc>
		<lastmod>2016-04-12T02:21:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/25/myeloma-morning-extramedullary-disease-zarxio-neupogen/</loc>
		<lastmod>2016-04-12T02:21:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/03/24/myeloma-morning-imwg-high-risk-cytogenetics/</loc>
		<lastmod>2016-04-12T02:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/06/myeloma-morning-allogeneic-transplantation-treatment-older-patients/</loc>
		<lastmod>2016-04-12T02:16:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/08/myeloma-morning-ccf642-bda-366-payloads-on-platelets/</loc>
		<lastmod>2016-04-12T02:14:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/10/myeloma-morning-genetics-velcade-peripheral-neuropathy/</loc>
		<lastmod>2016-04-12T02:12:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/04/11/myeloma-morning-revlimid-kidney-damage-velcade-retreatment/</loc>
		<lastmod>2016-04-12T02:10:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/04/11/myeloma-morning-darzalex-zulassung-europa-allogene-transplantation/</loc>
		<lastmod>2016-04-11T13:44:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/04/07/myeloma-morning-imwg-konsens-risikoreiche-zytogenetik-marizomib/</loc>
		<lastmod>2016-04-11T13:01:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/17/letters-from-cancerland-to-number-our-days/</loc>
		<lastmod>2016-04-10T23:08:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/22/mohrs-myeloma-musings-still-sleeping/</loc>
		<lastmod>2016-04-10T23:07:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2016/04/06/myeloma-morning-nexavar-mig-wirbelsaulenverletzungen-mangos/</loc>
		<lastmod>2016-04-06T15:42:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/04/06/seans-burgundy-thread-long-live-the-king/</loc>
		<lastmod>2016-04-06T08:57:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/university-of-arkansas-for-medical-sciences/</loc>
		<lastmod>2016-03-25T18:16:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3103-2/</loc>
		<lastmod>2016-03-25T13:37:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/24/myeloma-rocket-scientist-a-walter-cronkite-moment/</loc>
		<lastmod>2016-03-24T21:24:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/dana-farber-cancer-institute/</loc>
		<lastmod>2016-03-16T19:00:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/tufts-medical-center/</loc>
		<lastmod>2016-03-16T19:00:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/massachusetts-general-hospital-cancer-center/</loc>
		<lastmod>2016-03-16T18:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/15/myeloma-in-paradise-too-busy-to-be-sick/</loc>
		<lastmod>2016-03-15T14:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-colorado-cancer-center/</loc>
		<lastmod>2016-03-14T01:56:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/11/northern-lights-my-fiftieth-column-a-milestone/</loc>
		<lastmod>2016-03-11T20:40:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/18/bt-062-shows-activity-in-patients-with-advanced-myeloma-ash-2011/</loc>
		<lastmod>2016-03-10T20:58:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/31/myeloma-lessons-this-was-a-real-surprise/</loc>
		<lastmod>2016-03-09T14:31:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/03/myeloma-dispatches-worst-birthday-ever-or-not/</loc>
		<lastmod>2016-03-03T19:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/03/01/seans-burgundy-thread-blue-skies/</loc>
		<lastmod>2016-03-01T19:49:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/25/myeloma-rocket-scientist-calibration/</loc>
		<lastmod>2016-02-26T14:05:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/23/myeloma-party-of-two-and-the-oscar-goes-to/</loc>
		<lastmod>2016-02-23T14:37:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/19/mohrs-myeloma-musings-my-three-rs/</loc>
		<lastmod>2016-02-19T17:12:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/17/letters-from-cancerland-its-complicated/</loc>
		<lastmod>2016-02-17T15:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/15/northern-lights-winter-dreams/</loc>
		<lastmod>2016-02-15T11:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2016/02/11/remembering-pat-killingsworth/</loc>
		<lastmod>2016-02-12T03:43:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/04/23/pats-place-introducing-my-myeloma-column/</loc>
		<lastmod>2016-02-11T02:32:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/10/seans-burgundy-thread-give-me-a-k/</loc>
		<lastmod>2016-02-10T16:49:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/08/myeloma-dispatches-lessons-learned/</loc>
		<lastmod>2016-02-08T20:41:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/06/myeloma-lessons-decisions-decisions/</loc>
		<lastmod>2016-02-06T19:28:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/04/pats-place-dare-i-dream-again/</loc>
		<lastmod>2016-02-04T17:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/02/02/myeloma-in-paradise-this-ride-never-ends/</loc>
		<lastmod>2016-02-02T22:26:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/12/arnies-rebounding-world-my-stem-cell-transplant/</loc>
		<lastmod>2016-01-27T16:11:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/01/25/mohrs-myeloma-musings-climbing-that-mountain/</loc>
		<lastmod>2016-01-25T23:46:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/01/15/letters-from-cancerland-port-of-call/</loc>
		<lastmod>2016-01-15T15:57:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/01/12/northern-lights-my-myeloma-resolutions-for-2016/</loc>
		<lastmod>2016-01-12T22:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/01/09/myeloma-dispatches-in-between-times/</loc>
		<lastmod>2016-01-09T15:06:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2016/01/07/seans-burgundy-thread-rainy-days-and-myeloma-ways/</loc>
		<lastmod>2016-01-07T15:59:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/31/mohrs-myeloma-musings-waiting-games/</loc>
		<lastmod>2015-12-31T19:53:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/28/myeloma-party-of-two-letters-to-santa/</loc>
		<lastmod>2015-12-28T19:24:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/23/myeloma-party-of-two-the-things-we-carry/</loc>
		<lastmod>2015-12-28T19:10:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/20/</loc>
		<lastmod>2015-12-28T17:04:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/25/happy-holidays-5/</loc>
		<lastmod>2015-12-25T14:19:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/23/pats-place-holiday-cheer/</loc>
		<lastmod>2015-12-23T20:30:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/21/letters-from-cancerland-of-time-and-light/</loc>
		<lastmod>2015-12-21T19:23:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/375/</loc>
		<lastmod>2015-12-20T23:02:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4176/</loc>
		<lastmod>2015-12-20T14:17:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/28/</loc>
		<lastmod>2015-12-19T18:50:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4193/</loc>
		<lastmod>2015-12-19T13:29:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1857-2/</loc>
		<lastmod>2015-12-18T18:14:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3174-2/</loc>
		<lastmod>2015-12-18T15:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/18/myeloma-lessons-you-cant-make-this-stuff-up/</loc>
		<lastmod>2015-12-18T13:50:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/15/myeloma-rocket-scientist-apollo-8-versus-apollo-13/</loc>
		<lastmod>2015-12-15T15:19:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4241/</loc>
		<lastmod>2015-12-15T14:39:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3055/</loc>
		<lastmod>2015-12-14T23:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3040/</loc>
		<lastmod>2015-12-14T22:27:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/507/</loc>
		<lastmod>2015-12-14T14:54:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/396/</loc>
		<lastmod>2015-12-14T13:25:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4498/</loc>
		<lastmod>2015-12-13T20:44:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/29/</loc>
		<lastmod>2015-12-13T20:24:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3029/</loc>
		<lastmod>2015-12-11T21:27:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/634/</loc>
		<lastmod>2015-12-10T20:16:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/633/</loc>
		<lastmod>2015-12-10T20:13:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/10/northern-lights-stocking-stuffers/</loc>
		<lastmod>2015-12-10T17:12:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4246/</loc>
		<lastmod>2015-12-10T16:21:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2955/</loc>
		<lastmod>2015-12-10T16:21:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/es1-2/</loc>
		<lastmod>2015-12-10T16:21:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2965/</loc>
		<lastmod>2015-12-10T16:21:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3258/</loc>
		<lastmod>2015-12-10T16:20:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3926/</loc>
		<lastmod>2015-12-10T16:19:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4252/</loc>
		<lastmod>2015-12-10T16:17:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2982/</loc>
		<lastmod>2015-12-10T14:29:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2114/</loc>
		<lastmod>2015-12-10T14:27:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4258/</loc>
		<lastmod>2015-12-10T14:14:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1845-2/</loc>
		<lastmod>2015-12-10T14:09:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4501/</loc>
		<lastmod>2015-12-10T14:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1767/</loc>
		<lastmod>2015-12-10T14:04:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1789/</loc>
		<lastmod>2015-12-10T06:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3046/</loc>
		<lastmod>2015-12-10T06:07:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3043/</loc>
		<lastmod>2015-12-10T06:07:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2321/</loc>
		<lastmod>2015-12-10T06:07:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/727/</loc>
		<lastmod>2015-12-10T06:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4236/</loc>
		<lastmod>2015-12-10T06:07:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3012/</loc>
		<lastmod>2015-12-10T06:07:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/730/</loc>
		<lastmod>2015-12-10T06:05:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1121-2/</loc>
		<lastmod>2015-12-10T06:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4240/</loc>
		<lastmod>2015-12-10T06:05:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3700/</loc>
		<lastmod>2015-12-10T06:05:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3030/</loc>
		<lastmod>2015-12-10T06:05:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1848-2/</loc>
		<lastmod>2015-12-10T06:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/505/</loc>
		<lastmod>2015-12-10T06:05:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3047/</loc>
		<lastmod>2015-12-10T06:05:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4255/</loc>
		<lastmod>2015-12-10T06:05:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1975-2/</loc>
		<lastmod>2015-12-10T06:05:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4243/</loc>
		<lastmod>2015-12-10T06:05:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/25/</loc>
		<lastmod>2015-12-10T06:05:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4239/</loc>
		<lastmod>2015-12-10T06:05:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2966/</loc>
		<lastmod>2015-12-10T06:05:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2085/</loc>
		<lastmod>2015-12-10T06:05:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3155-2/</loc>
		<lastmod>2015-12-10T06:05:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4226-2/</loc>
		<lastmod>2015-12-10T06:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3193-2/</loc>
		<lastmod>2015-12-10T06:04:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1838/</loc>
		<lastmod>2015-12-10T06:02:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3033/</loc>
		<lastmod>2015-12-10T06:02:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1769/</loc>
		<lastmod>2015-12-10T06:02:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/392/</loc>
		<lastmod>2015-12-10T06:02:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3304/</loc>
		<lastmod>2015-12-10T06:02:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4264/</loc>
		<lastmod>2015-12-10T06:02:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4217/</loc>
		<lastmod>2015-12-10T06:02:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2203/</loc>
		<lastmod>2015-12-10T06:02:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1982-2/</loc>
		<lastmod>2015-12-10T06:02:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/731/</loc>
		<lastmod>2015-12-10T06:02:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/187/</loc>
		<lastmod>2015-12-10T06:02:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1842-2/</loc>
		<lastmod>2015-12-10T06:02:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1977-2/</loc>
		<lastmod>2015-12-10T06:02:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4174/</loc>
		<lastmod>2015-12-10T05:54:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3034/</loc>
		<lastmod>2015-12-10T05:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3309/</loc>
		<lastmod>2015-12-10T05:50:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/26/</loc>
		<lastmod>2015-12-10T05:17:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1993/</loc>
		<lastmod>2015-12-10T05:05:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/391/</loc>
		<lastmod>2015-12-10T05:04:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/395/</loc>
		<lastmod>2015-12-10T05:02:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/es2-2/</loc>
		<lastmod>2015-12-10T05:02:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2960/</loc>
		<lastmod>2015-12-10T05:02:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/27/</loc>
		<lastmod>2015-12-10T05:02:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1974-2/</loc>
		<lastmod>2015-12-10T05:02:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3187-2/</loc>
		<lastmod>2015-12-10T05:01:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2975/</loc>
		<lastmod>2015-12-10T02:51:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4219-2/</loc>
		<lastmod>2015-12-10T02:51:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3038/</loc>
		<lastmod>2015-12-10T02:51:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/258/</loc>
		<lastmod>2015-12-10T02:45:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3017/</loc>
		<lastmod>2015-12-10T02:45:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3683/</loc>
		<lastmod>2015-12-10T02:45:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3048/</loc>
		<lastmod>2015-12-10T02:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4223-2/</loc>
		<lastmod>2015-12-10T02:45:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1827/</loc>
		<lastmod>2015-12-10T02:45:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4228-2/</loc>
		<lastmod>2015-12-10T02:45:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/506-2/</loc>
		<lastmod>2015-12-10T02:44:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3015/</loc>
		<lastmod>2015-12-10T02:44:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3035/</loc>
		<lastmod>2015-12-10T02:44:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1821/</loc>
		<lastmod>2015-12-10T02:43:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4220/</loc>
		<lastmod>2015-12-10T02:43:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1801/</loc>
		<lastmod>2015-12-10T02:43:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/376/</loc>
		<lastmod>2015-12-10T02:43:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/728/</loc>
		<lastmod>2015-12-10T02:43:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4253/</loc>
		<lastmod>2015-12-10T02:42:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/509/</loc>
		<lastmod>2015-12-10T02:42:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/191/</loc>
		<lastmod>2015-12-10T02:35:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/515/</loc>
		<lastmod>2015-12-10T02:34:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1835/</loc>
		<lastmod>2015-12-10T02:32:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1852-2/</loc>
		<lastmod>2015-12-10T02:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1818/</loc>
		<lastmod>2015-12-10T02:00:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3053/</loc>
		<lastmod>2015-12-10T02:00:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4257/</loc>
		<lastmod>2015-12-10T02:00:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1819/</loc>
		<lastmod>2015-12-10T01:59:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4208/</loc>
		<lastmod>2015-12-10T01:58:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3001/</loc>
		<lastmod>2015-12-10T01:58:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1816/</loc>
		<lastmod>2015-12-10T01:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3250-2/</loc>
		<lastmod>2015-12-10T01:55:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3020/</loc>
		<lastmod>2015-12-10T01:55:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4265/</loc>
		<lastmod>2015-12-10T01:55:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1278/</loc>
		<lastmod>2015-12-10T01:53:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/378/</loc>
		<lastmod>2015-12-10T01:52:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3051/</loc>
		<lastmod>2015-12-10T01:50:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2084/</loc>
		<lastmod>2015-12-10T01:50:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/377/</loc>
		<lastmod>2015-12-10T01:50:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1854-2/</loc>
		<lastmod>2015-12-10T01:50:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1844-2/</loc>
		<lastmod>2015-12-10T01:49:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1286/</loc>
		<lastmod>2015-12-10T01:49:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/729/</loc>
		<lastmod>2015-12-10T01:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/30/</loc>
		<lastmod>2015-12-10T01:49:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4250/</loc>
		<lastmod>2015-12-10T01:49:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1825/</loc>
		<lastmod>2015-12-10T01:49:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1840/</loc>
		<lastmod>2015-12-10T01:49:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1907-2/</loc>
		<lastmod>2015-12-10T01:49:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/373/</loc>
		<lastmod>2015-12-10T01:49:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4215/</loc>
		<lastmod>2015-12-10T01:49:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4235/</loc>
		<lastmod>2015-12-10T01:49:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3028/</loc>
		<lastmod>2015-12-10T01:49:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1828/</loc>
		<lastmod>2015-12-10T01:49:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3052/</loc>
		<lastmod>2015-12-10T01:49:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4259/</loc>
		<lastmod>2015-12-10T01:49:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3021/</loc>
		<lastmod>2015-12-10T01:49:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4260/</loc>
		<lastmod>2015-12-10T01:49:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1902-2/</loc>
		<lastmod>2015-12-10T01:49:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/450/</loc>
		<lastmod>2015-12-10T01:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1772/</loc>
		<lastmod>2015-12-10T01:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4506/</loc>
		<lastmod>2015-12-10T01:49:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4230/</loc>
		<lastmod>2015-12-10T01:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4234/</loc>
		<lastmod>2015-12-10T01:48:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/914-2/</loc>
		<lastmod>2015-12-10T01:48:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3036/</loc>
		<lastmod>2015-12-10T01:48:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1971-2/</loc>
		<lastmod>2015-12-10T01:48:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4256/</loc>
		<lastmod>2015-12-10T01:48:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2986/</loc>
		<lastmod>2015-12-10T01:48:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1846-2/</loc>
		<lastmod>2015-12-10T01:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1765/</loc>
		<lastmod>2015-12-10T01:48:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4296/</loc>
		<lastmod>2015-12-10T01:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3023/</loc>
		<lastmod>2015-12-10T01:48:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1826/</loc>
		<lastmod>2015-12-10T01:48:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4233/</loc>
		<lastmod>2015-12-10T01:48:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1850-2/</loc>
		<lastmod>2015-12-10T01:48:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4504/</loc>
		<lastmod>2015-12-10T01:48:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/499/</loc>
		<lastmod>2015-12-10T01:48:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3027/</loc>
		<lastmod>2015-12-10T01:48:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3014/</loc>
		<lastmod>2015-12-10T01:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3026/</loc>
		<lastmod>2015-12-10T01:47:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1981/</loc>
		<lastmod>2015-12-10T01:47:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3181-2/</loc>
		<lastmod>2015-12-10T01:47:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4247/</loc>
		<lastmod>2015-12-10T01:47:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2480/</loc>
		<lastmod>2015-12-10T01:47:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1832/</loc>
		<lastmod>2015-12-10T01:47:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/316/</loc>
		<lastmod>2015-12-10T01:47:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/393/</loc>
		<lastmod>2015-12-10T01:47:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4213/</loc>
		<lastmod>2015-12-10T01:47:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/510/</loc>
		<lastmod>2015-12-10T01:47:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3032/</loc>
		<lastmod>2015-12-10T01:47:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4221/</loc>
		<lastmod>2015-12-10T01:47:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4227/</loc>
		<lastmod>2015-12-10T01:47:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3050/</loc>
		<lastmod>2015-12-10T01:47:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2972/</loc>
		<lastmod>2015-12-10T01:40:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1782/</loc>
		<lastmod>2015-12-10T01:40:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/367/</loc>
		<lastmod>2015-12-10T01:40:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4181/</loc>
		<lastmod>2015-12-10T01:40:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/721/</loc>
		<lastmod>2015-12-10T01:40:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2963/</loc>
		<lastmod>2015-12-10T01:40:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4192/</loc>
		<lastmod>2015-12-10T01:40:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2985/</loc>
		<lastmod>2015-12-10T01:40:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/sci-52/</loc>
		<lastmod>2015-12-10T01:40:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2979-2/</loc>
		<lastmod>2015-12-10T01:40:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1760/</loc>
		<lastmod>2015-12-10T01:40:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4202/</loc>
		<lastmod>2015-12-10T01:40:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1788/</loc>
		<lastmod>2015-12-10T01:40:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4212/</loc>
		<lastmod>2015-12-10T01:39:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2030-2/</loc>
		<lastmod>2015-12-10T01:36:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4373/</loc>
		<lastmod>2015-12-10T01:36:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4324/</loc>
		<lastmod>2015-12-10T01:36:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1968-2/</loc>
		<lastmod>2015-12-10T01:36:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3213-2/</loc>
		<lastmod>2015-12-10T01:36:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1942-2/</loc>
		<lastmod>2015-12-10T01:36:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4394/</loc>
		<lastmod>2015-12-10T01:36:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/929-2/</loc>
		<lastmod>2015-12-10T01:36:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3152-2/</loc>
		<lastmod>2015-12-10T01:36:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4396/</loc>
		<lastmod>2015-12-10T01:36:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4332/</loc>
		<lastmod>2015-12-10T01:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3031/</loc>
		<lastmod>2015-12-10T01:18:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/508/</loc>
		<lastmod>2015-12-10T01:18:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4225/</loc>
		<lastmod>2015-12-10T01:18:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1858-2/</loc>
		<lastmod>2015-12-10T01:18:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/374/</loc>
		<lastmod>2015-12-10T01:18:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1831/</loc>
		<lastmod>2015-12-10T01:18:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1853-2/</loc>
		<lastmod>2015-12-10T01:18:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4232/</loc>
		<lastmod>2015-12-10T01:18:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2964/</loc>
		<lastmod>2015-12-09T22:31:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3024/</loc>
		<lastmod>2015-12-09T22:31:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4308/</loc>
		<lastmod>2015-12-09T19:06:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1781/</loc>
		<lastmod>2015-12-09T19:06:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2988/</loc>
		<lastmod>2015-12-09T19:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4200-2/</loc>
		<lastmod>2015-12-09T19:06:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1837/</loc>
		<lastmod>2015-12-09T19:06:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4261/</loc>
		<lastmod>2015-12-09T19:06:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4305/</loc>
		<lastmod>2015-12-09T19:06:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1851-2/</loc>
		<lastmod>2015-12-09T19:06:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3025/</loc>
		<lastmod>2015-12-09T19:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1824/</loc>
		<lastmod>2015-12-09T19:05:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4519/</loc>
		<lastmod>2015-12-09T19:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3056/</loc>
		<lastmod>2015-12-09T19:05:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3189-2/</loc>
		<lastmod>2015-12-09T19:05:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4179/</loc>
		<lastmod>2015-12-09T19:05:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4190/</loc>
		<lastmod>2015-12-09T19:05:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1792/</loc>
		<lastmod>2015-12-09T19:05:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1849-2/</loc>
		<lastmod>2015-12-09T19:05:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2993/</loc>
		<lastmod>2015-12-09T19:05:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1893-2/</loc>
		<lastmod>2015-12-09T19:05:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2400/</loc>
		<lastmod>2015-12-09T19:05:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4270/</loc>
		<lastmod>2015-12-09T19:05:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4502/</loc>
		<lastmod>2015-12-09T19:05:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1802/</loc>
		<lastmod>2015-12-09T19:05:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1990-2/</loc>
		<lastmod>2015-12-09T19:05:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1787/</loc>
		<lastmod>2015-12-09T19:05:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1839/</loc>
		<lastmod>2015-12-09T19:05:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4186/</loc>
		<lastmod>2015-12-09T19:05:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1798/</loc>
		<lastmod>2015-12-09T19:05:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3182-2/</loc>
		<lastmod>2015-12-09T19:05:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4231/</loc>
		<lastmod>2015-12-09T19:05:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3321/</loc>
		<lastmod>2015-12-09T19:05:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3628-2/</loc>
		<lastmod>2015-12-09T19:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2994/</loc>
		<lastmod>2015-12-09T19:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2100/</loc>
		<lastmod>2015-12-09T19:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4182/</loc>
		<lastmod>2015-12-09T19:05:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2967/</loc>
		<lastmod>2015-12-09T19:05:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3010/</loc>
		<lastmod>2015-12-09T19:05:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1799/</loc>
		<lastmod>2015-12-09T19:05:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3022/</loc>
		<lastmod>2015-12-09T19:05:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2116/</loc>
		<lastmod>2015-12-09T19:05:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3294/</loc>
		<lastmod>2015-12-09T19:05:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3626/</loc>
		<lastmod>2015-12-09T19:05:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3200-2/</loc>
		<lastmod>2015-12-09T19:05:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3005/</loc>
		<lastmod>2015-12-09T19:05:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3243/</loc>
		<lastmod>2015-12-09T19:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4206/</loc>
		<lastmod>2015-12-09T19:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3138-2/</loc>
		<lastmod>2015-12-09T19:04:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3325/</loc>
		<lastmod>2015-12-09T19:04:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1886-2/</loc>
		<lastmod>2015-12-09T19:04:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3101-2/</loc>
		<lastmod>2015-12-09T19:04:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4185/</loc>
		<lastmod>2015-12-09T19:04:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4521-2/</loc>
		<lastmod>2015-12-09T19:04:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2958/</loc>
		<lastmod>2015-12-09T19:04:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2984/</loc>
		<lastmod>2015-12-09T19:04:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3006/</loc>
		<lastmod>2015-12-09T19:04:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1795/</loc>
		<lastmod>2015-12-09T19:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1806/</loc>
		<lastmod>2015-12-09T19:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1924-2/</loc>
		<lastmod>2015-12-09T19:04:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1812/</loc>
		<lastmod>2015-12-09T19:04:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4515/</loc>
		<lastmod>2015-12-09T19:04:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2987/</loc>
		<lastmod>2015-12-09T19:04:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2992/</loc>
		<lastmod>2015-12-09T19:04:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1755/</loc>
		<lastmod>2015-12-09T19:04:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3045/</loc>
		<lastmod>2015-12-09T19:04:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3194/</loc>
		<lastmod>2015-12-09T19:04:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3089-2/</loc>
		<lastmod>2015-12-09T19:04:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4188/</loc>
		<lastmod>2015-12-09T19:04:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1023/</loc>
		<lastmod>2015-12-09T19:04:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4214/</loc>
		<lastmod>2015-12-09T19:04:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1805/</loc>
		<lastmod>2015-12-09T19:04:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4210/</loc>
		<lastmod>2015-12-09T19:04:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4187/</loc>
		<lastmod>2015-12-09T19:04:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1817/</loc>
		<lastmod>2015-12-09T19:04:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2448/</loc>
		<lastmod>2015-12-09T19:04:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1762/</loc>
		<lastmod>2015-12-09T19:04:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2105/</loc>
		<lastmod>2015-12-09T19:04:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3002/</loc>
		<lastmod>2015-12-09T19:04:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4229/</loc>
		<lastmod>2015-12-09T19:04:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4222/</loc>
		<lastmod>2015-12-09T19:04:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3180-2/</loc>
		<lastmod>2015-12-09T19:04:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3567/</loc>
		<lastmod>2015-12-09T19:04:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3190-2/</loc>
		<lastmod>2015-12-09T19:04:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4194/</loc>
		<lastmod>2015-12-09T19:04:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1783/</loc>
		<lastmod>2015-12-09T19:04:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1811/</loc>
		<lastmod>2015-12-09T19:04:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1989-2/</loc>
		<lastmod>2015-12-09T19:04:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1925-2/</loc>
		<lastmod>2015-12-09T19:04:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4189/</loc>
		<lastmod>2015-12-09T19:04:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1856-2/</loc>
		<lastmod>2015-12-09T19:04:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3009/</loc>
		<lastmod>2015-12-09T19:04:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1764/</loc>
		<lastmod>2015-12-09T19:04:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4314/</loc>
		<lastmod>2015-12-09T19:04:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1756/</loc>
		<lastmod>2015-12-09T19:01:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4242/</loc>
		<lastmod>2015-12-09T19:01:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3709/</loc>
		<lastmod>2015-12-09T19:01:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1796/</loc>
		<lastmod>2015-12-09T19:01:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4211/</loc>
		<lastmod>2015-12-09T19:01:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3170-2/</loc>
		<lastmod>2015-12-09T19:01:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1829/</loc>
		<lastmod>2015-12-09T19:01:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2484/</loc>
		<lastmod>2015-12-09T19:01:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4178/</loc>
		<lastmod>2015-12-09T19:01:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3044/</loc>
		<lastmod>2015-12-09T19:01:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1843-2/</loc>
		<lastmod>2015-12-09T19:01:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2420/</loc>
		<lastmod>2015-12-09T19:01:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1855-2/</loc>
		<lastmod>2015-12-09T19:01:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4514/</loc>
		<lastmod>2015-12-09T19:01:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3007/</loc>
		<lastmod>2015-12-09T19:01:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1809/</loc>
		<lastmod>2015-12-09T19:01:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2997/</loc>
		<lastmod>2015-12-09T19:01:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3247/</loc>
		<lastmod>2015-12-09T19:01:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2989-2/</loc>
		<lastmod>2015-12-09T19:01:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1810/</loc>
		<lastmod>2015-12-09T19:01:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2995/</loc>
		<lastmod>2015-12-09T19:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1847-2/</loc>
		<lastmod>2015-12-09T19:01:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4177/</loc>
		<lastmod>2015-12-09T19:01:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4196/</loc>
		<lastmod>2015-12-09T19:01:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4209/</loc>
		<lastmod>2015-12-09T19:01:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3540/</loc>
		<lastmod>2015-12-09T19:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3175/</loc>
		<lastmod>2015-12-09T19:00:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2475/</loc>
		<lastmod>2015-12-09T19:00:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1996/</loc>
		<lastmod>2015-12-09T19:00:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2976/</loc>
		<lastmod>2015-12-09T19:00:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2419/</loc>
		<lastmod>2015-12-09T19:00:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1953-2/</loc>
		<lastmod>2015-12-09T19:00:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1815/</loc>
		<lastmod>2015-12-09T19:00:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/952/</loc>
		<lastmod>2015-12-09T19:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4248/</loc>
		<lastmod>2015-12-09T19:00:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2969/</loc>
		<lastmod>2015-12-09T19:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2996/</loc>
		<lastmod>2015-12-09T19:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3292/</loc>
		<lastmod>2015-12-09T19:00:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1822/</loc>
		<lastmod>2015-12-09T19:00:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3003/</loc>
		<lastmod>2015-12-09T19:00:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1803/</loc>
		<lastmod>2015-12-09T19:00:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1973-2/</loc>
		<lastmod>2015-12-09T19:00:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4224/</loc>
		<lastmod>2015-12-09T19:00:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2977/</loc>
		<lastmod>2015-12-09T19:00:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1979-2/</loc>
		<lastmod>2015-12-09T19:00:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3039/</loc>
		<lastmod>2015-12-09T19:00:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1900/</loc>
		<lastmod>2015-12-09T19:00:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3099-2/</loc>
		<lastmod>2015-12-09T19:00:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4207/</loc>
		<lastmod>2015-12-09T19:00:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3011/</loc>
		<lastmod>2015-12-09T19:00:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3059/</loc>
		<lastmod>2015-12-09T19:00:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2103/</loc>
		<lastmod>2015-12-09T19:00:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4203/</loc>
		<lastmod>2015-12-09T19:00:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4173/</loc>
		<lastmod>2015-12-09T19:00:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4297/</loc>
		<lastmod>2015-12-09T19:00:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3058/</loc>
		<lastmod>2015-12-09T19:00:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2974/</loc>
		<lastmod>2015-12-09T19:00:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2049/</loc>
		<lastmod>2015-12-09T19:00:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2954/</loc>
		<lastmod>2015-12-09T19:00:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4244/</loc>
		<lastmod>2015-12-09T19:00:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3018/</loc>
		<lastmod>2015-12-09T19:00:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1785/</loc>
		<lastmod>2015-12-09T18:59:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4440-2/</loc>
		<lastmod>2015-12-09T18:59:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4263/</loc>
		<lastmod>2015-12-09T18:59:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2346/</loc>
		<lastmod>2015-12-09T18:59:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4180/</loc>
		<lastmod>2015-12-09T18:59:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3315/</loc>
		<lastmod>2015-12-09T18:59:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3311/</loc>
		<lastmod>2015-12-09T18:59:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1758/</loc>
		<lastmod>2015-12-09T18:59:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3633/</loc>
		<lastmod>2015-12-09T18:59:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2060/</loc>
		<lastmod>2015-12-09T18:59:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3000/</loc>
		<lastmod>2015-12-09T18:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4436-2/</loc>
		<lastmod>2015-12-09T18:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1797/</loc>
		<lastmod>2015-12-09T18:59:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1768/</loc>
		<lastmod>2015-12-09T18:59:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1966-2/</loc>
		<lastmod>2015-12-09T18:59:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4195/</loc>
		<lastmod>2015-12-09T18:59:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1793/</loc>
		<lastmod>2015-12-09T18:59:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3203-2/</loc>
		<lastmod>2015-12-09T18:59:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3257/</loc>
		<lastmod>2015-12-09T18:59:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3042/</loc>
		<lastmod>2015-12-09T18:59:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4184/</loc>
		<lastmod>2015-12-09T18:59:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3251/</loc>
		<lastmod>2015-12-09T18:59:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1898-2/</loc>
		<lastmod>2015-12-09T18:59:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1808/</loc>
		<lastmod>2015-12-09T18:59:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2704/</loc>
		<lastmod>2015-12-09T18:59:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1759/</loc>
		<lastmod>2015-12-09T18:59:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3249/</loc>
		<lastmod>2015-12-09T18:59:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1991/</loc>
		<lastmod>2015-12-09T18:59:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4238/</loc>
		<lastmod>2015-12-09T18:59:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1776/</loc>
		<lastmod>2015-12-09T18:59:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4204/</loc>
		<lastmod>2015-12-09T18:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3327-2/</loc>
		<lastmod>2015-12-09T18:59:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1800/</loc>
		<lastmod>2015-12-09T18:59:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3008/</loc>
		<lastmod>2015-12-09T18:59:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3306/</loc>
		<lastmod>2015-12-09T18:59:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1830/</loc>
		<lastmod>2015-12-09T18:59:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4218/</loc>
		<lastmod>2015-12-09T18:59:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2053/</loc>
		<lastmod>2015-12-09T18:59:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4237/</loc>
		<lastmod>2015-12-09T18:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2957/</loc>
		<lastmod>2015-12-09T18:58:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1814/</loc>
		<lastmod>2015-12-09T18:58:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4175/</loc>
		<lastmod>2015-12-09T18:58:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3246/</loc>
		<lastmod>2015-12-09T18:58:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2962/</loc>
		<lastmod>2015-12-09T18:58:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1820/</loc>
		<lastmod>2015-12-09T18:58:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3873/</loc>
		<lastmod>2015-12-09T18:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2970/</loc>
		<lastmod>2015-12-09T18:58:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2086/</loc>
		<lastmod>2015-12-09T18:58:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2001/</loc>
		<lastmod>2015-12-09T18:58:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1794/</loc>
		<lastmod>2015-12-09T18:58:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1771/</loc>
		<lastmod>2015-12-09T18:58:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2961/</loc>
		<lastmod>2015-12-09T18:58:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4356/</loc>
		<lastmod>2015-12-09T18:58:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3013/</loc>
		<lastmod>2015-12-09T18:58:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3966/</loc>
		<lastmod>2015-12-09T18:58:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3094-2/</loc>
		<lastmod>2015-12-09T18:58:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4191/</loc>
		<lastmod>2015-12-09T18:58:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1823/</loc>
		<lastmod>2015-12-09T18:58:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4355/</loc>
		<lastmod>2015-12-09T18:58:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4254/</loc>
		<lastmod>2015-12-09T18:58:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1791/</loc>
		<lastmod>2015-12-09T18:58:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2999/</loc>
		<lastmod>2015-12-09T18:58:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1939-2/</loc>
		<lastmod>2015-12-09T18:58:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3320/</loc>
		<lastmod>2015-12-09T18:58:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3702/</loc>
		<lastmod>2015-12-09T18:58:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4306/</loc>
		<lastmod>2015-12-09T18:58:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2978/</loc>
		<lastmod>2015-12-09T18:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2115-2/</loc>
		<lastmod>2015-12-09T18:58:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1997/</loc>
		<lastmod>2015-12-09T18:57:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4205-2/</loc>
		<lastmod>2015-12-09T18:57:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1766/</loc>
		<lastmod>2015-12-09T18:57:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2959/</loc>
		<lastmod>2015-12-09T18:57:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2983/</loc>
		<lastmod>2015-12-09T18:57:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2402/</loc>
		<lastmod>2015-12-09T18:57:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4495/</loc>
		<lastmod>2015-12-09T18:57:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2143/</loc>
		<lastmod>2015-12-09T18:57:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1763/</loc>
		<lastmod>2015-12-09T18:57:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4249/</loc>
		<lastmod>2015-12-09T18:57:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1218/</loc>
		<lastmod>2015-12-09T18:57:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2093/</loc>
		<lastmod>2015-12-09T18:57:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2991-2/</loc>
		<lastmod>2015-12-09T18:57:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1074/</loc>
		<lastmod>2015-12-09T18:57:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4199/</loc>
		<lastmod>2015-12-09T18:57:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3571/</loc>
		<lastmod>2015-12-09T18:57:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4304/</loc>
		<lastmod>2015-12-09T18:57:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1775/</loc>
		<lastmod>2015-12-09T18:57:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4497/</loc>
		<lastmod>2015-12-09T18:57:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4432-2/</loc>
		<lastmod>2015-12-09T18:57:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3197/</loc>
		<lastmod>2015-12-09T18:57:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3625/</loc>
		<lastmod>2015-12-09T18:57:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1784/</loc>
		<lastmod>2015-12-09T18:57:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2990/</loc>
		<lastmod>2015-12-09T18:57:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4201/</loc>
		<lastmod>2015-12-09T18:57:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2087/</loc>
		<lastmod>2015-12-09T18:57:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3312-2/</loc>
		<lastmod>2015-12-09T18:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1813/</loc>
		<lastmod>2015-12-09T18:57:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3307/</loc>
		<lastmod>2015-12-09T18:57:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3057/</loc>
		<lastmod>2015-12-09T18:57:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2091/</loc>
		<lastmod>2015-12-09T18:57:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1770/</loc>
		<lastmod>2015-12-09T18:57:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4251/</loc>
		<lastmod>2015-12-09T18:57:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2981/</loc>
		<lastmod>2015-12-09T18:57:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3004/</loc>
		<lastmod>2015-12-09T18:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1998/</loc>
		<lastmod>2015-12-09T18:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2980/</loc>
		<lastmod>2015-12-09T18:57:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4516/</loc>
		<lastmod>2015-12-09T18:57:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4198/</loc>
		<lastmod>2015-12-09T18:57:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4183/</loc>
		<lastmod>2015-12-09T18:57:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3176-2/</loc>
		<lastmod>2015-12-09T18:57:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1011/</loc>
		<lastmod>2015-12-09T18:57:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4245/</loc>
		<lastmod>2015-12-09T18:57:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3288/</loc>
		<lastmod>2015-12-09T18:57:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4216/</loc>
		<lastmod>2015-12-09T18:57:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1761/</loc>
		<lastmod>2015-12-09T18:57:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1807/</loc>
		<lastmod>2015-12-09T18:57:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1804/</loc>
		<lastmod>2015-12-09T18:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3019/</loc>
		<lastmod>2015-12-09T18:57:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1988-2/</loc>
		<lastmod>2015-12-09T18:57:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3037/</loc>
		<lastmod>2015-12-09T18:57:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2998/</loc>
		<lastmod>2015-12-09T18:56:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/3297/</loc>
		<lastmod>2015-12-09T18:56:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1780/</loc>
		<lastmod>2015-12-09T18:56:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4508/</loc>
		<lastmod>2015-12-09T18:56:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/4485/</loc>
		<lastmod>2015-12-09T18:56:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1777/</loc>
		<lastmod>2015-12-09T18:56:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2973/</loc>
		<lastmod>2015-12-09T18:56:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/2968-2/</loc>
		<lastmod>2015-12-09T18:56:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/1754/</loc>
		<lastmod>2015-12-09T18:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/22/</loc>
		<lastmod>2015-12-09T18:55:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/838/</loc>
		<lastmod>2015-12-09T18:55:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/628/</loc>
		<lastmod>2015-12-09T18:55:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/836-2/</loc>
		<lastmod>2015-12-09T18:55:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/502/</loc>
		<lastmod>2015-12-09T18:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/879-2/</loc>
		<lastmod>2015-12-09T18:55:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/117/</loc>
		<lastmod>2015-12-09T18:55:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/504/</loc>
		<lastmod>2015-12-09T18:55:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/es3-2/</loc>
		<lastmod>2015-12-09T18:55:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/189/</loc>
		<lastmod>2015-12-09T18:55:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/913/</loc>
		<lastmod>2015-12-09T18:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/501/</loc>
		<lastmod>2015-12-09T18:55:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/sci-53/</loc>
		<lastmod>2015-12-09T18:54:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/21/</loc>
		<lastmod>2015-12-09T18:54:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/874/</loc>
		<lastmod>2015-12-09T18:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/23/</loc>
		<lastmod>2015-12-09T18:54:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/98/</loc>
		<lastmod>2015-12-09T18:54:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/837/</loc>
		<lastmod>2015-12-09T18:54:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/lba-1/</loc>
		<lastmod>2015-12-09T18:54:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/sci-55/</loc>
		<lastmod>2015-12-09T18:54:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/875/</loc>
		<lastmod>2015-12-09T18:54:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/726/</loc>
		<lastmod>2015-12-09T18:54:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/sss3/</loc>
		<lastmod>2015-12-09T18:54:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/500/</loc>
		<lastmod>2015-12-09T18:54:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/371/</loc>
		<lastmod>2015-12-09T18:54:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/120/</loc>
		<lastmod>2015-12-09T18:54:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/839/</loc>
		<lastmod>2015-12-09T18:54:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/370/</loc>
		<lastmod>2015-12-09T18:54:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/116/</loc>
		<lastmod>2015-12-09T18:54:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/368/</loc>
		<lastmod>2015-12-09T18:54:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/784/</loc>
		<lastmod>2015-12-09T18:54:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/115/</loc>
		<lastmod>2015-12-09T18:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/927/</loc>
		<lastmod>2015-12-09T18:53:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/372/</loc>
		<lastmod>2015-12-09T18:53:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/119/</loc>
		<lastmod>2015-12-09T18:53:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/369/</loc>
		<lastmod>2015-12-09T18:53:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/630/</loc>
		<lastmod>2015-12-09T18:53:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/725/</loc>
		<lastmod>2015-12-09T18:53:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/917/</loc>
		<lastmod>2015-12-09T18:53:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/918/</loc>
		<lastmod>2015-12-09T18:53:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/635/</loc>
		<lastmod>2015-12-09T18:53:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/868/</loc>
		<lastmod>2015-12-09T18:53:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/722/</loc>
		<lastmod>2015-12-09T18:53:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/118/</loc>
		<lastmod>2015-12-09T18:53:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/916/</loc>
		<lastmod>2015-12-09T18:53:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/516/</loc>
		<lastmod>2015-12-09T18:51:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/269/</loc>
		<lastmod>2015-12-09T18:51:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/915/</loc>
		<lastmod>2015-12-09T18:51:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/724/</loc>
		<lastmod>2015-12-09T18:51:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/394/</loc>
		<lastmod>2015-12-09T18:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/sw14/</loc>
		<lastmod>2015-12-09T18:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/19/</loc>
		<lastmod>2015-12-09T18:51:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/503/</loc>
		<lastmod>2015-12-09T18:51:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/835/</loc>
		<lastmod>2015-12-09T18:51:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/856/</loc>
		<lastmod>2015-12-09T18:51:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/24/</loc>
		<lastmod>2015-12-09T18:51:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/840/</loc>
		<lastmod>2015-12-09T18:51:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/723-2/</loc>
		<lastmod>2015-12-09T18:51:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/12/04/seans-burgundy-thread-myeloma-in-17-syllables/</loc>
		<lastmod>2015-12-04T21:15:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/126/</loc>
		<lastmod>2015-12-04T02:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2015/12/02/weill-cornell-medicine/</loc>
		<lastmod>2015-12-02T20:56:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/12/02/ninlaro-ixazomib-fda-multiples-myelom-zulassung/</loc>
		<lastmod>2015-12-02T18:14:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/25/myeloma-party-of-two-my-thanksgiving-story/</loc>
		<lastmod>2015-11-25T20:12:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/28/myeloma-party-of-two-sign-language-anyone/</loc>
		<lastmod>2015-11-25T19:15:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/23/mohrs-myeloma-musings-reflections-2-0/</loc>
		<lastmod>2015-11-23T20:36:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/18/letters-from-cancerland-party-on/</loc>
		<lastmod>2015-11-18T20:17:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/16/northern-lights-myeloma-a-chapter-of-my-life-or-more/</loc>
		<lastmod>2015-11-16T21:58:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/13/myeloma-rocket-scientist-early-treatment/</loc>
		<lastmod>2015-11-13T19:40:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/10/myeloma-in-paradise-why-is-cancer-so-hard/</loc>
		<lastmod>2015-11-10T22:56:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/21/myeloma-in-paradise-carrying-a-cancer-patient/</loc>
		<lastmod>2015-11-10T22:44:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/06/pats-place-the-power-of-momentum/</loc>
		<lastmod>2015-11-06T21:49:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/11/03/seans-burgundy-thread-answering-the-call/</loc>
		<lastmod>2015-11-03T20:21:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/31/myeloma-lessons-contradictions/</loc>
		<lastmod>2015-10-31T12:10:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/28/myeloma-dispatches-the-cancer-triathlon-continues/</loc>
		<lastmod>2015-10-28T19:34:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/23/myeloma-party-of-two-its-a-marathon-not-a-sprint/</loc>
		<lastmod>2015-10-23T21:20:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/20/letters-from-cancerland-further-down-the-road/</loc>
		<lastmod>2015-10-20T20:14:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/12/northern-lights-these-boots-are-made-for-walking/</loc>
		<lastmod>2015-10-12T21:08:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/08/myeloma-rocket-scientist-diagnosis-memories-2/</loc>
		<lastmod>2015-10-08T20:23:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/06/seans-burgundy-thread-answers-to-the-name-lucky/</loc>
		<lastmod>2015-10-06T21:31:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/03/pats-place-stem-cell-transplant-lets-play-two/</loc>
		<lastmod>2015-10-03T22:43:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-alabama-at-birmingham-comprehensive-cancer-center/</loc>
		<lastmod>2015-10-01T22:23:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/10/01/myeloma-lessons-help-from-my-myeloma-friends/</loc>
		<lastmod>2015-10-01T19:10:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/28/myeloma-dispatches-multiple-myeloma-as-a-triathlon-sport/</loc>
		<lastmod>2015-09-28T21:49:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/07/16/rvd-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2015-09-19T08:28:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/18/mohrs-myeloma-musings-a-life-changing-decision/</loc>
		<lastmod>2015-09-18T19:23:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/15/letters-from-cancerland-potty-mouth/</loc>
		<lastmod>2015-09-15T19:08:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/10/northern-lights-silver-linings/</loc>
		<lastmod>2015-09-10T19:12:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/08/pats-place-always-more-questions-than-answers/</loc>
		<lastmod>2015-09-09T00:37:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/09/02/seans-burgundy-thread-thank-you-notes/</loc>
		<lastmod>2015-09-02T22:51:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/31/myeloma-lessons-whats-next/</loc>
		<lastmod>2015-08-31T23:51:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/28/myeloma-party-of-two-the-caregivers-caregiver/</loc>
		<lastmod>2015-08-29T00:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/26/myeloma-mom-remembering-aunt-margie-with-a-stuffed-squirrel/</loc>
		<lastmod>2015-08-26T14:44:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/21/mohrs-myeloma-musings-reflections/</loc>
		<lastmod>2015-08-21T16:45:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/22/mohrs-myeloma-musings-fight-back-remember-celebrate/</loc>
		<lastmod>2015-08-20T15:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/18/letters-from-cancerland-the-death-dying-poetry-club/</loc>
		<lastmod>2015-08-18T22:35:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/15/northern-lights-my-spouse-as-my-caregiver/</loc>
		<lastmod>2015-08-15T22:32:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/14/northern-lights-passing-the-six-year-milestone/</loc>
		<lastmod>2015-08-14T14:34:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/huntsman-cancer-institute/</loc>
		<lastmod>2015-08-13T10:25:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/prognosis/</loc>
		<lastmod>2015-08-12T22:03:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/06/26/farydak-chmp-opinion-europe-approval/</loc>
		<lastmod>2015-08-12T21:08:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/12/myeloma-in-paradise-sometimes-you-just-endure/</loc>
		<lastmod>2015-08-12T20:53:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/10/pats-place-im-home/</loc>
		<lastmod>2015-08-10T20:33:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/06/seans-burgundy-thread-smile/</loc>
		<lastmod>2015-08-06T18:15:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/08/myeloma-lessons-the-year-or-two-in-review/</loc>
		<lastmod>2015-08-03T19:35:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/08/03/myeloma-lessons-some-bumps-in-the-road/</loc>
		<lastmod>2015-08-03T19:29:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/31/myeloma-party-of-two-fishing-in-the-river/</loc>
		<lastmod>2015-08-01T12:02:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/28/myeloma-mom-when-mom-is-sick-everyone-gets-cake/</loc>
		<lastmod>2015-07-28T20:26:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/06/16/letters-from-cancerland-telling-the-story/</loc>
		<lastmod>2015-07-21T13:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/20/letters-from-cancerland-state-secrets/</loc>
		<lastmod>2015-07-20T21:52:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/16/myeloma-in-paradise-why-is-death-so-hard/</loc>
		<lastmod>2015-07-16T21:45:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/07/14/myelom-hohepunkte-2015-asco-eha-imwg/</loc>
		<lastmod>2015-07-14T14:13:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/11/23/uzun-sureli-takip-sonunda-miyelom-hastalarinda-cift-kok-hucre-transplantasyonun-tandem-tek-transplantasyona-gore-cok-daha-etkili-oldugu-gorulmustur/</loc>
		<lastmod>2015-07-14T00:44:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/07/13/car-t-zelltherapie-multiples-myelom-asco-2015/</loc>
		<lastmod>2015-07-13T17:02:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/10/pats-place-tick-tock-flip-flop/</loc>
		<lastmod>2015-07-10T10:22:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/07/01/myeloma-party-of-two-managing-change-101/</loc>
		<lastmod>2015-07-01T18:23:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2015-multiple-myeloma-abstracts-oral-presentations/</loc>
		<lastmod>2015-06-25T03:14:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/09/ash-2008-vdd-initial-treatment-more-effective-than-td-initial-treatment/</loc>
		<lastmod>2015-06-24T02:15:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/06/23/myeloma-mom-were-all-in-this-together/</loc>
		<lastmod>2015-06-24T02:01:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/19/beacon-newsflashes-march-19-2012/</loc>
		<lastmod>2015-06-19T23:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/18/ash-2013-preview-treatments-in-early-phase-clinical-development-for-multiple-myeloma/</loc>
		<lastmod>2015-06-19T23:25:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/06/18/mohrs-myeloma-musings-information-overload-2/</loc>
		<lastmod>2015-06-18T22:49:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/21/mohrs-myeloma-musings-quality-of-life-or-longevity/</loc>
		<lastmod>2015-06-18T05:57:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2015-multiple-myeloma-abstracts-e-posters/</loc>
		<lastmod>2015-06-17T13:38:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2015-multiple-myeloma-abstracts-posters-june-12/</loc>
		<lastmod>2015-06-17T13:37:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2015-multiple-myeloma-abstracts-posters-june-13/</loc>
		<lastmod>2015-06-16T11:24:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/19/letters-from-cancerland-leaving-on-a-jet-plane-again/</loc>
		<lastmod>2015-06-14T20:29:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/06/14/asco-2015-update-multiples-myelom-poster-praesentationen-1/</loc>
		<lastmod>2015-06-14T20:28:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/06/12/pats-place-dont-forget-to-be-joyful/</loc>
		<lastmod>2015-06-12T21:28:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/eha-2015-multiple-myeloma-satellite-symposia/</loc>
		<lastmod>2015-06-11T04:21:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/06/10/seans-burgundy-thread-counting-down-the-days/</loc>
		<lastmod>2015-06-10T21:07:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2015-multiple-myeloma-poster-presentations/</loc>
		<lastmod>2015-06-08T18:56:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/06/06/northern-lights-being-a-myeloma-patient-is-a-part-time-job/</loc>
		<lastmod>2015-06-06T18:24:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2015-multiple-myeloma-oral-presentations/</loc>
		<lastmod>2015-06-05T23:12:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/06/04/neueste-myelomforschung-jahrestagung-asco-2015/</loc>
		<lastmod>2015-06-05T02:29:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2015-multiple-myeloma-education-presentations/</loc>
		<lastmod>2015-06-04T13:07:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/10/08/fda-delays-panobinostat-decision/</loc>
		<lastmod>2015-06-04T09:54:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/02/23/farydak-panobinostat-fda-approval/</loc>
		<lastmod>2015-06-04T09:53:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/506/</loc>
		<lastmod>2015-06-03T05:33:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/asco-2015-multiple-myeloma-eabstracts/</loc>
		<lastmod>2015-06-02T17:54:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/10/sequential-treatment-with-novel-agents-is-effective-and-safe-in-older-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2015-05-30T02:53:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/12/risk-factors-engraftment-syndrome-multiple-myeloma/</loc>
		<lastmod>2015-05-30T02:53:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/26/myeloma-mom-thank-you-mr-brokaw/</loc>
		<lastmod>2015-05-26T22:08:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/28/myeloma-mom-lordy-lordy-look-whos-forty/</loc>
		<lastmod>2015-05-26T14:15:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/17/letters-from-cancerland-theres-mayonnaise-all-over-cancerland/</loc>
		<lastmod>2015-05-19T20:25:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/14/pats-place-multiple-myeloma-clinical-trials/</loc>
		<lastmod>2015-05-14T19:26:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/12/northern-lights-shall-i-wear-purple/</loc>
		<lastmod>2015-05-12T20:55:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/08/northern-lights-six-months-into-restarting-treatment/</loc>
		<lastmod>2015-05-12T17:08:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/05/05/seans-burgundy-thread-too-brave-to-cry/</loc>
		<lastmod>2015-05-05T19:49:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/05/04/subkutanes-velcade-neu-diagnostiziertes-multiples-myelom/</loc>
		<lastmod>2015-05-05T01:24:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/02/myeloma-lessons-am-i-paranoid-or-just-vigilant/</loc>
		<lastmod>2015-04-30T17:54:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/08/researchers-develop-model-to-identify-myeloma-patients-with-mgus-like-disease/</loc>
		<lastmod>2015-04-27T16:13:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/21/mohrs-myeloma-musings-dont-let-fatigue-make-a-coward-out-of-you/</loc>
		<lastmod>2015-04-21T21:10:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/03/31/nonsecretory-multiple-myeloma-survival/</loc>
		<lastmod>2015-04-14T15:45:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/14/myeloma-in-paradise-what-if-i-were-cured/</loc>
		<lastmod>2015-04-14T15:38:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/10/seans-burgundy-thread-today/</loc>
		<lastmod>2015-04-10T18:21:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/04/09/farydak-panobinostat-kyprolis-carfilzomib-rezidiviertes-multiples-myelom/</loc>
		<lastmod>2015-04-09T20:07:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/03/23/pre-transplant-depth-of-response-multiple-myeloma/</loc>
		<lastmod>2015-04-08T13:52:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/04/08/ansprechen-vor-transplantation-uberleben-multiples-myelom/</loc>
		<lastmod>2015-04-08T13:51:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/19/mohrs-myeloma-musings-a-new-chapter-maintenance-therapy/</loc>
		<lastmod>2015-04-07T17:06:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/04/04/pats-place-decision-made-im-going-to-transplant-again/</loc>
		<lastmod>2015-04-04T09:20:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/27/myeloma-lessons-a-surprise-reuniting/</loc>
		<lastmod>2015-04-02T01:12:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/27/myeloma-party-of-two-the-token-wife/</loc>
		<lastmod>2015-03-27T20:48:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/25/myeloma-mom-smoldering-isnt-as-sexy-as-it-sounds/</loc>
		<lastmod>2015-03-25T13:34:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/26/treatment-recommendations-multiple-myeloma-bone-disease/</loc>
		<lastmod>2015-03-22T00:01:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/19/mohrs-myeloma-musings-how-and-what-do-we-tell-our-children/</loc>
		<lastmod>2015-03-19T17:51:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/17/letters-from-cancerland-write-your-own-obituary/</loc>
		<lastmod>2015-03-17T19:21:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/17/letters-from-cancerland-getting-my-affairs-in-order/</loc>
		<lastmod>2015-03-14T12:10:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/11/northern-lights-stress-busters/</loc>
		<lastmod>2015-03-11T19:29:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/03/10/kyprolis-velcade-endeavor-vergleichsstudie-multiples-myelom/</loc>
		<lastmod>2015-03-10T20:33:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/03/10/racial-differences-chromosomal-abnormalities-multiple-myeloma/</loc>
		<lastmod>2015-03-10T13:26:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/06/pats-place-multiple-myeloma-awareness-applies-to-patients-too/</loc>
		<lastmod>2015-03-06T20:22:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/04/seans-burgundy-thread-bacon-beacon-and-burgundy/</loc>
		<lastmod>2015-03-04T22:02:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/03/01/myeloma-party-of-two-piecing-together-myeloma/</loc>
		<lastmod>2015-03-01T14:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/09/myeloma-lessons-happy-anniversary-to-me/</loc>
		<lastmod>2015-02-27T20:30:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/02/26/farydak-panobinostat-questions-answers-fda-approval/</loc>
		<lastmod>2015-02-27T00:46:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/24/myeloma-mom-im-sorry-you-have-my-llama/</loc>
		<lastmod>2015-02-24T22:57:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/22/mohrs-myeloma-musings-common-sense-stem-cell-transplant/</loc>
		<lastmod>2015-02-19T21:49:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2015/02/18/revlimid-fda-approval-newly-diagnosed-myeloma/</loc>
		<lastmod>2015-02-19T00:45:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/05/pats-place-dont-let-denial-cost-you-your-life/</loc>
		<lastmod>2015-02-16T17:33:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/09/pats-place-go-with-the-flow/</loc>
		<lastmod>2015-02-15T23:46:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/04/pats-place-myeloma-and-the-holidays/</loc>
		<lastmod>2015-02-15T23:45:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/14/northern-lights-back-to-the-gym/</loc>
		<lastmod>2015-02-14T19:22:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/12/myeloma-in-paradise-a-state-of-confusion/</loc>
		<lastmod>2015-02-12T19:39:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/06/02/panobinostat-fda-approval-priority-review/</loc>
		<lastmod>2015-02-10T19:40:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/20/myeloma-lessons-was-it-a-good-day-or-a-bad-day/</loc>
		<lastmod>2015-02-09T23:19:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/26/myeloma-lessons-why-is-hair-so-important/</loc>
		<lastmod>2015-02-09T23:18:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/31/myeloma-lessons-i-have-a-dream-too/</loc>
		<lastmod>2015-02-09T23:17:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/02/03/seans-burgundy-thread-schedules-scans-superheroes/</loc>
		<lastmod>2015-02-03T18:19:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/28/myeloma-party-of-two-the-time-to-be-happy-is-now/</loc>
		<lastmod>2015-01-28T19:14:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/26/myeloma-mom-keeping-my-blood-to-myself/</loc>
		<lastmod>2015-01-26T23:21:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/20/arnies-rebounding-world-the-final-chapter/</loc>
		<lastmod>2015-01-20T17:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/02/guide-to-nutrition-in-multiple-myeloma-part-2-supplements/</loc>
		<lastmod>2015-01-18T07:22:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/15/northern-lights-traveling-while-receiving-treatment-for-multiple-myeloma/</loc>
		<lastmod>2015-01-15T22:07:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/11/03/evolution-intra-clonal-heterogeneity-multiple-myeloma/</loc>
		<lastmod>2015-01-15T20:49:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2015/01/15/evolution-intraklonale-heterogenitat-multiples-myelom/</loc>
		<lastmod>2015-01-15T20:49:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/14/myeloma-in-paradise-thinking-outside-the-box/</loc>
		<lastmod>2015-01-14T09:43:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/07/seans-burgundy-thread-happy-pneu-year/</loc>
		<lastmod>2015-01-07T19:45:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2015/01/05/mohrs-myeloma-musings-out-with-the-old-in-with-the-new/</loc>
		<lastmod>2015-01-05T13:32:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/28/myeloma-party-of-two-my-christmas-gift/</loc>
		<lastmod>2014-12-28T21:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/25/happy-holidays-4/</loc>
		<lastmod>2014-12-25T10:50:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/23/myeloma-mom-eat-the-fudge/</loc>
		<lastmod>2014-12-23T19:52:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/06/myeloma-experts-present-additional-data-on-revlimid-lenalidomide-and-secondary-cancers-malignancies-asco-2011/</loc>
		<lastmod>2014-12-22T19:49:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/12/ash-2011-multiple-myeloma-update-day-two/</loc>
		<lastmod>2014-12-22T19:48:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/19/myeloma-in-paradise-its-a-matter-of-perspective/</loc>
		<lastmod>2014-12-19T23:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/11/25/fda-postpones-panobinostat-farydak-decision/</loc>
		<lastmod>2014-12-17T21:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/17/seans-burgundy-thread-twas-the-first-day-of-chemo/</loc>
		<lastmod>2014-12-17T21:33:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/12/17/ash-2014-multiples-myelom-update-tag-zwei-fortbildungssitzung-und-vortrage-vom-mittag/</loc>
		<lastmod>2014-12-17T17:18:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/15/letters-from-cancerland-tunnel-vision/</loc>
		<lastmod>2014-12-15T23:05:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/18/letters-from-cancerland-on-being-mortal/</loc>
		<lastmod>2014-12-15T14:45:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/12/12/ash-2014-multiples-myelom-update-tag-eins-postersitzung/</loc>
		<lastmod>2014-12-12T18:19:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/12/11/ash-2014-multiples-myelom-update-tag-eins-vortrage/</loc>
		<lastmod>2014-12-12T17:59:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/12/11/northern-lights-my-grown-up-holiday-list/</loc>
		<lastmod>2014-12-11T22:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/13/northern-lights-rip-currents/</loc>
		<lastmod>2014-12-11T13:19:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/05/seans-burgundy-thread-answering-the-bell/</loc>
		<lastmod>2014-12-08T17:05:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/11/06/panobinostat-farydak-odac-meeting-vote/</loc>
		<lastmod>2014-12-08T17:04:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/28/myeloma-party-of-two-progression-isnt-the-end/</loc>
		<lastmod>2014-11-28T23:13:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/24/myeloma-mom-just-keep-swimming/</loc>
		<lastmod>2014-11-24T19:31:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/21/mohrs-myeloma-musings-inspiration-from-within-my-family/</loc>
		<lastmod>2014-11-21T18:35:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/15/myeloma-in-paradise-you-look-really-good/</loc>
		<lastmod>2014-11-11T22:24:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/11/myeloma-in-paradise-is-it-time-to-fire-your-doctor/</loc>
		<lastmod>2014-11-11T20:58:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/11/07/pats-place-taking-care-of-your-caregiver/</loc>
		<lastmod>2014-11-07T22:15:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/17/mohrs-myeloma-musings-what-a-difference-a-year-makes/</loc>
		<lastmod>2014-11-06T17:41:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/11/06/liveblog-panobinostat-farydak-odac-fda-advisory-committee-meeting/</loc>
		<lastmod>2014-11-06T17:00:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/10/26/new-multiple-myeloma-diagnostic-criteria/</loc>
		<lastmod>2014-11-06T12:13:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/11/04/panobinostat-farydak-odac-meeting-document-review/</loc>
		<lastmod>2014-11-05T14:03:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/11/04/panobinostat-farydak-odac-documents-released/</loc>
		<lastmod>2014-11-04T15:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/07/seans-burgundy-thread-remembered-and-revered/</loc>
		<lastmod>2014-11-04T13:43:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/29/myeloma-mom-happy-halloween-you-have-cancer/</loc>
		<lastmod>2014-10-29T15:32:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/23/myeloma-mom-imagination-gone-wild/</loc>
		<lastmod>2014-10-28T12:28:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/10/27/neue-kriterien-diagnose-multiples-myelom/</loc>
		<lastmod>2014-10-27T20:45:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/23/myeloma-party-of-two-developing-a-myeloma-preparedness-plan/</loc>
		<lastmod>2014-10-23T21:43:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/21/letters-from-cancerland-reefer-madness/</loc>
		<lastmod>2014-10-21T14:36:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/30/myeloma-lessons-walking-the-walk/</loc>
		<lastmod>2014-10-15T17:48:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/18/mohrs-myeloma-musings-fog-of-myeloma/</loc>
		<lastmod>2014-10-15T17:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/09/myeloma-in-paradise-diagnosis-is-its-own-disease/</loc>
		<lastmod>2014-10-14T19:37:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/10/northern-lights-tilting-at-windmills/</loc>
		<lastmod>2014-10-10T16:31:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/10/09/panobinostat-fda-review-on-schedule-novartis/</loc>
		<lastmod>2014-10-09T21:46:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/02/seans-burgundy-thread-positively-charged/</loc>
		<lastmod>2014-10-09T14:46:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/16/panobinostat-velcade-bortezomib-dexamethasone-decadron-myeloma/</loc>
		<lastmod>2014-10-08T18:12:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/17/panobinostat-combination-may-be-effective-in-relapsed-and-velcade-refractory-multiple-myeloma-ash-2011/</loc>
		<lastmod>2014-10-08T18:11:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/10/beacon-newsflashes-december-10-2010/</loc>
		<lastmod>2014-10-08T18:09:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/23/panobinostat-combinations-show-therapeutic-benefit-in-advanced-multiple-myeloma-asco-2010/</loc>
		<lastmod>2014-10-08T18:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/08/asco-2010-multiple-myeloma-update-day-four/</loc>
		<lastmod>2014-10-08T18:09:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/29/beacon-newsflashes-january-29-2009/</loc>
		<lastmod>2014-10-08T18:09:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/12/03/panobinostat/</loc>
		<lastmod>2014-10-08T18:08:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/22/zometa-increases-overall-survival-and-slows-bone-disease-in-multiple-myeloma-patients-asco-2010/</loc>
		<lastmod>2014-10-08T08:30:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/10/02/pats-place-its-all-about-the-journey/</loc>
		<lastmod>2014-10-02T19:25:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/01/multiple-myeloma-survival-significantly-increases-last-decade/</loc>
		<lastmod>2014-10-02T09:35:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3851/</loc>
		<lastmod>2014-09-27T03:28:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1951/</loc>
		<lastmod>2014-09-27T03:27:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2011/01/21/the-university-of-kansas-cancer-center/</loc>
		<lastmod>2014-09-27T00:05:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/26/myeloma-party-of-the-two-caregivers-tune/</loc>
		<lastmod>2014-09-26T19:58:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/10/imw-2009-physicians-debate-cure-versus-control-of-myeloma/</loc>
		<lastmod>2014-09-26T01:06:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/05/imw-2011-multiple-myeloma-update-day-two/</loc>
		<lastmod>2014-09-26T01:01:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/11/perifosine-multiple-myeloma-phase-3-trial-halted/</loc>
		<lastmod>2014-09-26T00:58:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/06/26/highlights-2014-international-myeloma-working-group-imwg-annual-summit/</loc>
		<lastmod>2014-09-25T20:34:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/myeloma-specialists/massachusetts/</loc>
		<lastmod>2014-09-25T09:20:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/myeloma-specialists/boston/</loc>
		<lastmod>2014-09-25T09:18:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/20/mohrs-myeloma-musings-full-time-status/</loc>
		<lastmod>2014-09-18T21:05:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/21/mohrs-myeloma-musings-reality-check/</loc>
		<lastmod>2014-09-18T21:04:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/17/mohrs-myeloma-musings-plant-your-feet-and-stand-firm/</loc>
		<lastmod>2014-09-18T21:04:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/20/mohrs-myeloma-musings-shelf-life/</loc>
		<lastmod>2014-09-18T21:03:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/11/mohrs-myeloma-musings-pre-game-nerves/</loc>
		<lastmod>2014-09-18T21:01:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/25/mohrs-myeloma-musings-then-and-now/</loc>
		<lastmod>2014-09-18T21:00:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/22/mohrs-myeloma-musings-the-purpose-driven-myeloma-life/</loc>
		<lastmod>2014-09-18T20:58:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/24/multiple-myeloma-asymptomatic-multiple-myeloma-and-mgus-may-be-linked-to-osteoporosis/</loc>
		<lastmod>2014-09-18T18:14:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/16/letters-from-cancerland-view-from-the-other-side/</loc>
		<lastmod>2014-09-16T19:56:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2014/09/15/sylvester-comprehensive-cancer-center/</loc>
		<lastmod>2014-09-15T15:28:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/11/pats-place-give-radiation-therapy-a-chance/</loc>
		<lastmod>2014-09-11T17:38:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/09/04/northern-lights-hiking-in-the-rockies/</loc>
		<lastmod>2014-09-05T02:13:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/02/ash-2013-revlimid-lenalidomide-maintenance-therapy/</loc>
		<lastmod>2014-09-04T21:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/10/04/ergebnisse-von-petct-scans-konnten-das-uberleben-bei-myelompatienen-vorhersagen/</loc>
		<lastmod>2014-09-04T17:36:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/21/results-of-pet-ct-scans-may-predict-survival-in-multiple-myeloma-patients/</loc>
		<lastmod>2014-09-04T17:35:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/08/ash-2010-multiple-myeloma-update-day-three-morning/</loc>
		<lastmod>2014-09-04T12:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/12/08/ash-2010-multiples-myelom-update-tag-3-morgen/</loc>
		<lastmod>2014-09-04T12:28:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/12/13/deri-alti-velcade-enjeksiyonu-ash-2010/</loc>
		<lastmod>2014-09-04T12:10:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/09/03/dyclonine-sucrets-velcade-multiple-myeloma/</loc>
		<lastmod>2014-09-03T11:41:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/13/myeloma-in-paradise-be-an-owner/</loc>
		<lastmod>2014-09-02T22:02:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/05/seans-burgundy-thread-old-blue-eyes/</loc>
		<lastmod>2014-08-30T12:02:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/28/myeloma-party-of-two-13-hours-16-minutes-and-45-seconds/</loc>
		<lastmod>2014-08-28T22:50:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/duke-cancer-institute/</loc>
		<lastmod>2014-08-28T20:21:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/comprehensive-cancer-center-of-wake-forest-university/</loc>
		<lastmod>2014-08-28T20:18:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/unc-lineberger-comprehensive-cancer-center/</loc>
		<lastmod>2014-08-28T20:17:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-ohio-state-university-comprehensive-cancer-center/</loc>
		<lastmod>2014-08-28T20:12:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-oregon-cancer-center/</loc>
		<lastmod>2014-08-28T19:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/mayo-clinic-cancer-center/</loc>
		<lastmod>2014-08-28T19:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/university-of-maryland-greenebaum-cancer-center/</loc>
		<lastmod>2014-08-28T19:25:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-chicago-cancer-research-center/</loc>
		<lastmod>2014-08-28T19:24:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-robert-h-lurie-comprehensive-cancer-center/</loc>
		<lastmod>2014-08-28T19:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/mayo-clinic-cancer-center-jacksonville/</loc>
		<lastmod>2014-08-28T19:22:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/mayo-clinic-cancer-center-scottsdale/</loc>
		<lastmod>2014-08-28T19:20:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/21/beacon-newsflashes-january-21-2013/</loc>
		<lastmod>2014-08-28T07:53:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/11/18/ash-2013-vorschau-neueste-behandlungen-multiples-myelom/</loc>
		<lastmod>2014-08-28T07:53:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/12/13/ash-2013-multipes-myelom-update-tag-eins/</loc>
		<lastmod>2014-08-28T07:51:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/18/ash-2012-multiples-myelom-update-tag-drei-postersitzungen/</loc>
		<lastmod>2014-08-28T07:48:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/11/27/ash-2013-vorschau-neue-behandlungen-multiples-myelom/</loc>
		<lastmod>2014-08-28T07:46:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/12/17/ash-2013-multiples-myelom-update-tag-zwei/</loc>
		<lastmod>2014-08-28T07:44:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/01/07/ash-2013-multiples-myelom-update-tag-drei-vortrage-nachmittag/</loc>
		<lastmod>2014-08-28T07:43:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/15/beacon-newsflashes-august-15-2012/</loc>
		<lastmod>2014-08-28T07:35:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/12/ash-2012-multiple-myeloma-update-day-three-poster-sessions/</loc>
		<lastmod>2014-08-28T07:32:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/08/27/oncopep-myeloma-beacon-sponsorship/</loc>
		<lastmod>2014-08-28T01:54:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/26/myeloma-mom-the-kindness-of-strangers/</loc>
		<lastmod>2014-08-26T21:17:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/08/26/mri-spine-high-risk-smoldering-myeloma/</loc>
		<lastmod>2014-08-26T05:30:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/31/myeloma-mom-playing-the-numbers-game/</loc>
		<lastmod>2014-08-25T18:55:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/19/letters-from-cancerland-not-the-august-column-id-planned/</loc>
		<lastmod>2014-08-19T19:54:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/18/northern-lights-preserving-the-past-for-the-future/</loc>
		<lastmod>2014-08-18T20:04:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/15/letters-from-cancerland-song-of-the-open-road/</loc>
		<lastmod>2014-08-13T14:33:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/08/11/remembering-stephen-kramer/</loc>
		<lastmod>2014-08-12T16:34:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/08/07/pats-place-finding-comfort-in-the-simple-things/</loc>
		<lastmod>2014-08-07T23:04:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/28/pats-place-refractory-to-revlimid-velcade-whats-next/</loc>
		<lastmod>2014-08-07T18:34:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/kaplan-comprehensive-cancer-center/</loc>
		<lastmod>2014-08-06T23:20:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-cancer-institute-of-new-jersey/</loc>
		<lastmod>2014-08-06T22:59:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/08/06/cpi-0610-multiple-myeloma-trial/</loc>
		<lastmod>2014-08-06T19:57:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/07/12/malaria-treatments-for-multiple-myeloma/</loc>
		<lastmod>2014-08-05T16:38:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/08/05/malariamedikamente-potenzielle-therapie-multiples-myelom/</loc>
		<lastmod>2014-08-05T16:38:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/11/northern-lights-reaching-the-five-year-milestone/</loc>
		<lastmod>2014-08-05T13:47:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/07/30/remembering-arnold-goodman/</loc>
		<lastmod>2014-08-01T05:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/19/pats-place-be-careful-what-you-wish-for/</loc>
		<lastmod>2014-07-28T20:46:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/24/myeloma-mom-parenthood-and-cancer-both-draw-unwanted-advice/</loc>
		<lastmod>2014-07-25T15:43:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/20/myeloma-party-of-two-cheering-for-the-world-cup-and-the-myeloma-community/</loc>
		<lastmod>2014-07-20T15:49:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/17/myeloma-in-paradise-carpe-diem/</loc>
		<lastmod>2014-07-17T20:01:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/15/myeloma-in-paradise-things-my-dad-taught-me/</loc>
		<lastmod>2014-07-16T06:55:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/16/treatment-of-myeloma-with-novel-agents-may-be-as-effective-as-stem-cell-transplantation-part-2-revlimid-velcade-dexamethasone-asco-2010/</loc>
		<lastmod>2014-07-16T06:21:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/17/letters-from-cancerland-where-on-earth/</loc>
		<lastmod>2014-07-15T05:06:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/20/long-term-exposure-to-benzene-may-increase-risk-of-multiple-myeloma/</loc>
		<lastmod>2014-07-12T22:48:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/10/arnies-rebounding-world-collateral-damage/</loc>
		<lastmod>2014-07-08T14:41:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/08/arnies-rebounding-world-myeloma-on-the-edge/</loc>
		<lastmod>2014-07-08T14:38:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/04/myeloma-lessons-i-am-not-alone-anymore/</loc>
		<lastmod>2014-07-04T17:19:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/07/01/seans-burgundy-thread-breathing-does-a-body-good/</loc>
		<lastmod>2014-07-01T14:40:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/27/myeloma-party-of-two-summer-for-now/</loc>
		<lastmod>2014-06-27T18:40:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/winship-cancer-institute-emory-university/</loc>
		<lastmod>2014-06-25T17:24:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/21/northern-lights-summer-reading/</loc>
		<lastmod>2014-06-21T13:05:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/06/12/asco-2014-multiples-myelom-update-tag-vier-vortrage/</loc>
		<lastmod>2014-06-12T22:29:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/06/11/asco-2014-multiples-myelom-update-tag-eins/</loc>
		<lastmod>2014-06-11T17:57:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/30/myeloma-lessons-disease-treatment-or-simply-age/</loc>
		<lastmod>2014-06-10T17:56:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/16/letters-from-cancerland-aging/</loc>
		<lastmod>2014-06-09T15:43:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/05/choosing-a-multiple-myeloma-specialist/</loc>
		<lastmod>2014-06-07T00:11:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/13/arnies-rebounding-world-n-of-1/</loc>
		<lastmod>2014-06-05T20:27:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/06/04/array-biopharma-sponsorship-myeloma-beacon/</loc>
		<lastmod>2014-06-04T20:40:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/06/03/seans-burgundy-thread-groovin-on-a-sunny-afternoon/</loc>
		<lastmod>2014-06-03T12:14:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/08/making-sense-multiple-myeloma-research-at-2012-ash-annual-meeting/</loc>
		<lastmod>2014-06-01T04:03:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/06/seans-burgundy-thread-see-sean-run-run-sean-run/</loc>
		<lastmod>2014-05-29T15:47:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/05/29/myeloma-beacon-five-new-medical-advisors/</loc>
		<lastmod>2014-05-29T07:51:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/27/myeloma-mom-its-fine-to-be-39/</loc>
		<lastmod>2014-05-27T17:44:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/05/09/nmp-myeloma-activity/</loc>
		<lastmod>2014-05-22T21:01:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/29/myeloma-party-of-two-searching-for-spring/</loc>
		<lastmod>2014-05-22T13:41:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/22/myeloma-mom-some-doctors-are-worth-stalking/</loc>
		<lastmod>2014-05-20T14:03:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/05/14/gewebetyp-unvertraglichkeiten-spendertransplantation/</loc>
		<lastmod>2014-05-14T15:41:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/29/tissue-type-mismatches-allogeneic-stem-cell-transplants/</loc>
		<lastmod>2014-05-14T15:40:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/05/12/nmp-multiples-myelom/</loc>
		<lastmod>2014-05-12T21:47:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/cancer-research-center-of-hawaii/</loc>
		<lastmod>2014-05-12T09:37:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/04/24/myeloma-quiz-april-2014/</loc>
		<lastmod>2014-05-09T15:41:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/08/northern-lights-ode-to-mothers/</loc>
		<lastmod>2014-05-08T15:59:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/04/08/minimal-residual-disease-deep-sequencing-prognosis-multiple-myeloma/</loc>
		<lastmod>2014-05-07T21:36:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/05/07/minimale-resterkrankung-hochdurchsatz-sequenzierung-prognose-multiples-myelom/</loc>
		<lastmod>2014-05-07T21:35:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/05/06/bildgebungstechniken-multiples-myelom/</loc>
		<lastmod>2014-05-06T18:42:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/11/northern-lights-myeloma-magnet/</loc>
		<lastmod>2014-05-06T13:06:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/05/01/pats-place-do-you-remember-when/</loc>
		<lastmod>2014-05-02T21:21:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/30/you-are-in-charge/</loc>
		<lastmod>2014-05-02T17:39:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/01/seans-burgundy-thread-itll-be-okay/</loc>
		<lastmod>2014-04-29T16:47:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/01/31/top-10-forschungsergebnisse-2013-multiples-myelom/</loc>
		<lastmod>2014-04-28T18:05:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/01/25/top-10-discoveries-multiple-myeloma-2013/</loc>
		<lastmod>2014-04-28T18:04:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2014/04/28/principales-descubrimientos-2013-mieloma-multiple/</loc>
		<lastmod>2014-04-28T18:02:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/04/28/siltuximab-sylvant-fda-approval/</loc>
		<lastmod>2014-04-28T15:45:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/03/siltuximab-may-be-effective-in-certain-patients-with-advanced-multiple-myeloma-ash-2011/</loc>
		<lastmod>2014-04-28T14:57:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/26/manhattan-tales-challenging-the-bell-shaped-curve/</loc>
		<lastmod>2014-04-26T17:56:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/04/26/beacon-newsflashes-april-26-2014/</loc>
		<lastmod>2014-04-26T05:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/24/lessons-from-my-first-year-of-multiple-myeloma-treatment/</loc>
		<lastmod>2014-04-25T22:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/25/myeloma-mom-dude-where-is-my-m-spike/</loc>
		<lastmod>2014-04-22T15:09:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/30/drug-induced-peripheral-neuropathy-in-multiple-myeloma-patients-part-2-treatment/</loc>
		<lastmod>2014-04-19T15:12:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/26/drug-induced-peripheral-neuropathy-in-multiple-myeloma-patients-part-1-what-is-it-and-who-is-at-risk/</loc>
		<lastmod>2014-04-19T15:12:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/15/letters-from-cancerland-toxic-dump/</loc>
		<lastmod>2014-04-15T14:23:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/18/letters-from-cancerland-by-the-skin-of-my-teeth/</loc>
		<lastmod>2014-04-09T14:25:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/21/two-studies-investigate-minimal-residual-disease-multiple-myeloma/</loc>
		<lastmod>2014-04-08T07:28:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2925/</loc>
		<lastmod>2014-04-06T02:15:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/14/northern-lights-changes-in-fashion/</loc>
		<lastmod>2014-04-04T21:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/24/immunoglobulin-levels-multiple-myeloma-prognosis/</loc>
		<lastmod>2014-04-04T21:24:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/11/arnies-rebounding-world-is-the-multiple-myeloma-treatment-glass-half-full-or-half-empty/</loc>
		<lastmod>2014-04-04T21:22:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/04/02/revlimid-velcade-dexamethasone-relapsed-multiple-myeloma/</loc>
		<lastmod>2014-04-03T22:11:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/04/03/pats-place-when-the-end-isnt-the-end/</loc>
		<lastmod>2014-04-03T21:39:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/06/pats-place-therapy-tolerability-is-relative/</loc>
		<lastmod>2014-04-03T13:48:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/01/experts-publish-consensus-statement-on-maintenance-therapy-in-multiple-myeloma/</loc>
		<lastmod>2014-03-28T10:06:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/03/27/immunglobuline-prognose-multiples-myelom/</loc>
		<lastmod>2014-03-27T18:32:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/13/pattern-relapse-progression-after-stem-cell-transplantation/</loc>
		<lastmod>2014-03-24T20:50:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/03/04/seans-burgundy-thread-great-unexpectations/</loc>
		<lastmod>2014-03-21T13:56:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/07/revlimid-melphalan-secondary-cancers-multiple-myeloma/</loc>
		<lastmod>2014-03-21T13:56:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/20/extramedullary-disease-scar-tissue-multiple-myeloma/</loc>
		<lastmod>2014-03-20T17:57:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/03/19/rezidiv-und-progressionsmuster-nach-stammzelltransplantation-multiples-myelom/</loc>
		<lastmod>2014-03-19T20:16:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/25/myeloma-mom-we-can-all-be-proud-of-tom-brokaw/</loc>
		<lastmod>2014-03-18T13:11:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/27/manhattan-tales-changing-perceptions/</loc>
		<lastmod>2014-03-18T13:07:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/17/whole-body-mri-smoldering-myeloma-progression/</loc>
		<lastmod>2014-03-17T20:52:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/03/13/revlimid-sekundare-malignome-melphalan-multiples-myelom/</loc>
		<lastmod>2014-03-13T14:34:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/26/complete-response-transplant-survival-multiple-myeloma/</loc>
		<lastmod>2014-03-12T14:53:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/19/multiple-myeloma-subtypes-mgus-smoldering-myeloma/</loc>
		<lastmod>2014-03-06T23:22:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/03/05/revlimid-dexamethasone-bone-disease-relapsed-multiple-myeloma/</loc>
		<lastmod>2014-03-06T01:15:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/04/seans-burgundy-thread-a-funny-thing-happened-on-my-way-to-an-infusion/</loc>
		<lastmod>2014-03-04T15:25:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/03/continuous-revlimid-lenalidomide-dexamethasone-older-newly-diagnosed-multiple-myeloma-ash-2013/</loc>
		<lastmod>2014-02-28T18:05:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/24/melphalan-prednisone-survival-rates-higher-than-thalidomide-dexamethasone-in-elderly/</loc>
		<lastmod>2014-02-28T17:55:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/15/revlimid-may-set-new-standard-for-treating-newly-diagnosed-multiple-myeloma-in-elderly-patients-ash-2009/</loc>
		<lastmod>2014-02-28T17:55:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/29/early-relapse-may-be-linked-to-shorter-survival-in-elderly-myeloma-patients/</loc>
		<lastmod>2014-02-28T17:55:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/17/stem-cell-transplants-may-be-feasible-in-elderly-multiple-myeloma-patients/</loc>
		<lastmod>2014-02-28T17:55:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/24/guidelines-for-the-management-of-side-effects-in-older-myeloma-patients-part-1-velcade-bortezomib-related-side-effects/</loc>
		<lastmod>2014-02-28T17:54:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/30/guidelines-for-the-management-of-side-effects-in-older-myeloma-patients-part-2-thalidomide-thalomid-related-side-effects/</loc>
		<lastmod>2014-02-28T17:54:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/08/guidelines-for-the-management-of-side-effects-in-older-myeloma-patients-part-3-revlimid-lenalidomide-related-side-effects/</loc>
		<lastmod>2014-02-28T17:54:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/12/guidelines-for-the-management-of-side-effects-in-older-myeloma-patients-part-4-novel-agent-use-in-specific-patient-populations/</loc>
		<lastmod>2014-02-28T17:54:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/16/multiple-myeloma-experts-recommend-tailored-therapies-for-elderly-myeloma-patients/</loc>
		<lastmod>2014-02-28T17:53:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/22/study-confirms-efficacy-of-revlimid-lenalidomide-dexamethasone-combination-in-elderly-multiple-myeloma-patients-with-relapsed-disease/</loc>
		<lastmod>2014-02-28T17:53:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/18/upfront-treatment-with-novel-agents-improves-survival-in-elderly-myeloma-patients/</loc>
		<lastmod>2014-02-28T17:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/29/velcade-bortezomib-thalidomide-thalomid-and-velcade-prednisone-may-be-effective-as-maintenance-therapy-for-elderly-multiple-myeloma-patients/</loc>
		<lastmod>2014-02-28T17:52:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/20/advanced-age-organ-damage-associated-with-poor-survival-in-elderly-myeloma-patients/</loc>
		<lastmod>2014-02-28T17:52:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/24/chromosomal-abnormalities-older-multiple-myeloma-patients/</loc>
		<lastmod>2014-02-28T17:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/04/beacon-newsflashes-february-4-2013/</loc>
		<lastmod>2014-02-26T21:03:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/15/top-myeloma-beacon-news-articles-of-2013/</loc>
		<lastmod>2014-02-26T20:47:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/25/dcep-bridging-therapy-relapsed-multiple-myeloma/</loc>
		<lastmod>2014-02-25T18:58:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/01/29/myeloma-mom-just-diagnosed-remember-youre-the-boss/</loc>
		<lastmod>2014-02-25T18:51:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/01/pats-place-risk-versus-reward-stem-cell-transplant/</loc>
		<lastmod>2014-02-22T23:47:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/08/northern-lights-could-environmental-factors-be-the-cause-of-my-myeloma/</loc>
		<lastmod>2014-02-22T23:46:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/02/21/me-vs-mm-life-after-dex/</loc>
		<lastmod>2014-02-22T23:45:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/02/12/arnies-rebounding-world-my-answer-came-too-soon/</loc>
		<lastmod>2014-02-22T23:42:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/22/top-myeloma-beacon-patient-columns-2013/</loc>
		<lastmod>2014-02-22T23:35:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/29/letters-from-cancerland-how-did-i-get-here-from-there/</loc>
		<lastmod>2014-02-21T18:11:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/18/letters-from-cancerland-one-from-the-heart/</loc>
		<lastmod>2014-02-18T16:08:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/01/23/manhattan-tales-new-patterns-and-rhythms-to-daily-life/</loc>
		<lastmod>2014-02-17T20:10:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/01/21/letters-from-cancerland-opening-doors/</loc>
		<lastmod>2014-02-17T20:07:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/22/beacon-newsflashes-july-22-2013/</loc>
		<lastmod>2014-02-14T22:36:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/22/infections-risk-of-developing-multiple-myeloma/</loc>
		<lastmod>2014-02-14T22:34:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/12/arnies-rebounding-world-compassionate-use/</loc>
		<lastmod>2014-02-14T19:48:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/13/northern-lights-communicating-with-caregivers/</loc>
		<lastmod>2014-02-13T20:44:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/16/me-vs-mm-sung-heroes/</loc>
		<lastmod>2014-02-13T20:32:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/07/29/pats-place-all-multiple-myeloma-patients-need-an-advocate/</loc>
		<lastmod>2014-02-13T20:29:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/01/caring-for-someone-with-multiple-myeloma-part-2-practical-caregiving/</loc>
		<lastmod>2014-02-13T20:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/06/caring-for-someone-with-multiple-myeloma-part-3-the-toll-of-caregiving/</loc>
		<lastmod>2014-02-13T20:27:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/29/caring-for-someone-with-multiple-myeloma-part-1-introduction-to-being-a-caregiver/</loc>
		<lastmod>2014-02-13T20:25:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/21/birds-in-spring-multiple-myeloma-caregivers-are-special/</loc>
		<lastmod>2014-02-13T20:25:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/21/pats-place-who-takes-care-of-the-caregivers/</loc>
		<lastmod>2014-02-13T20:25:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/31/pats-place-find-a-way-to-take-care-of-your-caregiver/</loc>
		<lastmod>2014-02-13T20:24:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/05/pats-place-tips-for-patients-and-caregivers/</loc>
		<lastmod>2014-02-13T20:24:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/11/pomalyst-pomalidomide-imnovid-approval-canada-multiple-myeloma/</loc>
		<lastmod>2014-02-11T18:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/01/16/mohrs-myeloma-musings-from-watch-and-wait-to-uncertain-certainty/</loc>
		<lastmod>2014-02-11T15:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/02/10/pomalyst-pomalidomide-imnovid-combination-regimens-2013/</loc>
		<lastmod>2014-02-10T21:20:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/02/06/pats-place-watchful-waiting-is-not-for-me/</loc>
		<lastmod>2014-02-06T21:02:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/01/07/seans-burgundy-thread-myel-stones/</loc>
		<lastmod>2014-02-03T16:28:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/01/30/injection-site-reactions-subcutaneous-velcade-bortezomib/</loc>
		<lastmod>2014-01-30T20:28:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/31/myeloma-mom-do-you-ever-forget/</loc>
		<lastmod>2014-01-29T17:33:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/01/06/pomalyst-pomalidomide-imnovid-dexamethasone-ash-2013/</loc>
		<lastmod>2014-01-29T15:22:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/ash-2013-multiple-myeloma-gateway/</loc>
		<lastmod>2014-01-28T19:22:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/10/24/manhattan-tales-side-effects-good-and-bad/</loc>
		<lastmod>2014-01-23T21:23:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/28/manhattan-tales-historical-reminiscence/</loc>
		<lastmod>2014-01-23T21:22:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/27/manhattan-tales-the-beauty-within/</loc>
		<lastmod>2014-01-23T18:45:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2014/01/15/long-term-revlimid-dexamethasone-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2014-01-15T16:45:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/01/13/sar650984-multiples-myelom-ash-2013/</loc>
		<lastmod>2014-01-13T20:43:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/16/letters-from-cancerland-muddling-through/</loc>
		<lastmod>2014-01-10T14:40:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/01/09/northern-lights-meeting-the-enemy/</loc>
		<lastmod>2014-01-09T21:15:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2014/01/06/ash-2013-multiples-myelom-update-tag-drei-vormittag/</loc>
		<lastmod>2014-01-06T22:03:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2014/01/02/pats-place-eight-great-ways-to-start-your-new-year/</loc>
		<lastmod>2014-01-02T20:42:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/05/pats-place-myeloma-counseling-helps-me-see-the-light/</loc>
		<lastmod>2014-01-02T20:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/thalidomide/</loc>
		<lastmod>2013-12-31T22:29:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/02/asco-2012-multiple-myeloma-update-day-two-education-session/</loc>
		<lastmod>2013-12-31T22:23:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/27/myeloma-mom-stem-cells-on-ice/</loc>
		<lastmod>2013-12-31T22:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/30/weight-at-diagnosis-survival-multiple-myeloma/</loc>
		<lastmod>2013-12-31T13:42:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/25/beacon-newsflashes-september-25-2013/</loc>
		<lastmod>2013-12-30T22:30:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/24/happy-holidays-3/</loc>
		<lastmod>2013-12-25T03:16:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/10/arnies-rebounding-world-how-are-you/</loc>
		<lastmod>2013-12-24T21:10:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3167/</loc>
		<lastmod>2013-12-24T11:36:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1938/</loc>
		<lastmod>2013-12-24T11:34:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1982/</loc>
		<lastmod>2013-12-24T11:24:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/285/</loc>
		<lastmod>2013-12-24T11:21:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/23/life-lessons-flowing-and-connectivity/</loc>
		<lastmod>2013-12-23T19:00:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/01/personal-perspective-former-football-star-and-young-father-dominates-cancer-with-optimism-information-and-support/</loc>
		<lastmod>2013-12-23T18:53:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/283/</loc>
		<lastmod>2013-12-21T15:02:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2089/</loc>
		<lastmod>2013-12-20T23:58:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4647/</loc>
		<lastmod>2013-12-20T23:45:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/536/</loc>
		<lastmod>2013-12-20T00:41:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1846/</loc>
		<lastmod>2013-12-20T00:19:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/685/</loc>
		<lastmod>2013-12-20T00:05:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3141/</loc>
		<lastmod>2013-12-19T17:32:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/19/seans-burgundy-thread-myeloma-and-my-friend-jack/</loc>
		<lastmod>2013-12-19T16:27:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/05/seans-burgundy-thread-dear-multiple-myeloma/</loc>
		<lastmod>2013-12-19T16:17:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/687/</loc>
		<lastmod>2013-12-19T15:41:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3210/</loc>
		<lastmod>2013-12-19T14:53:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/763/</loc>
		<lastmod>2013-12-18T17:00:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/539/</loc>
		<lastmod>2013-12-18T16:18:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/759/</loc>
		<lastmod>2013-12-18T02:52:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1952/</loc>
		<lastmod>2013-12-18T02:52:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4431/</loc>
		<lastmod>2013-12-18T02:52:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4437/</loc>
		<lastmod>2013-12-18T02:52:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3219/</loc>
		<lastmod>2013-12-18T02:52:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3190/</loc>
		<lastmod>2013-12-18T02:52:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/284/</loc>
		<lastmod>2013-12-17T20:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3224/</loc>
		<lastmod>2013-12-17T18:19:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3189/</loc>
		<lastmod>2013-12-17T04:57:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3178/</loc>
		<lastmod>2013-12-17T04:40:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1944/</loc>
		<lastmod>2013-12-17T04:38:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3099/</loc>
		<lastmod>2013-12-17T01:12:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1926/</loc>
		<lastmod>2013-12-17T00:39:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1969/</loc>
		<lastmod>2013-12-16T23:00:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1970/</loc>
		<lastmod>2013-12-16T22:45:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1910/</loc>
		<lastmod>2013-12-16T18:37:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/es3/</loc>
		<lastmod>2013-12-16T17:38:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/es2/</loc>
		<lastmod>2013-12-16T17:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/es1/</loc>
		<lastmod>2013-12-16T16:40:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3348/</loc>
		<lastmod>2013-12-16T16:36:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3366/</loc>
		<lastmod>2013-12-16T16:34:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3199/</loc>
		<lastmod>2013-12-16T15:22:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4441/</loc>
		<lastmod>2013-12-16T15:03:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/535/</loc>
		<lastmod>2013-12-16T13:15:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3198/</loc>
		<lastmod>2013-12-15T20:17:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4489/</loc>
		<lastmod>2013-12-15T12:08:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4433/</loc>
		<lastmod>2013-12-15T04:33:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1850/</loc>
		<lastmod>2013-12-15T03:23:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1948/</loc>
		<lastmod>2013-12-14T02:41:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3137/</loc>
		<lastmod>2013-12-13T20:15:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/762/</loc>
		<lastmod>2013-12-13T19:33:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2030/</loc>
		<lastmod>2013-12-13T18:46:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/690/</loc>
		<lastmod>2013-12-13T17:43:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1983/</loc>
		<lastmod>2013-12-13T17:30:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1939/</loc>
		<lastmod>2013-12-13T17:08:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1877/</loc>
		<lastmod>2013-12-13T16:54:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/121/</loc>
		<lastmod>2013-12-13T04:40:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/275/</loc>
		<lastmod>2013-12-13T02:00:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/27/beacon-newsflashes-september-27-2010/</loc>
		<lastmod>2013-12-13T01:04:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/19/letters-from-cancerland-multiple-myeloma-support-groups/</loc>
		<lastmod>2013-12-12T15:48:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3191/</loc>
		<lastmod>2013-12-11T22:56:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/154/</loc>
		<lastmod>2013-12-11T19:55:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/05/ash-2013-preview-smoldering-myeloma-and-mgus/</loc>
		<lastmod>2013-12-11T17:51:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/760/</loc>
		<lastmod>2013-12-11T17:32:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1947/</loc>
		<lastmod>2013-12-10T23:48:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1909/</loc>
		<lastmod>2013-12-10T20:47:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/13/arnies-rebounding-world-the-bucket-list/</loc>
		<lastmod>2013-12-10T16:55:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/09/ash-2013-multiple-myeloma-update-day-three-overview/</loc>
		<lastmod>2013-12-09T22:04:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3181/</loc>
		<lastmod>2013-12-09T20:12:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1986/</loc>
		<lastmod>2013-12-09T02:27:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1976/</loc>
		<lastmod>2013-12-09T02:26:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/12/07/ash-2013-multiple-myeloma-gateway-now-available/</loc>
		<lastmod>2013-12-07T14:26:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/sci-14/</loc>
		<lastmod>2013-12-07T01:48:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/sci-15/</loc>
		<lastmod>2013-12-07T01:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/sci-13/</loc>
		<lastmod>2013-12-07T01:46:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/767/</loc>
		<lastmod>2013-12-05T22:51:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3134/</loc>
		<lastmod>2013-12-05T17:07:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1876/</loc>
		<lastmod>2013-12-05T17:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/689/</loc>
		<lastmod>2013-12-05T16:58:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/920/</loc>
		<lastmod>2013-12-05T16:58:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/127/</loc>
		<lastmod>2013-12-05T16:58:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2979/</loc>
		<lastmod>2013-12-05T16:57:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3103/</loc>
		<lastmod>2013-12-05T16:57:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3499/</loc>
		<lastmod>2013-12-05T16:57:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1857/</loc>
		<lastmod>2013-12-05T16:57:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4223/</loc>
		<lastmod>2013-12-05T16:57:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1248/</loc>
		<lastmod>2013-12-05T16:57:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1903/</loc>
		<lastmod>2013-12-05T16:57:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4439/</loc>
		<lastmod>2013-12-05T16:57:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3124/</loc>
		<lastmod>2013-12-05T16:57:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3396/</loc>
		<lastmod>2013-12-05T16:57:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3129/</loc>
		<lastmod>2013-12-05T16:57:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3184/</loc>
		<lastmod>2013-12-05T16:57:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1989/</loc>
		<lastmod>2013-12-05T16:57:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1931/</loc>
		<lastmod>2013-12-05T16:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3148/</loc>
		<lastmod>2013-12-05T16:57:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3101/</loc>
		<lastmod>2013-12-05T16:57:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3146/</loc>
		<lastmod>2013-12-05T16:57:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4434/</loc>
		<lastmod>2013-12-05T16:57:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1892/</loc>
		<lastmod>2013-12-05T16:57:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4226/</loc>
		<lastmod>2013-12-05T16:57:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4507/</loc>
		<lastmod>2013-12-05T16:57:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3155/</loc>
		<lastmod>2013-12-05T16:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1870/</loc>
		<lastmod>2013-12-05T16:56:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1907/</loc>
		<lastmod>2013-12-05T16:56:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1977/</loc>
		<lastmod>2013-12-05T16:56:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3133/</loc>
		<lastmod>2013-12-05T16:56:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1888/</loc>
		<lastmod>2013-12-05T16:56:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1928/</loc>
		<lastmod>2013-12-05T16:56:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3119/</loc>
		<lastmod>2013-12-05T16:56:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3107/</loc>
		<lastmod>2013-12-05T16:56:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1988/</loc>
		<lastmod>2013-12-05T16:56:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4428/</loc>
		<lastmod>2013-12-05T16:56:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1844/</loc>
		<lastmod>2013-12-05T16:56:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4440/</loc>
		<lastmod>2013-12-05T16:56:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1956/</loc>
		<lastmod>2013-12-05T16:56:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3723/</loc>
		<lastmod>2013-12-05T16:56:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1980/</loc>
		<lastmod>2013-12-05T16:56:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3096/</loc>
		<lastmod>2013-12-05T16:56:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3147/</loc>
		<lastmod>2013-12-05T16:56:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4445/</loc>
		<lastmod>2013-12-05T16:56:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3845/</loc>
		<lastmod>2013-12-05T16:55:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3628/</loc>
		<lastmod>2013-12-05T16:55:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3203/</loc>
		<lastmod>2013-12-05T16:55:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3140/</loc>
		<lastmod>2013-12-05T16:55:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3104/</loc>
		<lastmod>2013-12-05T16:55:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1919/</loc>
		<lastmod>2013-12-05T16:55:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1709/</loc>
		<lastmod>2013-12-05T16:55:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3125/</loc>
		<lastmod>2013-12-05T16:55:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3168/</loc>
		<lastmod>2013-12-05T16:55:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3114/</loc>
		<lastmod>2013-12-05T16:55:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1920/</loc>
		<lastmod>2013-12-05T16:55:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3131/</loc>
		<lastmod>2013-12-05T16:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3324/</loc>
		<lastmod>2013-12-05T16:55:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4436/</loc>
		<lastmod>2013-12-05T16:55:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4446/</loc>
		<lastmod>2013-12-05T16:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1862/</loc>
		<lastmod>2013-12-05T16:55:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1887/</loc>
		<lastmod>2013-12-05T16:55:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1875/</loc>
		<lastmod>2013-12-05T16:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2005/</loc>
		<lastmod>2013-12-05T16:54:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3233/</loc>
		<lastmod>2013-12-05T16:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1914/</loc>
		<lastmod>2013-12-05T16:54:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1879/</loc>
		<lastmod>2013-12-05T16:54:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1750/</loc>
		<lastmod>2013-12-05T16:54:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1858/</loc>
		<lastmod>2013-12-05T16:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1943/</loc>
		<lastmod>2013-12-05T16:54:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3228/</loc>
		<lastmod>2013-12-05T16:54:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1891/</loc>
		<lastmod>2013-12-05T16:54:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1694/</loc>
		<lastmod>2013-12-05T16:54:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1899/</loc>
		<lastmod>2013-12-05T16:54:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3234/</loc>
		<lastmod>2013-12-05T16:54:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4450/</loc>
		<lastmod>2013-12-05T16:54:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1121/</loc>
		<lastmod>2013-12-05T16:54:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3276/</loc>
		<lastmod>2013-12-05T16:54:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3388/</loc>
		<lastmod>2013-12-05T16:54:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3144/</loc>
		<lastmod>2013-12-05T16:54:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3376/</loc>
		<lastmod>2013-12-05T16:54:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1667/</loc>
		<lastmod>2013-12-05T16:54:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2171/</loc>
		<lastmod>2013-12-05T16:53:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3122/</loc>
		<lastmod>2013-12-05T16:53:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2930/</loc>
		<lastmod>2013-12-05T16:53:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1929/</loc>
		<lastmod>2013-12-05T16:53:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1949/</loc>
		<lastmod>2013-12-05T16:53:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4200/</loc>
		<lastmod>2013-12-05T16:53:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1852/</loc>
		<lastmod>2013-12-05T16:53:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1963/</loc>
		<lastmod>2013-12-05T16:53:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3109/</loc>
		<lastmod>2013-12-05T16:53:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1918/</loc>
		<lastmod>2013-12-05T16:53:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3128/</loc>
		<lastmod>2013-12-05T16:53:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3169/</loc>
		<lastmod>2013-12-05T16:53:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2537/</loc>
		<lastmod>2013-12-05T16:53:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3164/</loc>
		<lastmod>2013-12-05T16:53:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3151/</loc>
		<lastmod>2013-12-05T16:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1960/</loc>
		<lastmod>2013-12-05T16:53:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3229/</loc>
		<lastmod>2013-12-05T16:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1959/</loc>
		<lastmod>2013-12-05T16:53:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3136/</loc>
		<lastmod>2013-12-05T16:52:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1735/</loc>
		<lastmod>2013-12-05T16:52:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3174/</loc>
		<lastmod>2013-12-05T16:52:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3156/</loc>
		<lastmod>2013-12-05T16:52:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1922/</loc>
		<lastmod>2013-12-05T16:52:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3357/</loc>
		<lastmod>2013-12-05T16:52:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2036/</loc>
		<lastmod>2013-12-05T16:52:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4453/</loc>
		<lastmod>2013-12-05T16:52:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3327/</loc>
		<lastmod>2013-12-05T16:52:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3115/</loc>
		<lastmod>2013-12-05T16:52:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3149/</loc>
		<lastmod>2013-12-05T16:52:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1746/</loc>
		<lastmod>2013-12-05T16:52:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1962/</loc>
		<lastmod>2013-12-05T16:52:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4442/</loc>
		<lastmod>2013-12-05T16:52:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1978/</loc>
		<lastmod>2013-12-05T16:52:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1861/</loc>
		<lastmod>2013-12-05T16:52:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1886/</loc>
		<lastmod>2013-12-05T16:52:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1946/</loc>
		<lastmod>2013-12-05T16:52:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1894/</loc>
		<lastmod>2013-12-05T16:52:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1961/</loc>
		<lastmod>2013-12-05T16:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3206/</loc>
		<lastmod>2013-12-05T16:51:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3172/</loc>
		<lastmod>2013-12-05T16:51:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1924/</loc>
		<lastmod>2013-12-05T16:51:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1893/</loc>
		<lastmod>2013-12-05T16:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1934/</loc>
		<lastmod>2013-12-05T16:51:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3214/</loc>
		<lastmod>2013-12-05T16:51:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1925/</loc>
		<lastmod>2013-12-05T16:51:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1945/</loc>
		<lastmod>2013-12-05T16:51:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1851/</loc>
		<lastmod>2013-12-05T16:51:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1898/</loc>
		<lastmod>2013-12-05T16:51:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1904/</loc>
		<lastmod>2013-12-05T16:51:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3112/</loc>
		<lastmod>2013-12-05T16:51:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3157/</loc>
		<lastmod>2013-12-05T16:51:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3100/</loc>
		<lastmod>2013-12-05T16:51:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3182/</loc>
		<lastmod>2013-12-05T16:51:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3771/</loc>
		<lastmod>2013-12-05T16:51:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3204/</loc>
		<lastmod>2013-12-05T16:51:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3108/</loc>
		<lastmod>2013-12-05T16:51:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1927/</loc>
		<lastmod>2013-12-05T16:50:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2520/</loc>
		<lastmod>2013-12-05T16:50:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2905/</loc>
		<lastmod>2013-12-05T16:41:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2968/</loc>
		<lastmod>2013-12-05T16:41:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4521/</loc>
		<lastmod>2013-12-05T16:41:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3390/</loc>
		<lastmod>2013-12-05T16:41:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2951/</loc>
		<lastmod>2013-12-05T16:41:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3859/</loc>
		<lastmod>2013-12-05T16:41:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2944/</loc>
		<lastmod>2013-12-05T16:41:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1937/</loc>
		<lastmod>2013-12-05T16:41:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2160/</loc>
		<lastmod>2013-12-05T16:41:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3820/</loc>
		<lastmod>2013-12-05T16:41:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3250/</loc>
		<lastmod>2013-12-05T16:41:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3165/</loc>
		<lastmod>2013-12-05T16:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3152/</loc>
		<lastmod>2013-12-05T16:41:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3161/</loc>
		<lastmod>2013-12-05T16:41:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3225/</loc>
		<lastmod>2013-12-05T16:41:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1878/</loc>
		<lastmod>2013-12-05T16:41:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1992/</loc>
		<lastmod>2013-12-05T16:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3213/</loc>
		<lastmod>2013-12-05T16:40:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3180/</loc>
		<lastmod>2013-12-05T16:40:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1965/</loc>
		<lastmod>2013-12-05T16:40:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1994/</loc>
		<lastmod>2013-12-05T16:40:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1895/</loc>
		<lastmod>2013-12-05T16:40:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3232/</loc>
		<lastmod>2013-12-05T16:40:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1958/</loc>
		<lastmod>2013-12-05T16:40:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1968/</loc>
		<lastmod>2013-12-05T16:40:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1843/</loc>
		<lastmod>2013-12-05T16:40:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4444/</loc>
		<lastmod>2013-12-05T16:40:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1881/</loc>
		<lastmod>2013-12-05T16:40:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1917/</loc>
		<lastmod>2013-12-05T16:40:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4363/</loc>
		<lastmod>2013-12-05T16:40:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1865/</loc>
		<lastmod>2013-12-05T16:40:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3160/</loc>
		<lastmod>2013-12-05T16:40:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3171/</loc>
		<lastmod>2013-12-05T16:40:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4228/</loc>
		<lastmod>2013-12-05T16:39:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2126/</loc>
		<lastmod>2013-12-05T16:39:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3205/</loc>
		<lastmod>2013-12-05T16:39:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3751/</loc>
		<lastmod>2013-12-05T16:39:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3329/</loc>
		<lastmod>2013-12-05T16:39:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3170/</loc>
		<lastmod>2013-12-05T16:39:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4607/</loc>
		<lastmod>2013-12-05T16:39:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1921/</loc>
		<lastmod>2013-12-05T16:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3193/</loc>
		<lastmod>2013-12-05T16:39:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1941/</loc>
		<lastmod>2013-12-05T16:39:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1889/</loc>
		<lastmod>2013-12-05T16:39:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3084/</loc>
		<lastmod>2013-12-05T16:39:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3088/</loc>
		<lastmod>2013-12-05T16:39:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1967/</loc>
		<lastmod>2013-12-05T16:39:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4435/</loc>
		<lastmod>2013-12-05T16:39:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3090/</loc>
		<lastmod>2013-12-05T16:39:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3215/</loc>
		<lastmod>2013-12-05T16:39:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1849/</loc>
		<lastmod>2013-12-05T16:39:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3218/</loc>
		<lastmod>2013-12-05T16:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3162/</loc>
		<lastmod>2013-12-05T16:38:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4430/</loc>
		<lastmod>2013-12-05T16:38:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2115/</loc>
		<lastmod>2013-12-05T16:38:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3121/</loc>
		<lastmod>2013-12-05T16:38:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4438/</loc>
		<lastmod>2013-12-05T16:38:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1915/</loc>
		<lastmod>2013-12-05T16:38:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3089/</loc>
		<lastmod>2013-12-05T16:38:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4443/</loc>
		<lastmod>2013-12-05T16:38:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1864/</loc>
		<lastmod>2013-12-05T16:38:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1745/</loc>
		<lastmod>2013-12-05T16:38:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1666/</loc>
		<lastmod>2013-12-05T16:38:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3487/</loc>
		<lastmod>2013-12-05T16:38:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4205/</loc>
		<lastmod>2013-12-05T16:38:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1727/</loc>
		<lastmod>2013-12-05T16:38:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1882/</loc>
		<lastmod>2013-12-05T16:38:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3230/</loc>
		<lastmod>2013-12-05T16:38:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1908/</loc>
		<lastmod>2013-12-05T16:37:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2991/</loc>
		<lastmod>2013-12-05T16:37:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3371/</loc>
		<lastmod>2013-12-05T16:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3183/</loc>
		<lastmod>2013-12-05T16:37:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4432/</loc>
		<lastmod>2013-12-05T16:37:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2989/</loc>
		<lastmod>2013-12-05T16:37:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2154/</loc>
		<lastmod>2013-12-05T16:37:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3395/</loc>
		<lastmod>2013-12-05T16:37:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1859/</loc>
		<lastmod>2013-12-05T16:37:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3159/</loc>
		<lastmod>2013-12-05T16:37:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3153/</loc>
		<lastmod>2013-12-05T16:37:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2128/</loc>
		<lastmod>2013-12-05T16:37:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1883/</loc>
		<lastmod>2013-12-05T16:37:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1885/</loc>
		<lastmod>2013-12-05T16:37:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2159/</loc>
		<lastmod>2013-12-05T16:37:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1896/</loc>
		<lastmod>2013-12-05T16:37:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1901/</loc>
		<lastmod>2013-12-05T16:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3123/</loc>
		<lastmod>2013-12-05T16:37:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3208/</loc>
		<lastmod>2013-12-05T16:36:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3158/</loc>
		<lastmod>2013-12-05T16:36:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1966/</loc>
		<lastmod>2013-12-05T16:36:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3145/</loc>
		<lastmod>2013-12-05T16:36:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2161/</loc>
		<lastmod>2013-12-05T16:36:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3353/</loc>
		<lastmod>2013-12-05T16:36:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4219/</loc>
		<lastmod>2013-12-05T16:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3354/</loc>
		<lastmod>2013-12-05T16:36:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1950/</loc>
		<lastmod>2013-12-05T16:36:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3102/</loc>
		<lastmod>2013-12-05T16:36:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1975/</loc>
		<lastmod>2013-12-05T16:36:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4452/</loc>
		<lastmod>2013-12-05T16:36:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1249/</loc>
		<lastmod>2013-12-05T16:36:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2129/</loc>
		<lastmod>2013-12-05T16:35:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3132/</loc>
		<lastmod>2013-12-05T16:35:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3179/</loc>
		<lastmod>2013-12-05T16:35:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1911/</loc>
		<lastmod>2013-12-05T16:35:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1954/</loc>
		<lastmod>2013-12-05T16:35:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3163/</loc>
		<lastmod>2013-12-05T16:35:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4427/</loc>
		<lastmod>2013-12-05T16:35:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1933/</loc>
		<lastmod>2013-12-05T16:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3127/</loc>
		<lastmod>2013-12-05T16:35:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3110/</loc>
		<lastmod>2013-12-05T16:35:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3083/</loc>
		<lastmod>2013-12-05T16:35:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3094/</loc>
		<lastmod>2013-12-05T16:35:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3138/</loc>
		<lastmod>2013-12-05T16:35:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3312/</loc>
		<lastmod>2013-12-05T16:35:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4451/</loc>
		<lastmod>2013-12-05T16:35:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3216/</loc>
		<lastmod>2013-12-05T16:34:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1957/</loc>
		<lastmod>2013-12-05T16:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3196/</loc>
		<lastmod>2013-12-05T16:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1863/</loc>
		<lastmod>2013-12-05T16:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4455/</loc>
		<lastmod>2013-12-05T16:34:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4449/</loc>
		<lastmod>2013-12-05T16:34:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3222/</loc>
		<lastmod>2013-12-05T16:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4520/</loc>
		<lastmod>2013-12-05T16:34:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1923/</loc>
		<lastmod>2013-12-05T16:34:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3186/</loc>
		<lastmod>2013-12-05T16:34:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3226/</loc>
		<lastmod>2013-12-05T16:34:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1845/</loc>
		<lastmod>2013-12-05T16:34:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1905/</loc>
		<lastmod>2013-12-05T16:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1932/</loc>
		<lastmod>2013-12-05T16:34:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1913/</loc>
		<lastmod>2013-12-05T16:34:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3116/</loc>
		<lastmod>2013-12-05T16:34:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3200/</loc>
		<lastmod>2013-12-05T16:34:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3202/</loc>
		<lastmod>2013-12-05T16:33:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1955/</loc>
		<lastmod>2013-12-05T16:33:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3195/</loc>
		<lastmod>2013-12-05T16:33:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3207/</loc>
		<lastmod>2013-12-05T16:33:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3105/</loc>
		<lastmod>2013-12-05T16:33:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1964/</loc>
		<lastmod>2013-12-05T16:33:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3177/</loc>
		<lastmod>2013-12-05T16:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3166/</loc>
		<lastmod>2013-12-05T16:33:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3176/</loc>
		<lastmod>2013-12-05T16:33:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3378/</loc>
		<lastmod>2013-12-05T16:33:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4429/</loc>
		<lastmod>2013-12-05T16:33:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3223/</loc>
		<lastmod>2013-12-05T16:33:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2074/</loc>
		<lastmod>2013-12-05T16:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3358/</loc>
		<lastmod>2013-12-05T16:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3097/</loc>
		<lastmod>2013-12-05T16:33:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3106/</loc>
		<lastmod>2013-12-05T16:33:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1953/</loc>
		<lastmod>2013-12-05T16:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2136/</loc>
		<lastmod>2013-12-05T16:32:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1936/</loc>
		<lastmod>2013-12-05T16:32:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3227/</loc>
		<lastmod>2013-12-05T16:32:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3113/</loc>
		<lastmod>2013-12-05T16:32:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3212/</loc>
		<lastmod>2013-12-05T16:32:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/4447/</loc>
		<lastmod>2013-12-05T16:32:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1855/</loc>
		<lastmod>2013-12-05T16:32:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1867/</loc>
		<lastmod>2013-12-05T16:32:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3092/</loc>
		<lastmod>2013-12-05T16:32:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3346/</loc>
		<lastmod>2013-12-05T16:32:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3082/</loc>
		<lastmod>2013-12-05T16:32:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2132/</loc>
		<lastmod>2013-12-05T16:32:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3192/</loc>
		<lastmod>2013-12-05T16:32:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3407/</loc>
		<lastmod>2013-12-05T16:31:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3188/</loc>
		<lastmod>2013-12-05T16:31:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3139/</loc>
		<lastmod>2013-12-05T16:31:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3117/</loc>
		<lastmod>2013-12-05T16:31:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3093/</loc>
		<lastmod>2013-12-05T16:31:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1987/</loc>
		<lastmod>2013-12-05T16:31:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1424/</loc>
		<lastmod>2013-12-05T16:31:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1916/</loc>
		<lastmod>2013-12-05T16:31:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1990/</loc>
		<lastmod>2013-12-05T16:31:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3209/</loc>
		<lastmod>2013-12-05T16:31:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3086/</loc>
		<lastmod>2013-12-05T16:31:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1854/</loc>
		<lastmod>2013-12-05T16:31:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3332/</loc>
		<lastmod>2013-12-05T16:31:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3173/</loc>
		<lastmod>2013-12-05T16:30:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3344/</loc>
		<lastmod>2013-12-05T16:30:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1856/</loc>
		<lastmod>2013-12-05T16:30:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3220/</loc>
		<lastmod>2013-12-05T16:30:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3201/</loc>
		<lastmod>2013-12-05T16:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3150/</loc>
		<lastmod>2013-12-05T16:30:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1873/</loc>
		<lastmod>2013-12-05T16:30:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1906/</loc>
		<lastmod>2013-12-05T16:30:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3118/</loc>
		<lastmod>2013-12-05T16:30:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1984/</loc>
		<lastmod>2013-12-05T16:30:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1880/</loc>
		<lastmod>2013-12-05T16:30:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2155/</loc>
		<lastmod>2013-12-05T16:30:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2939/</loc>
		<lastmod>2013-12-05T16:30:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1973/</loc>
		<lastmod>2013-12-05T16:29:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2090/</loc>
		<lastmod>2013-12-05T16:29:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1979/</loc>
		<lastmod>2013-12-05T16:29:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1897/</loc>
		<lastmod>2013-12-05T16:29:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3211/</loc>
		<lastmod>2013-12-05T16:29:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1866/</loc>
		<lastmod>2013-12-05T16:29:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3187/</loc>
		<lastmod>2013-12-05T16:29:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1847/</loc>
		<lastmod>2013-12-05T16:29:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3091/</loc>
		<lastmod>2013-12-05T16:29:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1912/</loc>
		<lastmod>2013-12-05T16:29:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3369/</loc>
		<lastmod>2013-12-05T16:29:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1868/</loc>
		<lastmod>2013-12-05T16:29:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3154/</loc>
		<lastmod>2013-12-05T16:29:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1848/</loc>
		<lastmod>2013-12-05T16:29:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3221/</loc>
		<lastmod>2013-12-05T16:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1869/</loc>
		<lastmod>2013-12-05T16:29:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1972/</loc>
		<lastmod>2013-12-05T16:28:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1721/</loc>
		<lastmod>2013-12-05T16:28:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1942/</loc>
		<lastmod>2013-12-05T16:28:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3126/</loc>
		<lastmod>2013-12-05T16:28:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1974/</loc>
		<lastmod>2013-12-05T16:28:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1842/</loc>
		<lastmod>2013-12-05T16:28:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1884/</loc>
		<lastmod>2013-12-05T16:28:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1902/</loc>
		<lastmod>2013-12-05T16:28:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1872/</loc>
		<lastmod>2013-12-05T16:28:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1971/</loc>
		<lastmod>2013-12-05T16:28:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1853/</loc>
		<lastmod>2013-12-05T16:28:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1940/</loc>
		<lastmod>2013-12-05T16:28:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3185/</loc>
		<lastmod>2013-12-05T16:27:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3385/</loc>
		<lastmod>2013-12-05T16:27:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3236/</loc>
		<lastmod>2013-12-05T16:27:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3085/</loc>
		<lastmod>2013-12-05T16:27:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3111/</loc>
		<lastmod>2013-12-05T16:27:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3130/</loc>
		<lastmod>2013-12-05T16:27:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/723/</loc>
		<lastmod>2013-12-05T16:27:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/158/</loc>
		<lastmod>2013-12-05T16:27:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/141/</loc>
		<lastmod>2013-12-05T16:27:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/904/</loc>
		<lastmod>2013-12-05T16:27:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/897/</loc>
		<lastmod>2013-12-05T16:27:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/605/</loc>
		<lastmod>2013-12-05T16:27:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/548/</loc>
		<lastmod>2013-12-05T16:27:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/836/</loc>
		<lastmod>2013-12-05T16:27:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/905/</loc>
		<lastmod>2013-12-05T16:27:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/417/</loc>
		<lastmod>2013-12-05T16:26:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/142/</loc>
		<lastmod>2013-12-05T16:26:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/914/</loc>
		<lastmod>2013-12-05T16:26:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/153/</loc>
		<lastmod>2013-12-05T16:26:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/761/</loc>
		<lastmod>2013-12-05T16:26:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/400/</loc>
		<lastmod>2013-12-05T16:26:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/230/</loc>
		<lastmod>2013-12-05T16:26:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/743/</loc>
		<lastmod>2013-12-05T16:26:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/132/</loc>
		<lastmod>2013-12-05T16:26:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/808/</loc>
		<lastmod>2013-12-05T16:26:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/397/</loc>
		<lastmod>2013-12-05T16:26:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/129/</loc>
		<lastmod>2013-12-05T16:26:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/878/</loc>
		<lastmod>2013-12-05T16:26:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/280/</loc>
		<lastmod>2013-12-05T16:26:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/756/</loc>
		<lastmod>2013-12-05T16:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/128/</loc>
		<lastmod>2013-12-05T16:25:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/130/</loc>
		<lastmod>2013-12-05T16:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/530/</loc>
		<lastmod>2013-12-05T16:25:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/1935/</loc>
		<lastmod>2013-12-05T16:25:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/282/</loc>
		<lastmod>2013-12-05T16:25:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/3316/</loc>
		<lastmod>2013-12-05T16:25:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/879/</loc>
		<lastmod>2013-12-05T16:25:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/123/</loc>
		<lastmod>2013-12-05T16:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/753/</loc>
		<lastmod>2013-12-05T16:25:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/125/</loc>
		<lastmod>2013-12-05T16:25:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/416/</loc>
		<lastmod>2013-12-05T16:25:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/281/</loc>
		<lastmod>2013-12-05T16:25:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/274/</loc>
		<lastmod>2013-12-05T16:25:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/277/</loc>
		<lastmod>2013-12-05T16:25:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/534/</loc>
		<lastmod>2013-12-05T16:25:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/680/</loc>
		<lastmod>2013-12-05T16:25:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/271/</loc>
		<lastmod>2013-12-05T16:24:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/279/</loc>
		<lastmod>2013-12-05T16:24:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/880/</loc>
		<lastmod>2013-12-05T16:24:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/533/</loc>
		<lastmod>2013-12-05T16:24:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/131/</loc>
		<lastmod>2013-12-05T16:24:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/601/</loc>
		<lastmod>2013-12-05T16:24:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/276/</loc>
		<lastmod>2013-12-05T16:24:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/537/</loc>
		<lastmod>2013-12-05T16:24:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/122/</loc>
		<lastmod>2013-12-05T16:24:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/278/</loc>
		<lastmod>2013-12-05T16:24:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/406/</loc>
		<lastmod>2013-12-05T16:24:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/679/</loc>
		<lastmod>2013-12-05T16:24:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/684/</loc>
		<lastmod>2013-12-05T16:24:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/405/</loc>
		<lastmod>2013-12-05T16:24:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/754/</loc>
		<lastmod>2013-12-05T16:24:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/929/</loc>
		<lastmod>2013-12-05T16:24:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/906/</loc>
		<lastmod>2013-12-05T16:24:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/401/</loc>
		<lastmod>2013-12-05T16:24:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/2/</loc>
		<lastmod>2013-12-05T16:24:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/529/</loc>
		<lastmod>2013-12-05T16:24:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/752/</loc>
		<lastmod>2013-12-05T16:23:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/881/</loc>
		<lastmod>2013-12-05T16:23:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/286/</loc>
		<lastmod>2013-12-05T16:23:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/407/</loc>
		<lastmod>2013-12-05T16:23:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/273/</loc>
		<lastmod>2013-12-05T16:23:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/877/</loc>
		<lastmod>2013-12-05T16:23:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/540/</loc>
		<lastmod>2013-12-05T16:23:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/682/</loc>
		<lastmod>2013-12-05T16:23:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/683/</loc>
		<lastmod>2013-12-05T16:23:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/882/</loc>
		<lastmod>2013-12-05T16:22:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/398/</loc>
		<lastmod>2013-12-05T16:22:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/14/</loc>
		<lastmod>2013-12-05T16:22:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/139/</loc>
		<lastmod>2013-12-05T16:22:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/758/</loc>
		<lastmod>2013-12-05T16:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/681/</loc>
		<lastmod>2013-12-05T16:22:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/287/</loc>
		<lastmod>2013-12-05T16:22:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/403/</loc>
		<lastmod>2013-12-05T16:22:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/531/</loc>
		<lastmod>2013-12-05T16:22:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/124/</loc>
		<lastmod>2013-12-05T16:22:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/532/</loc>
		<lastmod>2013-12-05T16:22:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/402/</loc>
		<lastmod>2013-12-05T16:22:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/755/</loc>
		<lastmod>2013-12-05T16:21:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/751/</loc>
		<lastmod>2013-12-05T16:21:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/686/</loc>
		<lastmod>2013-12-05T16:21:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/688/</loc>
		<lastmod>2013-12-05T16:21:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/766/</loc>
		<lastmod>2013-12-05T16:21:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/408/</loc>
		<lastmod>2013-12-05T16:21:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/599/</loc>
		<lastmod>2013-12-05T16:21:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/538/</loc>
		<lastmod>2013-12-05T16:21:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/404/</loc>
		<lastmod>2013-12-05T16:21:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/399/</loc>
		<lastmod>2013-12-05T16:20:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/765/</loc>
		<lastmod>2013-12-05T16:20:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/12/03/northern-lights-nifty-gifts-for-myeloma-patients/</loc>
		<lastmod>2013-12-05T04:02:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/10/08/arnies-rebounding-world-keeping-it-real/</loc>
		<lastmod>2013-12-04T13:55:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/23/ash-2013-preview-immunotherapy-multiple-myeloma/</loc>
		<lastmod>2013-12-03T02:19:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/12/02/ash-2013-vorschau-immuntherapie-multiples-myelom/</loc>
		<lastmod>2013-12-03T02:18:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/24/beacon-newsflashes-september-24-2012/</loc>
		<lastmod>2013-11-29T15:40:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/25/chemo-brain-multiple-myeloma-stem-cell-transplantation/</loc>
		<lastmod>2013-11-27T16:56:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/11/27/quimiocerebro-mieloma-multiple-trasplante/</loc>
		<lastmod>2013-11-27T16:56:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/10/30/myeloma-mom-i-dont-have-to-i-get-to/</loc>
		<lastmod>2013-11-25T20:15:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/10/10/northern-lights-a-canadian-thanksgiving/</loc>
		<lastmod>2013-11-24T05:24:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/21/reaper-stay-away-from-my-door/</loc>
		<lastmod>2013-11-21T21:06:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/06/beacon-newsflashes-november-6-2009/</loc>
		<lastmod>2013-11-21T15:10:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/14/northern-lights-keeping-on-an-even-keel/</loc>
		<lastmod>2013-11-14T19:52:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/10/31/infektionen-myelom-risiko/</loc>
		<lastmod>2013-11-13T21:12:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/11/13/infecciones-riesgo-de-desarrollar-mieloma-multiple/</loc>
		<lastmod>2013-11-13T21:11:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/11/04/sistema-inmunologico-supervivencia-mieloma-multiple/</loc>
		<lastmod>2013-11-13T21:07:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/11/07/pats-place-dont-give-up-on-seeking-help-to-improve-your-quality-of-life/</loc>
		<lastmod>2013-11-07T18:11:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/06/chromosomal-abnormalities-tumor-load-smoldering-myeloma-progression-risk/</loc>
		<lastmod>2013-11-06T22:13:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/10/01/seans-burgundy-thread-withering-heights/</loc>
		<lastmod>2013-11-05T18:24:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/10/30/immunsystem-langzeituberleben-multiples-myelom/</loc>
		<lastmod>2013-11-04T21:37:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/11/immune-system-long-term-survival-multiple-myeloma/</loc>
		<lastmod>2013-11-04T21:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/11/04/dinaciclib-velcade-bortezomib-dexamethasone-multiple-myeloma-clinical-trial/</loc>
		<lastmod>2013-11-04T18:03:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/18/dinaciclib-sch727965-shows-activity-in-relapsed-multiple-myeloma-ash-2012/</loc>
		<lastmod>2013-11-04T18:01:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/31/whole-body-mri-bone-lesions-mgus-progression-risk/</loc>
		<lastmod>2013-11-01T17:32:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/03/number-of-bone-lesions-after-stem-cell-transplant-may-predict-overall-survival/</loc>
		<lastmod>2013-11-01T00:43:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/15/bone-lesions-detected-by-mri-progression-smoldering-myeloma/</loc>
		<lastmod>2013-11-01T00:33:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/18/chromosomal-abnormalities-multiple-myeloma-symptoms/</loc>
		<lastmod>2013-10-31T13:08:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/29/stem-cell-transplant-advanced-kidney-disease-multiple-myeloma/</loc>
		<lastmod>2013-10-29T21:45:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/10/29/chromosomale-abnormitaten-multiples-myelom-symptome-diagnose/</loc>
		<lastmod>2013-10-29T18:05:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/19/me-vs-mm-a-healthier-me/</loc>
		<lastmod>2013-10-29T14:34:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/10/15/letters-from-cancerland-sandwiches/</loc>
		<lastmod>2013-10-28T19:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/28/fenofibrate-tricor-multiple-myeloma-clinical-trial/</loc>
		<lastmod>2013-10-28T18:46:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/11/pats-place-what-has-multiple-myeloma-done-to-my-organizational-skills-and-focus/</loc>
		<lastmod>2013-10-24T16:53:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/19/me-vs-mm-the-psychological-battle/</loc>
		<lastmod>2013-10-24T16:51:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/10/23/langfristige-gabe-revlimid-lenalidomid-dexamethason-rezidiviertes-refraktares-myelom/</loc>
		<lastmod>2013-10-24T16:27:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/23/milatuzumab-single-agent-relapsed-refractory-multiple-myeloma/</loc>
		<lastmod>2013-10-23T22:22:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/09/24/konsensus-risikoklassifikation-multiples-myelom/</loc>
		<lastmod>2013-10-23T21:45:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/04/revlimid-lenalidomide-dexamethasone-relapsed-refractory-multiple-myeloma/</loc>
		<lastmod>2013-10-23T21:44:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/13/imwg-risk-stratification-multiple-myeloma/</loc>
		<lastmod>2013-10-22T17:59:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/10/22/estratificacion-del-riesgo-mieloma-multiple-imwg/</loc>
		<lastmod>2013-10-22T17:57:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/09/09/mieloma-multiple-remision-completa/</loc>
		<lastmod>2013-10-22T14:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/02/seans-burgundy-thread-stoppage-time/</loc>
		<lastmod>2013-10-17T23:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/26/myeloma-mom-how-do-you-tell-the-kids/</loc>
		<lastmod>2013-10-16T19:44:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/16/zolinza-slightly-improves-velcade-treatment-for-relapsed-multiple-myeloma/</loc>
		<lastmod>2013-10-16T19:21:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/14/xgeva-denosumab-better-than-zometa-zoledronic-acid-in-reducing-pain/</loc>
		<lastmod>2013-10-15T21:10:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/14/beacon-newsflashes-october-14-2013/</loc>
		<lastmod>2013-10-14T20:04:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/21/researchers-identify-factors-that-predict-long-term-survival-in-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2013-10-13T03:04:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/01/understanding-prognosis-in-multiple-myeloma/</loc>
		<lastmod>2013-10-13T03:02:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/06/pats-place-the-switch/</loc>
		<lastmod>2013-10-11T21:31:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/19/achieving-very-good-partial-response-indicates-a-good-prognosis-for-multiple-myeloma-patients-study-finds/</loc>
		<lastmod>2013-10-11T21:30:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/28/thalidomide-thalomid-based-therapy-yields-mixed-outcomes-in-multiple-myeloma-patients-with-a-deletion-in-chromosome-17/</loc>
		<lastmod>2013-10-11T21:29:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/02/thalidomide-maintenance-therapy-fails-to-provide-consistent-overall-survival-benefit/</loc>
		<lastmod>2013-10-11T21:29:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/02/czech-researchers-look-at-impact-of-chromosomal-abnormalities-in-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2013-10-11T21:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/27/quality-of-response-following-stem-cell-transplant-may-predict-long-term-survival-in-myeloma-patients-eha-2012/</loc>
		<lastmod>2013-10-11T21:28:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/08/16/me-vs-mm-prognosis/</loc>
		<lastmod>2013-10-11T21:28:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/06/tandem-auto-allo-transplantation-prognosis-of-high-risk-myeloma-patients/</loc>
		<lastmod>2013-10-11T21:28:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/07/pats-place-the-elephant-in-the-room-death-and-dying/</loc>
		<lastmod>2013-10-11T21:27:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/07/comorbidity-index-multiple-myeloma-risk/</loc>
		<lastmod>2013-10-11T21:26:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/10/complete-response-multiple-myeloma-treatment/</loc>
		<lastmod>2013-10-11T21:26:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/22/follow-up-results-confirm-survival-benefit-of-velcade-melphalan-prednisone-therapy-in-multiple-myeloma-patients/</loc>
		<lastmod>2013-10-11T21:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/19/continued-revlimid-lenalidomide-dexamethasone-treatment-improves-patient-survival-outcomes/</loc>
		<lastmod>2013-10-11T21:25:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/23/pomalidomide-shows-survival-benefit-in-heavily-pretreated-multiple-myeloma/</loc>
		<lastmod>2013-10-11T21:25:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/17/letters-from-cancerland-unplugged/</loc>
		<lastmod>2013-10-10T18:27:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/09/velcade-bortezomib-treanda-bendamustine-prednisone-kidney-function-relapsed-multiple-myeloma/</loc>
		<lastmod>2013-10-09T22:52:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/10/arnies-rebounding-world-long-term-is-series-of-short-terms/</loc>
		<lastmod>2013-10-08T16:22:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/07/beacon-newsflashes-october-7-2013/</loc>
		<lastmod>2013-10-08T13:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/11/blood-clots-multiple-myeloma-thalidomide-revlimid/</loc>
		<lastmod>2013-10-04T22:37:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/17/velcade-doxil-dexamethasone-combination-is-effective-and-safe-in-elderly-myeloma-patients/</loc>
		<lastmod>2013-10-03T19:16:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/10/03/pats-place-did-testosterone-therapy-contribute-to-my-relapse/</loc>
		<lastmod>2013-10-03T18:02:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/05/pats-place-cant-a-guy-get-a-break/</loc>
		<lastmod>2013-10-03T16:43:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/10/02/pomalyst-pomalidomide-cyclophosphamide-prednisone-relapsed-multiple-myeloma/</loc>
		<lastmod>2013-10-03T15:27:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/03/seans-burgundy-thread-myeloma-mirrors-and-mercury/</loc>
		<lastmod>2013-10-01T16:23:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/30/manhattan-tales-summer-interlude-interrupted/</loc>
		<lastmod>2013-09-30T18:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/27/multiple-myeloma-and-pregnancy/</loc>
		<lastmod>2013-09-29T12:20:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/09/27/la-supervivencia-mieloma-multiple-grupos-etnicos-edad/</loc>
		<lastmod>2013-09-27T14:48:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/09/26/kyprolis-carfilzomib-revlimid-dexamethason-vielversprechende-therapieoption-rezidiviertes-multiples-myelom/</loc>
		<lastmod>2013-09-26T21:23:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/23/continued-response-stem-cell-transplant-myeloma-survival-impact/</loc>
		<lastmod>2013-09-25T01:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/29/manhattan-tales-milestones/</loc>
		<lastmod>2013-09-25T01:14:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/27/myeloma-mom-my-aunt-margie/</loc>
		<lastmod>2013-09-24T20:14:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/24/doxil-revlimid-lenalidomide-dexamethasone-newly-diagnosed-myeloma/</loc>
		<lastmod>2013-09-24T14:10:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/18/final-results-pomalyst-pomalidomide-imnovid-trial-approval-europe/</loc>
		<lastmod>2013-09-18T19:11:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/09/17/thalidomid-revlimid-thrombose-prophylaxe-multiples-myelom/</loc>
		<lastmod>2013-09-17T21:35:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/revlimid/</loc>
		<lastmod>2013-09-16T03:24:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/01/pats-cracked-cup-the-seasons-of-living-with-multiple-myeloma/</loc>
		<lastmod>2013-09-15T13:02:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/16/stem-cell-transplant-timing-multiple-myeloma/</loc>
		<lastmod>2013-09-13T21:31:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/09/12/northern-lights-returning-to-exercise/</loc>
		<lastmod>2013-09-12T17:41:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/09/09/beacon-newsflashes-september-9-2013/</loc>
		<lastmod>2013-09-10T01:16:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/13/arnies-rebounding-world-hope-is-not-a-strategy/</loc>
		<lastmod>2013-09-05T20:04:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/02/revlimid-lenalidomide-dexamethasone-high-risk-smoldering-myeloma/</loc>
		<lastmod>2013-09-05T19:27:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/28/newer-methods-assess-kidney-disease-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2013-08-29T13:58:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/26/beacon-newsflashes-august-26-2013/</loc>
		<lastmod>2013-08-28T17:10:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/08/09/wissenschaftler-veroffentlichen-endresultate-der-kyprolis-carfilzomib-studie-die-zur-fda-zulassung-gefuhrt-hat/</loc>
		<lastmod>2013-08-26T18:27:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/10/29/pomalidomid-zeigt-uberlebensvorteil-bei-schwer-vorbehandelten-myelompatienten/</loc>
		<lastmod>2013-08-26T10:19:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/22/protein-biomarkers-proteomic-profiling-predict-acute-gvhd/</loc>
		<lastmod>2013-08-22T21:39:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/21/stem-cell-collection-after-first-transplant-myeloma-mds-risk/</loc>
		<lastmod>2013-08-21T20:22:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/09/ash-2012-multiple-myeloma-update-day-one-poster-sessions/</loc>
		<lastmod>2013-08-21T19:40:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/11/spanish-translations-myeloma-beacon/</loc>
		<lastmod>2013-08-21T19:39:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/01/long-term-revlimid-lenalidomide-clarithromycin-dexamethasone-bird-effective-and-safe/</loc>
		<lastmod>2013-08-21T19:38:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/11/beacon-newsflashes-february-11-2013/</loc>
		<lastmod>2013-08-21T19:37:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/06/seans-burgundy-thread-sleepless-inconvenience/</loc>
		<lastmod>2013-08-19T16:36:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/19/beacon-newsflashes-august-19-2013/</loc>
		<lastmod>2013-08-19T15:16:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/08/16/pomalidomid-imnovid-europa-rezidiviertes-refraktares-multiples-myelom-zulassung/</loc>
		<lastmod>2013-08-18T19:12:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/08/15/me-vs-mm-support-groups-and-seminars/</loc>
		<lastmod>2013-08-15T20:11:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/15/velcade-bortezomib-dexamethasone-relapsed-multiple-myeloma/</loc>
		<lastmod>2013-08-15T15:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/30/myeloma-mom-undercover-cancer-patient/</loc>
		<lastmod>2013-08-13T16:36:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/26/clonal-evolution-myeloma-progression/</loc>
		<lastmod>2013-08-13T16:35:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/23/letters-from-cancerland-of-money-and-myeloma/</loc>
		<lastmod>2013-08-13T16:34:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/16/arnies-rebounding-world-medical-uncertainty/</loc>
		<lastmod>2013-08-13T16:22:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/01/pomalidomide-pomalyst-positive-opinion-chmp-europe-approval/</loc>
		<lastmod>2013-08-12T21:34:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/03/revlimid-lenalidomide-stem-cell-mobilization/</loc>
		<lastmod>2013-08-12T21:31:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/pomalidomide/</loc>
		<lastmod>2013-08-10T00:51:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/04/combination-actimid-and-dexamethasone-regimen-is-promising-for-relapsed-and-refractory-myeloma-patients/</loc>
		<lastmod>2013-08-10T00:50:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/07/pomalidomide-shows-promising-results-for-multiple-myeloma-patients-resistant-to-revlimid-and-velcade-ash-2010/</loc>
		<lastmod>2013-08-10T00:49:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/01/pomalidomide-may-be-effective-in-myeloma-patients-who-develop-extramedullary-disease/</loc>
		<lastmod>2013-08-10T00:49:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/17/myeloma-patients-relapsing-after-pomalidomide-therapy-may-benefit-from-certain-salvage-therapies/</loc>
		<lastmod>2013-08-10T00:49:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/30/pomalidomide-continues-to-show-promise-as-treatment-for-relapsed-multiple-myeloma-ash-2011/</loc>
		<lastmod>2013-08-10T00:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/26/celgene-updates-timeline-for-pomalidomide-approval-fda-ema/</loc>
		<lastmod>2013-08-10T00:48:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/25/updated-pomalidomide-clinical-trial-results-presented-asco-2012/</loc>
		<lastmod>2013-08-10T00:48:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/22/pomalyst-pomalidomide-which-multiple-myeloma-patients-will-physicians-treat-with-it/</loc>
		<lastmod>2013-08-10T00:47:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/10/pomalyst-low-dose-dexamethasone-high-risk-relapsed-myeloma-imw-2013/</loc>
		<lastmod>2013-08-10T00:47:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/12/cereblon-pomalyst-revlimid-thalidomide-in-multiple-myeloma-imw-2013/</loc>
		<lastmod>2013-08-10T00:47:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/08/05/beacon-newsflashes-august-5-2013/</loc>
		<lastmod>2013-08-06T15:39:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/26/early-treatment-for-high-risk-smoldering-myeloma-imw-2013/</loc>
		<lastmod>2013-08-02T21:51:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/18/donor-stem-cell-transplantation-may-benefit-high-risk-myeloma-patients/</loc>
		<lastmod>2013-08-01T15:58:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/15/high-risk-myeloma-patients-show-overall-lower-progression-free-survival-with-revlimid-dexamethosone-therapy/</loc>
		<lastmod>2013-08-01T15:58:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/14/sequential-treatment-using-velcade-bortezomib-and-thalidomide-thalomid-is-effective-in-high-risk-multiple-myeloma-patients/</loc>
		<lastmod>2013-08-01T15:57:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/15/trisomy-high-risk-multiple-myeloma-survival/</loc>
		<lastmod>2013-08-01T15:56:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/28/cyclophosphamide-velcade-and-dexamethasone-combination-shows-promise-for-newly-diagnosed-multiple-myeloma-asco-2010/</loc>
		<lastmod>2013-08-01T11:21:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/06/initial-treatment-with-cyclophosphamide-velcade-bortezomib-and-dexamethasone-cybord-compares-favorably-in-terms-of-response-rates-and-side-effects/</loc>
		<lastmod>2013-08-01T11:21:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/20/beacon-newsflashes-february-20-2012/</loc>
		<lastmod>2013-08-01T11:21:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/23/among-velcade-bortezomib-combinations-four-drug-combo-is-not-more-effective-than-similar-three-drug-combos-for-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2013-08-01T11:21:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/29/beacon-newsflashes-july-29-2013/</loc>
		<lastmod>2013-07-29T19:26:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/25/manhattan-tales-green-interlude-from-the-city/</loc>
		<lastmod>2013-07-25T17:37:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/19/revlimid-lenalidomide-leukemia-trial-halted-impact-in-myeloma/</loc>
		<lastmod>2013-07-19T21:11:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/27/pet-appreciation/</loc>
		<lastmod>2013-07-19T17:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/18/me-vs-mm-guilt-trips/</loc>
		<lastmod>2013-07-18T17:36:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/18/letters-from-cancerland-mediating-with-myeloma/</loc>
		<lastmod>2013-07-18T16:44:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/17/velcade-donor-stem-cell-transplantation-multiple-myeloma/</loc>
		<lastmod>2013-07-18T00:50:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/15/beacon-newsflashes-july-15-2013/</loc>
		<lastmod>2013-07-15T18:29:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/25/myeloma-mom-live-like-you-are-living/</loc>
		<lastmod>2013-07-15T18:22:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/10/arnies-rebounding-world-waiting-for-the-next-shoe-to-drop/</loc>
		<lastmod>2013-07-12T18:19:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/11/northern-lights-notes-on-nutrition/</loc>
		<lastmod>2013-07-11T17:43:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/11/donor-stem-cell-transplant-consolidation-therapy-multiple-myeloma/</loc>
		<lastmod>2013-07-10T15:25:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/28/blueprint-multiple-myeloma-cure/</loc>
		<lastmod>2013-07-10T13:24:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/09/seans-burgundy-thread-dreams-and-destinations/</loc>
		<lastmod>2013-07-09T18:07:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/20/me-vs-mm-two-years-of-chemo-what-has-it-done-to-me/</loc>
		<lastmod>2013-07-08T19:13:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0798/</loc>
		<lastmod>2013-07-05T17:12:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/04/manhattan-tales-entering-a-new-phase-of-life/</loc>
		<lastmod>2013-07-04T10:13:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/03/beacon-newsflashes-july-3-2013/</loc>
		<lastmod>2013-07-03T21:13:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s0578/</loc>
		<lastmod>2013-07-02T20:32:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s0115/</loc>
		<lastmod>2013-07-02T20:26:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s0579/</loc>
		<lastmod>2013-07-02T20:26:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s0580/</loc>
		<lastmod>2013-07-02T20:26:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s0576/</loc>
		<lastmod>2013-07-02T20:26:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s0577/</loc>
		<lastmod>2013-07-02T20:26:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s0543/</loc>
		<lastmod>2013-07-02T20:25:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0210/</loc>
		<lastmod>2013-07-02T20:25:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0236/</loc>
		<lastmod>2013-07-02T20:25:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0241/</loc>
		<lastmod>2013-07-02T20:25:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0242/</loc>
		<lastmod>2013-07-02T20:25:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0776/</loc>
		<lastmod>2013-07-02T20:25:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0779/</loc>
		<lastmod>2013-07-02T20:25:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0797/</loc>
		<lastmod>2013-07-02T20:25:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/p0765/</loc>
		<lastmod>2013-07-02T20:24:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/07/02/pats-place-risk-versus-reward/</loc>
		<lastmod>2013-07-02T18:44:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/07/01/beacon-newsflashes-july-1-2013/</loc>
		<lastmod>2013-07-02T03:21:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/17/beacon-newsflashes-june-17-2013/</loc>
		<lastmod>2013-07-01T15:56:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/14/beacon-newsflashes-july-14-2010/</loc>
		<lastmod>2013-06-26T23:27:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/28/myeloma-mom-greetings-from-a-young-myeloma-old-timer/</loc>
		<lastmod>2013-06-25T18:19:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/04/seans-burgundy-thread-happiness-in-a-word/</loc>
		<lastmod>2013-06-25T18:19:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/24/beacon-newsflashes-june-24-2013/</loc>
		<lastmod>2013-06-24T19:23:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/26/beacon-newsflashes-october-26-2011/</loc>
		<lastmod>2013-06-24T19:07:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/opinion/2013/06/24/vietnam-veteran-multiple-myeloma-speaks-up/</loc>
		<lastmod>2013-06-24T18:59:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/03/residual-disease-before-stem-cell-transplantation-may-predict-survival-in-multiple-myeloma-patients/</loc>
		<lastmod>2013-06-20T18:12:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/19/translocation-11-14-impact-transplant-outcomes-myeloma/</loc>
		<lastmod>2013-06-20T17:19:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/07/cell-based-multiple-myeloma-vaccine-after-stem-cell-transplantation/</loc>
		<lastmod>2013-06-19T19:51:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/06/14/zellbasierter-myelomimpfstoff-nach-stammzelltransplantation/</loc>
		<lastmod>2013-06-14T19:17:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s1155/</loc>
		<lastmod>2013-06-14T18:11:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s1152/</loc>
		<lastmod>2013-06-14T18:07:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s1154/</loc>
		<lastmod>2013-06-14T18:02:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/s1151/</loc>
		<lastmod>2013-06-14T17:57:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/06/13/asco-2013-multiples-myelom-update-tag-vier-poster-prasentationen/</loc>
		<lastmod>2013-06-14T01:38:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/06/12/asco-2013-multiples-myelom-update-tag-vier-vortrage/</loc>
		<lastmod>2013-06-13T23:52:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/13/northern-lights-social-media-and-the-myeloma-patient/</loc>
		<lastmod>2013-06-13T21:17:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/06/10/asco-2013-multiples-myelom-update-tag-drei-poster-prasentationen/</loc>
		<lastmod>2013-06-12T18:38:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/06/03/asco-2013-multiple-myeloma-update-day-two-education-session/</loc>
		<lastmod>2013-06-11T22:31:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/09/arnies-rebounding-world-the-donor-transplant-day-60/</loc>
		<lastmod>2013-06-10T16:24:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/14/arnies-rebounding-world-a-daughters-perspective-by-dori-goodman/</loc>
		<lastmod>2013-06-10T14:09:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/15/birds-in-spring-random-acts-of-kindness/</loc>
		<lastmod>2013-06-07T15:55:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/06/07/asco-2013-multiples-myelom-update-tag-zwei-fortbildungssitzung/</loc>
		<lastmod>2013-06-07T15:30:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/06/06/pats-place-surviving-cancer-boot-camp/</loc>
		<lastmod>2013-06-06T20:35:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/21/letters-from-cancerland-vacation/</loc>
		<lastmod>2013-06-06T13:05:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/05/17/trends-behandlung-neu-diagnostizierte-myelompatienten/</loc>
		<lastmod>2013-06-05T14:52:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/06/04/trends-stammzelltransplantationen-multiples-myelom/</loc>
		<lastmod>2013-06-05T14:48:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/30/trends-stem-cell-transplantation-multiple-myeloma/</loc>
		<lastmod>2013-06-05T01:44:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/27/ifm-pomalyst-pomalidomide-efficacy-safety-dosing/</loc>
		<lastmod>2013-06-01T09:41:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/30/treatment-trends-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2013-06-01T02:01:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/05/31/tendencias-tratamiento-pacientes-mieloma-multiple-recien-diagnosticado/</loc>
		<lastmod>2013-06-01T02:00:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/09/northern-lights-surprising-changes-in-my-life/</loc>
		<lastmod>2013-05-30T13:11:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/15/transplantation-versus-novel-agents-for-myeloma-study-supports-transplantation-eha-2011/</loc>
		<lastmod>2013-05-30T11:44:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/05/28/que-novedades-hay-a-la-vista-mas-alla-de-kyprolis-y-pomalyst/</loc>
		<lastmod>2013-05-28T19:48:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/11/04/marizomib/</loc>
		<lastmod>2013-05-28T12:16:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/07/seans-burgundy-thread-moving-mountains/</loc>
		<lastmod>2013-05-24T15:42:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/04/25/manhattan-tales-breaking-through-the-pain/</loc>
		<lastmod>2013-05-23T21:21:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/23/manhattan-tales-spring-awakening/</loc>
		<lastmod>2013-05-23T21:19:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/17/novel-agents-repeat-transplantation-relapsed-multiple-myeloma/</loc>
		<lastmod>2013-05-17T21:28:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/05/16/revlimid-lenalidomid-stammzellsammlung/</loc>
		<lastmod>2013-05-16T19:52:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/16/me-vs-mm-potpourri/</loc>
		<lastmod>2013-05-16T17:42:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/05/15/una-experta-espanola-aconseja-el-tratamiento-precoz-en-mieloma-indolente-de-alto-riesgo-imw-2013/</loc>
		<lastmod>2013-05-16T01:14:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/04/28/actualizacion-sobre-cereblon-y-la-resistencia-a-pomalyst-revlmid-y-talidomida-en-pacientes-con-mieloma-multiple/</loc>
		<lastmod>2013-05-16T00:59:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/15/velcade-consolidation-after-stem-cell-transplantation-multiple-myeloma/</loc>
		<lastmod>2013-05-15T20:50:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/04/09/arnies-rebounding-world-one-day-at-a-time/</loc>
		<lastmod>2013-05-13T22:20:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/05/13/beacon-newsflashes-may-13-2013/</loc>
		<lastmod>2013-05-13T21:37:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/04/16/letters-from-cancerland-the-numbers-we-count-the-words-we-speak/</loc>
		<lastmod>2013-05-12T22:37:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/04/height-not-obesity/</loc>
		<lastmod>2013-05-10T20:07:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/19/update-on-benefits-and-risks-of-revlimid-lenalidomide-maintenance-therapy-imw-2013/</loc>
		<lastmod>2013-05-05T02:14:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/05/04/actualizacion-riesgos-y-beneficios-terapia-de-mantenimiento-revlimid-lenalidomida-imw-2013/</loc>
		<lastmod>2013-05-05T02:14:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/13/velcade-bortezomib-melphalan-alkeran-and-double-stem-cell-transplant-combination-is-feasible-in-treatment-resistant-multiple-myeloma-patients/</loc>
		<lastmod>2013-05-04T13:37:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/28/high-level-of-stem-cells-in-the-blood-may-be-associated-with-favorable-prognosis-for-myeloma-patients/</loc>
		<lastmod>2013-05-04T13:32:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/20/sequential-velcade-bortezomib-therapy-poor-response-revlimid-lenalidomide-thalidomide/</loc>
		<lastmod>2013-05-04T13:28:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/01/revlimid-as-initial-myeloma-therapy-inhibits-stem-cell-collection/</loc>
		<lastmod>2013-05-04T13:26:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/21/study-shows-mozobil-induces-mobilization-of-stem-cells-but-not-tumor-cells/</loc>
		<lastmod>2013-05-04T13:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/30/new-drug-enters-phase-2-clinical-trial-for-stem-cell-collection-for-blood-cancer-patients/</loc>
		<lastmod>2013-05-04T13:25:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/04/combination-of-thalidomide-thalomid-and-cyclophosphamide-may-negatively-impact-stem-cell-collection/</loc>
		<lastmod>2013-05-04T13:25:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/08/mozobil-may-help-myeloma-patients-collect-enough-stem-cells-for-a-second-transplant/</loc>
		<lastmod>2013-05-04T13:24:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/01/short-course-revlimid-lenalidomide-before-stem-cell-transplantation-is-feasible-in-myeloma/</loc>
		<lastmod>2013-05-04T13:24:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/30/novel-myeloma-therapies-may-not-hinder-stem-cell-collection/</loc>
		<lastmod>2013-05-03T19:50:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/22/international-myeloma-working-group-issues-recommendations-on-chemotherapy-and-stem-cell-collection/</loc>
		<lastmod>2013-05-03T19:46:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/05/02/pats-place-improving-my-quality-of-life/</loc>
		<lastmod>2013-05-02T13:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/04/11/northern-lights-trying-out-yoga/</loc>
		<lastmod>2013-05-02T12:31:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/29/beacon-newsflashes-april-29-2013/</loc>
		<lastmod>2013-04-29T18:14:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/04/15/cereblon-resistenz-myelom-pomalyst-revlimid-thalidomid-imw-2013/</loc>
		<lastmod>2013-04-28T23:21:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/09/pats-place-one-way-or-another-we-all-need-to-keep-moving/</loc>
		<lastmod>2013-04-25T16:49:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/20/beacon-newsflashes-%e2%80%93-august-20-2009/</loc>
		<lastmod>2013-04-22T14:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/04/19/kyprolis-carfilzomib-revlimid-lenalidomida-dexametasona-muestra-resultados-prometedores-en-mieloma-indolente-de-alto-riesgo-imw-2013/</loc>
		<lastmod>2013-04-19T22:52:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/11/revlimid-lenalidomide-maintenance-therapy-studies-clarify-benefits-and-risks/</loc>
		<lastmod>2013-04-19T21:51:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/04/18/me-vs-mm-good-bad-and-indifferent/</loc>
		<lastmod>2013-04-18T16:04:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/15/beacon-newsflashes-april-15-2013/</loc>
		<lastmod>2013-04-15T21:59:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/29/chromosomal-abnormalities-smoldering-myeloma-high-risk-progression/</loc>
		<lastmod>2013-04-15T18:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/04/15/anomalias-cromosomicas-mieloma-indolente-mayor-riesgo-de-progresion/</loc>
		<lastmod>2013-04-15T18:07:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/04/02/seans-burgundy-thread-myeloma-sunrise/</loc>
		<lastmod>2013-04-15T17:31:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/04/12/pomalyst-plus-niedrig-dosiertes-dexamethason-hochrisiko-myelompatienten-rezidiv-aktiv-imw-2013/</loc>
		<lastmod>2013-04-12T19:20:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/05/additional-study-finds-auto-allo-transplants-can-provide-long-term-control-of-myeloma/</loc>
		<lastmod>2013-04-11T22:59:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/04/11/auto-allo-transplantationen-langfristige-kontrolle-multiples-myelom/</loc>
		<lastmod>2013-04-11T22:59:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/04/10/las-principales-novedades-2012-mieloma-multiple/</loc>
		<lastmod>2013-04-10T14:37:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/28/manhattan-tales-changing-the-topic-from-my-inglorious-state-of-health/</loc>
		<lastmod>2013-04-10T12:54:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/12/arnies-rebounding-world-my-new-occupation-as-multiple-myeloma-patient/</loc>
		<lastmod>2013-04-08T21:57:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/04/04/pats-place-denial-enlightened-multiple-myeloma-patient/</loc>
		<lastmod>2013-04-04T17:41:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/04/04/langfristige-analyse-uberlebensvorteil-auto-allo-tandem-transplantation-multiples-myelom/</loc>
		<lastmod>2013-04-04T17:19:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/27/long-term-analysis-autologous-allogeneic-transplantation-survival-outcomes/</loc>
		<lastmod>2013-04-04T14:35:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/21/me-vs-mm-the-cost-of-treatment/</loc>
		<lastmod>2013-04-04T14:34:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/03/international-myeloma-workshop-kyoto-kicks-off-today-imw-2013/</loc>
		<lastmod>2013-04-03T17:02:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/04/01/beacon-newsflashes-april-1-2013/</loc>
		<lastmod>2013-04-01T19:38:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/19/letters-from-cancerland-the-velcade-velocipede/</loc>
		<lastmod>2013-04-01T13:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/14/northern-lights-watching-the-detectives/</loc>
		<lastmod>2013-03-27T12:58:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/13/big-sis-in-burgundy-the-battle-plan-or-is-it/</loc>
		<lastmod>2013-03-26T18:03:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/26/big-sis-in-burgundy-moving-on/</loc>
		<lastmod>2013-03-26T16:54:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/03/05/seans-burgundy-thread-a-beautiful-morning/</loc>
		<lastmod>2013-03-25T21:32:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/15/extramedullary-disease-symptoms-challenges-multiple-myeloma/</loc>
		<lastmod>2013-03-25T18:02:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/25/beacon-newsflashes-march-25-2013/</loc>
		<lastmod>2013-03-25T16:02:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/03/18/extramedullare-erkrankung-symptome-herausforderungen-myelompatienten/</loc>
		<lastmod>2013-03-25T14:39:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/03/25/la-enfermedad-extramedular-de-los-pacientes-con-mieloma-multiple-presenta-sintomas-y-desafios-singulares/</loc>
		<lastmod>2013-03-25T14:37:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/13/pomalyst-pomalidomide-questions-and-answers-fda-approval/</loc>
		<lastmod>2013-03-22T18:12:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/18/mozobil-plerixafor-secondary-cancer-mds-aml/</loc>
		<lastmod>2013-03-21T16:28:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/02/23/velcade-therapie-kann-ergebnisse-fur-myelompatienten-verbessern-die-nicht-gut-auf-eine-initiale-therapie-mit-revlimid-oder-thalidomid-ansprechen/</loc>
		<lastmod>2013-03-18T14:57:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/03/18/la-terapia-basada-en-velcade-puede-mejorar-resultados-en-pacientes-con-mieloma-que-no-responden-bien-al-tratamiento-inicial-con-revlimid-o-talidomida/</loc>
		<lastmod>2013-03-18T14:53:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/22/myeloma-beacon-launches-new-myeloma-discussion-forums/</loc>
		<lastmod>2013-03-14T21:35:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/13/african-american-multiple-myeloma-patients-chromosome-14-translocations-abnormalities/</loc>
		<lastmod>2013-03-13T19:37:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/03/12/un-estudio-frances-aporta-nueva-informacion-sobre-sa-eficacia-seguridad-y-dosificacion-del-pomalyst/</loc>
		<lastmod>2013-03-12T17:56:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/11/beacon-newsflashes-march-11-2013/</loc>
		<lastmod>2013-03-11T16:56:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/10/pats-place-five-years-of-chemotherapy-take-their-toll/</loc>
		<lastmod>2013-03-07T16:47:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/02/07/pats-place-decisions-decisions/</loc>
		<lastmod>2013-03-07T16:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/06/beacon-newsflashes-march-6-2013/</loc>
		<lastmod>2013-03-06T18:42:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/03/04/franzosische-studie-gewahrt-weitere-einblicke-in-die-wirkung-sicherheit-und-dosierung-von-pomalyst/</loc>
		<lastmod>2013-03-06T04:05:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/07/curcumin-free-light-chains-mgus-and-smoldering-multiple-myeloma/</loc>
		<lastmod>2013-03-06T03:03:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/14/beacon-newsflashes-february-14-2011/</loc>
		<lastmod>2013-03-06T02:15:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/30/beacon-newsflashes-november-30-2011/</loc>
		<lastmod>2013-03-06T02:15:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/03/04/disease-status-second-stem-cell-transplant-in-multiple-myeloma/</loc>
		<lastmod>2013-03-04T20:09:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/11/infection-risk-multiple-myeloma-high-and-rising-ash-2012/</loc>
		<lastmod>2013-03-04T13:23:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/03/04/el-riesgo-de-infeccion-en-los-pacientes-con-mieloma-multiple-es-alto-y-subiendo-ash-2012/</loc>
		<lastmod>2013-03-04T13:22:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/08/pomalyst-pomalidomide-fda-approval-multiple-myeloma/</loc>
		<lastmod>2013-03-04T13:18:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/02/19/letters-from-cancerland-the-fatigue-factor/</loc>
		<lastmod>2013-03-04T13:16:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/28/pats-cracked-cup-end-of-year-reflections-from-a-multiple-myeloma-patient/</loc>
		<lastmod>2013-03-02T21:06:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/01/25/pats-cracked-cup-write-your-way-well/</loc>
		<lastmod>2013-03-02T21:05:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/02/22/pat%e2%80%99s-cracked-cup-movie-therapy/</loc>
		<lastmod>2013-03-02T21:05:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/26/pats-cracked-cup-finding-poetry-in-the-multiple-myeloma-experience/</loc>
		<lastmod>2013-03-02T21:03:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/24/pats-cracked-cup-moving-in-the-world/</loc>
		<lastmod>2013-03-02T21:02:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/28/pats-cracked-cup-transplant-birthday/</loc>
		<lastmod>2013-03-02T20:09:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/26/pats-cracked-cup-buying-time/</loc>
		<lastmod>2013-03-02T20:09:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/23/pats-cracked-cup-training-in-courage-multiple-myeloma/</loc>
		<lastmod>2013-03-02T20:08:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/27/pats-cracked-cup-coming-out-with-multiple-myeloma/</loc>
		<lastmod>2013-03-02T20:08:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/25/pats-cracked-cup-alchemy/</loc>
		<lastmod>2013-03-02T20:07:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/22/pats-cracked-cup-grateful-for-perspective/</loc>
		<lastmod>2013-03-02T20:06:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/27/pats-cracked-cup-aspirations-for-a-new-year/</loc>
		<lastmod>2013-03-02T20:05:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/24/pats-cracked-cup-the-year-of-the-dragon-and-chemotherapy-dreams/</loc>
		<lastmod>2013-03-02T20:05:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/28/pats-cracked-cup-multiple-myeloma-and-vulnerability/</loc>
		<lastmod>2013-03-02T20:04:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/24/pats-cracked-cup-chosen-by-multiple-myeloma/</loc>
		<lastmod>2013-03-02T20:03:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/22/pats-cracked-cup-managing-multiple-myeloma-while-living-alone/</loc>
		<lastmod>2013-03-02T20:03:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/26/pats-cracked-cup-one-week-at-a-time/</loc>
		<lastmod>2013-03-02T20:02:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/24/pats-cracked-cup-living-with-multiple-myeloma-and-quality-of-life/</loc>
		<lastmod>2013-03-02T20:01:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/08/28/pats-cracked-cup-viewing-multiple-myeloma-as-destiny/</loc>
		<lastmod>2013-03-02T20:00:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/24/pats-cracked-cup-multiple-myeloma-as-a-transformative-experience/</loc>
		<lastmod>2013-03-02T19:59:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/26/pats-cracked-cup-winter-holidays-and-cheer/</loc>
		<lastmod>2013-03-02T19:58:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/26/pats-cracked-cup-my-sea-of-sixty-carrying-on-in-the-uncharted-waters-of-multiple-myeloma/</loc>
		<lastmod>2013-03-02T19:54:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/24/pats-cracked-cup-finding-balance-in-the-multiple-myeloma-journey/</loc>
		<lastmod>2013-03-02T19:53:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/02/28/manhattan-tales-the-good-the-bad-and-the-ugly/</loc>
		<lastmod>2013-03-01T15:25:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/24/manhattan-tales-the-stem-cell-transplant-and-beyond/</loc>
		<lastmod>2013-02-28T17:22:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/16/ash-2008-trial-results-compare-multiple-myeloma-transplantation-procedures/</loc>
		<lastmod>2013-02-27T01:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/22/long-term-outcome-of-combination-autoallo-stem-cell-transplant-treatment-reported/</loc>
		<lastmod>2013-02-27T01:09:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/20/statins-reduce-acute-graft-versus-host-disease-in-allogeneic-stem-cell-transplants-study-finds/</loc>
		<lastmod>2013-02-27T01:09:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/09/donor-stem-cell-transplant-is-not-more-effective-than-existing-treatments-for-multiple-myeloma-eha-2010/</loc>
		<lastmod>2013-02-27T00:43:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/13/experts-recommend-against-donor-stem-cell-transplantation-for-multiple-myeloma-patients-until-safety-and-efficacy-is-improved/</loc>
		<lastmod>2013-02-27T00:43:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/19/revlimid-lenalidomide-maintenance-therapy-after-donor-stem-cell-transplantation-is-not-recommended-for-multiple-myeloma-patients/</loc>
		<lastmod>2013-02-27T00:42:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/26/mini-donor-stem-cell-transplant-as-second-transplant-may-improve-outcomes-in-multiple-myeloma/</loc>
		<lastmod>2013-02-27T00:41:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/17/preemptive-donor-lymphocyte-infusions-multiple-myeloma/</loc>
		<lastmod>2013-02-27T00:39:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/08/22/birds-in-spring-stem-cells-for-sale/</loc>
		<lastmod>2013-02-27T00:37:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/01/beacon-newsflashes-october-1-2012/</loc>
		<lastmod>2013-02-27T00:36:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/26/beacon-newsflashes-november-26-2012/</loc>
		<lastmod>2013-02-27T00:35:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/06/donor-stem-cell-transplants-come-up-short-as-second-transplant-option-in-multiple-myeloma-patients-ash-2010/</loc>
		<lastmod>2013-02-27T00:33:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/02/05/seans-burgundy-thread-stormy-weather/</loc>
		<lastmod>2013-02-26T22:18:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/26/velcade-bortezomib-donor-lymphocyte-infusions-multiple-myeloma-relapse-donor-allogeneic-transplant/</loc>
		<lastmod>2013-02-26T21:44:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/25/beacon-newsflashes-february-25-2013/</loc>
		<lastmod>2013-02-25T17:21:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/29/sorafenib-shows-no-effect-in-phase-2-study-asco-2009/</loc>
		<lastmod>2013-02-25T16:27:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/02/21/kyprolis-carfilzomib-mieloma-multiple-dano-renal/</loc>
		<lastmod>2013-02-21T19:39:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/02/15/el-tratamiento-a-largo-plazo-con-revlimid-claritromicina-dexametasona-es-eficaz-y-seguro-en-pacientes-con-mieloma-de-diagnostico-reciente/</loc>
		<lastmod>2013-02-15T19:58:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/02/14/northern-lights-blood-and-the-gift-of-life/</loc>
		<lastmod>2013-02-14T17:21:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/24/radiation-not-linked-to-mgus-progression-to-multiple-myeloma/</loc>
		<lastmod>2013-02-11T22:10:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/04/blood-disorder-mgus-precedes-most-cases-of-multiple-myeloma/</loc>
		<lastmod>2013-02-11T22:09:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/22/eradicating-h-pylori-infection-not-linked-to-mgus-regression/</loc>
		<lastmod>2013-02-11T22:09:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/27/beacon-newsflashes-%e2%80%93-august-27-2009/</loc>
		<lastmod>2013-02-11T22:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/18/beacon-newsflashes-%e2%80%93-february-18-2010/</loc>
		<lastmod>2013-02-11T22:09:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/29/patients-with-myeloma-precursor-disease-mgus-may-have-an-increased-risk-of-developing-blood-clots/</loc>
		<lastmod>2013-02-11T22:08:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/opinion/2010/11/12/paradigm-shift-mgus-smoldering-myeloma-and-multiple-myeloma-are-all-one-disease/</loc>
		<lastmod>2013-02-11T22:08:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/17/beacon-newsflashes-november-17-2010/</loc>
		<lastmod>2013-02-11T22:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/10/multiple-myeloma-and-mgus-patients-may-have-an-increased-risk-of-developing-certain-cancers/</loc>
		<lastmod>2013-02-11T22:06:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/22/study-suggests-mgus-patients-receive-inadequate-evaluation-follow-up-and-treatment/</loc>
		<lastmod>2013-02-11T22:06:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/22/myeloma-precursor-disease-mgus-may-increase-risk-of-developing-infections/</loc>
		<lastmod>2013-02-11T22:06:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/23/beacon-newsflashes-april-23-2012/</loc>
		<lastmod>2013-02-11T22:05:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/14/beacon-newsflashes-may-14-2012/</loc>
		<lastmod>2013-02-11T22:05:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/30/beacon-newsflashes-may-30-2012/</loc>
		<lastmod>2013-02-11T22:05:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/25/personal-perspective-former-nurse-battles-mgus-and-other-immune-disorders-with-a-positive-attitude/</loc>
		<lastmod>2013-02-11T22:05:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/02/11/mieloma-multiple-amiloidosis-asociada-lo-que-todo-paciente-deberia-saber/</loc>
		<lastmod>2013-02-11T17:46:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/02/11/entendiendo-el-pronostico-en-el-mieloma-multiple/</loc>
		<lastmod>2013-02-11T17:45:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/02/11/plasmocitoma-solitario-del-hueso-lo-que-todo-paciente-deberia-saber/</loc>
		<lastmod>2013-02-11T17:44:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/04/solitary-bone-plasmacytoma/</loc>
		<lastmod>2013-02-11T17:32:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/02/11/nuevos-tratamientos-en-el-horizonte-para-el-mieloma-multiple-ash-2012/</loc>
		<lastmod>2013-02-11T17:21:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/11/29/neue-behandlungen-fur-das-multiple-myelom-in-sicht-ash-2012/</loc>
		<lastmod>2013-02-11T17:17:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/2013/02/11/curcumina-y-mieloma-multiple-prometedores-resultados-en-estudios-preclinicos-y-en-ensayos-en-pase-inicial-todavia-a-la-espera-de-mas-evidencia-clinica/</loc>
		<lastmod>2013-02-11T17:16:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/05/08/solitares-plasmozytom-des-knochens-was-jeder-patient-wissen-sollte/</loc>
		<lastmod>2013-02-11T16:52:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/05/10/myelom-assoziierte-amyloidose-was-jeder-patient-wissen-sollte/</loc>
		<lastmod>2013-02-11T16:49:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/02/08/pomalidomide-pomalyst-the-waiting-game/</loc>
		<lastmod>2013-02-08T15:50:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/02/08/tandem-auto-allo-transplantation-kann-prognose-von-risikoreichen-myelompatienten-verbessern/</loc>
		<lastmod>2013-02-08T14:24:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/27/new-velcade-combination-therapy-effective-for-newly-diagnosed-myeloma-patients-ash-2009/</loc>
		<lastmod>2013-02-07T21:21:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/30/velcade-torisel-combination-proves-highly-effective-in-multiple-myeloma-patients-ash-2009/</loc>
		<lastmod>2013-02-07T21:20:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/02/velcade-melphalan-prednisone-thalidomide-vmpt-treatment-is-highly-active-in-elderly-myeloma-patients-ash-2009/</loc>
		<lastmod>2013-02-07T21:20:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/14/tanespimycin-velcade-combination-proves-highly-effective-in-multiple-myeloma-patients-ash-2009/</loc>
		<lastmod>2013-02-07T21:17:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/22/zolinza-combination-treatments-offer-benefit-for-multiple-myeloma-patients-ash-2009/</loc>
		<lastmod>2013-02-07T21:16:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/26/novel-therapeutic-agents-may-improve-kidney-impairment-in-newly-diagnosed-myeloma-patients-ash-2009/</loc>
		<lastmod>2013-02-07T21:15:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/29/addition-of-thalidomide-to-induction-therapy-increases-response-rates-in-younger-and-older-multiple-myeloma-patients-ash-2009/</loc>
		<lastmod>2013-02-07T21:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/30/velcade-thalidomide-dexamethasone-treatment-is-promising-for-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2013-02-07T21:13:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/01/multiple-myeloma-patients-on-thalidomide-at-risk-for-infection-despite-preventative-medication-ash-2009/</loc>
		<lastmod>2013-02-07T21:13:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/18/study-compares-out-of-pocket-expenses-for-myeloma-patients-treated-with-velcade-revlimid-or-thalidomide-ash-2009/</loc>
		<lastmod>2013-02-07T21:12:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/26/velcade-induction-and-maintenance-combinations-are-highly-effective-in-elderly-multiple-myeloma-patients-study-finds-ash-2009/</loc>
		<lastmod>2013-02-07T21:11:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/08/zometa-may-improve-survival-in-myeloma-patients-ash-2010/</loc>
		<lastmod>2013-02-07T21:07:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/17/early-stem-cell-transplantation-may-improve-survival-in-newly-diagnosed-multiple-myeloma-patients-ash-2010/</loc>
		<lastmod>2013-02-07T21:04:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/22/weekly-velcade-bortezomib-maintenance-therapy-after-velcade-based-initial-therapy-improves-response-rates-in-elderly-newly-diagnosed-myeloma-patients-ash-2010/</loc>
		<lastmod>2013-02-07T21:03:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/01/zolinza-shows-promise-in-clinical-trials-for-the-treatment-of-multiple-myeloma-ash-2010/</loc>
		<lastmod>2013-02-07T21:02:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/05/experimental-drug-pd-0332991-shows-encouraging-phase-1-trial-results-in-relapsedrefractory-multiple-myeloma-patients-ash-2010/</loc>
		<lastmod>2013-02-07T21:00:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/07/torisel-temsirolimus-and-velcade-bortezomib-combination-shows-promise-as-treatment-for-relapsed-refractory-multiple-myeloma-ash-2010/</loc>
		<lastmod>2013-02-07T20:59:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/26/celgene-submits-pomalidomide-for-fda-approval/</loc>
		<lastmod>2013-02-07T00:03:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/21/pomalidomide-standard-fda-review-application-european-approval/</loc>
		<lastmod>2013-02-07T00:02:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/19/pomalidomide-fda-advisory-board-meeting-date-set/</loc>
		<lastmod>2013-02-07T00:01:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/03/pomalidomide-fda-advisory-committee-meeting-canceled/</loc>
		<lastmod>2013-02-07T00:00:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/07/pomalyst-is-proposed-brand-name-for-pomalidomide/</loc>
		<lastmod>2013-02-06T23:57:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/23/mayo-pethema-risk-of-progression-smoldering-myeloma-more-disagreement-than-agreement/</loc>
		<lastmod>2013-02-06T23:52:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/10/thalidomide-may-delay-disease-progression-in-smoldering-myeloma/</loc>
		<lastmod>2013-02-06T23:50:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/29/personal-perspective-smoldering-myeloma-patient-becomes-her-own-best-advocate/</loc>
		<lastmod>2013-02-06T23:49:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2013/02/05/colorado-blood-cancer-insitute/</loc>
		<lastmod>2013-02-05T17:07:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/17/me-vs-mm-two-year-cancerversary/</loc>
		<lastmod>2013-02-05T16:16:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/17/birds-in-spring-quality-of-life-and-multiple-myeloma-have-we-all-seen-better-days/</loc>
		<lastmod>2013-02-04T20:13:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/18/birds-in-spring-thoughts-about-multiple-myeloma-survival/</loc>
		<lastmod>2013-02-04T20:09:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/30/birds-in-spring-the-post-transplant-life/</loc>
		<lastmod>2013-02-04T20:08:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/31/short-term-velcade-bortezomib-therapies-may-be-effective-and-safe-for-multiple-myeloma/</loc>
		<lastmod>2013-01-31T20:40:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/22/stem-cell-transplantation-trends-for-multiple-myeloma-ash-2012/</loc>
		<lastmod>2013-01-30T18:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/08/arnies-rebounding-world-the-health-insurance-dilemma/</loc>
		<lastmod>2013-01-29T17:18:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/18/top-myeloma-beacon-news-articles-of-2012/</loc>
		<lastmod>2013-01-29T17:17:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/28/beacon-newsflashes-january-28-2013/</loc>
		<lastmod>2013-01-28T19:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/24/anti-dkk1-antibody-as-new-treatment-for-myeloma-bone-disease/</loc>
		<lastmod>2013-01-28T18:48:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/25/top-myeloma-beacon-patient-and-caregiver-columns-of-2012/</loc>
		<lastmod>2013-01-25T19:02:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/02/seans-burgundy-thread-a-letter-to-myself/</loc>
		<lastmod>2013-01-25T16:36:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/04/seans-burgundy-thread-saying-goodbye/</loc>
		<lastmod>2013-01-25T16:25:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/19/me-vs-mm-practical-considerations/</loc>
		<lastmod>2013-01-25T14:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/06/arnies-rebounding-world-the-roller-coaster-ride/</loc>
		<lastmod>2013-01-24T22:38:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2013/01/24/mayo-klinik-pethema-und-das-progressionsrisiko-beim-schwelenden-myelom-mehr-unstimmigkeiten-als-ubereinstimmungen/</loc>
		<lastmod>2013-01-24T21:18:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/11/heavylight-chain-ratios-may-be-a-prognostic-marker-for-myeloma-patients/</loc>
		<lastmod>2013-01-23T21:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/18/re-infused-lymphocyte-dose-outcomes-upfront-stem-cell-transplantation/</loc>
		<lastmod>2013-01-23T21:15:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/14/blood-tests-may-be-sufficient-to-monitor-for-relapse-or-progression-of-multiple-myeloma-after-stem-cell-transplantation/</loc>
		<lastmod>2013-01-23T21:15:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/28/kepivance-palifermin-may-increase-the-tolerability-of-higher-doses-of-melphalan-for-multiple-myeloma/</loc>
		<lastmod>2013-01-23T21:14:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/16/stem-cell-transplants-may-increase-risk-of-heart-disease/</loc>
		<lastmod>2013-01-23T21:14:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/05/intravenous-busulfan-melphalan-combo-prior-to-stem-cell-transplantation-in-multiple-myeloma/</loc>
		<lastmod>2013-01-23T21:14:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/16/factors-linked-to-longer-survival-in-multiple-myeloma-patients-receiving-stem-cell-transplants/</loc>
		<lastmod>2013-01-23T21:14:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/20/birds-in-spring-taking-in-good-news-with-the-bad/</loc>
		<lastmod>2013-01-23T21:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/28/second-transplant-as-salvage-therapy-for-relapsed-refractory-multiple-myeloma/</loc>
		<lastmod>2013-01-23T21:13:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/03/early-relapse-multiple-myeloma-after-stem-cell-transplant-second-transplant-velcade-bortezomib-melphalan/</loc>
		<lastmod>2013-01-23T21:13:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/05/beacon-newsflashes-december-5-2012/</loc>
		<lastmod>2013-01-23T21:13:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/10/ash-2012-multiple-myeloma-update-day-two-poster-sessions/</loc>
		<lastmod>2013-01-23T21:12:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/11/ash-2012-multiple-myeloma-update-day-three-early-afternoon-oral-session/</loc>
		<lastmod>2013-01-23T21:11:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/19/beacon-newsflashes-december-19-2012/</loc>
		<lastmod>2013-01-23T21:10:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/07/stem-cell-transplants-irregular-heart-beat-in-multiple-myeloma/</loc>
		<lastmod>2013-01-23T21:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/02/50th-annual-meeting-of-the-american-society-of-hematology-only-days-away/</loc>
		<lastmod>2013-01-18T18:36:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/05/multiple-myeloma-survivors-honored-at-2008-ash-meeting/</loc>
		<lastmod>2013-01-18T18:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/08/scientists-reveal-promising-four-drug-regimen-for-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2013-01-18T18:35:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/09/ash-2008-pomalidomide-dexamethasone-combination-highly-effective-in-treating-relapsed-or-refractory-multiple-myeloma/</loc>
		<lastmod>2013-01-18T18:35:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/10/ash-2008-updated-velcade-melphalan-prednisone-trial-results-for-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2013-01-18T18:35:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/11/ash-2008-clinical-trial-update-for-velcade-thalidomide-dexamethasone-with-autologous-stem-cell-transplantation-in-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2013-01-18T18:35:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/12/ash-2008-perifosine-effective-against-multiple-myeloma-in-combination-with-dexamethasone-revlimid-and-dexamethasone-velcade/</loc>
		<lastmod>2013-01-18T18:35:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/16/ash-2008-venous-thrombotic-events-in-newly-diagnosed-myeloma-patients-decrease-overall-survival/</loc>
		<lastmod>2013-01-18T18:35:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/17/ash-2008-results-of-treatment-for-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2013-01-18T18:35:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/26/ash-2008-pad-induction-therapy-for-elderly-patients/</loc>
		<lastmod>2013-01-18T18:35:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/20/xii-international-myeloma-workshop-begins-next-week/</loc>
		<lastmod>2013-01-18T18:35:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/21/trial-reporting/</loc>
		<lastmod>2013-01-18T18:35:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/24/imw-2009-physicians-offer-standardized-guidelines-for-diagnosing-suspected-multiple-myeloma/</loc>
		<lastmod>2013-01-18T18:35:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/02/imw-2009-consensus-on-risk-stratification-in-multiple-myeloma/</loc>
		<lastmod>2013-01-18T18:35:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/06/imw-2009-waldenstroms-award-goes-to-co-founder-and-chairman-of-imf/</loc>
		<lastmod>2013-01-18T18:35:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/12/imw-2009-physicians-discuss-symptom-management-strategies/</loc>
		<lastmod>2013-01-18T18:35:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/20/beacon-newsflashes-march-20-2009/</loc>
		<lastmod>2013-01-18T18:35:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/03/imw-2009-physicians-discuss-upfront-and-induction-therapy-for-transplant-candidates/</loc>
		<lastmod>2013-01-18T18:35:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/09/imw-2009-elotuzumab-and-panobinostat-clinical-trials-with-velcade/</loc>
		<lastmod>2013-01-18T18:35:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/09/imw-2009-physicians-discuss-induction-therapy-for-non-transplant-candidates/</loc>
		<lastmod>2013-01-18T18:35:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/09/beacon-newsflashes-may-9-2009/</loc>
		<lastmod>2013-01-18T18:35:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/16/asco-2009-45th-meeting-of-the-american-society-of-clinical-oncology-only-two-weeks-away/</loc>
		<lastmod>2013-01-18T18:35:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/20/phase-3-study-show-high-response-rates-for-four-drug-combination-asco-2009/</loc>
		<lastmod>2013-01-18T18:35:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/21/autologous-stem-cell-transplant-therapy-with-velcade-revlimid-or-velcade-thalomid-in-new-multiple-myeloma-patients-asco-2009/</loc>
		<lastmod>2013-01-18T18:35:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/21/trial-investigates-effects-of-tanespimycin-velcade-combination-treatment-asco-2009/</loc>
		<lastmod>2013-01-18T18:35:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/29/onj-as-a-prognostic-factor-in-myeloma-patients-treated-with-zometa-asco-2009/</loc>
		<lastmod>2013-01-18T18:34:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/02/study-examines-romidepsin-velcade-combination-treatment-in-myeloma-patients-asco-2009/</loc>
		<lastmod>2013-01-18T18:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/09/study-shows-acute-kidney-failure-can-be-reversed-by-velcade-adriamycin-decadron-in-multiple-myeloma/</loc>
		<lastmod>2013-01-18T18:34:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/20/myeloma-research-to-be-presented-at-the-american-society-of-hematologys-51st-annual-meeting-beginning-december-5-ash-2009/</loc>
		<lastmod>2013-01-18T18:34:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/25/beacon-newsflashes-january-25-2010/</loc>
		<lastmod>2013-01-18T18:32:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/26/beacon-newsflashes-april-26-2010/</loc>
		<lastmod>2013-01-18T18:32:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/28/myeloma-research-to-be-presented-at-the-american-society-of-clinical-oncologys-46th-annual-meeting-asco-2010/</loc>
		<lastmod>2013-01-18T18:32:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/09/revlimid-maintenance-therapy-is-effective-for-multiple-myeloma-after-stem-cell-transplant-asco-2010/</loc>
		<lastmod>2013-01-18T18:32:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/11/reduced-dose-velcade-thalidomide-dexamethasone-combination-shows-promise-as-induction-treatment-prior-to-stem-cell-transplantation-asco-2010/</loc>
		<lastmod>2013-01-18T18:31:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/14/prevention-of-blood-clots-in-multiple-myeloma-patients-is-important-asco-2010/</loc>
		<lastmod>2013-01-18T18:31:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/15/management-of-nerve-damage-in-myeloma-patients-asco-2010/</loc>
		<lastmod>2013-01-18T18:31:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/16/treatment-of-myeloma-with-novel-agents-may-be-as-effective-as-stem-cell-transplantation-part-1-melphalan-prednisone-revlimid-asco-2010/</loc>
		<lastmod>2013-01-18T18:31:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/17/addition-of-thalidomide-to-standard-treatment-for-elderly-multiple-myeloma-patients-increases-efficacy-asco-2010/</loc>
		<lastmod>2013-01-18T18:31:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/18/recent-advances-in-treatment-of-myeloma-bone-disease-asco-2010/</loc>
		<lastmod>2013-01-18T18:31:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/29/afinitor-in-combination-with-revlimid-shows-potential-for-relapsed-multiple-myeloma-asco-2010/</loc>
		<lastmod>2013-01-18T18:31:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/30/multiple-myeloma-research-presented-at-15th-annual-european-hematology-association-meeting-eha-2010/</loc>
		<lastmod>2013-01-18T18:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/07/maintenance-thalidomide-improves-progression-free-survival-but-not-overall-survival-eha-2010/</loc>
		<lastmod>2013-01-18T18:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/13/chromosomal-abnormalities-may-predict-response-to-initial-velcade-based-myeloma-therapy-eha-2010/</loc>
		<lastmod>2013-01-18T18:30:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/16/abnormal-plasma-cells-in-the-blood-may-indicate-aggressive-and-treatment-resistant-multiple-myeloma-eha-2010/</loc>
		<lastmod>2013-01-18T18:30:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/25/beacon-newsflashes-october-25-2010/</loc>
		<lastmod>2013-01-18T18:30:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/01/latest-myeloma-research-to-be-presented-at-the-52nd-meeting-of-the-american-society-of-hematology-ash-2010/</loc>
		<lastmod>2013-01-18T18:30:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/02/the-myeloma-beacon-to-provide-comprehensive-coverage-of-the-2010-american-society-of-hematology-meeting/</loc>
		<lastmod>2013-01-18T18:30:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/06/ash-2010-multiple-myeloma-update-day-two/</loc>
		<lastmod>2013-01-18T18:30:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/11/beacon-newsflashes-january-11-2011/</loc>
		<lastmod>2013-01-18T18:28:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/20/myeloma-research-to-be-presented-at-the-13th-international-myeloma-workshop/</loc>
		<lastmod>2013-01-18T18:28:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/02/beacon-newsflashes-may-2-2011/</loc>
		<lastmod>2013-01-18T18:27:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/04/imw-2011-multiple-myeloma-update-day-one/</loc>
		<lastmod>2013-01-18T18:27:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/05/beacon-breakingnews-updated-data-on-revlimid-maintenance-and-second-cancers-presented-at-imw/</loc>
		<lastmod>2013-01-18T18:27:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/10/imw-2011-multiple-myeloma-update-day-three-part-2/</loc>
		<lastmod>2013-01-18T18:27:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/11/imw-2011-multiple-myeloma-update-day-4/</loc>
		<lastmod>2013-01-18T18:27:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/13/experts-recommend-intravenous-bisphosphonates-for-multiple-myeloma-bone-disease-imw-2011/</loc>
		<lastmod>2013-01-18T18:27:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/20/the-2011-international-myeloma-workshop-key-themes-and-learnings/</loc>
		<lastmod>2013-01-18T18:27:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/23/experts-develop-guidelines-for-treating-anemia-in-multiple-myeloma-patients-imw-2011/</loc>
		<lastmod>2013-01-18T18:27:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/01/experts-draft-guidelines-for-the-prevention-of-blood-clots-in-multiple-myeloma-patients-imw-2011/</loc>
		<lastmod>2013-01-18T18:27:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/07/lorvotuzumab-mertansine-in-combination-with-revlimid-dexamethasone-shows-activity-in-relapsedrefractory-myeloma-asco-2011/</loc>
		<lastmod>2013-01-18T18:26:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/07/asco-2011-multiple-myeloma-update-day-three-part-two/</loc>
		<lastmod>2013-01-18T18:26:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/11/myeloma-research-to-be-presented-at-eha-congress/</loc>
		<lastmod>2013-01-18T18:26:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/17/residual-disease-and-chromosomal-abnormalities-may-predict-early-multiple-myeloma-relapse-eha-2011/</loc>
		<lastmod>2013-01-18T18:26:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/22/velcade-bortezomib-thalidomide-dexamethasone-may-be-a-highly-effective-consolidation-therapy-for-myeloma-eha-2011/</loc>
		<lastmod>2013-01-18T18:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/24/experts-provide-guidelines-to-help-multiple-myeloma-patients-prevent-infections-imw-2011/</loc>
		<lastmod>2013-01-18T18:25:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/08/myeloma-beacon-to-provide-comprehensive-coverage-of-2011-american-society-of-hematology-meeting-ash-2011/</loc>
		<lastmod>2013-01-18T18:25:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/13/ash-2011-multiple-myeloma-update-day-three-morning-current-therapies/</loc>
		<lastmod>2013-01-18T18:25:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/21/ash-2011-multiple-myeloma-update-day-four/</loc>
		<lastmod>2013-01-18T18:24:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/28/ash-2011-the-meetings-myeloma-related-hidden-gem/</loc>
		<lastmod>2013-01-18T18:24:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/04/zolinza-vorinostat-tallies-mixed-results-in-relapsed-refractory-multiple-myeloma-patients-ash-2011/</loc>
		<lastmod>2013-01-18T18:24:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/09/revlimid-lenalidomide-dexamethasone-combination-delays-disease-progression-in-patients-with-smoldering-multiple-myeloma-ash-2011/</loc>
		<lastmod>2013-01-18T18:24:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/23/marizomib-npi0052-may-be-effective-in-relapsedrefractory-multiple-myeloma-ash-2011/</loc>
		<lastmod>2013-01-18T18:24:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/08/perifosine-combination-may-be-effective-in-relapsed-refractory-multiple-myeloma-ash-2011/</loc>
		<lastmod>2013-01-18T18:23:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/10/sequence-velcade-bortezomib-revlimid-lenalidomide-treatment-multiple-myeloma-ash-2011/</loc>
		<lastmod>2013-01-18T18:23:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/05/asco-2012-multiple-myeloma-update-day-four-poster-presentations-on-current-myeloma-treatments/</loc>
		<lastmod>2013-01-18T18:22:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/05/asco-2012-multiple-myeloma-update-day-four-poster-presentations-on-various-myeloma-related-topics/</loc>
		<lastmod>2013-01-18T18:22:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/14/myeloma-research-to-be-presented-at-eha-congress-2/</loc>
		<lastmod>2013-01-18T18:22:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/29/individualized-therapy-for-newly-diagnosed-multiple-myeloma-asco-2012/</loc>
		<lastmod>2013-01-18T18:21:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/02/genetic-changes-responsible-for-multiple-myeloma-eha-2012/</loc>
		<lastmod>2013-01-18T18:21:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/06/stem-cell-transplantation-in-multiple-myeloma-asco-2012/</loc>
		<lastmod>2013-01-18T18:21:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/10/revlimid-lenalidomide-treanda-bendamustine-prednisone-combo-is-active-and-well-tolerated-for-relapsed-refractory-myeloma-eha-2012/</loc>
		<lastmod>2013-01-18T18:21:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/27/maintenance-therapy-for-multiple-myeloma-asco-2012/</loc>
		<lastmod>2013-01-18T18:21:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/30/the-myeloma-beacon-to-report-the-latest-research-from-the-upcoming-american-society-of-hematology-annual-meeting-ash-2012/</loc>
		<lastmod>2013-01-18T18:21:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/17/circularly-permuted-trail-may-be-effective-for-relapsedrefractory-multiple-myeloma-ash-2012/</loc>
		<lastmod>2013-01-18T18:19:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/12/28/tabalumab-plus-velcade-bortezomib-in-previously-treated-multiple-myeloma-ash-2012/</loc>
		<lastmod>2013-01-18T18:19:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/04/lorvotuzumab-mertansine-combination-in-relapsed-refractory-multiple-myeloma-patients-ash-2012/</loc>
		<lastmod>2013-01-18T18:19:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2013/01/16/different-m-spike-after-stem-cell-transplantation-linked-to-improved-survival-ash-2012/</loc>
		<lastmod>2013-01-18T18:19:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/27/top-myeloma-beacon-patient-and-caregiver-columns-of-2011/</loc>
		<lastmod>2013-01-18T16:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/20/me-vs-mm-humble-thyself/</loc>
		<lastmod>2013-01-17T15:32:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/22/me-vs-mm-the-hair-dryer-phenomenon/</loc>
		<lastmod>2013-01-17T14:50:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/18/me-vs-mm-dreamweaver/</loc>
		<lastmod>2013-01-17T14:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/09/deep-vein-thrombosis-risk-higher-in-multiple-myeloma/</loc>
		<lastmod>2013-01-07T22:40:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/18/guide-to-clinical-trials-for-multiple-myeloma-patients-part-5-dons-trial-and-success/</loc>
		<lastmod>2013-01-07T22:39:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/12/arnies-rebounding-world-the-donor-transplant-the-first-100-days-and-beyond/</loc>
		<lastmod>2013-01-07T20:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/21/beacon-newsflashes-november-21-2012/</loc>
		<lastmod>2013-01-07T17:36:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2013/01/03/northern-lights-pace-bunnies-and-new-years-resolutions/</loc>
		<lastmod>2013-01-03T20:23:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/08/northern-lights-youve-got-a-friend/</loc>
		<lastmod>2013-01-03T15:40:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/27/manhattan-tales-2012-in-review/</loc>
		<lastmod>2012-12-27T19:40:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/23/manhattan-tales-steroid-adventures/</loc>
		<lastmod>2012-12-27T18:25:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/04/seans-burgundy-thread-wednesdays-with-murray/</loc>
		<lastmod>2012-12-26T14:03:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/24/happy-holidays-2/</loc>
		<lastmod>2012-12-24T21:17:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/18/ash-2012-multiples-myelom-update-tag-vier-prasentationen/</loc>
		<lastmod>2012-12-18T17:11:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/17/ash-2012-tag-drei-prasentationen-am-spaten-nachmittag/</loc>
		<lastmod>2012-12-17T18:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/17/ash-2012-multiples-myelom-update-tag-drei-prasentationen-am-fruhen-nachmittag/</loc>
		<lastmod>2012-12-17T17:29:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/14/ash-2012-multiples-myelom-update-tag-drei-prasentationen-am-spaten-vormittag/</loc>
		<lastmod>2012-12-15T00:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/14/ash-2012-multiples-myelom-update-tag-drei-prasentationen-am-fruhen-vormittag/</loc>
		<lastmod>2012-12-14T18:04:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/14/ash-2012-multiples-myelom-update-tag-zwei-poster-sitzungen/</loc>
		<lastmod>2012-12-14T17:55:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/14/ash-2012-multiples-myelom-update-tag-zwei-prasentationen-am-spatnachmittag/</loc>
		<lastmod>2012-12-14T17:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/14/ash-2012-multiples-myelom-update-tag-zwei-prasentationen-am-fruhen-nachmittag/</loc>
		<lastmod>2012-12-14T17:41:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/14/ash-2012-tag-eins-poster-sitzungen/</loc>
		<lastmod>2012-12-14T17:35:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/12/13/northern-lights-cheers-for-volunteers/</loc>
		<lastmod>2012-12-13T19:19:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/22/manhattan-tales-thanksgiving-in-sandys-wake/</loc>
		<lastmod>2012-12-11T15:01:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/12/05/zweite-transplantation-kann-bei-bestimmten-rezidivierten-und-refraktaren-myelompatienten-eine-wirksame-und-sichere-salvage-therapie-sein/</loc>
		<lastmod>2012-12-05T23:54:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/13/seans-burgundy-thread-multiple-myeloma-the-leader-of-the-band/</loc>
		<lastmod>2012-12-04T17:26:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/15/me-vs-mm-community/</loc>
		<lastmod>2012-11-28T20:39:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/06/arnies-rebounding-world-lance-and-me/</loc>
		<lastmod>2012-11-28T20:38:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/14/lower-dose-velcade-bortezomib-melphalan-prednisone-salvage-therapy-for-older-multiple-myeloma-patients/</loc>
		<lastmod>2012-11-14T19:38:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/12/big-sis-in-burgundy-semper-fi/</loc>
		<lastmod>2012-11-14T04:24:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/09/kidney-transplants-should-more-multiple-myeloma-patients-receive-them/</loc>
		<lastmod>2012-11-09T19:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/11/07/heavylight-chain-test-for-monitoring-multiple-myeloma/</loc>
		<lastmod>2012-11-07T17:54:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/11/northern-lights-a-look-into-the-bone-marrow/</loc>
		<lastmod>2012-11-06T14:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/11/01/pats-place-how-many-ways-are-there-to-remove-a-band-aid/</loc>
		<lastmod>2012-11-02T18:57:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/29/beacon-newsflashes-october-29-2012/</loc>
		<lastmod>2012-10-29T15:52:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/26/vulnerability-score-to-assess-survival-in-multiple-myeloma/</loc>
		<lastmod>2012-10-26T16:17:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/25/manhattan-tales-creaking-bones/</loc>
		<lastmod>2012-10-25T15:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/19/donor-allogeneic-stem-cell-transplants-in-multiple-myeloma-upfront-vs-at-relapse/</loc>
		<lastmod>2012-10-22T19:31:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/22/beacon-newsflashes-october-22-2012/</loc>
		<lastmod>2012-10-22T15:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/03/smoldering-multiple-myeloma-patients-with-high-percentage-of-plasma-cells-in-the-blood-are-at-increased-risk-of-early-progression/</loc>
		<lastmod>2012-10-18T15:44:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/17/velcade-bortezomib-and-thalidomide-abnormal-lung-function-in-multiple-myeloma/</loc>
		<lastmod>2012-10-17T17:44:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/10/10/patienten-mit-schwelendem-myelom-und-hohem-prozentsatz-an-plasmazellen-im-blut-haben-hoheres-risiko-eines-fruhen-progresses/</loc>
		<lastmod>2012-10-10T19:53:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/13/northern-lights-weather-report-fog-and-freezing-rain/</loc>
		<lastmod>2012-10-09T20:28:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/21/revlimid-lenalidomide-velcade-bortezomib-dexamethasone-decadron-may-be-an-option-for-advanced-multiple-myeloma/</loc>
		<lastmod>2012-10-09T20:27:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/08/big-sis-in-burgundy-approaching-deanas-new-birthday/</loc>
		<lastmod>2012-10-09T13:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/10/05/velcade-bortezomib-cyclophosphamide-dexamethasone-combination-may-be-effective-in-myeloma-patients-with-kidney-damage/</loc>
		<lastmod>2012-10-05T18:38:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/11/arnies-rebounding-world-the-donor-allogeneic-transplant/</loc>
		<lastmod>2012-10-05T17:40:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/10/04/pats-place-fourteen-months-and-still-no-go/</loc>
		<lastmod>2012-10-04T19:57:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/06/10/pats-place-having-multiple-myeloma-isnt-simple-its-hard/</loc>
		<lastmod>2012-10-01T02:47:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/27/manhattan-tales-intermission/</loc>
		<lastmod>2012-09-27T15:14:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/06/beacon-newsflashes-february-6-2012/</loc>
		<lastmod>2012-09-26T14:54:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/02/subcutaneous-velcade-bortezomib-information-for-multiple-myeloma-patients/</loc>
		<lastmod>2012-09-25T19:55:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/13/smoldering-myeloma-what-do-the-latest-research-findings-mean-a-discussion-with-dr-ola-landgren/</loc>
		<lastmod>2012-09-25T19:38:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/04/extramedullary-myeloma/</loc>
		<lastmod>2012-09-25T19:34:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/20/me-vs-mm-how-did-i-get-here/</loc>
		<lastmod>2012-09-20T16:22:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/09/18/nordlichter-wetterbericht-nebel-und-gefrierender-regen/</loc>
		<lastmod>2012-09-18T21:38:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/20/donor-allogeneic-stem-cell-transplantation-plus-revlimid-lenalidomide-maintenance-for-relapsed-refractory-multiple-myeloma/</loc>
		<lastmod>2012-09-13T15:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/30/immune-system-of-multiple-myeloma-patients-with-long-term-disease-control/</loc>
		<lastmod>2012-09-13T15:39:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/09/11/forschung-gibt-aufschluss-uber-das-immunsystem-von-myelompatienten-mit-langfristiger-krankheitskontrolle/</loc>
		<lastmod>2012-09-11T14:26:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/what-is-multiple-myeloma/</loc>
		<lastmod>2012-09-10T17:35:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/10/big-sis-in-burgundy-lifes-a-lot-like-football/</loc>
		<lastmod>2012-09-10T14:58:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/07/higher-progression-risk-for-smoldering-myeloma-patients-with-high-percentage-of-plasma-cells-in-bone-marrow/</loc>
		<lastmod>2012-09-07T16:51:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/13/skipped-bone-marrow-exams-lead-to-false-positives-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-09-07T16:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/09/06/pats-place-what-is-it-about-the-moon/</loc>
		<lastmod>2012-09-06T13:43:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/09/05/velcade-bortezomib-thalidomide-dexamethasone-combination-improves-responses-before-and-after-stem-cell-transplantation/</loc>
		<lastmod>2012-09-05T16:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/16/multiple-myeloma-total-therapy-regimen-claims-50-percent-cure-rate/</loc>
		<lastmod>2012-09-05T16:08:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/31/manhattan-tales-stem-cell-transplants-how-far-we-have-come/</loc>
		<lastmod>2012-08-30T14:11:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/08/novel-agents-help-reverse-kidney-impairment-in-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2012-08-28T15:39:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/04/20/cx-4945/</loc>
		<lastmod>2012-08-25T00:52:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/mage-a3-and-ny-eso-1-immunotherapy/</loc>
		<lastmod>2012-08-25T00:49:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/genasense/</loc>
		<lastmod>2012-08-25T00:44:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/doxil/</loc>
		<lastmod>2012-08-25T00:43:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/bexxar/</loc>
		<lastmod>2012-08-25T00:04:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/avastin/</loc>
		<lastmod>2012-08-24T23:38:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/atiprimod/</loc>
		<lastmod>2012-08-24T23:37:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/aplidin/</loc>
		<lastmod>2012-08-24T23:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/11/04/zolinza/</loc>
		<lastmod>2012-08-24T22:49:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/05/09/treanda/</loc>
		<lastmod>2012-08-24T22:46:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/12/03/torisel/</loc>
		<lastmod>2012-08-24T22:45:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/10/08/immucin/</loc>
		<lastmod>2012-08-24T22:31:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/06/04/istodax/</loc>
		<lastmod>2012-08-24T22:00:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/10/04/bt-062/</loc>
		<lastmod>2012-08-24T20:24:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/10/02/bi-505/</loc>
		<lastmod>2012-08-24T20:23:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/11/10/at9283/</loc>
		<lastmod>2012-08-24T20:21:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/deforolimus/</loc>
		<lastmod>2012-08-24T20:20:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/denosumab/</loc>
		<lastmod>2012-08-24T20:20:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/12/26/ace-011/</loc>
		<lastmod>2012-08-24T20:18:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/12/26/afinitor/</loc>
		<lastmod>2012-08-24T20:13:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/24/oligosecretory-myeloma-can-often-be-detected-with-free-light-chain-assay/</loc>
		<lastmod>2012-08-24T18:09:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/23/recent-advances-in-the-treatment-of-multiple-myeloma-bone-disease/</loc>
		<lastmod>2012-08-24T16:15:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/08/23/beacon-newsflashes-august-23-2012/</loc>
		<lastmod>2012-08-23T21:34:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/26/beacon-newsflashes-september-26-2011/</loc>
		<lastmod>2012-08-13T15:54:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/20/beacon-newsflashes-may-20-2011/</loc>
		<lastmod>2012-08-13T15:53:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/08/13/big-sis-in-burgundy-revlimid-lenalidomide-delivery-issues/</loc>
		<lastmod>2012-08-13T15:19:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/19/me-vs-mm-stats-101/</loc>
		<lastmod>2012-08-10T19:06:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/08/09/anzahl-von-knochenlasionen-nach-der-stammzelltransplantation-kann-gesamtuberleben-voraussagen/</loc>
		<lastmod>2012-08-09T20:18:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/08/09/northern-lights-getting-my-cv-in-order/</loc>
		<lastmod>2012-08-09T15:31:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/08/02/pats-place-what-a-wonderful-word-remission/</loc>
		<lastmod>2012-08-08T18:39:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/02/revlimid-lenalidomide-dosing-will-continue-in-multiple-myeloma-mm-015-trial/</loc>
		<lastmod>2012-08-08T16:47:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/13/questions-and-answers-about-the-fda-investigation-into-the-safety-of-revlimid-and-thalidomide/</loc>
		<lastmod>2012-08-08T16:46:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/27/hemodialysis-improves-health-of-multiple-myeloma-patients/</loc>
		<lastmod>2012-08-08T15:33:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/17/new-revlimid-warning-for-patients-with-impaired-kidney-function/</loc>
		<lastmod>2012-08-08T15:33:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/25/stem-cell-transplants-may-improve-kidney-function-of-myeloma-patients/</loc>
		<lastmod>2012-08-08T15:33:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/26/an-overview-of-kidney-failure-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-08-08T15:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/14/treatment-for-kidney-failure-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-08-08T15:33:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/21/kidney-failure-in-multiple-myeloma-patients-%e2%80%93-part-3-time-and-care-commitments/</loc>
		<lastmod>2012-08-08T15:32:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/17/kidney-failure-in-multiple-myeloma-patients-part-4-hemodialysis/</loc>
		<lastmod>2012-08-08T15:32:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/11/dose-adjusted-revlimid-dexamethasone-combination-is-safe-and-effective-in-multiple-myeloma-patients-with-reduced-kidney-function-study-suggests/</loc>
		<lastmod>2012-08-08T15:32:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/17/thalidomide-dexamethasone-is-safe-and-effective-in-newly-diagnosed-myeloma-patients-with-impaired-kidney-function/</loc>
		<lastmod>2012-08-08T15:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/24/velcade-doxorubicin-dexamethasone-treatment-can-reverse-kidney-damage-associated-with-multiple-myeloma/</loc>
		<lastmod>2012-08-08T15:31:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/03/study-suggests-longer-infusion-time-does-not-improve-safety-of-zometa-zoledronic-acid-for-multiple-myeloma-patients/</loc>
		<lastmod>2012-08-08T15:31:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/27/high-cut-off-hemodialysis-helps-restore-kidney-function-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-08-08T15:31:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/01/velcade-bortezomib-treanda-bendamustine-prednisone-combination-may-be-effective-in-newly-diagnosed-myeloma-patients-with-kidney-impairment/</loc>
		<lastmod>2012-08-08T15:30:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/08/07/seans-burgundy-thread-multiple-myeloma-and-faith/</loc>
		<lastmod>2012-08-07T14:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/08/03/die-rolle-der-stammzelltransplantation-beim-multiplen-myelom-asco-2012/</loc>
		<lastmod>2012-08-03T17:03:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/30/better-treatments-for-extramedullary-multiple-myeloma-still-needed/</loc>
		<lastmod>2012-07-31T17:18:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/12/northern-lights-coping-with-a-weak-immune-system/</loc>
		<lastmod>2012-07-30T15:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/03/seans-burgundy-thread-dex-man-walking/</loc>
		<lastmod>2012-07-24T18:29:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/13/to-maintain-or-not-to-maintain-that-is-the-question/</loc>
		<lastmod>2012-07-24T18:28:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/23/velcade-bortezomib-thalidomide-thalomid-dexamethasone-decadron-superior-to-thalidomide-dexamethasone-in-multiple-myeloma-patients-relapsing-after-transplant/</loc>
		<lastmod>2012-07-23T17:36:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/18/preventative-antibiotics-and-infections-in-multiple-myeloma-patients-undergoing-initial-treatment/</loc>
		<lastmod>2012-07-19T15:43:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/16/cyclophosphamide-thalidomide-dexamethasone-may-deepen-responses-after-transplantation-in-multiple-myeloma/</loc>
		<lastmod>2012-07-16T19:29:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/21/safety-concerns-force-withdrawal-of-revlimid-lenalidomide-application-for-expanded-use-in-europe/</loc>
		<lastmod>2012-07-13T17:37:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/28/manhattan-tales-aches-and-pains/</loc>
		<lastmod>2012-07-13T17:24:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/07/09/big-sis-in-burgundy-perhaps-i-spoke-too-soon/</loc>
		<lastmod>2012-07-11T17:28:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/07/11/beacon-newsflashes-july-11-2012/</loc>
		<lastmod>2012-07-11T15:16:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/04/22/beacon-siteupdate-%e2%80%93-patient-and-caregiver-columns-to-be-added-to-the-myeloma-beacon/</loc>
		<lastmod>2012-07-03T19:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/30/big-sis-in-burgundy-my-sister-has-what/</loc>
		<lastmod>2012-07-03T19:14:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/27/big-sis-in-burgundy-me-and-my-big-mouth/</loc>
		<lastmod>2012-07-03T19:14:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/11/big-sis-in-burgundy-a-call-to-action/</loc>
		<lastmod>2012-07-03T19:14:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/01/big-sis-in-burgundy-article-responses-action/</loc>
		<lastmod>2012-07-03T19:14:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/15/big-sis-in-burgundy-out-of-the-mouths-of-babes/</loc>
		<lastmod>2012-07-03T19:14:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/29/big-sis-in-burgundy-a-four-month-report-on-deanas-multiple-myeloma/</loc>
		<lastmod>2012-07-03T19:14:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/12/big-sis-in-burgundy-saluting-those-who-go-above-and-beyond/</loc>
		<lastmod>2012-07-03T19:13:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/26/big-sis-in-burgundy-this-is-a-marathon-not-a-sprint/</loc>
		<lastmod>2012-07-03T19:13:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/10/big-sis-in-burgundy-running-the-chicago-marathon-for-multiple-myeloma/</loc>
		<lastmod>2012-07-03T19:13:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/24/big-sis-in-burgundy-onward/</loc>
		<lastmod>2012-07-03T19:13:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/07/big-sis-in-burgundy-the-most-difficult-day/</loc>
		<lastmod>2012-07-03T19:13:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/21/big-sis-in-burgundy-we-give-thanks/</loc>
		<lastmod>2012-07-03T19:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/05/big-sis-in-burgundy-at-long-last-the-transplant/</loc>
		<lastmod>2012-07-03T19:13:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/19/big-sis-in-burgundy-christmas-came-early/</loc>
		<lastmod>2012-07-03T19:12:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/02/big-sis-in-burgundy-hope-for-2012/</loc>
		<lastmod>2012-07-03T19:12:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/16/big-sis-in-burgundy-looking-ahead/</loc>
		<lastmod>2012-07-03T19:12:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/30/big-sis-in-burgundy-r-is-for-remission/</loc>
		<lastmod>2012-07-03T19:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/13/big-sis-in-burgundy-myeloma-makes-me-wish-i-could-be-in-two-places-at-once/</loc>
		<lastmod>2012-07-03T19:11:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/12/big-sis-in-burgundy-be-an-inspiration/</loc>
		<lastmod>2012-07-03T19:11:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/09/big-sis-in-burgundy-what-a-difference-a-year-makes/</loc>
		<lastmod>2012-07-03T19:11:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/08/big-sis-in-burgundy-lordy-lordy-deana-is-40/</loc>
		<lastmod>2012-07-03T19:10:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/11/big-sis-in-burgundy-thankful-for-a-quiet-month/</loc>
		<lastmod>2012-07-03T19:10:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/12/seans-burgundy-thread-learning-to-go-with-the-flow/</loc>
		<lastmod>2012-07-03T16:37:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/06/19/birds-in-spring-getting-by-getting-along-and-hanging-on/</loc>
		<lastmod>2012-06-28T15:11:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/06/25/sicherheitsbedenken-erzwingen-die-rucknahme-des-zulassungsantrags-fur-eine-breitere-revlimid-anwendung-in-europa/</loc>
		<lastmod>2012-06-25T15:05:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/17/birds-in-spring-turning-simple-into-difficult/</loc>
		<lastmod>2012-06-20T02:30:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/25/detection-of-bone-lesions-in-multiple-myeloma-patients-is-better-with-ct-scans/</loc>
		<lastmod>2012-06-12T15:05:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/06/12/beacon-newsflashes-june-12-2012/</loc>
		<lastmod>2012-06-12T13:40:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/29/researchers-identify-factors-that-may-put-multiple-myeloma-patients-at-higher-risk-for-osteonecrosis-of-the-jaw/</loc>
		<lastmod>2012-06-11T08:51:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/30/laser-surgery-may-be-an-effective-alternative-for-the-treatment-of-jawbone-death/</loc>
		<lastmod>2012-06-11T08:42:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/04/beacon-newsflashes-april-4-2012/</loc>
		<lastmod>2012-06-11T08:40:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/06/top-myeloma-beacon-news-articles-of-2011/</loc>
		<lastmod>2012-06-11T01:25:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/14/beacon-newsflashes-july-14-2009/</loc>
		<lastmod>2012-06-05T20:36:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/08/beacon-newsflashes-october-8-2010/</loc>
		<lastmod>2012-06-05T20:35:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/24/beacon-newsflashes-january-24-2011/</loc>
		<lastmod>2012-06-05T20:32:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/30/beacon-newsflashes-august-30-2011/</loc>
		<lastmod>2012-06-05T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/06/04/carfilzomib-in-kombination-mit-revlimid-und-dexamethason-wird-von-myelompatienten-als-langzeitbehandlung-gut-vertragen-asco-2010/</loc>
		<lastmod>2012-05-31T18:23:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/29/day-of-rest-between-melphalan-alkeran-and-stem-cell-infusion-not-necessary-for-multiple-myeloma/</loc>
		<lastmod>2012-05-29T14:12:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/27/skeletal-imaging-for-bone-lesions-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-05-26T02:32:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/06/15/birds-in-spring-introducing-my-myeloma-column-and-thoughts-on-pet-scans/</loc>
		<lastmod>2012-05-26T02:28:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/13/impact-of-pet-scans-consistent-across-all-types-of-cancer/</loc>
		<lastmod>2012-05-26T02:21:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/08/cms-decides-to-cover-pet-scans-for-myeloma-patients/</loc>
		<lastmod>2012-05-26T02:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/22/study-on-myeloma-diagnosis-techniques-favors-newer-imaging-methods/</loc>
		<lastmod>2012-05-26T02:19:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/10/northern-lights-autumn-leaves-and-the-effects-of-initial-chemotherapy/</loc>
		<lastmod>2012-05-25T15:55:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/05/24/neue-myelombehandlungen-am-horizont-asco-2012/</loc>
		<lastmod>2012-05-24T21:12:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/05/22/forscher-identifizieren-faktoren-die-das-langzeituberleben-bei-neu-diagnostizierten-myelompatienten-vorhersagen/</loc>
		<lastmod>2012-05-22T21:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/01/seans-burgundy-thread-are-you-listening/</loc>
		<lastmod>2012-05-22T17:18:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/05/22/dosis-reinfundierter-lymphozyten-scheint-keinen-einfluss-auf-die-prognose-nach-fruher-stammzelltransplantation-zu-haben/</loc>
		<lastmod>2012-05-22T15:42:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/10/two-myeloma-experts-debate-role-of-stem-cell-transplantation-in-the-treatment-of-multiple-myeloma/</loc>
		<lastmod>2012-05-21T21:52:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/05/role-of-autologous-stem-cell-transplantation-in-multiple-myeloma/</loc>
		<lastmod>2012-05-21T21:50:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/31/complete-response-after-stem-cell-transplantation-for-multiple-myeloma-indicates-best-prognosis/</loc>
		<lastmod>2012-05-21T21:49:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/07/fda-issues-extensive-update-about-revlimid-lenalidomide-and-second-cancers/</loc>
		<lastmod>2012-05-21T15:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/07/development-of-perifosine-for-multiple-myeloma-to-continue/</loc>
		<lastmod>2012-05-17T21:00:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/09/new-study-highlights-role-of-blood-clots-in-multiple-myeloma-survival/</loc>
		<lastmod>2012-05-16T00:48:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/melphalan/</loc>
		<lastmod>2012-05-15T20:26:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/zometa/</loc>
		<lastmod>2012-05-15T20:22:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/12/northern-lights-a-crash-course-in-multiple-myeloma-and-initial-chemotherapy/</loc>
		<lastmod>2012-05-04T22:52:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/05/03/pats-place-have-you-thanked-your-oncology-nurses-lately/</loc>
		<lastmod>2012-05-03T15:31:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/05/02/beacon-newsflashes-may-2-2012/</loc>
		<lastmod>2012-05-02T18:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/20/mozobil-plerixafor-may-help-revlimid-lenalidomide-treated-multiple-myeloma-patients-collect-enough-stem-cells-for-transplantation/</loc>
		<lastmod>2012-05-02T15:09:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/02/drug-induced-peripheral-neuropathy-in-multiple-myeloma-patients-part-3-prevention-and-future-directions/</loc>
		<lastmod>2012-05-02T15:05:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/30/gain-in-chromosome-1-negatively-affects-prognosis-only-in-certain-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2012-05-02T14:13:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/03/seans-burgundy-thread-multiple-myeloma-by-the-word/</loc>
		<lastmod>2012-05-01T14:51:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/27/manhattan-tales-an-unexpected-and-welcome-delay/</loc>
		<lastmod>2012-04-27T15:14:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/09/stem-cell-transplantation-as-salvage-therapy-is-most-effective-in-myeloma-patients-with-previous-long-remission/</loc>
		<lastmod>2012-04-27T15:04:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/25/addition-of-velcade-bortezomib-improves-thalidomide-dexamethasone-consolidation-therapy-for-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2012-04-25T14:53:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/17/birds-in-spring-treatments-for-pain-can-fall-short/</loc>
		<lastmod>2012-04-17T17:26:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/04/16/medikamenteninduzierte-periphere-neuropathie-bei-myelompatienten-teil-3-vermeidung-und-zukunftsperspektiven/</loc>
		<lastmod>2012-04-16T19:01:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/16/beacon-newsflashes-april-16-2012/</loc>
		<lastmod>2012-04-16T16:22:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/04/13/medikamenteninduzierte-periphere-neuropathie-bei-multiplen-myelompatienten-teil-2-behandlung/</loc>
		<lastmod>2012-04-13T17:00:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2011/01/11/sns01-t/</loc>
		<lastmod>2012-04-12T17:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/04/11/medikamenteninduzierte-periphere-neuropathie-bei-multiplem-myelom-teil-1-worum-handelt-es-sich-und-wer-ist-gefahrdet/</loc>
		<lastmod>2012-04-11T19:28:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/20/birds-in-spring-dog-gone-doggone-it/</loc>
		<lastmod>2012-04-09T16:10:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/04/06/study-investigates-cement-leakage-risk-following-vertebroplasty-and-kyphoplasty-in-myeloma-patients/</loc>
		<lastmod>2012-04-06T15:29:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/04/05/pats-place-what-would-i-do-if-i-didnt-have-multiple-myeloma/</loc>
		<lastmod>2012-04-05T14:01:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/15/revlimid-prescribing-information-updated-to-include-secondary-cancer-warning/</loc>
		<lastmod>2012-04-02T16:21:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/15/me-vs-mm-i-prefer-the-old-normal/</loc>
		<lastmod>2012-03-30T14:43:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/29/beacon-newsflashes-march-29-2012/</loc>
		<lastmod>2012-03-29T16:26:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/28/mini-unrelated-donor-stem-cell-transplantation-may-be-feasible-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-03-28T21:25:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/13/arnies-rebounding-world-reflecting-back-looking-forward/</loc>
		<lastmod>2012-03-23T18:25:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/21/family-history-of-blood-clots-increases-risk-of-clots-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-03-21T19:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/21/birds-in-spring-this-is-your-brain-on-multiple-myeloma/</loc>
		<lastmod>2012-03-20T16:57:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/16/alternating-revlimid-lenalidomide-and-thalidomide-is-as-effective-as-either-drug-alone-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2012-03-16T16:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/14/revlimid-lenalidomide-velcade-bortezomib-doxil-dexamethasone-combination-may-be-effective-and-tolerable-in-relapsedrefractory-myeloma/</loc>
		<lastmod>2012-03-14T20:51:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/03/14/die-wichtigsten-myelom-forschungsergebnisse-aus-2011/</loc>
		<lastmod>2012-03-14T20:18:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/14/arnies-rebounding-world-thoughts-on-quality-of-life/</loc>
		<lastmod>2012-03-13T14:25:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/09/northern-lights-late-frost-in-the-foothills/</loc>
		<lastmod>2012-03-08T21:55:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/08/northern-lights-a-medical-detective-story/</loc>
		<lastmod>2012-03-08T20:29:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/07/dear-doctor-empower-the-e-patient/</loc>
		<lastmod>2012-03-07T16:25:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2011/04/14/john-theurer-cancer-center/</loc>
		<lastmod>2012-03-07T14:16:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/06/seans-burgundy-thread-chicken-storm-clouds-and-multiple-myeloma/</loc>
		<lastmod>2012-03-06T16:22:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/07/seans-burgundy-thread-just-this-week/</loc>
		<lastmod>2012-03-06T15:43:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/03/05/pats-place-why-should-a-multiple-myeloma-patient-get-a-second-opinion/</loc>
		<lastmod>2012-03-05T16:06:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/03/02/velcade-bortezomib-thalidomide-sequential-maintenance-therapy-yields-positive-initial-results/</loc>
		<lastmod>2012-03-02T21:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/29/revlimid-lenalidomide-may-boost-vaccine-responses-in-multiple-myeloma-patients/</loc>
		<lastmod>2012-02-29T19:16:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/09/21/birds-in-spring-what-to-do-if-you-and-your-doctor-are-a-mismatch/</loc>
		<lastmod>2012-02-28T17:21:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/02/28/studie-zeigt-dass-donor-lymphozyten-infusionen-bei-transplantierten-myelompatienten-wirksamer-sind-wenn-sie-prophylaktisch-eingesetzt-werden/</loc>
		<lastmod>2012-02-28T15:08:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/02/24/velcade-bortezomib-based-therapy-may-improve-survival-of-multiple-myeloma-patients-with-deletion-in-chromosome-17/</loc>
		<lastmod>2012-02-24T17:39:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/19/velcade-and-zolina-for-cell-death-in-myeloma-patients/</loc>
		<lastmod>2012-02-10T21:58:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/05/zolinza-velcade-combination-may-be-effective-in-relapsedrefractory-myeloma/</loc>
		<lastmod>2012-02-10T21:54:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2012/02/10/experten-veroffentlichen-konsensuspapier-uber-die-erhaltungstherapie-beim-multiplem-myelom/</loc>
		<lastmod>2012-02-10T06:36:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/11/new-review-looks-at-treatment-strategies-for-relapsed-and-refractory-multiple-myeloma-patients-part-2-treatment-strategies-at-relapse/</loc>
		<lastmod>2012-02-06T10:38:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/09/new-review-looks-at-treatment-strategies-for-relapsed-and-refractory-multiple-myeloma-part-1-retreatment-with-novel-agents/</loc>
		<lastmod>2012-02-06T07:51:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/02/02/pats-place-multiple-myeloma-survivors-need-to-take-regular-myeloma-breaks/</loc>
		<lastmod>2012-02-02T19:02:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/25/questions-and-answers-about-the-fda-approval-of-subcutaneous-velcade-bortezomib/</loc>
		<lastmod>2012-02-02T17:16:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/20/top-myeloma-beacon-resource-articles-of-2011/</loc>
		<lastmod>2012-01-30T19:54:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/10/arnies-rebounding-world-multiple-myeloma-on-the-ropes-really/</loc>
		<lastmod>2012-01-27T20:58:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/26/manhattan-tales-life-had-changed/</loc>
		<lastmod>2012-01-26T23:25:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/22/manhattan-tales-the-diagnosis/</loc>
		<lastmod>2012-01-26T23:19:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/06/seans-burgundy-thread-positively-multiple-myeloma/</loc>
		<lastmod>2012-01-26T20:46:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/10/pats-place-dealing-with-peripheral-neuropathy/</loc>
		<lastmod>2012-01-26T20:26:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/23/beacon-breakingnews-subcutaneous-velcade-bortezomib-receives-fda-approval/</loc>
		<lastmod>2012-01-23T22:35:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/29/birds-in-spring-communicating-across-doctor-lines/</loc>
		<lastmod>2012-01-18T22:06:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/13/new-myeloma-drugs-target-different-mechanisms-misfolded-proteins/</loc>
		<lastmod>2012-01-16T22:23:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/11/04/perifosine/</loc>
		<lastmod>2012-01-16T22:19:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/02/04/defibrotide/</loc>
		<lastmod>2012-01-16T22:07:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/20/beacon-newsflashes-%e2%80%93-april-20-2009/</loc>
		<lastmod>2012-01-16T17:04:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/12/manhattan-tales-a-trip-to-the-wilderness/</loc>
		<lastmod>2012-01-12T18:35:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2012/01/12/beacon-newsflashes-january-12-2012/</loc>
		<lastmod>2012-01-12T15:53:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/15/me-vs-mm-the-beginning/</loc>
		<lastmod>2012-01-10T23:01:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/05/pats-place-my-multiple-myeloma-treatment-side-effects-keep-changing/</loc>
		<lastmod>2012-01-05T18:54:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2012/01/03/seans-burgundy-thread-its-a-matter-of-time/</loc>
		<lastmod>2012-01-03T17:01:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/24/happy-holidays-2011/</loc>
		<lastmod>2011-12-24T20:26:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/13/arnies-rebounding-world-the-idea-of-the-new-normal/</loc>
		<lastmod>2011-12-22T18:52:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/07/seans-burgundy-thread-myeloma-christmas-memories/</loc>
		<lastmod>2011-12-15T19:38:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/12/09/spanish-experts-ask-what-is-the-path-to-a-cure-for-multiple-myeloma/</loc>
		<lastmod>2011-12-15T19:32:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/12/13/ash-2011-multiples-myelom-update-tag-zwei/</loc>
		<lastmod>2011-12-14T03:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/28/genetic-difference-linked-to-increased-risk-of-multiple-myeloma/</loc>
		<lastmod>2011-12-07T03:44:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/31/study-finds-early-and-delayed-stem-cell-transplants-have-comparable-efficacy-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2011-12-07T03:43:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/12/01/genetische-unterschiede-sind-mit-erhohtem-myelom-risiko-verbunden/</loc>
		<lastmod>2011-12-01T17:28:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/12/01/pats-place-my-myeloma-therapy-is-working-but-not-without-significant-side-effects/</loc>
		<lastmod>2011-12-01T13:49:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/23/canadian-study-takes-in-depth-look-at-second-stem-cell-transplants-as-salvage-therapy-multiple-myeloma/</loc>
		<lastmod>2011-12-01T02:10:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/11/30/kanadische-studie-wirft-eingehenden-blick-auf-zweite-stammzelltransplantation-als-salvage-therapie/</loc>
		<lastmod>2011-12-01T02:09:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/08/arnies-rebounding-world-genomics-and-personalized-medicine-promise-versus-reality/</loc>
		<lastmod>2011-11-29T23:08:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/15/birds-in-spring-as-time-goes-by/</loc>
		<lastmod>2011-11-29T23:08:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/18/high-sclerostin-levels-linked-to-advanced-disease-and-poor-bone-formation-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-11-29T23:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/17/pats-place-the-purgatory-of-waiting/</loc>
		<lastmod>2011-11-17T21:19:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/16/disease-stability-affects-transplant-outcomes-in-myeloma-patients-unresponsive-to-initial-treatment/</loc>
		<lastmod>2011-11-17T21:08:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/11/14/lower-dose-thalidomide-thalomid-compares-well-to-higher-dose-option-in-advanced-myeloma-patients/</loc>
		<lastmod>2011-11-15T20:15:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/11/15/niedrig-dosiertes-thalidomid-stellt-sich-gut-im-vergleich-zur-hoheren-dosis-bei-der-behandlung-von-fortgeschrittenen-myelompatienten/</loc>
		<lastmod>2011-11-15T20:15:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/12/multiple-myeloma-vaccine-shows-promise-in-mice/</loc>
		<lastmod>2011-11-15T16:35:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/07/nccn-modifies-guidelines-for-multiple-myeloma-a-second-time-in-2011/</loc>
		<lastmod>2011-11-10T18:55:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/01/pats-place-battling-my-health-insurance-company-to-pay-for-my-multiple-myeloma-treatment/</loc>
		<lastmod>2011-11-10T17:08:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/08/pats-place-tips-for-maximizing-health-insurance-coverage/</loc>
		<lastmod>2011-11-10T17:07:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/15/pats-place-my-opinion-on-whether-treatment-for-multiple-myeloma-is-a-privilege-or-a-right-whats-yours/</loc>
		<lastmod>2011-11-10T17:06:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/22/pats-place-flying-the-friendly-skies-should-i-wear-a-mask-post-transplant/</loc>
		<lastmod>2011-11-10T17:05:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/29/pats-place-is-feeling-the-love-worth-risking-a-post-transplant-infection/</loc>
		<lastmod>2011-11-10T17:04:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/06/pats-place-are-there-too-many-therapy-choices-for-multiple-myeloma/</loc>
		<lastmod>2011-11-10T17:03:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/13/pats-place-things-you-can-do-to-take-control-of-your-multiple-myeloma-therapy/</loc>
		<lastmod>2011-11-10T17:02:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/20/pats-place-i-want-my-money-back/</loc>
		<lastmod>2011-11-10T17:01:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/05/06/pats-place-tips-for-battling-peripheral-neuropathy-from-a-patients-perspective/</loc>
		<lastmod>2011-11-10T16:55:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/11/07/experten-prufen-gegenwartige-und-zukunftige-forschung-uber-neue-behandlungsoptionen-beim-multiplen-myelom/</loc>
		<lastmod>2011-11-08T02:27:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/03/pats-place-thank-you-team-myeloma/</loc>
		<lastmod>2011-11-03T17:21:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/11/01/seans-burgundy-thread-turkey-touchdowns-and-multiple-myeloma/</loc>
		<lastmod>2011-11-01T20:14:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/18/birds-in-spring-may-the-force-be-with-you/</loc>
		<lastmod>2011-10-28T16:09:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/21/nonsecretory-multiple-myeloma/</loc>
		<lastmod>2011-10-28T15:46:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/27/pats-place-tips-for-infusion-days/</loc>
		<lastmod>2011-10-27T18:23:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/10/26/nicht-sekretorisches-multiples-myelom/</loc>
		<lastmod>2011-10-27T12:32:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/03/istodax-romidepsin-velcade-bortezomib-dexamethasone-combination-may-be-effective-in-relapsedrefractory-myeloma/</loc>
		<lastmod>2011-10-26T19:48:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/26/progression-free-survival-can-we-find-another-term/</loc>
		<lastmod>2011-10-26T17:14:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/12/the-majority-of-rare-myelomas-are-associated-with-poorer-survival-than-common-myelomas/</loc>
		<lastmod>2011-10-22T15:35:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/22/scientists-develop-serum-immunoglobulin-free-light-chain-assay-develop-for-early-myeloma-diagnosis/</loc>
		<lastmod>2011-10-22T15:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/14/treanda-bendamustine-in-combination-with-steroids-may-be-effective-in-relapsed-and-refractory-multiple-myeloma-patients/</loc>
		<lastmod>2011-10-16T01:22:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/12/neupogen-and-neulasta-show-comparable-activity-in-multiple-myeloma-patients-after-stem-cell-transplantation/</loc>
		<lastmod>2011-10-12T18:49:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/10/11/arnies-rebounding-world-the-second-salvage-transplant/</loc>
		<lastmod>2011-10-12T18:08:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/23/long-term-follow-up-results-indicate-double-transplantation-is-superior-to-single-transplantation-for-multiple-myeloma/</loc>
		<lastmod>2011-10-11T19:42:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/29/revlimid-and-secondary-cancers-an-update/</loc>
		<lastmod>2011-10-11T19:40:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/31/oral-busulfan-treatment-may-be-more-effective-but-not-as-safe-as-melphalan-prior-to-stem-cell-transplant-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-10-11T19:39:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/22/studies-aim-to-improve-transplantation-response-rates-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-10-11T19:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/11/myeloma-beacon-introduces-new-service-for-tracking-postings-at-myeloma-related-blogs/</loc>
		<lastmod>2011-10-11T15:19:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/09/arnies-rebounding-world-the-clinical-trial/</loc>
		<lastmod>2011-10-05T19:27:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/20/birds-in-spring-does-having-cancer-change-others-opinions-of-you/</loc>
		<lastmod>2011-10-05T16:24:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/10/05/addition-of-doxil-doxorubicin-to-velcade-bortezomib-improves-treatment-outcomes-for-multiple-myeloma-patients/</loc>
		<lastmod>2011-10-05T16:21:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/10/03/subkutane-gabe-von-velcade-informationen-fur-myelompatienten/</loc>
		<lastmod>2011-10-03T21:48:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/12/treating-multiple-myeloma-patients-optimizing-response-while-minimizing-side-effects/</loc>
		<lastmod>2011-09-30T15:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/23/european-regulators-conclude-revlimid-lenalidomide-safety-review-say-drugs-benefit-risk-balance-remains-positive/</loc>
		<lastmod>2011-09-27T14:29:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/09/13/arnies-rebounding-world-how-doctors-think/</loc>
		<lastmod>2011-09-26T21:09:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/29/percentage-of-cancerous-plasma-cells-post-transplant-may-predict-outcome-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-09-22T14:11:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/19/researchers-find-high-rates-of-sexual-dysfunction-after-stem-cell-transplantation/</loc>
		<lastmod>2011-09-19T14:43:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/09/07/myeloma-beacon-launches-sponsorship-program-and-patient-advisory-board/</loc>
		<lastmod>2011-09-07T19:21:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/25/beacon-newsflashes-april-25-2011/</loc>
		<lastmod>2011-09-02T19:38:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/25/pats-place-multiple-myeloma-burnout/</loc>
		<lastmod>2011-09-01T13:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/31/failure-to-respond-to-novel-agents-velcade-revlimid-thalidomide-indicates-poor-prognosis-for-multiple-myeloma-patients/</loc>
		<lastmod>2011-09-01T02:30:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/16/birds-in-spring-ten-self-preservation-tips-for-a-hospital-admission/</loc>
		<lastmod>2011-08-30T19:42:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/08/26/revlimid-erhaltungstherapie-nach-spender-stammzelltransplantation-wird-fur-myelompatienten-nicht-empfohlen/</loc>
		<lastmod>2011-08-26T19:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/24/beacon-newsflashes-august-24-2011/</loc>
		<lastmod>2011-08-24T16:18:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/14/mmrf-meeting-discusses-racial-disparities-in-multiple-myeloma/</loc>
		<lastmod>2011-08-22T15:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/21/mmrf-meeting-discusses-prognosis-and-treatments-for-myeloma-patients/</loc>
		<lastmod>2011-08-22T15:11:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/09/multiple-myeloma-conferences-to-be-held-in-hawaii-arizona-canada-and-greece/</loc>
		<lastmod>2011-08-22T15:11:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/11/beacon-newsflashes-november-11-2008/</loc>
		<lastmod>2011-08-22T15:10:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/27/blood-cancers-the-subject-of-seminar-at-university-of-chicago-medical-center/</loc>
		<lastmod>2011-08-22T15:09:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/28/beacon-newsflashes-march-28-2011/</loc>
		<lastmod>2011-08-22T15:06:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/25/beacon-newsflashes-july-25-2011/</loc>
		<lastmod>2011-08-22T15:05:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/06/steroid-free-three-drug-combination-treatment-may-be-effective-in-multiple-myeloma/</loc>
		<lastmod>2011-08-22T15:02:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/08/18/gentherapie-fortschritte-bei-leukamie-deuten-neue-behandlungsoptionen-fur-myelompatienten-an/</loc>
		<lastmod>2011-08-18T23:07:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/18/pats-place-post-transplant-let-down/</loc>
		<lastmod>2011-08-18T15:14:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/08/12/minimale-resterkrankung-vor-stammzelltransplantation-ist-ein-unabhangiger-prognoseparameter-bei-myelompatienten/</loc>
		<lastmod>2011-08-18T13:46:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/02/seans-burgundy-thread-mri-dreams/</loc>
		<lastmod>2011-08-15T21:04:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/30/short-course-kepivance-reduces-mouth-ulcers-and-need-for-supportive-care-after-stem-cell-transplantation-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-08-12T13:59:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/19/birds-in-spring-hospitals-good-places-where-bad-things-can-happen/</loc>
		<lastmod>2011-08-10T20:13:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/21/birds-in-spring-the-story-of-my-myeloma-diagnosis-and-initial-treatment/</loc>
		<lastmod>2011-08-09T14:15:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/08/addition-of-cyclophosphamide-cytoxan-to-revlimid-lenalidomide-and-dexamethasone-decadron-may-improve-responses-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2011-08-08T21:04:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/08/04/pats-place-is-undergoing-a-stem-cell-transplant-for-multiple-myeloma-worth-the-pain-and-discomfort-only-if-it-works/</loc>
		<lastmod>2011-08-04T13:00:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/08/seans-burgundy-thread-multiple-myeloma-and-may-winds/</loc>
		<lastmod>2011-08-01T20:36:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/08/01/beacon-newsflashes-august-1-2011/</loc>
		<lastmod>2011-08-01T13:17:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/28/pats-place-stem-cell-transplant-patients-are-brave-and-determined-people/</loc>
		<lastmod>2011-07-28T16:05:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/15/fatigue-and-multiple-myeloma-study-highlights-role-of-mood-reevaluates-role-of-pain/</loc>
		<lastmod>2011-07-28T12:53:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/12/arnies-rebounding-world-the-decision-to-stop-working-employment/</loc>
		<lastmod>2011-07-28T12:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/08/17/birds-in-spring-your-quality-of-life-dont-forget-to-live/</loc>
		<lastmod>2011-07-27T19:50:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/27/cyclophosphamide-thalidomide-thalomid-dexamethasone-improves-response-but-not-survival-in-elderly-myeloma-patients/</loc>
		<lastmod>2011-07-27T14:35:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/22/new-response-type-may-help-determine-multiple-myeloma-patients-prognoses/</loc>
		<lastmod>2011-07-22T15:34:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/21/pats-place-when-and-how-a-myeloma-patient-should-get-a-second-medical-opinion/</loc>
		<lastmod>2011-07-21T16:38:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/20/melphalan-prednisone-thalidomide-thalomid-may-increase-survival-in-elderly-multiple-myeloma-patients/</loc>
		<lastmod>2011-07-20T16:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/08/obesity-impact-on-multiple-myeloma-stem-cell-transplant-outcomes/</loc>
		<lastmod>2011-07-20T14:30:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/05/seans-burgundy-thread-myeloma-shiny-yellow-volkswagens/</loc>
		<lastmod>2011-07-20T14:28:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/14/pats-place-poor-communication-can-cost-a-multiple-myeloma-patient-time-and-money/</loc>
		<lastmod>2011-07-18T17:01:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/07/07/pats-place-my-new-unexpected-superpower/</loc>
		<lastmod>2011-07-18T16:43:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/07/13/velcade-bortezomib-dexamethasone-maintenance-therapy-appears-to-be-effective-in-myeloma-patients-who-respond-to-velcade-rescue-therapy/</loc>
		<lastmod>2011-07-13T15:05:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2011/06/30/baylor-charles-a-sammons-cancer-center-at-dallas/</loc>
		<lastmod>2011-06-30T15:30:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/30/pats-place-thoughts-from-a-brand-new-stem-cell-transplant-patient/</loc>
		<lastmod>2011-06-30T13:54:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/14/arnies-rebounding-world-the-relapse-rollercoaster/</loc>
		<lastmod>2011-06-29T16:13:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/06/28/stammzelltransplantation-versus-neue-substanzen-zur-behandlung-des-multiplen-myeloms-eha-2011/</loc>
		<lastmod>2011-06-28T20:35:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/23/pats-place-sometimes-you-just-have-to-laugh/</loc>
		<lastmod>2011-06-23T13:36:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/12/03/elotuzumab/</loc>
		<lastmod>2011-06-23T12:39:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/17/dental-exams-recommended-before-bisphosphonate-therapy/</loc>
		<lastmod>2011-06-23T12:37:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/22/phase-3-trial-indicates-denosumab-delays-skeletal-related-events/</loc>
		<lastmod>2011-06-23T12:36:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/31/preventive-measures-can-reduce-osteonecrosis-of-the-jaw-in-patients-taking-zometa/</loc>
		<lastmod>2011-06-23T12:32:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/20/beacon-newsflashes-june-20-2011/</loc>
		<lastmod>2011-06-20T15:08:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/06/17/asco-2011-update-multiples-myelom-tag-4/</loc>
		<lastmod>2011-06-17T18:40:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/16/pats-place-overcoming-my-life-long-fear-of-giving-myself-an-injection/</loc>
		<lastmod>2011-06-16T15:58:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/06/14/asco-2011-update-multiple-myeloma-tag-3-teil-2/</loc>
		<lastmod>2011-06-14T22:18:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/09/pats-place-individual-dosing-could-it-improve-our-survival/</loc>
		<lastmod>2011-06-09T19:49:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/06/09/investigational-drug-ly2127399-in-combination-with-velcade-shows-potential-for-multiple-myeloma-asco-2011/</loc>
		<lastmod>2011-06-09T19:43:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/07/new-myeloma-drugs-target-different-mechanisms-signaling-pathways/</loc>
		<lastmod>2011-06-09T19:40:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/06/09/asco-2011-update-multiples-myelom-tag-3-teil-1/</loc>
		<lastmod>2011-06-09T18:44:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/06/06/myelomexperten-prasentieren-weitere-daten-zum-thema-revlimid-und-sekundare-malignome-asco-2011/</loc>
		<lastmod>2011-06-07T18:16:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/06/04/asco-2011-multiples-myelom-update-tag-1-und-2/</loc>
		<lastmod>2011-06-06T03:32:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/17/birds-in-spring-navigating-myeloma-treatment-and-its-side-effects/</loc>
		<lastmod>2011-06-02T17:34:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/06/02/pats-place-reflections-on-an-unfortunate-summer-holiday-tradition/</loc>
		<lastmod>2011-06-02T14:22:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/27/certain-chromosomal-abnormalities-may-negatively-affect-prognosis-in-relapsed-and-refractory-myeloma-patients-receiving-revlimid-lenalidomide-dexamethasone-therapy/</loc>
		<lastmod>2011-06-01T20:28:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/26/pats-place-following-multiple-myeloma-research-can-be-frustrating-yet-exhilarating/</loc>
		<lastmod>2011-05-26T19:12:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/19/pats-place-for-me-watchful-waiting-becomes-hopeful-waiting-subcutaneous-velcade-bortezomib/</loc>
		<lastmod>2011-05-19T14:56:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/03/arnies-rebounding-world-after-the-transplant/</loc>
		<lastmod>2011-05-19T14:13:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/05/18/velcade-doxil-dexamethasone-thalidomide-combination-may-be-effective-in-relapsedrefractory-myeloma/</loc>
		<lastmod>2011-05-18T21:27:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/opinion/2010/11/22/multiple-myeloma-treatment-individualizing-the-dosing/</loc>
		<lastmod>2011-05-17T18:51:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/14/beacon-newsflashes-march-14-2011/</loc>
		<lastmod>2011-05-16T15:36:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/12/pats-place-extraordinary-people-who-inspire-me-since-my-myeloma-diagnosis/</loc>
		<lastmod>2011-05-13T18:12:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/05/11/imw-2011-multiples-myelom-update-tag-4/</loc>
		<lastmod>2011-05-13T16:05:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/05/09/imw-2011-multiple-myeloma-update-tag-3-teil-1/</loc>
		<lastmod>2011-05-12T18:23:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/05/10/imw-2011-multiples-myelom-update-tag-3-teil-2/</loc>
		<lastmod>2011-05-12T15:22:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/05/05/imw-2011-multiple-myeloma-update-tag-2/</loc>
		<lastmod>2011-05-11T22:27:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/05/04/imw-2011-multiples-myelom-update-tag-1/</loc>
		<lastmod>2011-05-06T22:25:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/28/thalidomide-thalomid-receives-new-safety-warning-in-europe-and-korea/</loc>
		<lastmod>2011-05-06T16:02:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/19/birds-in-spring-two-inspirational-women-who-faced-multiple-myeloma-with-strength-and-courage-geraldine-ferraro-and-faith-hamer/</loc>
		<lastmod>2011-05-06T16:01:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/05/05/pats-place-public-figures-who-have-inspired-me-since-my-multiple-myeloma-diagnosis/</loc>
		<lastmod>2011-05-05T14:13:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/28/pats-place-everyday-things-that-inspire-me/</loc>
		<lastmod>2011-04-28T21:30:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/27/more-studies-are-needed-on-medications-to-prevent-blood-clots-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-04-28T17:07:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/09/beacon-newsflashes-%e2%80%93-march-9-2010/</loc>
		<lastmod>2011-04-27T20:09:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/03/beacon-newsflashes-december-3-2009/</loc>
		<lastmod>2011-04-27T20:07:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/16/beacon-newsflashes-%e2%80%93-september-16-2009/</loc>
		<lastmod>2011-04-27T20:06:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/01/beacon-newsflashes-%e2%80%93-september-1-2009/</loc>
		<lastmod>2011-04-27T20:06:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/19/the-imf-announces-new-global-research-partnership-to-study-multiple-myeloma-related-biomarkers/</loc>
		<lastmod>2011-04-26T18:30:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/19/new-technique-shows-improved-detection-of-tumor-cells-after-myeloma-treatment/</loc>
		<lastmod>2011-04-26T18:29:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/20/imf-continues-support-of-the-peter-boyle-memorial-fund/</loc>
		<lastmod>2011-04-26T18:27:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/21/increased-risk-of-venous-thromboembolism-reported-in-cancer-patients-treated-with-bevacizumab/</loc>
		<lastmod>2011-04-26T18:26:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/23/beacon-newsflashes-november-23-2008/</loc>
		<lastmod>2011-04-26T18:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/26/us-cancer-incidence-and-mortality-rates-fall-for-the-first-time/</loc>
		<lastmod>2011-04-26T18:24:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/25/lenalidomide-plus-dexamethasone-is-more-effective-in-treating-relapsed-or-refractory-multiple-myeloma-than-dexamethasone-alone/</loc>
		<lastmod>2011-04-26T18:23:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/09/split-may-be-emerging-regarding-long-term-revlimid-lenalidomide-use/</loc>
		<lastmod>2011-04-26T18:20:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/05/revlimid-lenalidomide-cancer-controversy-flares/</loc>
		<lastmod>2011-04-26T18:19:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/06/revlimid-lenalidomide-dosing-to-continue-in-calgb-maintenance-trial/</loc>
		<lastmod>2011-04-26T18:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/31/revlimid-lenalidomide-maintenance-and-secondary-cancers-in-multiple-myeloma-patients-more-details-emerge/</loc>
		<lastmod>2011-04-26T18:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/11/revlimid-cyclophosphamide-prednisone-combination-may-be-highly-effective-for-refractory-multiple-myeloma-patients/</loc>
		<lastmod>2011-04-26T18:12:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/07/revlimid-may-be-more-effective-than-thalidomide-in-newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2011-04-26T18:11:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/12/revlimid-maintenance-therapy-is-added-to-multiple-myeloma-treatment-guidelines/</loc>
		<lastmod>2011-04-26T18:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/06/new-therapies-show-promise-for-multiple-myeloma-treatment/</loc>
		<lastmod>2011-04-26T18:05:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/01/physicians-discuss-past-progress-and-future-goals-in-treating-multiple-myeloma/</loc>
		<lastmod>2011-04-26T18:03:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/06/immunotherapy-shows-promise-in-preclinical-study/</loc>
		<lastmod>2011-04-26T18:01:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/09/revlimid-may-be-equally-effective-in-thalidomide-resistant-and-thalidomide-sensitive-multiple-myeloma-patients/</loc>
		<lastmod>2011-04-22T19:16:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/08/fda-announces-investigation-into-revlimid-lenalidomide-thalidomide-thalomid-and-secondary-cancers/</loc>
		<lastmod>2011-04-21T17:44:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/18/new-advances-in-multiple-myeloma-vaccines-part-5-participating-in-a-clinical-trial-for-a-novel-multiple-myeloma-vaccine/</loc>
		<lastmod>2011-04-21T17:43:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/11/vertebroplasty-relieves-pain-for-multiple-myeloma-patients-with-spinal-fractures/</loc>
		<lastmod>2011-04-21T17:43:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/05/seans-burgundy-thread-spring-break-in-myelomaville/</loc>
		<lastmod>2011-04-21T16:19:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/18/mitoxantrone-novantrone-and-melphalan-alkeran-regimen-is-effective-and-well-tolerated-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-04-18T20:32:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/14/pats-place-we-need-to-help-speed-up-the-learning-curve-for-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2011-04-14T15:41:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/18/new-advances-in-multiple-myeloma-vaccines-part-1-introduction/</loc>
		<lastmod>2011-04-14T15:02:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/23/new-advances-in-multiple-myeloma-vaccines-part-2-types-of-potential-myeloma-therapeutic-vaccines/</loc>
		<lastmod>2011-04-14T15:02:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/04/new-advances-in-multiple-myeloma-vaccines-part-3-completed-clinical-trials/</loc>
		<lastmod>2011-04-14T15:01:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/11/new-advances-in-multiple-myeloma-vaccines-part-4-ongoing-research/</loc>
		<lastmod>2011-04-14T15:01:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/17/beacon-newsflashes-november-17-2008/</loc>
		<lastmod>2011-04-13T15:33:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/16/treatment-with-folic-acid-vitamin-b6-and-vitamin-b12-has-little-effect-on-risk-of-multiple-myeloma-among-women/</loc>
		<lastmod>2011-04-13T15:32:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/13/link-between-gene-variation/</loc>
		<lastmod>2011-04-13T15:29:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/13/immunocellular-therapeutics-present-data-showing-immune-response-on-cancer-stem-cells/</loc>
		<lastmod>2011-04-13T15:26:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/13/occupation-and-chemical-exposure-linked-to-multiple-myeloma/</loc>
		<lastmod>2011-04-13T15:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/12/multiple-myeloma-most-prevalent-in-african-americans/</loc>
		<lastmod>2011-04-13T15:24:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/10/cigna-leukemia-lymphoma-society-promote-financial-aid-program/</loc>
		<lastmod>2011-04-13T15:23:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/07/beacon-newsflashes-november-7th-2008/</loc>
		<lastmod>2011-04-13T15:22:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/07/international-myeloma-foundation-calls-for-patient-access-to-novel-myeloma-treatments/</loc>
		<lastmod>2011-04-12T14:17:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/06/beacon-newsflashes-%e2%80%93-november-6th-2008/</loc>
		<lastmod>2011-04-12T14:14:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/06/immunotherapy-treatment-in-mice-shows-antitumor-activity/</loc>
		<lastmod>2011-04-12T14:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/05/cephalons-treanda-fda-approved-for-second-cancer-indication/</loc>
		<lastmod>2011-04-12T14:11:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/06/prolexys-pharmaceuticals-raises-20-million-to-further-work-on-anti-tumor-molecule/</loc>
		<lastmod>2011-04-12T14:10:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/04/the-mmrf-raised-over-15-million-in-annual-fall-gala/</loc>
		<lastmod>2011-04-12T14:04:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/02/england-and-wales-may-halt-funding-for-revlimid/</loc>
		<lastmod>2011-04-12T14:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/01/scientist-receives-720000-grant-to-research-new-myeloma-drug-targets/</loc>
		<lastmod>2011-04-12T14:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/04/07/pats-place-acceptance-may-be-the-key-to-living-a-worry-free-new-normal-life/</loc>
		<lastmod>2011-04-07T14:19:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/04/06/researchers-identify-risk-factors-for-infectious-complications-in-multiple-myeloma-patients-treated-with-thalidomide-based-combination-therapies/</loc>
		<lastmod>2011-04-06T17:56:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/15/birds-in-spring-emailing-your-doctor/</loc>
		<lastmod>2011-04-05T15:27:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/04/01/pomalidomid-kann-bei-myelompatienten-wirksam-sein-die-eine-extramedullare-manifestation-des-myeloms-entwickeln/</loc>
		<lastmod>2011-04-05T15:23:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/10/vertebroplasty-relieves-pain-and-restores-mobility-in-myeloma-related-spinal-fractures-study-finds/</loc>
		<lastmod>2011-04-05T13:56:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/31/pats-place-living-one-day-at-a-time/</loc>
		<lastmod>2011-03-31T16:00:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/01/continuous-low-dose-cyclophosphamide-and-prednisone-regimen-is-safe-and-effective-salvage-treatment-for-multiple-myeloma/</loc>
		<lastmod>2011-03-30T19:25:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/30/aredia-does-not-prevent-disease-progression-in-smoldering-myeloma-patients/</loc>
		<lastmod>2011-03-30T19:22:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/opinion/2011/03/28/kadian-morphine-a-little-known-pain-drug/</loc>
		<lastmod>2011-03-28T15:13:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/25/beacon-breakingnews-european-multiple-myeloma-researchers-issue-statement-on-revlimid-and-secondary-cancers/</loc>
		<lastmod>2011-03-25T13:05:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/23/genome-sequencing-reveals-clues-about-the-underlying-causes-of-multiple-myeloma/</loc>
		<lastmod>2011-03-25T12:14:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/16/the-top-multiple-myeloma-research-of-2010/</loc>
		<lastmod>2011-03-24T20:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/24/pats-place-anger-rises-among-some-multiple-myeloma-patients-as-they-anxiously-await-a-cure/</loc>
		<lastmod>2011-03-24T15:27:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/08/arnies-rebounding-world-induction-therapy-with-vincristine-adriamycin-dexamethasone/</loc>
		<lastmod>2011-03-23T20:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/03/18/neue-fortschritte-bei-myelom-impfstoffen-teil-5-teilnahme-an-einer-klinischen-studie-fur-einen-neuentwickelten-myelom-impfstoff/</loc>
		<lastmod>2011-03-23T15:57:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/21/national-comprehensive-cancer-network-modifies-guidelines-for-multiple-myeloma/</loc>
		<lastmod>2011-03-22T14:27:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/17/pats-place-radiation-oncology-has-come-a-long-way-in-four-years/</loc>
		<lastmod>2011-03-17T16:55:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/03/11/neue-fortschritte-bei-myelom-impfstoffen-teil-4-laufende-forschungsprojekte/</loc>
		<lastmod>2011-03-17T14:49:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/03/11/fortschritte-bei-myelom-impfstoffen-teil-3-beendete-klinische-studien/</loc>
		<lastmod>2011-03-17T14:42:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/01/seans-burgundy-thread-hows-your-multiple-myeloma-l-spike/</loc>
		<lastmod>2011-03-16T14:27:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/02/08/arnies-rebounding-world-a-journey-from-diagnosis-to-relapse-and-beyond/</loc>
		<lastmod>2011-03-15T15:18:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/01/18/birds-in-spring-versed-midazolam-forgetting-surgical-unpleasantness-and-everything-else/</loc>
		<lastmod>2011-03-15T14:02:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/10/pats-place-living-with-survivors-guilt/</loc>
		<lastmod>2011-03-10T13:15:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/03/07/kyphoplasty-is-more-effective-than-non-surgical-care-in-multiple-myeloma-patients-with-spinal-fractures/</loc>
		<lastmod>2011-03-07T21:12:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/09/meinungsverschiedenheiten-scheinen-sich-bezuglich-der-revlimid-erhaltungstherapie-zu-entwickeln/</loc>
		<lastmod>2011-03-07T20:01:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2011/02/09/uzun-sureli-revlimid-kullanimi-konusunda-kamplasma-basladi/</loc>
		<lastmod>2011-03-07T19:59:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/03/03/pats-place-march-is-multiple-myeloma-awareness-month/</loc>
		<lastmod>2011-03-03T20:49:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/28/interview-mit-einem-der-fuhrenden-myelomexperten-dr-kenneth-anderson-teil-2-die-zukunft-der-myelombehandlung/</loc>
		<lastmod>2011-03-02T21:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/23/fortschritte-bei-myelom-impfstoffen%e2%80%93teil-2-arten-von-potenziellen-myelom-impfstoffen/</loc>
		<lastmod>2011-03-01T22:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/21/thought-leader-perspective-dr-kenneth-anderson-on-treating-multiple-myeloma/</loc>
		<lastmod>2011-03-01T21:43:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/25/first-day-of-stem-cell-collection-for-multiple-myeloma-patients-predicts-likelihood-of-collecting-enough-stem-cells-for-transplantation/</loc>
		<lastmod>2011-02-25T23:05:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/18/fortschritte-bei-myelom-impfstoffen-%e2%80%93-teil-1-einfuhrung/</loc>
		<lastmod>2011-02-25T15:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/03/beacon-newsflashes-september-3-2010/</loc>
		<lastmod>2011-02-25T14:29:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/doxorubicin/</loc>
		<lastmod>2011-02-25T14:27:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/02/24/pat%e2%80%99s-place-what-can-long-lived-multiple-myeloma-survivors-teach-us/</loc>
		<lastmod>2011-02-24T17:34:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/21/interview-mit-einem-der-fuhrenden-myelomexperten-dr-kenneth-anderson-teil-1-behandlung-des-multiplen-myeloms/</loc>
		<lastmod>2011-02-24T15:58:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/15/myeloma-working-group-postpones-statement-on-revlimid-lenalidomide-potential-link-to-second-cancers/</loc>
		<lastmod>2011-02-23T21:42:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/15/myelom-arbeitsgruppe-verschiebt-aussage-uber-potentielle-verbindung-von-revlimid-zu-zweitmalignomen/</loc>
		<lastmod>2011-02-23T21:42:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/05/kontroverse-uber-revlimid-und-zweitmalignome-weitet-sich-aus/</loc>
		<lastmod>2011-02-23T21:26:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/02/bone-marrow-examination-can-predict-progression-of-multiple-myeloma/</loc>
		<lastmod>2011-02-23T15:38:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/02/01/seans-burgundy-thread-fevers-flu-and-a-few-new-multiple-myeloma-friends/</loc>
		<lastmod>2011-02-23T15:36:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/02/17/pats-place-common-traits-among-long-lived-multiple-myeloma-survivors/</loc>
		<lastmod>2011-02-17T19:39:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/16/variations-in-nervous-system-genes-may-put-multiple-myeloma-patients-at-higher-risk-for-thalidomide-related-neuropathy/</loc>
		<lastmod>2011-02-16T20:51:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/02/11/prognosis-for-multiple-myeloma-patients-with-chromosomal-abnormality-t414-remains-poor/</loc>
		<lastmod>2011-02-15T23:52:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/15/prognose-fur-myelom-patienten-mit-der-chromosomalen-abnormitat-t414-bleibt-schlecht/</loc>
		<lastmod>2011-02-15T23:52:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2011/01/15/revlimid-idame-tedavisi-ve-ikincil-kanserler-ayrintilar-ortaya-cikiyor/</loc>
		<lastmod>2011-02-15T19:39:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/10/managing-the-side-effects-of-revlimid-and-velcade/</loc>
		<lastmod>2011-02-15T16:50:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/02/10/pats-place-communication-with-your-multiple-myeloma-physician-is-key-patient-suggestions-and-input-are-important/</loc>
		<lastmod>2011-02-10T19:23:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/opinion/2011/02/07/randomized-clinical-trials-a-multiple-myeloma-patients-viewpoint/</loc>
		<lastmod>2011-02-07T22:05:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/02/02/knochenmarksuntersuchung-kann-myelomprogression-vorhersagen/</loc>
		<lastmod>2011-02-03T21:40:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/02/03/pats-place-how-much-does-a-multiple-myeloma-patient-need-to-know-about-various-treatment-options/</loc>
		<lastmod>2011-02-03T15:48:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/21/novel-agents-as-salvage-therapy-after-stem-cell-transplantation-improve-survival-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-02-02T20:31:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/14/targeted-irradiation-and-stem-cell-transplantation-show-promise-in-phase-1-clinical-trial-for-multiple-myeloma/</loc>
		<lastmod>2011-02-02T20:30:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/28/thalidomide-velcade-combination-without-steroids-is-effective-for-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2011-01-28T20:48:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/01/04/seans-burgundy-thread-my-new-years-multiple-myeloma-resolutions-for-2011/</loc>
		<lastmod>2011-01-27T21:41:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/01/27/pats-place-tracking-multiple-myeloma-numbers/</loc>
		<lastmod>2011-01-27T21:33:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2011/01/26/chemotherapy-regimen-without-high-dose-dexamethasone-reduces-infections-in-multiple-myeloma-patients/</loc>
		<lastmod>2011-01-26T17:47:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/tanespimycin/</loc>
		<lastmod>2011-01-24T20:00:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/01/20/pats-place-my-multiple-myeloma-has-relapsed-now-what/</loc>
		<lastmod>2011-01-20T16:32:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/opinion/2011/01/11/stem-cell-collection-and-hyperbaric-oxygen-treatment/</loc>
		<lastmod>2011-01-20T14:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/01/18/phase-1-studie-mit-gezielter-bestrahlung-und-stammzelltransplantation-zeigt-gute-resultate-beim-multiplen-myelom/</loc>
		<lastmod>2011-01-19T21:00:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2011/01/18/die-mehrzahl-seltener-myelomerkrankungen-sind-mit-einer-schlechteren-prognose-verbunden/</loc>
		<lastmod>2011-01-18T19:57:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/01/13/pats-place-new-years-resolution-suggestions-for-multiple-myeloma-survivors/</loc>
		<lastmod>2011-01-13T14:59:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2011/01/10/talidomid-ve-revlimid-e-dayanikli-multipl-miyelom-hastalarinda-nuks-sonrasi-revlimid-ve-pomalidomid-kurtarma-tedavisi-ile-cok-iyi-yanit-oranlarina-ulasilmistir-ash-2010/</loc>
		<lastmod>2011-01-12T18:34:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/22/beacon-newsflashes-november-22-2010/</loc>
		<lastmod>2011-01-11T21:41:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2011/01/06/pats-place-can-curcumin-resveratrol-or-other-nutritional-supplements-help-fight-multiple-myeloma/</loc>
		<lastmod>2011-01-06T15:48:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/14/seans-burgundy-thread-myeloma-for-a-season/</loc>
		<lastmod>2011-01-03T21:13:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/30/pats-place-reasons-why-multiple-myeloma-patients-should-use-or-avoid-certain-nutritional-supplements/</loc>
		<lastmod>2010-12-26T22:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/24/happy-holidays/</loc>
		<lastmod>2010-12-24T15:31:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/23/pats-place-nutritional-supplements-that-i-take-as-a-multiple-myeloma-patient/</loc>
		<lastmod>2010-12-23T19:12:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/12/03/riske-bagli-multipl-miyelom-tedavisi/</loc>
		<lastmod>2010-12-22T15:02:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/16/pats-place-taking-nutritional-supplements-is-like-walking-through-a-mine-field-for-multiple-myeloma-patients/</loc>
		<lastmod>2010-12-16T15:25:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/12/08/ash-2010-multiples-myelom-update-tag-3-nachmittag-abend/</loc>
		<lastmod>2010-12-14T23:47:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/12/09/ash-2010-multiple-myelom-update-tag-4/</loc>
		<lastmod>2010-12-14T23:08:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/11/29/bazi-kromozom-anomalileri-nuksetmis-ve-refrakter-multipl-miyelom-hastalarinda-revlimid-deksametazon-tedavisini-negatif-etkilemektedir/</loc>
		<lastmod>2010-12-13T22:26:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/29/certain-chromosomal-abnormalities-negatively-impact-the-outcome-of-revlimid-dexamethasone-therapy-in-relapsed-and-refractory-multiple-myeloma-patients/</loc>
		<lastmod>2010-12-13T19:17:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/09/growth-factor-may-not-be-required-following-stem-cell-transplantation-in-multiple-myeloma-patients/</loc>
		<lastmod>2010-12-10T20:06:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/06/07/asco-2010-multiples-myelom-update-%e2%80%93-tag-3/</loc>
		<lastmod>2010-12-10T20:04:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/06/08/asco-2010-multiples-myelom-update-%e2%80%93-tag-4/</loc>
		<lastmod>2010-12-10T20:04:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/03/researchers-identify-factors-associated-with-improved-survival-in-myeloma-patients-after-surgery-for-skeletal-complications/</loc>
		<lastmod>2010-12-10T19:56:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/11/18/pats-place-beware-of-myeloma-speak/</loc>
		<lastmod>2010-12-10T15:28:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/12/05/ash-2010-multiples-myelom-update-%e2%80%93-tag-1/</loc>
		<lastmod>2010-12-10T15:16:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/12/06/ash-2010-multiples-myelom-update-%e2%80%93-tag-2/</loc>
		<lastmod>2010-12-08T14:20:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/06/06/asco-2010-multiples-myelom-update-%e2%80%93-tag-2/</loc>
		<lastmod>2010-12-08T00:10:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/04/addition-of-defibrotide-to-melphalan-prednisone-thalidomide-combination-produces-fewer-side-effects-in-multiple-myeloma-patients/</loc>
		<lastmod>2010-12-08T00:09:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/08/05/pats-place-a-multiple-myeloma-patients-perception-of-time/</loc>
		<lastmod>2010-12-08T00:05:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/09/02/pats-place-a-patients-reflections-on-the-progress-of-multiple-myeloma-research/</loc>
		<lastmod>2010-12-08T00:05:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/11/16/birds-in-spring-making-the-most-of-these-few-precious-footsteps-while-living-with-multiple-myeloma/</loc>
		<lastmod>2010-12-07T04:09:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/12/02/pats-place-inspiration-from-a-fellow-cancer-survivor/</loc>
		<lastmod>2010-12-02T14:44:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/12/01/beacon-siteupdate-%e2%80%93-physician-columns-to-be-added-to-the-myeloma-beacon/</loc>
		<lastmod>2010-12-01T20:46:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/30/glaxosmithkline-halts-all-further-development-of-resveratrol-drug-srt501/</loc>
		<lastmod>2010-12-01T19:58:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/03/resveratrol-trial-in-multiple-myeloma-suspended-due-to-safety-concerns/</loc>
		<lastmod>2010-11-30T21:19:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/06/suspended-resveratrol-clinical-trial-more-details-emerge/</loc>
		<lastmod>2010-11-30T21:16:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/11/23/langfristige-anschlussergebnisse-zeigen-dass-fur-das-multiple-myelom-die-doppeltransplantation-der-einfachtransplantation-uberlegen-ist/</loc>
		<lastmod>2010-11-29T23:48:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/23/study-measures-effects-of-novel-drugs-on-myeloma-patients-with-chromosomal-abnormalities/</loc>
		<lastmod>2010-11-29T21:56:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/11/08/multitpl-miyelom-asisi-1-evre-klinik-deneylerde-ileri-evre-hastalarda-umit-veren-sonuclar-gostermistir/</loc>
		<lastmod>2010-11-29T16:56:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/11/08/phase-1-studie-mit-impfstoff-gegen-multiples-myelom-liefert-vielversprechende-ergebnisse/</loc>
		<lastmod>2010-11-29T16:56:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/11/25/pats-place-things-im-thankful-for-as-a-multiple-myeloma-patient/</loc>
		<lastmod>2010-11-24T23:21:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/24/turkish-translations-of-myeloma-beacon-articles-now-available/</loc>
		<lastmod>2010-11-24T22:33:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/26/velcade-bortezomib-maintenance-shows-little-improvement-for-multiple-myeloma-patients-who-fail-to-achieve-complete-response-post-stem-cell-transplant/</loc>
		<lastmod>2010-11-24T21:59:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/02/german-translations-of-myeloma-beacon-articles-now-available/</loc>
		<lastmod>2010-11-24T21:55:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/10/07/carfilzomib-in-fda-basvurusu-gecikti/</loc>
		<lastmod>2010-11-24T19:36:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/11/19/fda-xgeva-yi-sadece-kati-tumorler-icin-onayladi-multipl-miyelom-icin-onaylamadi/</loc>
		<lastmod>2010-11-24T19:35:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/10/26/nakil-sonrasi-tam-yanit-vermeyen-miyelom-hastalarinda-sadece-velcade-ile-pekistirme-tedavisi-yetersiz-iyilestirme-gosteriyor/</loc>
		<lastmod>2010-11-24T16:50:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/10/22/bei-neu-diagnostizierten-myelompatienten-ist-die-niedrigere-aredia-dosis-ebenso-wirksam-aber-besser-vertraglich/</loc>
		<lastmod>2010-11-24T16:41:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/2010/09/24/velcade-doxurubicin-dexamethasone-tedavisi-multipl-miyelomdan-kaynaklanan-bobrek-hasarlarini-geriye-dondurebilir/</loc>
		<lastmod>2010-11-24T16:33:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/19/beacon-breakingnews-xgeva-denosumab-prolia-receives-fda-approval-for-bone-disease-in-solid-tumors-but-not-multiple-myeloma/</loc>
		<lastmod>2010-11-20T01:46:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/29/clinical-trials-for-new-form-of-radiotherapy/</loc>
		<lastmod>2010-11-19T13:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/11/18/iph-2101/</loc>
		<lastmod>2010-11-18T21:50:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2010/11/18/national-cancer-institute-national-institutes-of-health/</loc>
		<lastmod>2010-11-18T15:38:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/15/velcade-bortezomib-may-increase-bone-formation-in-multiple-myeloma-patients/</loc>
		<lastmod>2010-11-15T22:25:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/11/11/pats-place-living-the-life-of-an-average-multiple-myeloma-survivor/</loc>
		<lastmod>2010-11-11T15:49:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/10/19/birds-in-spring-confronting-the-initial-diagnosis/</loc>
		<lastmod>2010-11-10T23:20:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/10/beacon-newsflashes-november-10-2010/</loc>
		<lastmod>2010-11-10T22:56:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/16/tandem-autologous-stem-cell-transplantation-compared-to-single-autologous-stem-cell-transplantation/</loc>
		<lastmod>2010-11-09T02:29:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/11/01/detection-of-rapidly-dividing-plasma-cells-may-lead-to-more-targeted-treatment-for-multiple-myeloma-patients/</loc>
		<lastmod>2010-11-05T20:08:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/11/01/entdeckung-sich-schnell-teilender-plasmazellen-kann-zu-einer-gezielten-behandlung-bei-patienten-mit-multiplem-myelom-fuhren/</loc>
		<lastmod>2010-11-05T20:07:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/11/04/pats-place-a-multiple-myeloma-patients-reflections-on-maintenance-therapy/</loc>
		<lastmod>2010-11-04T18:09:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/10/05/seans-burgundy-thread-staying-connected-to-yourself-while-living-with-multiple-myeloma/</loc>
		<lastmod>2010-11-02T14:52:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/22/lower-dose-of-aredia-is-equally-effective-but-better-tolerated-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2010-11-01T21:45:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/09/28/die-einmal-wochentliche-gabe-von-velcade-ist-bei-alteren-myelompatienten-genauso-effektiv-und-besser-vertraglich/</loc>
		<lastmod>2010-11-01T21:39:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/10/28/pats-place-flying-the-friendly-skies-with-multiple-myeloma/</loc>
		<lastmod>2010-10-28T16:11:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/10/21/pats-place-hockey-promotion-gives-hope-to-multiple-myeloma-patients-and-their-families/</loc>
		<lastmod>2010-10-28T15:33:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/20/experts-assess-key-proteins-of-bone-formation-and-degradation-as-prognostic-tools-for-multiple-myeloma-and-myeloma-related-bone-disease/</loc>
		<lastmod>2010-10-22T15:05:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/11/arthrocare-receives-fda-clearance-for-a-new-device-to-treat-spinal-fractures/</loc>
		<lastmod>2010-10-19T21:21:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/18/istodax-achieves-little-response-in-refractory-multiple-myeloma/</loc>
		<lastmod>2010-10-18T21:43:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/10/14/pats-place-we-need-to-be-respectful-of-our-fellow-myeloma-patients-therapy-choices/</loc>
		<lastmod>2010-10-14T18:38:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/12/itraconazole-may-worsen-velcade-induced-side-effects-in-relapsed-multiple-myeloma-patients/</loc>
		<lastmod>2010-10-12T21:33:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/10/07/pats-place-multiple-myeloma-patients-give-yourself-a-break/</loc>
		<lastmod>2010-10-07T14:07:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/23/radiation-therapy-vertebroplasty-and-kyphoplasty-three-treatments-for-myeloma-bone-disease/</loc>
		<lastmod>2010-10-06T15:46:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/10/04/chinese-study-suggests-that-velcade-may-protect-against-blood-clots-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2010-10-05T02:47:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/10/04/milatuzumab/</loc>
		<lastmod>2010-10-05T02:36:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/04/20/dacetuzumab/</loc>
		<lastmod>2010-10-03T03:46:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2009/11/04/cep-18770/</loc>
		<lastmod>2010-10-03T03:23:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/09/30/pats-place-thank-god-for-oncology-multiple-myeloma-nurses/</loc>
		<lastmod>2010-09-30T20:28:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/mozobil/</loc>
		<lastmod>2010-09-28T16:47:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/08/25/die-velcade-dexamethason-therapie-verbessert-die-prognose-von-myelompatienten-mit-der-chromosomalen-abnormitat-t414/</loc>
		<lastmod>2010-09-24T17:05:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/09/23/pats-place-visiting-your-primary-care-physician-is-important/</loc>
		<lastmod>2010-09-23T20:07:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/09/09/pats-place-dealing-with-dexamethasone-side-effects/</loc>
		<lastmod>2010-09-23T14:25:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/22/study-finds-it-is-better-to-dose-velcade-after-melphalan-prior-to-stem-cell-transplantation/</loc>
		<lastmod>2010-09-22T18:58:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/08/31/orale-busulfan-behandlung-vor-stammzelltransplantation-ist-wirksamer-aber-nicht-so-sicher-wie-melphalan-bei-patienten-mit-multiplem-myelom/</loc>
		<lastmod>2010-09-22T13:01:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/25/velcade-dexamethasone-therapy-improves-prognosis-of-multiple-myeloma-patients-with-the-chromosomal-abnormality-t414/</loc>
		<lastmod>2010-09-22T12:54:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/20/the-addition-of-velcade-to-revlimid-dexamethasone-therapy-may-yield-better-prognosis-for-multiple-myeloma-patients-with-certain-chromosomal-abnormalities/</loc>
		<lastmod>2010-09-22T12:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/09/personal-perspective-cancer-inspires-multiple-myeloma-patient-and-wife-to-help-other-cancer-patients/</loc>
		<lastmod>2010-09-21T16:28:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/09/16/pats-place-waiting-and-watching-as-a-multiple-myeloma-patient-is-not-a-death-sentence-its-an-opportunity/</loc>
		<lastmod>2010-09-16T17:09:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/10/cyclophosphamide-low-dose-thalidomide-and-dexamethasone-combination-is-safe-and-effective-for-multiple-myeloma-patients/</loc>
		<lastmod>2010-09-10T16:18:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/09/08/complete-response-with-velcade-melphalan-prednisone-is-associated-with-improved-outcomes-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2010-09-08T14:30:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/09/07/seans-burgundy-thread-making-important-myeloma-connections/</loc>
		<lastmod>2010-09-07T18:40:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/08/26/pats-place-suggestions-to-help-improve-a-multiple-myeloma-patients-quality-of-life/</loc>
		<lastmod>2010-09-02T18:48:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/30/nice-recommends-thalidomide-over-velcade-as-first-line-treatment-for-multiple-myeloma-in-the-u-k/</loc>
		<lastmod>2010-08-30T17:02:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/02/new-four-drug-combination-may-be-effective-and-safe-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2010-08-24T22:23:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/08/02/eine-neue-kombination-aus-vier-medikamenten-erweist-sich-bei-neu-diagnostizierten-myelompatienten-als-wirksam-und-sicher/</loc>
		<lastmod>2010-08-24T22:23:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/22/tanespimycin-development-halted/</loc>
		<lastmod>2010-08-24T22:08:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/07/22/bristol-myers-squibb-stoppt-die-entwicklung-von-tanespimycin/</loc>
		<lastmod>2010-08-24T22:07:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/23/etoposide-is-highly-effective-for-stem-cell-mobilization-in-multiple-myeloma-patients/</loc>
		<lastmod>2010-08-24T19:41:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/20/hycamtin-cyclophosphamide-melphalan-may-be-effective-and-safe-for-multiple-myeloma-patients/</loc>
		<lastmod>2010-08-20T20:10:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/08/19/pats-place-suggestions-from-multiple-myeloma-patients-to-help-us-all-stay-positive/</loc>
		<lastmod>2010-08-19T16:04:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/18/beacon-newsflashes-august-18-2010/</loc>
		<lastmod>2010-08-19T14:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/13/velcade-may-not-be-as-effective-in-relapsed-and-refractory-multiple-myeloma-patients-with-duplications-in-chromosome-1/</loc>
		<lastmod>2010-08-19T14:10:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/08/12/pats-place-the-philosophy-of-dealing-with-side-effects-from-multiple-myeloma-treatment/</loc>
		<lastmod>2010-08-12T21:11:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/30/double-stem-cell-transplant-with-low-dose-and-high-dose-melphalan-is-an-effective-treatment-for-multiple-myeloma/</loc>
		<lastmod>2010-08-12T20:53:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/11/plitidepsin-aplidin-is-not-very-effective-for-multiple-myeloma-but-merits-further-study-in-combination-with-other-treatments/</loc>
		<lastmod>2010-08-11T20:01:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/08/06/neurological-monitoring-may-help-reduce-velcade-induced-nerve-damage-in-multiple-myeloma-patients/</loc>
		<lastmod>2010-08-06T17:54:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/26/thalidomide-interferon-maintenance-therapy-increases-progression-free-survival-time-in-elderly-multiple-myeloma-patients/</loc>
		<lastmod>2010-07-29T15:01:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/07/06/seans-burgundy-thread-you-have-myeloma-welcome-to-little-rock/</loc>
		<lastmod>2010-07-27T20:53:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/25/guide-to-clinical-trials-for-multiple-myeloma-patients-part-6-phils-trial-and-success/</loc>
		<lastmod>2010-07-27T20:52:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/19/heparin-warfarin-and-aspirin-are-equally-effective-in-preventing-blood-clots-in-myeloma-patients-receiving-thalidomide-eha-2010/</loc>
		<lastmod>2010-07-27T16:00:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/19/an-overview-of-myeloma-treatment-options-in-europe-part-4-management-of-side-effects/</loc>
		<lastmod>2010-07-22T19:18:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/05/19/eine-ubersicht-uber-die-behandlungsmoglichkeiten-des-multiplen-myeloms-in-europa-%e2%80%93-teil-4-behandlung-von-nebenwirkungen/</loc>
		<lastmod>2010-07-22T19:18:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/05/10/eine-ubersicht-uber-die-behandlungsmoglichkeiten-des-multiplen-myeloms-in-europa-%e2%80%93-teil-3-behandlungsmoglichkeiten-fur-rezidivierte-patienten/</loc>
		<lastmod>2010-07-22T19:02:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/10/an-overview-of-myeloma-treatment-options-in-europe-%e2%80%93-part-3-treatment-practices-at-relapse/</loc>
		<lastmod>2010-07-22T19:02:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/03/an-overview-of-myeloma-treatment-options-in-europe-part-2-first-line-treatment-practices/</loc>
		<lastmod>2010-07-22T18:51:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/05/03/eine-ubersicht-uber-die-behandlungsmoglichkeiten-des-multiplen-myeloms-in-europa-%e2%80%93-teil-2-therapien-fur-neu-diagnostizierte-patienten/</loc>
		<lastmod>2010-07-22T18:51:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/30/an-overview-of-treatment-options-in-europe-part-1-drug-availability/</loc>
		<lastmod>2010-07-22T18:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/04/30/eine-ubersicht-uber-die-behandlungsmoglichkeiten-des-multiplen-myeloms-in-europa-%e2%80%93-teil-1-verfugbarkeit-von-medikamenten/</loc>
		<lastmod>2010-07-22T18:41:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/07/22/pats-place-encouraging-minorities-with-multiple-myeloma-to-seek-the-best-cancer-care/</loc>
		<lastmod>2010-07-22T17:18:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/07/21/research-shows-no-difference-between-early-and-later-treatment-for-smoldering-asymptomatic-multiple-myeloma/</loc>
		<lastmod>2010-07-22T17:06:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/07/15/pats-place-how-do-others-view-our-cancer-multiple-myeloma/</loc>
		<lastmod>2010-07-15T14:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/24/guide-to-clinical-trials-for-myeloma-patients-part-2-benefits-and-risks-of-clinical-trials/</loc>
		<lastmod>2010-07-14T20:51:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/12/guide-to-clinical-trials-for-myeloma-patients-part-3-myths-and-facts-about-clinical-trials/</loc>
		<lastmod>2010-07-14T20:51:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/21/guide-to-clinical-trials-for-multiple-myeloma-patients-%e2%80%93-part-4-selecting-a-clinical-trial-that-is-right-for-you/</loc>
		<lastmod>2010-07-14T20:50:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/13/beacon-newsflashes-%e2%80%93-january-13-2009/</loc>
		<lastmod>2010-07-12T14:18:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/07/08/pats-place-creating-a-life-plan-budgeting-for-life-with-multiple-myeloma/</loc>
		<lastmod>2010-07-08T20:09:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/06/17/pats-place-planning-for-your-new-life-with-cancer-creating-a-life-plan-and-budget/</loc>
		<lastmod>2010-07-08T16:00:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/07/01/pats-place-creating-a-life-plan-setting-goals/</loc>
		<lastmod>2010-07-06T19:25:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/06/24/pats-place-creating-a-life-plan-identifying-your-priorities/</loc>
		<lastmod>2010-06-25T20:13:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/22/beacon-newsflashes-%e2%80%93-june-22-2010/</loc>
		<lastmod>2010-06-23T15:06:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/06/05/asco-2010-multiples-myelom-update-tag-1/</loc>
		<lastmod>2010-06-16T15:46:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/16/causes-of-and-treatments-for-multiple-myeloma-drug-induced-nerve-damage/</loc>
		<lastmod>2010-06-16T15:39:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/11/beacon-newsflashes-june-11-2010/</loc>
		<lastmod>2010-06-11T15:04:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/13/expert-panel-suggests-management-of-side-effects-to-optimize-thalidomide-treatment-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2010-06-08T19:27:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/06/04/beacon-newsflashes-%e2%80%93-june-4-2010/</loc>
		<lastmod>2010-06-05T02:18:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/06/03/pats-place-dealing-with-vertigo-and-other-treatment-side-effects/</loc>
		<lastmod>2010-06-03T16:20:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/05/27/pats-place-how-do-you-know-which-therapy-is-right-for-you/</loc>
		<lastmod>2010-06-03T16:12:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/15/unresponsiveness-to-revlimid-or-thalidomide-indicates-poor-response-to-stem-cell-transplant-study-finds/</loc>
		<lastmod>2010-06-03T01:40:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/01/international-effort-updates-results-from-multiple-myeloma-stem-cell-transplant-trials/</loc>
		<lastmod>2010-06-03T01:39:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/02/15/studie-zeigt-dass-nichtansprechen-auf-revlimid-oder-thalidomid-mit-schlechtem-ansprechen-auf-stammzelltransplantation-korrespondiert/</loc>
		<lastmod>2010-06-02T20:02:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/03/01/internationales-update-der-resultate-von-stammzelltransplantationsstudien-beim-multiplen-myelom/</loc>
		<lastmod>2010-06-02T20:00:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/2010/02/11/revlimid-cyclophosphamid-prednison-kombination-kann-hochwirksam-fur-patienten-mit-refraktarem-myelom-sein/</loc>
		<lastmod>2010-06-02T19:44:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/26/melphalan-prednisone-thalidomide-combination-shows-anti-myeloma-effects-but-no-survival-benefit-in-elderly-patients/</loc>
		<lastmod>2010-05-26T12:53:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/100-questions-and-answers-about-multiple-myeloma/</loc>
		<lastmod>2010-05-21T12:34:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/05/20/pat%e2%80%99s-place-tips-for-creating-a-winning-health-care-team/</loc>
		<lastmod>2010-05-19T19:54:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/signs-and-symptoms/</loc>
		<lastmod>2010-05-17T19:16:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/who-is-at-risk/</loc>
		<lastmod>2010-05-17T19:15:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/05/14/beacon-newsflashes-may-14-2010/</loc>
		<lastmod>2010-05-14T18:14:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/26/retreatment-with-velcade-as-a-treatment-option-for-relapsed-myeloma-patients/</loc>
		<lastmod>2010-05-14T18:10:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/29/beacon-newsflashes-march-29-2010/</loc>
		<lastmod>2010-05-14T18:07:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/05/13/pat%e2%80%99s-place-joining-a-support-group-saved-my-life-so-why-arent-more-patients-involved/</loc>
		<lastmod>2010-05-14T02:26:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/event-submission-form/</loc>
		<lastmod>2010-05-10T15:35:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/myeloma-the-biology-of-cancer/</loc>
		<lastmod>2010-05-03T15:36:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/multiple-myeloma-the-plain-english-handbook-for-patients-and-care-givers/</loc>
		<lastmod>2010-05-03T15:35:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/living-proof-a-medical-mutiny/</loc>
		<lastmod>2010-05-03T15:34:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/biology-and-management-of-multiple-myeloma-current-clinical-oncology/</loc>
		<lastmod>2010-05-03T15:33:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2010/04/08/living-with-multiple-myeloma-2/</loc>
		<lastmod>2010-05-03T15:32:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/2010/04/29/pats-place-keeping-a-positive-mental-attitude-during-treatment/</loc>
		<lastmod>2010-04-28T18:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/27/elafin-may-be-good-indicator-of-a-common-stem-cell-transplant-complication/</loc>
		<lastmod>2010-04-28T16:35:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/vincristine/</loc>
		<lastmod>2010-04-27T17:11:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/dexamethasone/</loc>
		<lastmod>2010-04-27T16:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/cyclophosphamide/</loc>
		<lastmod>2010-04-27T16:41:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/aredia/</loc>
		<lastmod>2010-04-27T16:36:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/20/revlimid-melphalan-prednisone-thalidomide-combination-is-effective-and-safe-in-relapsedrefractory-myeloma/</loc>
		<lastmod>2010-04-20T17:32:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/12/beacon-newsflashes-%e2%80%93-april-12-2010/</loc>
		<lastmod>2010-04-12T15:17:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/07/addition-of-second-drug-could-dramatically-improve-velcade-response/</loc>
		<lastmod>2010-04-08T21:53:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/08/velcade-doxorubicin-dexamethasone-combination-followed-by-thalidomide-dexamethasone-is-safe-and-effective-in-relapsedrefractory-multiple-myeloma/</loc>
		<lastmod>2010-04-08T15:53:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/31/study-shows-stable-multiple-myeloma-rates-over-the-past-50-years-in-sweden/</loc>
		<lastmod>2010-04-08T15:28:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/06/velcade-thalidomide-dexamethasone-therapy-after-stem-cell-transplant-improves-response-in-multiple-myeloma-patients/</loc>
		<lastmod>2010-04-07T20:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/04/05/beacon-newsflashes-april-5-2010/</loc>
		<lastmod>2010-04-05T15:53:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/03/genetic-risk-factors-and-treatment-history-may-predict-response-in-patients-with-relapsedrefractory-myeloma-study-finds/</loc>
		<lastmod>2010-03-31T16:22:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/03/blood-cancers-forum-focuses-on-importance-of-clinical-trials/</loc>
		<lastmod>2010-03-30T02:58:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/12/new-test-helps-predict-more-specific-prognoses-for-smoldering-myeloma-patients/</loc>
		<lastmod>2010-03-26T19:16:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/26/non-marrow-tumors-increase-among-myeloma-patients-as-survival-and-detection-methods-improve-not-from-use-of-novel-agents/</loc>
		<lastmod>2010-03-26T17:10:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/23/beacon-newsflashes-%e2%80%93-march-23-2010/</loc>
		<lastmod>2010-03-23T16:12:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/19/cyclophosphamide-thalidomide-dexamethasone-combination-is-promising-as-first-line-treatment-for-myeloma-prior-to-stem-cell-transplant/</loc>
		<lastmod>2010-03-19T20:31:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/10/regardless-of-prior-therapies-velcade-is-superior-over-dexamethasone-in-relapsed-multiple-myeloma-patients/</loc>
		<lastmod>2010-03-09T23:25:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/03/05/study-points-to-age-as-significant-risk-factor-for-survival-in-myeloma-patients/</loc>
		<lastmod>2010-03-08T19:51:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/21/thought-leader-perspective-dr-robert-kyle-on-myeloma-treatments-that-require-further-study/</loc>
		<lastmod>2010-03-04T17:59:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/25/thalidomide-as-induction-and-maintenance-therapy-improves-response-rates-in-multiple-myeloma-patients/</loc>
		<lastmod>2010-02-25T19:35:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/08/total-therapy-emerges-as-prospect-for-multiple-myeloma-cure/</loc>
		<lastmod>2010-02-16T18:13:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/01/medicare-expands-coverage-of-off-label-uses-of-cancer-drugs-%e2%80%93-part-2-medicare-approved-compendia/</loc>
		<lastmod>2010-02-12T19:00:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/09/bone-formation-and-degradation-proteins-may-predict-progression-of-multiple-myeloma-and-myeloma-related-bone-disease/</loc>
		<lastmod>2010-02-11T20:11:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/14/thalomid-plus-prednisolone-shown-to-improve-survival-after-asct/</loc>
		<lastmod>2010-02-10T20:25:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/13/celgene-plans-to-seek-approval-of-revlimid-as-an-initial-treatment-for-multiple-myeloma/</loc>
		<lastmod>2010-02-05T17:59:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/02/02/velcade-doxil-dexamethasone-regimen-followed-by-post-transplant-revlimid-may-be-a-highly-effective-treatment-for-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2010-02-02T20:39:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/28/post-transplant-revlimid-therapy-increases-complete-response-rates-in-multiple-myeloma-patients-study-finds-ash-2009/</loc>
		<lastmod>2010-01-29T17:32:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/27/despite-side-effects-high-dose-melphalan-remains-the-most-effective-dosage-in-preparation-for-stem-cell-transplantation/</loc>
		<lastmod>2010-01-27T23:10:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/12/m-csf-may-act-as-powerful-prognostic-factor-for-multiple-myeloma/</loc>
		<lastmod>2010-01-12T19:07:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2010/01/07/fda-approves-velcade%e2%80%99s-data-showing-survival-benefit-in-newly-diagnosed-myeloma-patients/</loc>
		<lastmod>2010-01-07T22:57:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/13/current-information-on-response-criteria-for-multiple-myeloma/</loc>
		<lastmod>2010-01-06T20:13:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/22/revlimid-maintenance-therapy-significantly-extends-disease-free-survival/</loc>
		<lastmod>2009-12-23T02:51:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/lombardi-cancer-center/</loc>
		<lastmod>2009-12-16T18:57:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/yale-cancer-center/</loc>
		<lastmod>2009-12-16T17:42:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/12/08/beacon-newsflashes-december-8-2009/</loc>
		<lastmod>2009-12-08T22:16:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/24/treatment-trends-for-multiple-myeloma-%e2%80%93-part-3-options-for-elderly-multiple-myeloma-patients/</loc>
		<lastmod>2009-11-24T23:04:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/21/torisel-achieves-little-response-in-relapsed-multiple-myeloma-patients/</loc>
		<lastmod>2009-11-23T18:24:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/23/beacon-newsflashes-%e2%80%93-november-23-2009/</loc>
		<lastmod>2009-11-23T17:39:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/18/vitamin-c-inhibits-anti-myeloma-activity-of-velcade/</loc>
		<lastmod>2009-11-20T17:40:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/city-of-hope/</loc>
		<lastmod>2009-11-13T21:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/13/beacon-newsflashes-%e2%80%93-november-13-2009/</loc>
		<lastmod>2009-11-13T20:54:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/12/treatment-trends-for-multiple-myeloma-%e2%80%93-part-2-allogeneic-stem-cell-transplants/</loc>
		<lastmod>2009-11-12T18:10:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/22/revlimid-velcade-dexamethasone/</loc>
		<lastmod>2009-11-12T16:39:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/04/lawsuit-filed-to-overturn-ban-on-payment-for-bone-marrow-donations/</loc>
		<lastmod>2009-11-05T14:19:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/19/study-supports-use-of-kyphoplasty-for-multiple-myeloma-patients/</loc>
		<lastmod>2009-11-04T15:05:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/11/03/treatment-trends-for-multiple-myeloma-%e2%80%93-part-1-autologous-stem-cell-transplants/</loc>
		<lastmod>2009-11-03T22:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/30/beacon-newsflashes-%e2%80%93-october-30-2009/</loc>
		<lastmod>2009-10-30T20:23:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/30/velcade-doxil-dexamethasone-combination-treatment-is-highly-effective-in-newly-diagnosed-multiple-myeloma-patients/</loc>
		<lastmod>2009-10-30T13:57:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/28/thalidomide-improves-outcome-of-double-stem-cell-transplants-in-younger-myeloma-patients/</loc>
		<lastmod>2009-10-28T22:24:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/23/beacon-newsflashes-%e2%80%93-october-23-2009/</loc>
		<lastmod>2009-10-27T16:49:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/23/study-shows-benefits-of-vesselplasty-in-the-treatment-of-spinal-fractures/</loc>
		<lastmod>2009-10-27T15:59:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/15/beacon-newflashes-october-15-2009/</loc>
		<lastmod>2009-10-15T14:45:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/14/new-directory-could-assist-in-myeloma-treatment/</loc>
		<lastmod>2009-10-15T01:30:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/03/beacon-newsflashes-%e2%80%93-june-3-2009/</loc>
		<lastmod>2009-10-13T15:02:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/08/beacon-newsflashes-%e2%80%93-october-8-2009/</loc>
		<lastmod>2009-10-09T02:27:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/07/immune-system-cells-protect-myeloma-cancer-cells-study-finds/</loc>
		<lastmod>2009-10-07T15:24:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/04/timp-1-biomarker-predicts-myeloma-progression-and-survival/</loc>
		<lastmod>2009-10-06T16:40:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/10/02/beacon-newsflashes-%e2%80%93-october-2-2009/</loc>
		<lastmod>2009-10-02T17:14:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/03/scientists-find-a-protein-that-causes-resistance-to-velcade-treatment/</loc>
		<lastmod>2009-10-02T15:57:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/30/taking-vitamin-d-and-calcium-supplements-together-may-prevent-cancer/</loc>
		<lastmod>2009-10-01T02:43:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/25/vitamin-d-may-cause-skeletal-complications/</loc>
		<lastmod>2009-09-30T21:52:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/25/new-study-highlights-myeloma-treatment-infection-risks/</loc>
		<lastmod>2009-09-30T15:29:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/29/second-dose-of-aloxi-further-reduces-chemotherapy-induced-nausea-in-cancer-patients/</loc>
		<lastmod>2009-09-29T19:03:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/23/beacon-breakingnews-clinical-trial-supports-revlimid-as-first-line-therapy-for-myeloma/</loc>
		<lastmod>2009-09-25T01:42:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/23/beacon-newsflashes-%e2%80%93-september-23-2009/</loc>
		<lastmod>2009-09-24T00:26:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/17/thalomide-approved-for-first-line-treatment-in-scotland/</loc>
		<lastmod>2009-09-16T18:33:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/24/clinical-trial-supports-revlimid-as-first-line-therapy-for-myeloma/</loc>
		<lastmod>2009-09-16T18:33:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/12/beacon-newsflashes-%e2%80%93-september-12-2009/</loc>
		<lastmod>2009-09-12T21:33:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/07/fda-to-review-velcade-melphalan-prednisone-regimen/</loc>
		<lastmod>2009-09-09T15:38:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/31/study-shows-toxicity-of-second-transplant-for-myeloma-patients/</loc>
		<lastmod>2009-09-05T05:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/10/shortage-of-clinical-trial-participants-hinders-war-on-cancer/</loc>
		<lastmod>2009-09-03T20:50:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/09/02/macrophages-may-contribute-to-survival-of-myeloma-cells/</loc>
		<lastmod>2009-09-02T21:24:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/08/beacon-newsflashes-%e2%80%93-august-6-2009/</loc>
		<lastmod>2009-08-31T14:43:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/03/beacon-newsflashes-august-3-2009/</loc>
		<lastmod>2009-08-30T00:32:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/30/clinical-cancer-advances-2008/</loc>
		<lastmod>2009-08-28T19:51:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/25/pathologic-fractures-in-bisphosphonate-treated-patients-not-indicative-of-myeloma-progression/</loc>
		<lastmod>2009-08-26T13:04:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/glossary/2008/10/15/glossary/</loc>
		<lastmod>2009-08-23T03:28:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/14/beacon-newsflashes-august-13-2009/</loc>
		<lastmod>2009-08-17T15:46:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/09/beacon-newsflashes-june-9-2009/</loc>
		<lastmod>2009-08-13T21:55:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/08/beacon-newsflashes-%e2%80%93-july-8-2009/</loc>
		<lastmod>2009-08-13T21:55:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/30/beacon-newsflashes-%e2%80%94-june-30-2009/</loc>
		<lastmod>2009-08-13T21:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/28/beacon-newsflashes-%e2%80%93-july-28-2009/</loc>
		<lastmod>2009-08-13T21:50:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/24/beacon-newsflashes-june-24-2009/</loc>
		<lastmod>2009-08-13T21:47:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/21/beacon-newsflashes-%e2%80%93-july-21-2009/</loc>
		<lastmod>2009-08-13T21:46:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/11/high-incidence-of-multiple-myeloma-in-world-trade-center-responders/</loc>
		<lastmod>2009-08-11T19:57:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/08/10/research-shows-velcade%e2%80%99s-possible-mechanism-of-action/</loc>
		<lastmod>2009-08-11T18:33:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/14/novel-therapies-for-myeloma-bone-disease/</loc>
		<lastmod>2009-08-07T17:59:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/09/bisphosphonate-treatment-for-myeloma-bone-disease/</loc>
		<lastmod>2009-08-07T17:58:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/chemotherapy/</loc>
		<lastmod>2009-08-06T01:35:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/29/researchers-sequence-full-multiple-myeloma-genome/</loc>
		<lastmod>2009-08-05T14:31:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/30/clinical-trials-start-for-a-pre-transplant-treatment/</loc>
		<lastmod>2009-07-30T18:46:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/27/dr-sagar-lonial-provides-insight-into-high-risk-myeloma/</loc>
		<lastmod>2009-07-27T20:56:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/29/clinical-trial-shows-ginger-reduces-nausea-in-chemotherapy-patients-asco-2009/</loc>
		<lastmod>2009-07-23T18:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/08/study-examines-quality-of-life-after-stem-cell-transplantation/</loc>
		<lastmod>2009-07-14T22:03:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/11/quality-of-life-warrants-more-consideration-in-multiple-myeloma-treatment-recommendations/</loc>
		<lastmod>2009-07-14T22:00:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/07/07/vegetarians-less-likely-to-develop-multiple-myeloma/</loc>
		<lastmod>2009-07-08T13:07:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/29/beacon-newsflashes-%e2%80%94-april-28-2009/</loc>
		<lastmod>2009-07-06T20:23:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/25/xrcc5-gene-variants-associated-with-greater-blood-clot-risk-during-thalidomide-treatment/</loc>
		<lastmod>2009-06-26T12:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/22/u-k-organization-nice-finalizes-revlimid-therapy-guidelines/</loc>
		<lastmod>2009-06-22T19:24:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/01/deal-brings-revlimid-to-uk-myeloma-patients/</loc>
		<lastmod>2009-06-22T15:18:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/15/beacon-newsflashes-june-15-2009/</loc>
		<lastmod>2009-06-21T14:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/18/canadian-authorities-confiscating-thalidomide-at-border/</loc>
		<lastmod>2009-06-19T16:29:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/17/velcade-plus-dexamethasone-produces-robust-yet-short-lived-response-in-myeloma-patients/</loc>
		<lastmod>2009-06-18T14:35:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/10/revlimid-boosts-immune-system-of-some-myeloma-patients/</loc>
		<lastmod>2009-06-18T14:11:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/prednisone/</loc>
		<lastmod>2009-06-10T18:06:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/02/beacon-newsflashes-%e2%80%93-december-2-2008/</loc>
		<lastmod>2009-06-10T18:04:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/04/pesticide-exposure-linked-to-increased-risk-of-mgus/</loc>
		<lastmod>2009-06-05T12:53:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatments-under-development/2009/06/04/sorafenib-nexavar-sorafenib-tosylate-bay-43-9006/</loc>
		<lastmod>2009-06-04T23:02:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/06/02/expert-panel-recommends-european-approval-of-mozobil/</loc>
		<lastmod>2009-06-02T20:43:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/29/beacon-newsflashes-may-29-2009/</loc>
		<lastmod>2009-05-29T22:33:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/29/mmrf-announces-research-collaboration-with-the-broad-institute/</loc>
		<lastmod>2009-05-29T12:35:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/23/igf-1-an-important-myeloma-growth-factor/</loc>
		<lastmod>2009-05-23T23:40:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/stem-cell-transplants/</loc>
		<lastmod>2009-05-20T18:08:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/18/beacon-newsflashes-may-18-2009/</loc>
		<lastmod>2009-05-19T17:08:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/18/formaldehyde-exposure-linked-to-increased-risk-of-multiple-myeloma/</loc>
		<lastmod>2009-05-18T20:30:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/09/velcade-enhances-standard-chemotherapy-and-increases-patient-response-and-survival/</loc>
		<lastmod>2009-05-16T18:12:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/12/iowa-firefighters-and-police-officers-to-benefit-from-cancer-bill/</loc>
		<lastmod>2009-05-15T02:48:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/13/mozobil-with-neupogen-increases-stem-cell-harvest-efficiency/</loc>
		<lastmod>2009-05-15T00:46:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/13/beacon-newsflashes-%e2%80%93-may-13-2009/</loc>
		<lastmod>2009-05-14T20:49:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/14/myeloma-patients-in-canada-smuggle-low-priced-thalidomide/</loc>
		<lastmod>2009-05-14T20:47:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/16/oregon-firefighters-get-cancer-coverage/</loc>
		<lastmod>2009-05-12T13:47:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/11/durie-salmon-staging-system-and-international-staging-system-compared-in-patients-after-asct/</loc>
		<lastmod>2009-05-11T04:17:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/10/socioeconomic-standing-may-affect-survival-for-swedish-myeloma-patients/</loc>
		<lastmod>2009-05-11T01:37:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/07/study-projects-rising-cancer-rates-in-the-united-states/</loc>
		<lastmod>2009-05-09T15:01:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/30/study-finds-lack-of-evidence-for-link-between-firefighting-and-cancer/</loc>
		<lastmod>2009-05-07T18:58:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/05/05/new-hampshire-legislature-approves-medical-marijuana-bill/</loc>
		<lastmod>2009-05-05T14:23:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/29/the-access-to-cancer-trials-act-of-2009-brought-before-congress/</loc>
		<lastmod>2009-04-30T19:29:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/22/7917/</loc>
		<lastmod>2009-04-29T13:29:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/27/beacon-newsflashes-april-27-2009/</loc>
		<lastmod>2009-04-29T13:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/27/nice-recommends-revlimid-for-multiple-myeloma-patients-in-uk/</loc>
		<lastmod>2009-04-28T18:19:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/06/cylene-pharmaceuticals-begins-phase-i-clinical-trial-with-cx-4945/</loc>
		<lastmod>2009-04-21T02:21:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/18/beacon-newsflashes-%e2%80%93-april-17-2009/</loc>
		<lastmod>2009-04-20T15:59:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/16/gene-identification-could-lead-to-better-treatment-options-for-multiple-myeloma/</loc>
		<lastmod>2009-04-17T17:38:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/22/new-drug-for-preventing-nausea-and-vomiting-during-chemotherapy/</loc>
		<lastmod>2009-04-15T15:45:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/19/part-i-induction-therapy-in-young-multiple-myeloma-patients/</loc>
		<lastmod>2009-04-15T15:41:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/13/7853/</loc>
		<lastmod>2009-04-13T16:55:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/10/beacon-newsflashes-%e2%80%93-april-10-2009/</loc>
		<lastmod>2009-04-11T00:18:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/supportive-care/</loc>
		<lastmod>2009-04-08T14:18:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/07/beacon-newsflashes-%e2%80%93-april-7-2009/</loc>
		<lastmod>2009-04-07T16:43:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/06/tools-for-diagnosing-multiple-myeloma-part-4-specialized-studies/</loc>
		<lastmod>2009-04-06T16:09:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/25/tools-for-diagnosing-multiple-myeloma-part-3-prognostic-evaluation/</loc>
		<lastmod>2009-04-06T16:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/19/tools-for-diagnosing-multiple-myeloma-part-1-diagnostic-evaluation/</loc>
		<lastmod>2009-04-06T15:10:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/14/tools-for-diagnosing-multiple-myeloma-part-2-end-organ-damage-evaluation/</loc>
		<lastmod>2009-04-06T15:06:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/15/medicare-expands-coverage-of-off-label-uses-of-cancer-drugs/</loc>
		<lastmod>2009-04-04T20:14:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/04/growth-in-off-label-drug-use-slows/</loc>
		<lastmod>2009-04-04T20:12:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/04/01/beacon-newsflashes-%e2%80%94-april-2009/</loc>
		<lastmod>2009-04-03T21:42:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/31/new-gene-implicated-in-multiple-myeloma-and-other-cancers/</loc>
		<lastmod>2009-04-01T15:44:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/29/beacon-newsflashes-%e2%80%93-march-29-2008/</loc>
		<lastmod>2009-03-31T13:12:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/30/kennedy-renews-war-on-cancer/</loc>
		<lastmod>2009-03-31T02:23:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/30/the-mmrf-marathon-and-half-marathon-program-seeks-runners/</loc>
		<lastmod>2009-03-30T16:17:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/26/genetic-blood-tests-could-soon-identify-multiple-myeloma-and-other-disorders/</loc>
		<lastmod>2009-03-28T16:32:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/27/beacon-newsflashes-march-27-2009/</loc>
		<lastmod>2009-03-27T22:56:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/25/beacon-newsflashes-%e2%80%93-march-25-2009/</loc>
		<lastmod>2009-03-27T18:47:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/23/beacon-newsflashes-%e2%80%93-march-23-2009/</loc>
		<lastmod>2009-03-24T21:31:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/21/beacon-newsflashes-%e2%80%93-march-21-2009/</loc>
		<lastmod>2009-03-21T15:07:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/20/scotland-expected-to-improve-patient-access-to-new-cancer-therapies/</loc>
		<lastmod>2009-03-20T16:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/16/beacon-newsflashes-march-16-2009/</loc>
		<lastmod>2009-03-16T17:45:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/14/beacon-newsflashes-march-14-2009/</loc>
		<lastmod>2009-03-14T22:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/10/beacon-newsflashes-march-10-2009/</loc>
		<lastmod>2009-03-10T15:16:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/08/current-information-on-risk-statification-in-multiple-myeloma/</loc>
		<lastmod>2009-03-09T17:14:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/09/beacon-newsflashes-%e2%80%93-march-9-2009/</loc>
		<lastmod>2009-03-09T15:22:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/06/beacon-newsflashes-march-6-2009/</loc>
		<lastmod>2009-03-07T02:11:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/01/beacon-newsflashes-march-1-2009/</loc>
		<lastmod>2009-03-04T19:31:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/04/the-mmrf-awards-1-million-for-promising-early-stage-drug-development/</loc>
		<lastmod>2009-03-04T16:16:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/03/02/beacon-newsflashes-%e2%80%93-march-2-2009/</loc>
		<lastmod>2009-03-03T20:55:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/27/new-myeloma-drugs-target-different-mechanisms-of-action-cell-surface-receptors/</loc>
		<lastmod>2009-02-28T02:21:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/27/current-information-on-staging-multiple-myeloma/</loc>
		<lastmod>2009-02-27T23:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/26/canadian-survey-highlights-myeloma-awareness-and-access-to-treatment/</loc>
		<lastmod>2009-02-26T19:54:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/25/beacon-newsflashes-february-24-2009/</loc>
		<lastmod>2009-02-26T17:54:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/23/beacon-newsflashes-february-23-2009/</loc>
		<lastmod>2009-02-24T03:30:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/21/physicians-perform-first-bone-marrow-transplant-at-public-hospital-in-west-bengal-india/</loc>
		<lastmod>2009-02-21T18:35:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/21/health-care-associated-mrsa-in-decline/</loc>
		<lastmod>2009-02-21T18:22:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/09/leukemia-lymphoma-society-and-women%e2%80%99s-running-magazine-join-forces-to-launch-new-women%e2%80%99s-half-marathon/</loc>
		<lastmod>2009-02-20T22:00:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/19/clarifications-and-updates-in-diagnosis-criteria-of-multiple-myeloma/</loc>
		<lastmod>2009-02-20T13:33:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/18/beacon-newsflashes-february-18-2009/</loc>
		<lastmod>2009-02-19T01:52:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/15/mmrf-and-lls-grant-500000-for-study-of-the-multiple-myeloma-stem-cell/</loc>
		<lastmod>2009-02-15T18:11:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/13/long-term-survival-estimates-increase-for-young-multiple-myeloma-patients/</loc>
		<lastmod>2009-02-15T03:05:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/13/the-american-society-of-clinical-oncology-provides-a-financial-guide-to-cancer-care/</loc>
		<lastmod>2009-02-14T03:09:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/12/researchers-identify-novel-tumor-feeding-mechanism/</loc>
		<lastmod>2009-02-12T19:47:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/30/fruits-and-vegetables-do-not-decrease-risk-of-multiple-myeloma/</loc>
		<lastmod>2009-02-12T19:45:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/11/beacon-newsflashes-february-11-2009-2/</loc>
		<lastmod>2009-02-12T04:11:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/11/beacon-newsflashes-february-11-2009/</loc>
		<lastmod>2009-02-12T04:07:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/09/regulations-and-the-rising-cost-of-cancer-drugs/</loc>
		<lastmod>2009-02-09T17:06:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/06/mmrf-is-the-official-charity-of-the-rite-aid-cleveland-5k/</loc>
		<lastmod>2009-02-08T02:43:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/06/beacon-newsflashes-february-6-2009/</loc>
		<lastmod>2009-02-06T16:39:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/04/beacon-newsflashes-february-4-2009/</loc>
		<lastmod>2009-02-05T15:21:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/02/beacon-newsflashes-%e2%80%93-february-2-2009/</loc>
		<lastmod>2009-02-03T05:06:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/02/01/beacon-newsflashes-february-1-2009/</loc>
		<lastmod>2009-02-02T23:34:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/06/nice-to-expand-access-to-drugs-for-terminally-ill/</loc>
		<lastmod>2009-02-02T16:22:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/28/fjc-awards-1-million-grant-to-institute-for-myeloma-and-bone-cancer-research/</loc>
		<lastmod>2009-01-30T23:07:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/29/beacon-newsflashes-%e2%80%93-january-28-2008/</loc>
		<lastmod>2009-01-30T19:21:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/26/beacon-newsflashes-%e2%80%93-january-26-2009/</loc>
		<lastmod>2009-01-27T17:43:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/22/chemical-used-in-rubber-synthesis-increases-risk-of-myeloma/</loc>
		<lastmod>2009-01-24T22:04:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/21/beacon-newsflashes-%e2%80%93-january-21-2009/</loc>
		<lastmod>2009-01-23T20:30:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/20/multiple-myeloma-treatment-approaches-and-objectives/</loc>
		<lastmod>2009-01-21T00:52:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/20/phase-iii-zolinzavorinostatvelcadebortezomib-trial-opening-soon/</loc>
		<lastmod>2009-01-20T19:35:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/19/new-clinical-trials-combine-zolinza-and-velcade-for-multiple-myeloma-treatment/</loc>
		<lastmod>2009-01-20T19:18:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/17/induction-therapy-in-elderly-multiple-myeloma-patients/</loc>
		<lastmod>2009-01-20T17:34:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/19/beacon-newsflashes-january-19-2009/</loc>
		<lastmod>2009-01-20T01:40:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/15/how-to-manage-steroid-related-side-effects-in-myeloma-patients/</loc>
		<lastmod>2009-01-19T20:34:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/09/beacon-newsflashes-%e2%80%93-january-9-2009/</loc>
		<lastmod>2009-01-15T14:37:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/05/bisphosphonates-increase-risk-of-esophageal-cancer-and-jaw-complications/</loc>
		<lastmod>2009-01-14T20:19:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/31/beacon-newsflashes-december-30-2008/</loc>
		<lastmod>2009-01-09T22:38:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/06/vorinostat-shows-potential-as-first-drug-in-new-class-of-anti-cancer-agents/</loc>
		<lastmod>2009-01-09T22:04:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2009/01/05/beacon-newflashes-%e2%80%93-january-5-2009/</loc>
		<lastmod>2009-01-08T21:20:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/07/phase-iii-trials-of-hsp90-inhibitors-in-cancer-patients-underway/</loc>
		<lastmod>2009-01-07T22:59:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/19/genzyme%e2%80%99s-mozobil-improves-transplantation-therapies/</loc>
		<lastmod>2009-01-07T22:56:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/30/cancer-drugs-to-cost-more-under-medicare-plans/</loc>
		<lastmod>2009-01-01T21:04:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/05/beacon-newsflashes-december-5-2008/</loc>
		<lastmod>2008-12-31T22:02:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/14/beacon-newsflashes-november-14-2008/</loc>
		<lastmod>2008-12-22T16:25:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/27/parade-in-new-zealand-to-benefit-families-living-with-multiple-myeloma/</loc>
		<lastmod>2008-12-22T16:21:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/20/february-16-2009-an-evening-with-diana-krall-fundraiser/</loc>
		<lastmod>2008-12-21T04:00:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/16/beacon-newsflashes-december-16-2008/</loc>
		<lastmod>2008-12-16T19:15:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/12/beacon-newsflashes-december-12-2008/</loc>
		<lastmod>2008-12-12T18:49:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/10/multiple-myeloma-research-consortium-announces-center-of-the-year/</loc>
		<lastmod>2008-12-11T00:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/12/06/outpatient-stem-cell-transplant-for-multiple-myeloma/</loc>
		<lastmod>2008-12-07T04:45:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/2008/11/29/holiday-party-in-las-vegas-to-benefit-the-leukemia-lymphoma-society/</loc>
		<lastmod>2008-12-01T18:14:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/abramson-cancer-center-of-the-university-of-pennsylvania/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/kimmel-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-pittsburgh-medical-center-upmc-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-johns-hopkins-oncology-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/arizona-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/chao-family-comprehensive-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/jonsson-comprehensive-cancer-center-at-ucla/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/uc-davis-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-california-san-diego-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-california-san-francisco-comprehensive-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/uscnorris-comprehensive-cancer-center-and-hospital/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/h-lee-moffitt-cancer-center-research-institute/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/indiana-university-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-holden-comprehensive-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/barbara-ann-karmanos-cancer-institute/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-michigan-comprehensive-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-minnesota-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/siteman-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/unmc-eppley-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/norris-cotton-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/cancer-research-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/herbert-irving-comprehensive-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/memorial-sloan-kettering-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/roswell-park-cancer-institute/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/ireland-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/fox-chase-cancer-center-2/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/st-jude-childrens-research-hospital/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-vanderbilt-ingram-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/san-antonio-cancer-institute/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-university-of-texas-m-d-anderson-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/vermont-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/massey-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/the-cancer-center-at-the-university-of-virginia/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/fred-hutchinson-cancer-research-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/2008/10/15/university-of-wisconsin-comprehensive-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/quadramet/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/cancer-treatment-centers-of-america/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/cancer-treatment-centers-of-america-2/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/cancer-treatment-centers-of-america-3/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/cancer-treatment-centers-of-america-4/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/cleveland-clinic/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/2008/10/15/stanford-cancer-center/</loc>
		<lastmod>2008-10-15T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/abs/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/abs/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/abs/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/abs/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/announce/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2013/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2015/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/ash2016/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/books/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/events/conferences/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/deutsch/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/eha2013/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/espanol/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/featured/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/events/fundraisers/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/glossary/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/headline/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/holiday/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/mtgs/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/ct/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/pr/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/myeloma-specialists/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/news/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/opinion/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/events/seminarsworkshops/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/events/support-groups-events/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatment-centers/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatments-resources/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/resources/treatments-under-development/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/turkce/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/thumper1/</loc>
		<lastmod>2018-06-06T14:04:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/katherinegoodman/</loc>
		<lastmod>2019-08-24T20:25:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/jessicalangholtz/</loc>
		<lastmod>2020-07-07T11:39:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/rachelyu/</loc>
		<lastmod>2013-12-31T22:26:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/amritapurohit/</loc>
		<lastmod>2017-02-01T04:07:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/joannamandecki/</loc>
		<lastmod>2017-12-25T15:36:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/laurenwang/</loc>
		<lastmod>2020-07-07T11:39:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/minglu/</loc>
		<lastmod>2012-05-26T02:21:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/emilycole/</loc>
		<lastmod>2013-01-18T18:36:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/michaelsalgado/</loc>
		<lastmod>2013-11-21T15:10:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/borissimkovich/</loc>
		<lastmod>2020-08-06T03:43:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/brianpan/</loc>
		<lastmod>2011-04-12T14:00:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/julieshilane/</loc>
		<lastmod>2020-07-07T11:38:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/myelomabeaconstaff/</loc>
		<lastmod>2020-07-07T11:37:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/christenbrandt/</loc>
		<lastmod>2009-09-16T18:33:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/edsuczewski/</loc>
		<lastmod>2009-02-21T18:22:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/kristenoconnor/</loc>
		<lastmod>2017-12-25T15:27:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/maikehaehle/</loc>
		<lastmod>2020-07-15T14:51:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/dorothyahn/</loc>
		<lastmod>2009-06-22T18:18:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/sophiaahn/</loc>
		<lastmod>2017-12-25T15:25:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/francie-diep/</loc>
		<lastmod>2018-10-09T18:51:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/julie-karceski/</loc>
		<lastmod>2020-07-07T11:39:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/alyssa-liguori/</loc>
		<lastmod>2018-05-30T16:33:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/lisa-stefany/</loc>
		<lastmod>2018-05-30T16:33:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/saniya-tabani/</loc>
		<lastmod>2017-12-25T16:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/gillian-losh/</loc>
		<lastmod>2011-04-27T20:07:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/funmi-adewale/</loc>
		<lastmod>2020-07-07T11:39:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/norell-hadzimichalis/</loc>
		<lastmod>2011-04-26T18:11:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/kate-keets/</loc>
		<lastmod>2013-11-01T00:33:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/beacon-staff/</loc>
		<lastmod>2012-06-12T21:32:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/garyblau/</loc>
		<lastmod>2011-05-17T18:51:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/pat-killingsworth/</loc>
		<lastmod>2020-07-07T11:39:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/dr-bijay-nair/</loc>
		<lastmod>2011-10-28T15:46:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/boris-simkovich/</loc>
		<lastmod>2019-09-04T19:07:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/christine-mclaren/</loc>
		<lastmod>2014-02-13T20:27:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/jessica-kendra/</loc>
		<lastmod>2015-07-14T00:44:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/sean-murray/</loc>
		<lastmod>2019-05-12T10:59:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/melissa-cobleigh/</loc>
		<lastmod>2020-07-07T11:38:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/michelle-spektor/</loc>
		<lastmod>2020-03-02T21:32:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/lou-ganim/</loc>
		<lastmod>2018-05-30T16:32:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/carole-g/</loc>
		<lastmod>2013-02-11T22:08:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/buffalopat/</loc>
		<lastmod>2019-04-24T13:32:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/habubrat/</loc>
		<lastmod>2012-03-07T16:25:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/vincent-rajkumar/</loc>
		<lastmod>2020-07-07T11:38:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/howard-chang/</loc>
		<lastmod>2020-07-07T11:37:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/jim-omel/</loc>
		<lastmod>2011-02-07T22:05:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/arnold-goodman/</loc>
		<lastmod>2016-06-02T14:35:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/dr-david-vesole/</loc>
		<lastmod>2020-07-07T11:28:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/deborah-dietzler/</loc>
		<lastmod>2013-03-26T18:03:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/gavin-mcstay/</loc>
		<lastmod>2018-05-30T16:32:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/david-roodman/</loc>
		<lastmod>2012-08-24T16:15:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/david-mitchell/</loc>
		<lastmod>2011-10-26T17:14:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/virginia-li/</loc>
		<lastmod>2020-06-10T16:06:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/kevin-jones/</loc>
		<lastmod>2018-05-30T16:31:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/stephen-kramer/</loc>
		<lastmod>2014-04-26T17:56:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/nancy-shamanna/</loc>
		<lastmod>2020-11-20T23:47:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/sruti-krishna/</loc>
		<lastmod>2018-10-30T11:38:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/navneet-ramesh/</loc>
		<lastmod>2020-07-07T11:37:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/mohr-steve/</loc>
		<lastmod>2018-05-17T18:42:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/april-nelson/</loc>
		<lastmod>2020-06-02T21:57:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/karen-crowley/</loc>
		<lastmod>2018-05-17T17:49:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/david-willson/</loc>
		<lastmod>2013-06-24T18:59:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/emma-blake/</loc>
		<lastmod>2014-09-04T21:59:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/ilene-levy/</loc>
		<lastmod>2013-12-23T19:00:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/mike-burns/</loc>
		<lastmod>2014-04-25T22:33:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/paul-jakubowski/</loc>
		<lastmod>2014-06-07T00:11:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/ravi-vij/</loc>
		<lastmod>2020-07-07T11:28:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/tabitha-burns/</loc>
		<lastmod>2020-10-10T11:32:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/andrew-gordon/</loc>
		<lastmod>2019-04-24T14:38:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/tom-shell/</loc>
		<lastmod>2019-05-12T23:36:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/gareth-morgan/</loc>
		<lastmod>2015-01-15T20:49:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/merle-goodman/</loc>
		<lastmod>2015-01-20T17:31:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/maureen-nuckols/</loc>
		<lastmod>2020-07-07T11:27:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/trevor-williams/</loc>
		<lastmod>2019-04-24T14:41:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/mark-pouley/</loc>
		<lastmod>2019-08-15T20:59:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/marjorie-smith/</loc>
		<lastmod>2020-04-16T22:23:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/clinical-trial-reporter/</loc>
		<lastmod>2019-04-02T15:22:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/press-release-reporter/</loc>
		<lastmod>2020-11-20T13:29:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/mark-pajak/</loc>
		<lastmod>2020-11-26T00:19:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/albert-vetere-lannon/</loc>
		<lastmod>2020-07-07T11:34:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/else-sokol/</loc>
		<lastmod>2020-10-21T23:14:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/author/marilyn-page/</loc>
		<lastmod>2020-07-07T11:33:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/2016-asco-jahrestagung/</loc>
		<lastmod>2016-07-14T15:04:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/a-northwest-lens-on-myeloma/</loc>
		<lastmod>2019-08-15T16:56:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/abcb1/</loc>
		<lastmod>2013-02-11T17:02:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/abscopal-effect/</loc>
		<lastmod>2016-04-24T18:52:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/abt-199/</loc>
		<lastmod>2016-06-09T14:37:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ace-011/</loc>
		<lastmod>2011-10-19T12:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/acetylon/</loc>
		<lastmod>2012-02-20T15:07:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/actimab-m/</loc>
		<lastmod>2017-02-07T08:00:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/actimid/</loc>
		<lastmod>2010-12-07T15:37:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/activin/</loc>
		<lastmod>2011-09-23T15:46:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/activin-a/</loc>
		<lastmod>2012-04-16T12:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/acy-1215/</loc>
		<lastmod>2015-12-07T10:00:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/adriamycin/</loc>
		<lastmod>2013-07-31T14:29:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/advanced-multiple-myeloma/</loc>
		<lastmod>2018-05-09T11:29:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/aeterna-zentaris/</loc>
		<lastmod>2013-03-11T17:25:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/afinitor/</loc>
		<lastmod>2012-09-26T11:37:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/african-american/</loc>
		<lastmod>2016-05-10T08:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/afuresertib/</loc>
		<lastmod>2013-12-13T21:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ago2/</loc>
		<lastmod>2016-05-06T16:47:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/al102/</loc>
		<lastmod>2018-12-20T08:45:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/alcohol-consumption/</loc>
		<lastmod>2013-08-26T16:04:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/alert-act/</loc>
		<lastmod>2009-03-30T21:13:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/alkeran/</loc>
		<lastmod>2014-06-26T13:06:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/allo-715/</loc>
		<lastmod>2020-01-13T06:00:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/allogene-stammzelltransplantation/</loc>
		<lastmod>2016-05-16T16:39:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/allogene-transplantation/</loc>
		<lastmod>2016-04-11T09:34:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/allogeneic-cellular-therapies/</loc>
		<lastmod>2020-11-17T20:00:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/allogeneic-stem-cell-transplant/</loc>
		<lastmod>2019-08-13T17:36:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/aloxi/</loc>
		<lastmod>2009-09-29T14:03:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/alpha-1-acid-glycoprotein/</loc>
		<lastmod>2013-12-24T11:47:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/alt-801/</loc>
		<lastmod>2012-08-23T14:17:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/altere-patienten/</loc>
		<lastmod>2018-10-19T15:49:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/alvocidib/</loc>
		<lastmod>2012-12-10T13:18:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/american-cancer-society/</loc>
		<lastmod>2008-11-01T13:00:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/american-society-of-clinical-oncology/</loc>
		<lastmod>2009-02-13T21:22:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/american-society-of-hematology/</loc>
		<lastmod>2009-11-06T15:45:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amg-420/</loc>
		<lastmod>2016-09-01T09:00:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amgen/</loc>
		<lastmod>2013-08-26T12:41:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amifostine/</loc>
		<lastmod>2013-06-14T18:13:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amiloidosis/</loc>
		<lastmod>2013-02-11T11:10:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amitriptyline/</loc>
		<lastmod>2013-05-31T06:49:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amrubicin/</loc>
		<lastmod>2012-12-12T14:57:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amyloidose/</loc>
		<lastmod>2012-05-10T18:01:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/amyloidosis/</loc>
		<lastmod>2013-04-29T14:07:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anemia/</loc>
		<lastmod>2011-05-23T14:54:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ang-2/</loc>
		<lastmod>2013-01-28T14:33:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/angiopoietin/</loc>
		<lastmod>2011-04-25T11:19:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anomalias-cromosomicas/</loc>
		<lastmod>2013-04-15T14:06:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/antabuse/</loc>
		<lastmod>2012-02-20T15:07:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anti-cd137/</loc>
		<lastmod>2008-11-06T11:07:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anti-pd-l-1-therapies/</loc>
		<lastmod>2018-12-12T07:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anti-pd-l1-therapies/</loc>
		<lastmod>2019-10-02T17:33:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anti-pd-l1-therapien/</loc>
		<lastmod>2019-10-08T15:29:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anti-tigit-therapies/</loc>
		<lastmod>2019-10-02T17:33:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/anti-tigit-therapien/</loc>
		<lastmod>2019-10-08T15:29:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/antibody-drug-conjugates/</loc>
		<lastmod>2020-08-26T14:06:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/antikorper-wirkstoff-konjugat/</loc>
		<lastmod>2019-10-01T11:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/aplidin/</loc>
		<lastmod>2018-12-11T02:10:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/apo010/</loc>
		<lastmod>2016-03-10T10:42:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/april/</loc>
		<lastmod>2018-08-22T16:01:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ar-42/</loc>
		<lastmod>2012-12-10T13:18:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/aredia/</loc>
		<lastmod>2015-05-31T09:18:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/argonaut-2/</loc>
		<lastmod>2016-07-01T17:40:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/argonaute-2/</loc>
		<lastmod>2016-05-06T16:47:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/arnies-rebounding-world/</loc>
		<lastmod>2015-01-20T12:18:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/arno-therapeutics/</loc>
		<lastmod>2010-06-22T12:54:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/array-biopharma/</loc>
		<lastmod>2010-12-10T15:53:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/arry-520/</loc>
		<lastmod>2013-12-24T11:47:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/arsenic-trioxide/</loc>
		<lastmod>2013-02-25T12:20:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/arterial-thromboembolism/</loc>
		<lastmod>2012-05-09T13:06:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/artesunate/</loc>
		<lastmod>2014-07-12T14:41:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2009-meeting/</loc>
		<lastmod>2009-06-02T12:27:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2010-daily-update/</loc>
		<lastmod>2010-06-08T17:01:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2010-jahrestreffen/</loc>
		<lastmod>2010-06-08T17:01:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2010-meeting/</loc>
		<lastmod>2010-06-29T08:17:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2011-daily-update/</loc>
		<lastmod>2011-06-08T18:13:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2011-jahrestreffen/</loc>
		<lastmod>2011-06-06T15:49:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2011-meeting/</loc>
		<lastmod>2011-06-10T14:01:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2012-daily-update/</loc>
		<lastmod>2012-06-05T21:13:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2012-meeting/</loc>
		<lastmod>2012-07-27T11:32:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2013-daily-update/</loc>
		<lastmod>2013-06-06T11:06:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2013-jahrestreffen/</loc>
		<lastmod>2013-06-13T21:38:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2013-meeting/</loc>
		<lastmod>2013-06-21T17:22:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2014-daily-update/</loc>
		<lastmod>2014-06-14T21:59:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2014-jahrestreffen/</loc>
		<lastmod>2014-06-12T18:29:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2014-meeting/</loc>
		<lastmod>2014-06-14T21:59:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2015-daily-update/</loc>
		<lastmod>2015-06-07T13:15:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2015-jahrestagung/</loc>
		<lastmod>2015-06-14T16:27:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2015-meeting/</loc>
		<lastmod>2015-06-25T15:02:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2016-daily-update/</loc>
		<lastmod>2016-06-15T15:33:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2016-meeting/</loc>
		<lastmod>2016-06-15T15:33:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2018-jahrestagung/</loc>
		<lastmod>2018-06-22T09:57:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2018-meeting/</loc>
		<lastmod>2018-06-20T21:55:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/asco-2018-meeting-update/</loc>
		<lastmod>2018-06-04T15:34:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2008-meeting/</loc>
		<lastmod>2008-12-26T20:15:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2009-meeting/</loc>
		<lastmod>2010-02-23T15:32:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2010-daily-update/</loc>
		<lastmod>2010-12-09T15:15:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2010-meeting/</loc>
		<lastmod>2011-01-11T16:51:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2010-toplantisi/</loc>
		<lastmod>2011-01-10T16:19:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2011-daily-update/</loc>
		<lastmod>2011-12-21T17:56:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2011-meeting/</loc>
		<lastmod>2012-02-10T11:28:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2012-daily-update/</loc>
		<lastmod>2012-12-13T08:46:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2012-meeting/</loc>
		<lastmod>2013-01-22T14:35:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-2-dg/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-abc294640/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-abt-199/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-abt-737/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-acy-1215/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-afuresertib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-allogeneic-transplantation/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-amd3100/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-amyloidosis/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-animal-models/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-arry-520/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-artesunate/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-at7519m/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-autologous-transplantation/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-b-ap15/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-bc2059/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-bendamustine/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-bi-505/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-biomarkers/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-bisphosphonates/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-bone-disease/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-bortezomib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-bp-4-018/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-brondomain-inhibitors/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-busulfan/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-byl917/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-carfilzomib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-cc-122/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-cc-223/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-cereblon/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-chromosomal-abnormalities/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-clarithromycin/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-clinical-trial-results/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-consolidation-therapy/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-cx-5461/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-cyclophosphamide/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-daily-update/</loc>
		<lastmod>2013-12-11T18:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-daratumumab/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-dexamethasone/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-doxorubicin/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-doxorubicin-liposomal/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-ds-5272/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-extramedullary-disease/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-filanesib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-filgrastim/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-fludarabine/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-g-csf/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-gdc0941/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-gemcitabine/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-gene-expression-profiling/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-gsk-j4/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-hdac-inhibitors/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-hsp-inhibitors/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-i-bet151/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-i-bet762/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-imaging/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-immucin/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-immunoglobulin-g/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-immunomodulatory-agents/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-indatuximab-ravtansine/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-infection/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-iph-2101/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-ixazomib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-jahrestagung/</loc>
		<lastmod>2014-01-13T15:43:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-kidney-failure/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-kpt330/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-ksp-inhibitors/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-kw-2478/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-lcl161/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-lenalidomide/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-lgh447/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-maintenance-therapy/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-meeting/</loc>
		<lastmod>2014-02-10T15:38:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-meeting-abstract/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-melphalan/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-metformin/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-mgus/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-minimal-residual-disease/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-monoclonal-antibodies/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-new-therapies/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-nox-a12/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-olaptesed-pegol/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-oprozomib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-osteonecrosis-of-the-jaw/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-pamidronate/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-panobinostat/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-pat-sm6/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-perifosine/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-pim-kinase-inhibitors/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-plasma-cell-leukemia/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-plerixafor/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-pomalidomide/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-pralatrexate/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-preclinical-research/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-prednisone/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-preview/</loc>
		<lastmod>2013-12-05T10:15:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-prevnar/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-proteasome-inhibitors/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-quality-of-life/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-quisinostat/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-reolysin/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-reovirus/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-ricolinostat/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-ritonavir/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-sar650984/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-scientific-program/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-secondary-cancer/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-selinexor/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-shikonin/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-sl-401/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-smoldering-myeloma/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-sns01-t/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-solitary-plasmacytoma/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-stem-cell-mobilization/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-survival/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-tadalafil/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-tas-116/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-tg0054-03/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-tg02/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-tgr1202/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-th-302/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-thalidomide/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-thioredoxin/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-tivantinib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-tm-233/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-transplantation/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-unc1062/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-veliparib/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-vorinostat/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-vs-5584/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-waldenstroms-macroglobulinemia/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-ym155/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-ys110/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2013-zoledronic-acid/</loc>
		<lastmod>2013-11-07T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2014-daily-update/</loc>
		<lastmod>2014-12-10T15:12:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2014-jahrestagung/</loc>
		<lastmod>2014-12-17T11:44:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2014-meeting/</loc>
		<lastmod>2014-12-10T15:12:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2014-preview/</loc>
		<lastmod>2014-12-05T07:41:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-allogeneic-transplantation/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-autologous-transplantation/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-bendamustine/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-bortezomib/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-carfilzomib/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-daratumumab/</loc>
		<lastmod>2016-05-26T11:25:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-elotuzumab/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-filanesib/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-hdac-inhibitors/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-isatuximab/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-ixazomib/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-lenalidomide/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-maintenance-therapy/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-marizomib/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-meeting-abstract/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-mgus/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-minimal-residual-disease/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-mor202/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-new-therapies/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-oral-presentation-abstract/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-panobinostat/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-pembrolizumab/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-pomalidomide/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-poster-presentation-abstract/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-proteasome-inhibitors/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-ricolinostat/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-selinexor/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6169/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6178/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6196/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6494/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6498/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6499/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6503/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6506/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6513/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6517/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6538/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6539/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6540/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6544/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6545/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6546/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6547/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6548/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6549/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6550/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6552/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6553/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6554/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6598/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6609/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6610/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6635/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6663/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6664/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6665/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6666/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6667/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6668/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6669/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6670/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6675/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6677/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6683/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6686/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6688/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6693/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6694/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6699/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6700/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6701/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6702/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6714/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6715/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6717/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6718/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6732/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6736/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6750/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6760/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6772/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6775/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6776/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6777/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6783/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6787/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6788/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6790/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6791/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6793/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6794/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6795/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6796/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6813/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6814/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6815/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6835/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6836/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6837/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6838/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6839/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6841/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6846/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6847/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6848/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6849/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6851/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6852/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6853/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6854/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6855/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6856/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6857/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6858/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6860/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6861/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6862/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6864/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-session-6865/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-smoldering-multiple-myeloma/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-transplantation/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-venetoclax/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2015-vorinostat/</loc>
		<lastmod>2015-11-05T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-allogeneic-transplantation/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-autologous-transplantation/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-bendamustine/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-biomarkers/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-bisphosphonates/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-bortezomib/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-car-t-cell-therapies/</loc>
		<lastmod>2018-11-05T08:00:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-carfilzomib/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-chromosomal-abnormalities/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-clinical-trial-results/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-consolidation-therapy/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-cyclophosphamide/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-daratumumab/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-disease-biology/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-edo-s101/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-elotuzumab/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-gene-expression-profiling/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-hdac-inhibitors/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-immunomodulatory-agents/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-isatuximab/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-ixazomib/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-lenalidomide/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-maintenance-therapy/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-marizomib/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-meeting-abstract/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-melphalan/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-mgus/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-minimal-residual-disease/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-monoclonal-antibodies/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-mor202/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-new-therapies/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-oral-presentation-abstract/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-panobinostat/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-pembrolizumab/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-plasma-cell-leukemia/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-plerixafor/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-pomalidomide/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-poster-presentation-abstract/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-preclinical-research/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-prednisone/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-prognosis-survival/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-proteasome-inhibitors/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-selinexor/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8527/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8644/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8676/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8711/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8751/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8752/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8753/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8754/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8755/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8756/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8757/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8758/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8759/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8766/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8768/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8773/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8780/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8781/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8782/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8793/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8794/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8795/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8796/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8798/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8799/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8801/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8802/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8806/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8808/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8809/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8810/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8811/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8812/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8815/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8822/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8837/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8848/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8850/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8859/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8862/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8863/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8864/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8866/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8868/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8870/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8872/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8874/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8875/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8876/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8935/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8937/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8949/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8964/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8966/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8967/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8978/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8982/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-8993/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9013/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9014/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9015/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9016/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9017/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9018/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9022/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9023/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9024/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9026/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9027/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9028/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9029/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9030/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9031/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9032/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9035/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9036/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9038/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9039/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9042/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-session-9043/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-smoldering-multiple-myeloma/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-stem-cell-mobilization/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-thalidomide/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-transplantation/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ash-2016-venetoclax/</loc>
		<lastmod>2016-11-03T09:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/aspartame/</loc>
		<lastmod>2012-11-21T12:37:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/aspirin/</loc>
		<lastmod>2013-09-11T14:35:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/at7519/</loc>
		<lastmod>2010-08-18T08:57:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/at7519m/</loc>
		<lastmod>2013-12-08T17:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/at9283/</loc>
		<lastmod>2010-11-10T17:34:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/atezolizumab/</loc>
		<lastmod>2018-05-29T20:08:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/atrial-fibrillation/</loc>
		<lastmod>2012-12-07T13:58:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/australian-leukaemia-foundation/</loc>
		<lastmod>2009-01-29T21:42:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/autoimmune-diseases/</loc>
		<lastmod>2013-06-14T18:13:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/autologous-cellular-therapies/</loc>
		<lastmod>2020-11-04T08:13:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/autologous-stem-cell-transplant/</loc>
		<lastmod>2019-08-13T17:36:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/avastin/</loc>
		<lastmod>2009-02-27T18:09:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/avm0703/</loc>
		<lastmod>2020-06-11T10:20:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/azd6244/</loc>
		<lastmod>2010-07-14T11:16:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/azd7762/</loc>
		<lastmod>2012-06-12T09:21:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/b-cell/</loc>
		<lastmod>2012-08-30T11:26:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/background-information/</loc>
		<lastmod>2008-10-15T08:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bacterial-infection/</loc>
		<lastmod>2016-05-27T17:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bafetinib/</loc>
		<lastmod>2011-02-14T16:09:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/baff/</loc>
		<lastmod>2013-08-19T11:16:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/balp/</loc>
		<lastmod>2010-02-09T14:34:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bay80-6946/</loc>
		<lastmod>2013-10-07T16:19:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bb2121/</loc>
		<lastmod>2020-09-22T06:59:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bcl2-inhibitors/</loc>
		<lastmod>2019-06-24T08:45:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bcma/</loc>
		<lastmod>2016-05-03T15:58:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bcma-targeted-therapies/</loc>
		<lastmod>2020-10-05T06:30:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bcma-gerichtete-therapie/</loc>
		<lastmod>2019-10-01T11:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bda-366/</loc>
		<lastmod>2016-04-08T14:56:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/beacon-breakingnews/</loc>
		<lastmod>2014-06-02T12:21:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/beacon-siteupdate/</loc>
		<lastmod>2018-06-01T12:50:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/belantamab-mafodotin/</loc>
		<lastmod>2020-08-26T14:06:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bendamustine/</loc>
		<lastmod>2016-05-27T17:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/beta-2-microglobulin/</loc>
		<lastmod>2010-01-12T14:07:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bexxar/</loc>
		<lastmod>2012-12-09T06:50:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bhq880/</loc>
		<lastmod>2013-05-24T16:23:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bi-2536/</loc>
		<lastmod>2011-02-07T17:36:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bi-836908/</loc>
		<lastmod>2016-09-01T09:00:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bi-505/</loc>
		<lastmod>2016-12-09T10:56:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/biaxin/</loc>
		<lastmod>2018-10-05T11:24:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/big-sis-in-burgundy/</loc>
		<lastmod>2013-03-26T12:54:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bildgebungstechniken/</loc>
		<lastmod>2014-05-06T14:42:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bile-acid/</loc>
		<lastmod>2014-10-14T08:59:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bilimsel-calisma-ozeti/</loc>
		<lastmod>2010-12-13T15:23:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bion-1301/</loc>
		<lastmod>2019-05-15T17:05:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/biotest-ag/</loc>
		<lastmod>2010-12-10T15:53:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/biovaxid/</loc>
		<lastmod>2009-06-30T11:28:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bird/</loc>
		<lastmod>2013-02-01T14:28:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/birds-in-spring/</loc>
		<lastmod>2013-01-15T11:59:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bispecific-antibodies/</loc>
		<lastmod>2020-10-08T06:00:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bispezifische-antikorper/</loc>
		<lastmod>2019-09-04T15:06:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bisphosphonates/</loc>
		<lastmod>2018-11-24T13:38:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bite-antibodies/</loc>
		<lastmod>2010-05-14T14:14:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bkm120/</loc>
		<lastmod>2012-01-12T10:53:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bl-8040/</loc>
		<lastmod>2020-10-30T07:00:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/blenrep/</loc>
		<lastmod>2020-08-26T14:06:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/blepharitis/</loc>
		<lastmod>2019-05-30T10:59:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/blood-clots/</loc>
		<lastmod>2013-09-11T14:35:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/blood-tests/</loc>
		<lastmod>2013-03-14T13:23:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/blood-vessels/</loc>
		<lastmod>2013-07-29T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/blutgerinsel/</loc>
		<lastmod>2013-09-17T17:34:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bmi/</loc>
		<lastmod>2013-12-30T23:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/body-mass-index/</loc>
		<lastmod>2013-12-30T23:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/body-weight/</loc>
		<lastmod>2013-12-30T23:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/boehringer-ingelheim/</loc>
		<lastmod>2011-02-07T17:36:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-death/</loc>
		<lastmod>2011-09-30T12:07:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-disease/</loc>
		<lastmod>2016-04-17T15:51:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-lesions/</loc>
		<lastmod>2014-05-02T16:53:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-marrow-aspiration/</loc>
		<lastmod>2016-05-04T23:54:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-marrow-biopsy/</loc>
		<lastmod>2020-08-05T19:26:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-marrow-biospy/</loc>
		<lastmod>2012-10-11T12:14:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-marrow-exam/</loc>
		<lastmod>2011-02-02T15:41:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bone-tumor/</loc>
		<lastmod>2012-05-04T12:32:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bonefos/</loc>
		<lastmod>2012-06-03T20:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/boris-on-myeloma/</loc>
		<lastmod>2019-05-02T04:06:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bortezomib/</loc>
		<lastmod>2019-07-10T07:00:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/borviz/</loc>
		<lastmod>2009-05-13T22:52:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/breakthrough-therapy-designation/</loc>
		<lastmod>2014-05-19T11:11:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/british-society-for-haematology/</loc>
		<lastmod>2011-03-28T13:43:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bromodomain-inhibitors/</loc>
		<lastmod>2014-05-09T10:17:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/bt-062/</loc>
		<lastmod>2013-12-11T18:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/busulfan/</loc>
		<lastmod>2014-05-31T21:17:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/busulfex/</loc>
		<lastmod>2014-05-31T21:17:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/c3b3/</loc>
		<lastmod>2012-03-29T11:21:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cabozantinib/</loc>
		<lastmod>2016-03-30T12:35:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/calcium/</loc>
		<lastmod>2012-06-26T10:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/calisma-ozeti/</loc>
		<lastmod>2011-01-10T16:19:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/canada/</loc>
		<lastmod>2014-02-11T13:22:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cancer-rates/</loc>
		<lastmod>2009-12-03T09:45:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cancer-stem-cell/</loc>
		<lastmod>2012-03-29T11:21:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cancer-stem-cells/</loc>
		<lastmod>2011-02-28T11:40:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cancer-vaccine/</loc>
		<lastmod>2013-11-23T09:04:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cancercare/</loc>
		<lastmod>2010-07-14T11:16:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/car-nk-cell-therapies/</loc>
		<lastmod>2020-10-08T06:00:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/car-t-cell-therapies/</loc>
		<lastmod>2020-11-17T20:00:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/car-t-zelltherapie/</loc>
		<lastmod>2019-10-01T11:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/carcinogen/</loc>
		<lastmod>2009-08-11T15:57:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cardamomin/</loc>
		<lastmod>2012-01-12T10:53:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/caregiving/</loc>
		<lastmod>2020-11-20T19:46:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/carfilzomib/</loc>
		<lastmod>2020-08-20T18:43:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cart-ddbcma/</loc>
		<lastmod>2020-03-12T07:00:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cc-292/</loc>
		<lastmod>2013-06-13T11:55:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ccf642/</loc>
		<lastmod>2016-04-13T13:47:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ccs1477/</loc>
		<lastmod>2019-09-10T02:00:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cd20/</loc>
		<lastmod>2013-08-19T11:16:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cd38-targeted-therapies/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cd38-arm/</loc>
		<lastmod>2019-06-18T07:35:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cd38-gerichtete-therapien/</loc>
		<lastmod>2019-10-22T11:27:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cd44/</loc>
		<lastmod>2013-09-09T15:17:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cd47/</loc>
		<lastmod>2012-06-12T09:21:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cdk-inhibitor/</loc>
		<lastmod>2011-01-05T12:52:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cdx-353/</loc>
		<lastmod>2010-03-23T12:12:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cdy1/</loc>
		<lastmod>2013-02-11T17:02:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/celgene/</loc>
		<lastmod>2013-07-01T13:58:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cellprotect/</loc>
		<lastmod>2020-11-04T08:13:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/centocor-ortho-biotech/</loc>
		<lastmod>2011-02-07T17:36:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cep-18770/</loc>
		<lastmod>2012-10-29T11:52:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cereblon/</loc>
		<lastmod>2013-04-29T14:07:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cetrotide/</loc>
		<lastmod>2010-11-22T17:47:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cetuximab/</loc>
		<lastmod>2013-07-01T13:58:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chalazia/</loc>
		<lastmod>2019-05-23T17:03:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chalazion/</loc>
		<lastmod>2019-05-30T10:59:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/checkpoint-inhibitors/</loc>
		<lastmod>2019-10-02T17:33:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/checkpointhemmer/</loc>
		<lastmod>2019-10-08T15:29:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chemo-brain/</loc>
		<lastmod>2019-02-19T17:56:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chemohirn/</loc>
		<lastmod>2012-09-18T17:38:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chemotherapy/</loc>
		<lastmod>2013-04-30T15:09:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chromosomal-abnormalities/</loc>
		<lastmod>2016-05-14T02:14:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chromosomal-instability/</loc>
		<lastmod>2013-07-29T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chromosomale-abnormitat/</loc>
		<lastmod>2015-06-14T16:27:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/chronic-lymphocytic-leukemia/</loc>
		<lastmod>2012-08-31T15:25:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cid-103/</loc>
		<lastmod>2020-06-08T07:00:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cigna/</loc>
		<lastmod>2008-11-10T15:59:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cilengitide/</loc>
		<lastmod>2016-05-27T17:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cilta-cel/</loc>
		<lastmod>2020-08-05T17:37:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ciltacabtagene-autoleucel/</loc>
		<lastmod>2020-08-05T17:37:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/circularly-permuted-trail/</loc>
		<lastmod>2012-12-21T19:14:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cisplatin/</loc>
		<lastmod>2014-02-25T13:58:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/clarithromycin/</loc>
		<lastmod>2018-10-05T11:24:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/claritromicina/</loc>
		<lastmod>2013-02-15T14:58:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/clinical-trial/</loc>
		<lastmod>2018-11-27T07:30:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/clinical-trial-results/</loc>
		<lastmod>2020-10-30T07:00:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/clodronate/</loc>
		<lastmod>2012-06-03T20:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/clonal-evolution/</loc>
		<lastmod>2016-03-24T11:30:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/clr-131/</loc>
		<lastmod>2020-09-09T08:00:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cognitive-impairment/</loc>
		<lastmod>2013-10-25T18:29:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cometriq/</loc>
		<lastmod>2016-03-30T12:35:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/community/</loc>
		<lastmod>2012-11-15T12:55:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/compassionate-use/</loc>
		<lastmod>2016-06-02T17:46:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/complementary-medicine/</loc>
		<lastmod>2010-01-21T09:47:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/complete-response/</loc>
		<lastmod>2018-11-06T21:31:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/conditioning-regimen/</loc>
		<lastmod>2013-05-13T15:18:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/consolidation-therapy/</loc>
		<lastmod>2015-05-29T23:52:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/continued-response/</loc>
		<lastmod>2013-08-23T16:36:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/continuous-therapy/</loc>
		<lastmod>2015-06-25T15:02:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/contour/</loc>
		<lastmod>2010-10-11T10:38:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/coronavirus/</loc>
		<lastmod>2020-03-14T16:34:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/coumadin/</loc>
		<lastmod>2016-12-28T13:24:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/covid-19/</loc>
		<lastmod>2020-10-21T19:10:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cpi-0610/</loc>
		<lastmod>2014-08-06T15:57:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cr2408/</loc>
		<lastmod>2012-01-12T10:53:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/creatinine/</loc>
		<lastmod>2013-08-28T15:20:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cs3003/</loc>
		<lastmod>2019-03-12T22:06:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ct-scans/</loc>
		<lastmod>2013-02-25T12:20:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ct053/</loc>
		<lastmod>2020-04-27T06:00:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ct103a/</loc>
		<lastmod>2019-10-02T08:55:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ctl019/</loc>
		<lastmod>2015-09-09T17:00:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ctx-1/</loc>
		<lastmod>2013-06-14T18:13:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cudc-907/</loc>
		<lastmod>2016-04-05T15:08:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/curcumin/</loc>
		<lastmod>2013-07-03T16:48:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/curcumina/</loc>
		<lastmod>2013-02-11T11:00:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cure/</loc>
		<lastmod>2013-06-28T16:37:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cx-4945/</loc>
		<lastmod>2010-09-27T11:43:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cxcl9/</loc>
		<lastmod>2016-03-23T11:18:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cyad-211/</loc>
		<lastmod>2020-07-14T01:00:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cybord/</loc>
		<lastmod>2014-06-14T21:59:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cyclophosphamid/</loc>
		<lastmod>2010-02-11T17:23:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cyclophosphamide/</loc>
		<lastmod>2016-12-16T09:20:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cynk-001/</loc>
		<lastmod>2020-09-08T10:00:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cystatin-c/</loc>
		<lastmod>2013-08-28T15:20:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cyt-0851/</loc>
		<lastmod>2019-10-15T07:30:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cytarabine/</loc>
		<lastmod>2013-07-03T16:48:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cytogenetics/</loc>
		<lastmod>2013-07-26T16:32:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cytokine/</loc>
		<lastmod>2010-01-12T14:07:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cytokine-release-syndrome/</loc>
		<lastmod>2020-06-11T10:20:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cytopenia/</loc>
		<lastmod>2010-05-19T14:57:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/cytoxan/</loc>
		<lastmod>2014-06-26T13:06:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dacetuzumab/</loc>
		<lastmod>2012-09-26T11:37:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dano-renal/</loc>
		<lastmod>2013-02-21T14:39:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/daratumumab/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/daratumumab-and-hyaluronidase-fihj/</loc>
		<lastmod>2020-08-04T07:30:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/darzalex/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/darzalex-faspro/</loc>
		<lastmod>2020-08-04T07:30:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/darzalex-sc/</loc>
		<lastmod>2020-08-04T07:30:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dating/</loc>
		<lastmod>2012-11-27T13:09:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dcep/</loc>
		<lastmod>2014-02-25T13:58:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/decadron/</loc>
		<lastmod>2020-06-16T08:00:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/deep-sequencing/</loc>
		<lastmod>2014-04-08T07:41:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/deep-vein-thrombosis/</loc>
		<lastmod>2011-06-01T16:39:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/defibrotide/</loc>
		<lastmod>2016-03-31T12:16:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/defitelio/</loc>
		<lastmod>2016-03-31T12:16:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dekadron/</loc>
		<lastmod>2010-11-29T17:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/deksametazon/</loc>
		<lastmod>2010-11-29T17:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/delanzomib/</loc>
		<lastmod>2012-10-29T11:52:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/denosumab/</loc>
		<lastmod>2018-01-05T09:00:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/descubrimientos-principales/</loc>
		<lastmod>2014-04-28T14:02:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/desipramine/</loc>
		<lastmod>2013-08-12T17:28:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/destiny/</loc>
		<lastmod>2012-08-28T11:30:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dexamethasone/</loc>
		<lastmod>2020-06-16T08:00:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/diabetes/</loc>
		<lastmod>2012-07-11T11:16:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/diagnose/</loc>
		<lastmod>2014-10-27T16:10:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/diagnosekriterien/</loc>
		<lastmod>2014-10-27T16:10:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/diarrhea/</loc>
		<lastmod>2015-05-01T10:09:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dichloromethane/</loc>
		<lastmod>2013-09-25T14:50:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dietary-supplement/</loc>
		<lastmod>2010-09-02T15:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/difitelio/</loc>
		<lastmod>2016-03-30T12:55:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dinaciclib/</loc>
		<lastmod>2013-11-04T13:03:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/disability/</loc>
		<lastmod>2013-01-08T10:06:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/disease-progression/</loc>
		<lastmod>2018-05-15T01:52:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/disulfiram/</loc>
		<lastmod>2012-02-20T15:07:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dkk/</loc>
		<lastmod>2011-09-23T15:46:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dkk1/</loc>
		<lastmod>2013-01-28T14:33:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dkn-01/</loc>
		<lastmod>2013-01-28T14:33:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/doktor-kose-yazisi/</loc>
		<lastmod>2010-12-03T09:15:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/donor-lymphocyte-infusion/</loc>
		<lastmod>2013-11-23T09:04:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/donor-stem-cell-transplant/</loc>
		<lastmod>2016-06-02T17:46:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dopamine/</loc>
		<lastmod>2016-11-18T15:38:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/doppeltransplantation/</loc>
		<lastmod>2010-11-23T17:52:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dosing/</loc>
		<lastmod>2010-11-22T17:33:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/doxil/</loc>
		<lastmod>2016-05-23T11:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/doxorubicin/</loc>
		<lastmod>2013-10-08T08:00:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/doxorubicin-liposomal/</loc>
		<lastmod>2019-03-07T08:30:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/doxycycline/</loc>
		<lastmod>2016-05-10T08:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dr-kenneth-anderson/</loc>
		<lastmod>2011-02-28T11:40:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dr-robert-kyle/</loc>
		<lastmod>2010-01-21T09:47:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/durvalumab/</loc>
		<lastmod>2017-09-07T07:30:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dyclonine/</loc>
		<lastmod>2014-09-03T07:39:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/dyspnea/</loc>
		<lastmod>2017-01-24T12:44:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/early-myeloma/</loc>
		<lastmod>2013-06-28T16:37:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/early-relapse/</loc>
		<lastmod>2012-12-10T13:18:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ebmt-2016-meeting/</loc>
		<lastmod>2016-04-26T23:31:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ecstasy/</loc>
		<lastmod>2011-08-24T12:14:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ect-001/</loc>
		<lastmod>2019-04-29T18:56:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eculizumab/</loc>
		<lastmod>2016-04-12T14:44:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/edad/</loc>
		<lastmod>2013-09-27T10:48:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/edo-s101/</loc>
		<lastmod>2019-03-05T08:30:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2009-meeting/</loc>
		<lastmod>2009-06-09T01:11:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2010-meeting/</loc>
		<lastmod>2010-07-16T12:25:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2011-meeting/</loc>
		<lastmod>2011-06-22T15:34:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2012-meeting/</loc>
		<lastmod>2012-07-10T11:55:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2013-meeting/</loc>
		<lastmod>2013-06-14T18:13:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2013-meeting-abstract/</loc>
		<lastmod>2013-06-20T10:02:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2015-meeting/</loc>
		<lastmod>2015-06-25T15:02:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2018-jahrestagung/</loc>
		<lastmod>2018-06-22T09:57:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eha-2018-meeting/</loc>
		<lastmod>2018-06-20T21:55:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/elafin/</loc>
		<lastmod>2010-04-27T15:27:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/eloquent-2-trial/</loc>
		<lastmod>2015-07-30T15:26:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/elotuzumab/</loc>
		<lastmod>2020-03-09T06:59:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/elzonris/</loc>
		<lastmod>2020-06-10T08:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/empliciti/</loc>
		<lastmod>2020-03-09T06:59:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/enfermedad-extramedular/</loc>
		<lastmod>2013-03-25T10:37:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/engraftment-syndrome/</loc>
		<lastmod>2017-03-18T16:07:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/enmd-2076/</loc>
		<lastmod>2011-01-06T15:12:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/entinostat/</loc>
		<lastmod>2013-04-01T12:53:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/entremed/</loc>
		<lastmod>2011-01-06T15:12:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/epogen/</loc>
		<lastmod>2010-09-27T11:43:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/erbgut/</loc>
		<lastmod>2011-12-01T12:28:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/erbitux/</loc>
		<lastmod>2013-07-01T13:58:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/erhaltungstherapie/</loc>
		<lastmod>2016-06-15T11:19:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ernahrung/</loc>
		<lastmod>2018-11-29T14:48:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/erstlinientherapie/</loc>
		<lastmod>2018-11-28T15:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/erythropoiesis-stimulating-agents/</loc>
		<lastmod>2011-05-23T14:54:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/erythropoietin/</loc>
		<lastmod>2013-07-29T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/esmo-2010-meeting/</loc>
		<lastmod>2010-10-25T16:36:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ethnicity/</loc>
		<lastmod>2018-04-17T17:49:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ethyol/</loc>
		<lastmod>2013-06-14T18:13:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/etoposide/</loc>
		<lastmod>2014-02-25T13:58:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/europa/</loc>
		<lastmod>2016-05-26T11:25:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/europe/</loc>
		<lastmod>2015-06-26T15:03:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/european-approval/</loc>
		<lastmod>2020-08-26T14:06:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/european-commission/</loc>
		<lastmod>2016-05-24T17:09:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/european-hematology-association/</loc>
		<lastmod>2010-06-04T09:43:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/european-medicines-agency/</loc>
		<lastmod>2012-06-21T19:47:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/european-american/</loc>
		<lastmod>2013-03-13T15:34:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/everolimus/</loc>
		<lastmod>2010-06-29T08:17:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/evirolimus/</loc>
		<lastmod>2012-09-26T11:37:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/evofosfamide/</loc>
		<lastmod>2015-06-07T13:15:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/evolution/</loc>
		<lastmod>2014-11-03T09:25:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/evomela/</loc>
		<lastmod>2019-08-12T09:00:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/exelixis/</loc>
		<lastmod>2012-08-01T12:15:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/exercise/</loc>
		<lastmod>2016-11-18T15:38:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/expressive-writing/</loc>
		<lastmod>2012-04-24T09:55:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/extramedullare-manifestation/</loc>
		<lastmod>2013-03-18T12:55:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/extramedullary-disease/</loc>
		<lastmod>2016-03-25T11:50:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/faith/</loc>
		<lastmod>2012-08-07T10:37:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/farydak/</loc>
		<lastmod>2019-03-12T10:03:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fatigue/</loc>
		<lastmod>2015-04-21T17:03:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fda/</loc>
		<lastmod>2018-10-07T17:28:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fda-approval/</loc>
		<lastmod>2020-08-20T18:43:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fenofibrate/</loc>
		<lastmod>2013-10-28T14:28:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fertility/</loc>
		<lastmod>2013-09-27T19:41:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/filanesib/</loc>
		<lastmod>2013-12-24T11:47:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/filgrastim/</loc>
		<lastmod>2016-03-25T11:50:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/financial-aid/</loc>
		<lastmod>2009-02-13T21:22:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/firefighters/</loc>
		<lastmod>2009-05-12T13:15:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fjc/</loc>
		<lastmod>2009-01-28T11:50:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/flufenamide/</loc>
		<lastmod>2013-08-12T17:28:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/focal-lesions/</loc>
		<lastmod>2014-08-26T01:26:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/folic-acid/</loc>
		<lastmod>2008-11-16T02:01:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/for46/</loc>
		<lastmod>2018-11-06T09:00:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/forschung/</loc>
		<lastmod>2014-01-31T13:29:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fotemustine/</loc>
		<lastmod>2012-12-10T13:18:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/free-light-chains/</loc>
		<lastmod>2018-05-15T01:52:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/freiburg-comorbidity-index/</loc>
		<lastmod>2013-08-07T15:56:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fruit-intake/</loc>
		<lastmod>2018-11-27T16:31:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ft516/</loc>
		<lastmod>2019-02-06T08:00:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ft538/</loc>
		<lastmod>2020-05-20T08:00:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/fundraiser/</loc>
		<lastmod>2012-11-12T10:39:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/g-csf/</loc>
		<lastmod>2013-05-03T19:33:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/galectin-1/</loc>
		<lastmod>2016-05-27T17:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/galinpepimut-s/</loc>
		<lastmod>2018-09-13T08:30:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gamma-secretase-inhibitors/</loc>
		<lastmod>2020-09-21T07:00:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ganetespib/</loc>
		<lastmod>2012-04-16T12:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ganzkorperbestrahlung/</loc>
		<lastmod>2011-01-18T11:08:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gbr-1342/</loc>
		<lastmod>2019-10-15T07:45:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gdc-0570/</loc>
		<lastmod>2020-01-27T09:00:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gdc-0941/</loc>
		<lastmod>2013-01-21T12:52:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gender/</loc>
		<lastmod>2018-04-17T17:49:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gene-expression-profiling/</loc>
		<lastmod>2016-04-04T15:19:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gene-therapy/</loc>
		<lastmod>2013-11-23T09:04:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/genetic-testing/</loc>
		<lastmod>2011-05-20T19:59:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/genetic-variations/</loc>
		<lastmod>2013-08-26T16:04:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/genetically-tailored-therapy/</loc>
		<lastmod>2009-10-14T09:29:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/genmab/</loc>
		<lastmod>2011-01-06T15:12:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/genome/</loc>
		<lastmod>2013-08-26T16:04:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gentherapie/</loc>
		<lastmod>2011-08-18T14:01:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/geraldine-ferraro/</loc>
		<lastmod>2011-03-28T13:43:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gesamtuberleben/</loc>
		<lastmod>2019-05-15T16:22:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/getting-to-know/</loc>
		<lastmod>2019-10-02T17:33:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gewebetypisierung/</loc>
		<lastmod>2014-05-14T11:37:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gf-15/</loc>
		<lastmod>2012-09-24T11:38:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ginger/</loc>
		<lastmod>2010-09-02T15:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gleevec/</loc>
		<lastmod>2009-02-27T18:09:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/go-y030/</loc>
		<lastmod>2011-11-30T11:20:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/go-y078/</loc>
		<lastmod>2011-11-30T11:20:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gossypol-acetate/</loc>
		<lastmod>2013-06-17T15:36:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/graft-versus-host-disease/</loc>
		<lastmod>2013-08-22T17:28:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/green-tea/</loc>
		<lastmod>2012-02-06T17:29:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/growth-factors/</loc>
		<lastmod>2010-11-09T14:36:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/grupos-etnicos/</loc>
		<lastmod>2013-09-27T10:48:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gsk2857916/</loc>
		<lastmod>2020-08-26T14:06:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/gsk3377794/</loc>
		<lastmod>2018-07-24T07:30:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/guide-to-clinical-trials/</loc>
		<lastmod>2010-06-25T11:17:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/h-pylori/</loc>
		<lastmod>2009-08-22T17:33:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/h1n1/</loc>
		<lastmod>2009-11-10T13:32:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hagelkorn/</loc>
		<lastmod>2019-05-30T10:59:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hair-loss/</loc>
		<lastmod>2017-02-14T11:28:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/halofuginone/</loc>
		<lastmod>2012-05-02T14:35:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hdac-inhibitors/</loc>
		<lastmod>2020-09-24T05:12:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/headline/</loc>
		<lastmod>2018-06-22T14:14:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/health-canada/</loc>
		<lastmod>2014-02-11T13:22:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/heart-disease/</loc>
		<lastmod>2019-05-14T14:52:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/heavy-light-chains/</loc>
		<lastmod>2013-04-15T14:54:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/helical-tomotherapy/</loc>
		<lastmod>2011-01-14T17:05:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hemodialysis/</loc>
		<lastmod>2016-05-10T08:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/heparin/</loc>
		<lastmod>2013-09-11T14:35:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hepatitis-b/</loc>
		<lastmod>2013-03-06T13:42:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hepatitis-e/</loc>
		<lastmod>2013-07-22T14:17:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/herpes-virus/</loc>
		<lastmod>2013-05-31T06:49:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/high-cut-off-hemodialysis/</loc>
		<lastmod>2016-05-10T08:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/high-risk-multiple-myeloma/</loc>
		<lastmod>2017-02-28T15:26:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hipaa/</loc>
		<lastmod>2018-06-15T20:58:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hla/</loc>
		<lastmod>2014-03-29T12:03:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hochdurchsatz-sequenzierung/</loc>
		<lastmod>2014-05-07T17:35:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hochrisiko-patienten/</loc>
		<lastmod>2013-04-12T15:19:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hope/</loc>
		<lastmod>2013-08-13T12:48:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hpn217/</loc>
		<lastmod>2020-04-27T06:30:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hsp70-inhibitor/</loc>
		<lastmod>2013-08-05T16:23:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hsp90/</loc>
		<lastmod>2013-06-24T15:20:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hsp90-inhibitor/</loc>
		<lastmod>2012-08-01T12:15:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hsp90-inhibitors/</loc>
		<lastmod>2010-07-22T23:55:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/humor/</loc>
		<lastmod>2014-03-04T10:24:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hybrid-drug-therapy/</loc>
		<lastmod>2013-07-03T16:48:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hycamtin/</loc>
		<lastmod>2010-08-20T16:10:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hydroxychloroquine/</loc>
		<lastmod>2014-07-12T14:41:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hyperbaric-oxygen-treatment/</loc>
		<lastmod>2011-01-11T16:25:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hyperdiploid-myeloma/</loc>
		<lastmod>2013-06-17T15:36:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/hypodiploid-myeloma/</loc>
		<lastmod>2013-06-17T15:36:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ibrutinib/</loc>
		<lastmod>2016-10-28T15:48:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ict-69/</loc>
		<lastmod>2010-03-09T14:23:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/idame-tedavisi/</loc>
		<lastmod>2011-02-09T16:11:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ide-cel/</loc>
		<lastmod>2020-09-22T06:59:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/idecabtagene-vicleucel/</loc>
		<lastmod>2020-09-22T06:59:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/igf/</loc>
		<lastmod>2016-04-26T23:31:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ikincil-kanser/</loc>
		<lastmod>2011-02-09T16:11:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/il/</loc>
		<lastmod>2013-07-29T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/il-17/</loc>
		<lastmod>2013-07-29T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/il-2/</loc>
		<lastmod>2013-10-14T16:02:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/il-27/</loc>
		<lastmod>2013-07-29T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imaging/</loc>
		<lastmod>2019-05-17T11:10:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imbruvica/</loc>
		<lastmod>2016-10-28T15:48:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imetelstat/</loc>
		<lastmod>2011-10-19T12:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imfinzi/</loc>
		<lastmod>2017-09-07T07:30:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imgn901/</loc>
		<lastmod>2013-01-04T15:54:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imids/</loc>
		<lastmod>2013-09-11T14:35:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immucin/</loc>
		<lastmod>2015-06-22T07:00:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immune-system/</loc>
		<lastmod>2013-10-11T17:36:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immune-system-therapeutics/</loc>
		<lastmod>2011-07-04T10:14:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunfunktion/</loc>
		<lastmod>2013-10-30T16:59:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunglobuline/</loc>
		<lastmod>2014-03-27T14:32:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunmodulatorische-substanzen/</loc>
		<lastmod>2013-09-17T17:34:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunocellular-therapeutics/</loc>
		<lastmod>2010-03-09T14:23:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunodulatory-agents/</loc>
		<lastmod>2020-11-13T16:27:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunomodulatory-agents/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunoparesis/</loc>
		<lastmod>2019-10-10T15:45:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunotherapy/</loc>
		<lastmod>2016-04-09T14:42:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immunsystem/</loc>
		<lastmod>2013-10-30T16:59:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/immuntherapie/</loc>
		<lastmod>2018-06-07T16:06:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imnovid/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/impfstoff/</loc>
		<lastmod>2011-03-18T10:23:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imw-2009/</loc>
		<lastmod>2009-04-10T08:02:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imw-2011/</loc>
		<lastmod>2011-06-24T14:07:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imw-2011-daily-update/</loc>
		<lastmod>2011-05-11T18:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imw-2013/</loc>
		<lastmod>2013-04-26T14:04:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/imwg/</loc>
		<lastmod>2016-03-24T11:30:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/indatuximab-ravtansine/</loc>
		<lastmod>2013-12-11T18:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/induction-therapy/</loc>
		<lastmod>2012-09-05T12:33:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/infeccion/</loc>
		<lastmod>2013-11-13T16:10:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/infection/</loc>
		<lastmod>2018-09-23T00:23:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/infektionen/</loc>
		<lastmod>2019-08-22T14:27:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/inflammation/</loc>
		<lastmod>2013-05-06T13:24:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/infusion-reactions/</loc>
		<lastmod>2018-04-30T19:08:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/inno-206/</loc>
		<lastmod>2012-05-30T11:14:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/institute-for-myeloma-and-bone-cancer-research/</loc>
		<lastmod>2009-05-09T16:26:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/insurance/</loc>
		<lastmod>2013-01-08T10:06:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/intellikine/</loc>
		<lastmod>2010-04-05T11:53:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/interferon/</loc>
		<lastmod>2011-12-02T11:57:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/interleukin-16/</loc>
		<lastmod>2012-07-11T11:16:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/international-myeloma-foundation/</loc>
		<lastmod>2012-10-29T11:52:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/international-myeloma-working-group/</loc>
		<lastmod>2015-06-25T15:02:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/international-society-of-hematology/</loc>
		<lastmod>2010-10-08T12:04:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/international-staging-system/</loc>
		<lastmod>2013-09-13T17:24:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/intra-clonal-heterogeneity/</loc>
		<lastmod>2014-11-03T09:25:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/intraklonale-heterogenitat/</loc>
		<lastmod>2015-01-15T15:48:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/iodione-131-tositumomab/</loc>
		<lastmod>2012-12-09T06:50:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/iowa/</loc>
		<lastmod>2009-05-12T13:15:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/iph-2101/</loc>
		<lastmod>2013-12-09T13:13:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ipi-504/</loc>
		<lastmod>2011-08-30T15:36:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/iron/</loc>
		<lastmod>2013-01-14T11:25:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/irregular-heartbeat/</loc>
		<lastmod>2012-12-07T13:58:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/isatuximab/</loc>
		<lastmod>2020-07-08T07:15:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/istodax/</loc>
		<lastmod>2011-10-19T12:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/itraconazole/</loc>
		<lastmod>2012-12-05T11:59:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ixazomib/</loc>
		<lastmod>2020-09-09T19:15:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/jakafi/</loc>
		<lastmod>2014-12-05T07:41:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/jnj-4528/</loc>
		<lastmod>2020-08-05T17:37:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/jnj-63723283/</loc>
		<lastmod>2018-05-29T20:08:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/jnj-64007957/</loc>
		<lastmod>2020-09-14T06:30:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/jnj-68284528/</loc>
		<lastmod>2020-08-05T17:37:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/jnj-7957/</loc>
		<lastmod>2020-09-14T06:30:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/john-theurer-cancer-center/</loc>
		<lastmod>2011-05-20T10:06:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/jq1/</loc>
		<lastmod>2016-04-15T15:48:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/k-nk004/</loc>
		<lastmod>2020-07-08T01:00:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kadian/</loc>
		<lastmod>2011-03-28T11:13:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kathy-giusti/</loc>
		<lastmod>2011-04-25T11:19:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kepivance/</loc>
		<lastmod>2012-12-19T14:16:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/keytruda/</loc>
		<lastmod>2019-10-01T11:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kidney-cancer/</loc>
		<lastmod>2011-09-26T16:59:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kidney-damage/</loc>
		<lastmod>2016-05-23T11:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kidney-failure/</loc>
		<lastmod>2016-05-10T08:09:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kidney-impairment/</loc>
		<lastmod>2016-05-23T11:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kidney-transplant/</loc>
		<lastmod>2012-11-09T13:56:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/klinische-studie/</loc>
		<lastmod>2018-05-31T11:56:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/knochenbeteiligung/</loc>
		<lastmod>2011-06-14T18:17:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/knochenlasionen/</loc>
		<lastmod>2012-08-09T16:18:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/knochenmarksuntersuchen/</loc>
		<lastmod>2011-02-02T15:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kombinationstherapie/</loc>
		<lastmod>2010-08-02T17:25:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kp1237/</loc>
		<lastmod>2020-09-08T08:30:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kromozomal-anormallikler/</loc>
		<lastmod>2010-11-29T17:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kurtarma-tedavisi/</loc>
		<lastmod>2011-01-10T16:19:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kw-2478/</loc>
		<lastmod>2013-12-08T17:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kyan-001/</loc>
		<lastmod>2020-09-24T05:12:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kyphoplasty/</loc>
		<lastmod>2016-03-23T11:18:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kyprolis/</loc>
		<lastmod>2020-08-20T18:43:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/kytril/</loc>
		<lastmod>2009-01-22T19:29:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/langzeituberleben/</loc>
		<lastmod>2013-10-30T16:59:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lansoprazole/</loc>
		<lastmod>2016-04-18T16:08:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lbh589/</loc>
		<lastmod>2014-11-25T01:15:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lc53-0110/</loc>
		<lastmod>2016-03-27T10:59:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lc53-0151/</loc>
		<lastmod>2016-03-27T10:59:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lcar-b38m/</loc>
		<lastmod>2020-08-05T17:37:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lcl161/</loc>
		<lastmod>2013-10-14T16:02:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/leichtketten/</loc>
		<lastmod>2018-05-16T15:56:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/leichtketten-mgus/</loc>
		<lastmod>2018-05-16T15:56:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lenalidomid/</loc>
		<lastmod>2019-10-03T11:14:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lenalidomida/</loc>
		<lastmod>2013-05-04T22:12:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lenalidomide/</loc>
		<lastmod>2020-09-17T06:59:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lesions/</loc>
		<lastmod>2012-08-03T11:58:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/letters-from-cancerland/</loc>
		<lastmod>2020-06-02T17:31:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/leukemia-lymphoma-society/</loc>
		<lastmod>2013-05-31T06:49:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/levact/</loc>
		<lastmod>2010-03-23T12:12:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lgh447/</loc>
		<lastmod>2013-11-15T22:52:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/life-lessons/</loc>
		<lastmod>2013-12-23T13:47:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/linsitinib/</loc>
		<lastmod>2012-09-24T11:38:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lipodox/</loc>
		<lastmod>2012-03-14T09:43:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lirilumab/</loc>
		<lastmod>2014-10-01T10:00:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lisa-ray/</loc>
		<lastmod>2009-09-12T01:07:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/live-blog/</loc>
		<lastmod>2014-11-06T04:08:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/living-for-lamingtons/</loc>
		<lastmod>2020-04-16T18:23:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lls/</loc>
		<lastmod>2013-01-21T12:52:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/long-term-disease-control/</loc>
		<lastmod>2012-08-30T11:26:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/long-term-survival/</loc>
		<lastmod>2016-04-24T18:52:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lorvotuzumab-mertansine/</loc>
		<lastmod>2013-01-04T15:54:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/low-molecular-weight-heparin/</loc>
		<lastmod>2010-07-19T15:27:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lucatumumab/</loc>
		<lastmod>2012-08-15T12:25:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lung-function/</loc>
		<lastmod>2012-10-17T13:43:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ly2127399/</loc>
		<lastmod>2012-12-28T15:52:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ly3039478/</loc>
		<lastmod>2017-12-06T09:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lymphocytes/</loc>
		<lastmod>2013-08-05T16:23:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/lymphozyten/</loc>
		<lastmod>2012-05-22T11:41:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/m-protein/</loc>
		<lastmod>2013-08-23T16:36:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/m-csf/</loc>
		<lastmod>2010-01-12T14:07:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/macrophage/</loc>
		<lastmod>2013-07-29T15:26:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mage-a3/</loc>
		<lastmod>2013-11-23T09:04:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mage-c1ct7/</loc>
		<lastmod>2011-11-30T11:20:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/maintenance-therapy/</loc>
		<lastmod>2020-10-21T16:48:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/majestic-research/</loc>
		<lastmod>2010-01-25T14:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/malaria/</loc>
		<lastmod>2014-07-12T14:41:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/malariamedikamente/</loc>
		<lastmod>2014-08-05T12:37:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/manhattan-tales/</loc>
		<lastmod>2014-08-11T16:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mannkind/</loc>
		<lastmod>2010-03-29T13:09:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mapatumumab/</loc>
		<lastmod>2010-06-11T11:04:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/marizomib/</loc>
		<lastmod>2016-11-17T20:20:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/masitinib/</loc>
		<lastmod>2011-10-26T15:37:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mayo-clinic/</loc>
		<lastmod>2010-04-26T17:15:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mb-104/</loc>
		<lastmod>2019-05-08T07:30:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mdg1011/</loc>
		<lastmod>2019-02-26T06:36:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mds/</loc>
		<lastmod>2013-02-11T17:02:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mdx-1097/</loc>
		<lastmod>2013-06-14T18:13:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/me-vs-mm/</loc>
		<lastmod>2013-09-19T13:52:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/medical-marijuana/</loc>
		<lastmod>2014-10-21T10:34:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/medicare/</loc>
		<lastmod>2013-01-08T10:06:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/meeting-update/</loc>
		<lastmod>2013-11-18T22:22:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mefloquine/</loc>
		<lastmod>2014-07-12T14:41:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/melflufen/</loc>
		<lastmod>2020-10-12T02:19:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/meloxicam/</loc>
		<lastmod>2013-03-25T12:02:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/melphalan/</loc>
		<lastmod>2019-08-12T09:00:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/melphalan-flufenamide/</loc>
		<lastmod>2020-10-12T02:19:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/memory/</loc>
		<lastmod>2013-10-25T18:29:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/methotrexate/</loc>
		<lastmod>2013-07-03T16:48:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/methylene-chloride/</loc>
		<lastmod>2013-09-25T14:50:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/methyljasmonate/</loc>
		<lastmod>2012-10-01T11:25:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/metronomic-therapy/</loc>
		<lastmod>2012-06-02T16:47:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mfgr1877s/</loc>
		<lastmod>2012-12-12T14:57:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mgus/</loc>
		<lastmod>2018-11-27T16:31:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mieloma-indolente/</loc>
		<lastmod>2013-05-15T21:14:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mig/</loc>
		<lastmod>2016-03-23T11:18:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/milatuzumab/</loc>
		<lastmod>2013-10-23T18:16:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/milatuzumab-doxorubicin/</loc>
		<lastmod>2010-07-01T13:43:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/millennium-pharmaceuticals/</loc>
		<lastmod>2010-03-23T12:12:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/minimal-residual-disease/</loc>
		<lastmod>2018-09-28T15:00:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/minimale-resterkrankung/</loc>
		<lastmod>2014-05-07T17:35:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mitoxantrone/</loc>
		<lastmod>2011-04-18T16:32:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mln0128/</loc>
		<lastmod>2012-12-12T14:57:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mln4924/</loc>
		<lastmod>2011-10-19T12:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mln8237/</loc>
		<lastmod>2012-12-09T06:50:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mln9708/</loc>
		<lastmod>2020-09-09T19:15:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mmp-13/</loc>
		<lastmod>2016-04-07T14:47:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mmrf/</loc>
		<lastmod>2012-04-04T11:25:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mmset/</loc>
		<lastmod>2016-04-26T23:31:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mobic/</loc>
		<lastmod>2013-03-25T12:02:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mohrs-myeloma-musings/</loc>
		<lastmod>2017-02-16T16:12:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/molecular-remission/</loc>
		<lastmod>2013-02-06T14:41:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/molekulare-remission/</loc>
		<lastmod>2011-12-13T22:56:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/monoclonal-antibodies/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/monoclonal-banding/</loc>
		<lastmod>2013-01-16T13:13:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/monoclonal-gammopathy-of-renal-significance/</loc>
		<lastmod>2016-04-25T19:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/monoclonal-gammopathy-of-undetermined-significance/</loc>
		<lastmod>2018-11-27T16:31:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/monoclonal-protein/</loc>
		<lastmod>2014-03-25T16:30:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/monoklonale-antikorper/</loc>
		<lastmod>2019-10-22T11:27:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/monoklonale-gammopathie-unklarer-signifikanz/</loc>
		<lastmod>2018-05-16T15:56:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mor202/</loc>
		<lastmod>2020-04-27T16:01:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/morphine/</loc>
		<lastmod>2011-03-28T11:13:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/morphosys/</loc>
		<lastmod>2013-07-01T13:58:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/motixafortide/</loc>
		<lastmod>2020-10-30T07:00:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mozobil/</loc>
		<lastmod>2016-12-16T09:20:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mp0250/</loc>
		<lastmod>2019-12-27T01:00:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mri/</loc>
		<lastmod>2014-08-26T01:26:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/msmart-guidelines/</loc>
		<lastmod>2013-04-08T13:46:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/mtv273/</loc>
		<lastmod>2019-10-01T11:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/multiparameter-flow-cytometry/</loc>
		<lastmod>2014-04-08T07:41:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/multiple-myeloma-research-consortium/</loc>
		<lastmod>2012-04-16T12:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/multiple-myeloma-research-foundation/</loc>
		<lastmod>2012-06-12T09:21:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/multiple-myeoma/</loc>
		<lastmod>2019-05-07T15:45:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/muphoran/</loc>
		<lastmod>2012-12-10T13:18:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/my-myelomaverse/</loc>
		<lastmod>2020-10-21T19:10:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myelodysplastic-syndromes/</loc>
		<lastmod>2013-08-21T16:19:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-beacon-forums/</loc>
		<lastmod>2014-05-29T03:50:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-canada/</loc>
		<lastmod>2010-08-18T08:57:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-dispatches/</loc>
		<lastmod>2017-07-13T20:32:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-in-paradise/</loc>
		<lastmod>2017-01-10T10:16:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-kidney/</loc>
		<lastmod>2012-04-16T12:22:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-lessons/</loc>
		<lastmod>2017-02-08T13:26:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-mom/</loc>
		<lastmod>2015-09-24T14:02:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-morning/</loc>
		<lastmod>2016-06-02T17:46:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-on-the-high-plains/</loc>
		<lastmod>2020-11-25T20:19:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-party-of-two/</loc>
		<lastmod>2020-10-09T19:05:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-rocket-scientist/</loc>
		<lastmod>2018-02-08T16:19:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-uk/</loc>
		<lastmod>2009-11-23T12:39:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/myeloma-vaccine/</loc>
		<lastmod>2012-03-19T09:40:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/n-methyl-2-pyrrolidone/</loc>
		<lastmod>2014-05-09T10:17:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/natalizumab/</loc>
		<lastmod>2011-10-26T15:37:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/natco-pharma/</loc>
		<lastmod>2010-09-03T15:35:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/national-cancer-institute/</loc>
		<lastmod>2010-07-14T11:16:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/national-league-of-cities/</loc>
		<lastmod>2009-05-12T13:15:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/natural-killer-nk-cell-therapies/</loc>
		<lastmod>2020-11-04T08:13:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/natural-killer-cells/</loc>
		<lastmod>2013-08-05T16:23:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nccn-guidelines/</loc>
		<lastmod>2013-03-19T11:53:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ndc/</loc>
		<lastmod>2012-07-26T12:35:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nebenwirkungen/</loc>
		<lastmod>2019-05-30T10:59:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nek2-gene/</loc>
		<lastmod>2013-02-25T12:20:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nelfinavir/</loc>
		<lastmod>2019-10-03T11:14:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/neu-diagnostiziertes-multiples-myelom/</loc>
		<lastmod>2013-05-17T07:35:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/neue-substanzen/</loc>
		<lastmod>2013-11-27T11:02:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/neulasta/</loc>
		<lastmod>2013-05-03T19:33:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/neupogen/</loc>
		<lastmod>2016-03-25T11:50:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/neutropenia/</loc>
		<lastmod>2016-05-17T17:35:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/new-drug-application/</loc>
		<lastmod>2009-07-08T11:02:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/newly-diagnosed-multiple-myeloma/</loc>
		<lastmod>2020-09-09T19:15:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/newly-diagnosed-multipled-myeloma/</loc>
		<lastmod>2020-03-10T08:00:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nexavar/</loc>
		<lastmod>2016-03-23T11:18:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nexi-002/</loc>
		<lastmod>2020-10-06T08:30:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nhs/</loc>
		<lastmod>2009-11-13T15:54:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nice/</loc>
		<lastmod>2011-08-01T09:17:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nicht-sekretorisches-myelom/</loc>
		<lastmod>2011-10-26T18:19:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nierenfunktion/</loc>
		<lastmod>2016-04-22T16:27:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ninlaro/</loc>
		<lastmod>2020-09-09T19:15:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nirogacestat/</loc>
		<lastmod>2020-10-05T06:30:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nivolumab/</loc>
		<lastmod>2018-12-12T07:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nkg2d/</loc>
		<lastmod>2016-02-25T01:00:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nkr-2/</loc>
		<lastmod>2016-02-25T01:00:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nktr-255/</loc>
		<lastmod>2019-10-16T09:00:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nmp/</loc>
		<lastmod>2014-05-12T17:46:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/non-marrow-tumors/</loc>
		<lastmod>2011-04-01T11:17:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nonsecretory-myeloma/</loc>
		<lastmod>2015-03-31T17:22:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/norpramin/</loc>
		<lastmod>2013-08-12T17:28:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/northern-lights/</loc>
		<lastmod>2020-11-20T19:46:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/novantrone/</loc>
		<lastmod>2011-04-18T16:32:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nox-a12/</loc>
		<lastmod>2014-12-08T07:02:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/npi-0052/</loc>
		<lastmod>2013-05-24T16:23:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nuevos-tratamientos/</loc>
		<lastmod>2013-02-11T11:55:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/nutrition/</loc>
		<lastmod>2013-09-19T13:52:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/obatoclax/</loc>
		<lastmod>2012-06-03T20:26:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/obesity/</loc>
		<lastmod>2016-05-14T02:14:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/off-label-prescribing/</loc>
		<lastmod>2009-04-04T15:12:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/olaptesed-pegol/</loc>
		<lastmod>2013-12-08T17:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/older-patients/</loc>
		<lastmod>2018-10-18T15:18:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/oligoclonal-banding/</loc>
		<lastmod>2013-01-16T13:13:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/oligosecretory-myeloma/</loc>
		<lastmod>2012-08-24T14:06:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/oncopep/</loc>
		<lastmod>2014-08-27T21:52:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/oncovin/</loc>
		<lastmod>2011-02-16T15:34:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ondansetron/</loc>
		<lastmod>2011-09-26T16:59:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/onj/</loc>
		<lastmod>2013-03-25T12:02:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/onkord/</loc>
		<lastmod>2020-10-12T04:45:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/onyx-pharmaceuticals/</loc>
		<lastmod>2013-08-26T12:41:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/opd5/</loc>
		<lastmod>2020-10-19T02:51:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/opdivo/</loc>
		<lastmod>2018-12-12T07:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/opinion/</loc>
		<lastmod>2013-06-24T15:20:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/oprozomib/</loc>
		<lastmod>2014-12-07T09:07:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/oral-mucositis/</loc>
		<lastmod>2010-03-30T15:24:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/osteonecrosis-of-the-jaw/</loc>
		<lastmod>2016-03-09T09:46:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/overall-survival/</loc>
		<lastmod>2018-11-06T21:31:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/oxycodone/</loc>
		<lastmod>2012-06-26T10:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/p-bcma-101/</loc>
		<lastmod>2019-10-01T11:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pain/</loc>
		<lastmod>2013-09-05T14:53:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/palifermin/</loc>
		<lastmod>2012-12-19T14:16:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/palonosetron/</loc>
		<lastmod>2009-01-22T19:29:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pamidronate/</loc>
		<lastmod>2015-05-31T09:18:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/panobinostat/</loc>
		<lastmod>2019-03-12T10:03:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/papain/</loc>
		<lastmod>2010-09-02T15:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/papaya/</loc>
		<lastmod>2010-09-02T15:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pats-cracked-cup/</loc>
		<lastmod>2013-03-01T12:14:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pats-place/</loc>
		<lastmod>2016-02-11T22:42:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pat-sm6/</loc>
		<lastmod>2014-03-26T23:00:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/patent-status/</loc>
		<lastmod>2020-09-17T06:59:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/patient-collumn/</loc>
		<lastmod>2017-03-02T17:27:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/patient-column/</loc>
		<lastmod>2020-11-25T20:19:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/patient-interview/</loc>
		<lastmod>2012-11-29T12:48:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/patient-seminar/</loc>
		<lastmod>2013-05-31T06:49:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/patienteninterview/</loc>
		<lastmod>2011-03-18T10:23:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/patientenkolumne/</loc>
		<lastmod>2012-09-18T17:38:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pbcar269a/</loc>
		<lastmod>2020-09-21T07:00:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pbox-15/</loc>
		<lastmod>2011-01-06T15:12:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pci-32765/</loc>
		<lastmod>2012-06-26T10:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pd-0332991/</loc>
		<lastmod>2011-01-05T12:52:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pegfilgrastim/</loc>
		<lastmod>2012-04-20T11:55:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pelareorep/</loc>
		<lastmod>2018-12-12T07:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pembrolizumab/</loc>
		<lastmod>2019-10-01T11:47:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/perifosine/</loc>
		<lastmod>2013-11-20T20:53:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/peripheral-neuropathy/</loc>
		<lastmod>2019-04-24T09:11:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/periphere-neuropathie/</loc>
		<lastmod>2012-04-16T15:01:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/personalized-therapy/</loc>
		<lastmod>2015-06-25T15:02:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pertofrane/</loc>
		<lastmod>2013-08-12T17:28:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pet-scans/</loc>
		<lastmod>2019-05-17T11:10:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pf-04929113/</loc>
		<lastmod>2013-06-24T15:20:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pf-06863135/</loc>
		<lastmod>2020-10-05T06:30:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pfs2/</loc>
		<lastmod>2014-07-23T14:56:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/phospholipid-ether-drug-conjugates/</loc>
		<lastmod>2020-09-09T08:00:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/physical-activity/</loc>
		<lastmod>2012-10-22T11:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/physician-column/</loc>
		<lastmod>2016-01-31T19:33:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/physician-perspective/</loc>
		<lastmod>2012-01-13T12:57:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/physicians-education-resource/</loc>
		<lastmod>2009-02-23T09:52:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/plasma-cells/</loc>
		<lastmod>2012-10-03T11:35:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/plasmacytoid-dendritic-cells/</loc>
		<lastmod>2009-10-07T08:29:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/plasmapheresis/</loc>
		<lastmod>2009-07-21T12:43:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/plasmocitoma-solitario/</loc>
		<lastmod>2013-02-11T11:30:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/platelets/</loc>
		<lastmod>2016-04-08T14:56:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/plerixafor/</loc>
		<lastmod>2016-12-16T09:20:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/plitidepsin/</loc>
		<lastmod>2018-12-11T02:10:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pm00104/</loc>
		<lastmod>2012-12-12T14:57:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pomalidomid/</loc>
		<lastmod>2013-08-16T18:30:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pomalidomide/</loc>
		<lastmod>2020-11-13T16:27:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pomalyst/</loc>
		<lastmod>2020-11-13T16:27:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prednison/</loc>
		<lastmod>2010-02-11T17:23:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prednisone/</loc>
		<lastmod>2014-02-03T11:09:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pregnancy/</loc>
		<lastmod>2013-09-27T19:41:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prevacid/</loc>
		<lastmod>2016-04-18T16:08:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prevention/</loc>
		<lastmod>2009-09-30T16:57:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prevnar/</loc>
		<lastmod>2012-02-29T14:15:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/principales-novedades/</loc>
		<lastmod>2013-04-10T10:37:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prlx-93936/</loc>
		<lastmod>2012-10-15T11:10:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prlx93936/</loc>
		<lastmod>2014-12-08T07:02:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/procrit/</loc>
		<lastmod>2010-09-27T11:43:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prognose/</loc>
		<lastmod>2018-05-02T10:33:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prognosis/</loc>
		<lastmod>2019-11-04T16:46:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prognostic-factor/</loc>
		<lastmod>2019-11-04T16:46:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/progress/</loc>
		<lastmod>2018-05-16T15:56:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/progressionsrisiko/</loc>
		<lastmod>2018-11-29T14:48:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prolia/</loc>
		<lastmod>2010-11-19T19:35:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pronostico/</loc>
		<lastmod>2013-09-09T15:35:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prophylaxis/</loc>
		<lastmod>2012-07-18T14:28:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/propranolol/</loc>
		<lastmod>2012-10-29T11:52:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/proteasome-inhibitors/</loc>
		<lastmod>2020-09-09T19:15:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/prt1419/</loc>
		<lastmod>2020-09-30T07:00:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pseudo-autologous-stem-cell-transplant/</loc>
		<lastmod>2013-03-11T11:56:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/psychological-intervention/</loc>
		<lastmod>2013-04-22T14:16:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pt-112/</loc>
		<lastmod>2020-07-23T08:15:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/pvx-410/</loc>
		<lastmod>2014-12-05T07:41:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/quad/</loc>
		<lastmod>2014-05-31T21:17:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/quadramet/</loc>
		<lastmod>2008-10-15T08:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/quality-of-life/</loc>
		<lastmod>2014-03-06T11:11:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/quimiocerebro/</loc>
		<lastmod>2013-11-27T11:55:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/quinine/</loc>
		<lastmod>2014-07-12T14:41:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/quisinostat/</loc>
		<lastmod>2013-11-18T22:22:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/race/</loc>
		<lastmod>2018-04-17T17:49:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/radiation-therapy/</loc>
		<lastmod>2019-05-06T13:05:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/random-acts-of-kindness/</loc>
		<lastmod>2013-01-15T11:59:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/rapamune/</loc>
		<lastmod>2012-10-01T11:25:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/rapamycin/</loc>
		<lastmod>2012-10-01T11:25:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/rapid-cell-growth/</loc>
		<lastmod>2010-11-01T16:59:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/rare-myelomas/</loc>
		<lastmod>2011-01-12T15:36:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/recall/</loc>
		<lastmod>2010-11-22T17:47:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/recovery/</loc>
		<lastmod>2012-10-04T14:09:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/red-wine/</loc>
		<lastmod>2009-09-11T20:20:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/refractory/</loc>
		<lastmod>2013-12-11T18:20:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/regenerative-medicine-advanced-therapy-rmat-designation/</loc>
		<lastmod>2019-04-23T08:05:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/relapse/</loc>
		<lastmod>2016-04-02T13:59:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/relapsed-multiple-myeloma/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/remission/</loc>
		<lastmod>2012-08-02T10:48:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/reolysin/</loc>
		<lastmod>2018-12-12T07:00:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/reovirus/</loc>
		<lastmod>2013-09-09T15:17:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/residual-disease/</loc>
		<lastmod>2012-12-05T11:59:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/resources-on-bone-disease/</loc>
		<lastmod>2009-01-23T21:47:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/resources-on-caregiving/</loc>
		<lastmod>2010-10-06T16:01:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/resources-on-kidney-failure/</loc>
		<lastmod>2009-08-17T23:36:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/resources-on-myeloma-vaccines/</loc>
		<lastmod>2011-03-18T10:23:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/resources-on-nutrition/</loc>
		<lastmod>2010-09-02T15:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/response/</loc>
		<lastmod>2018-04-23T15:25:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/respuesta/</loc>
		<lastmod>2013-09-09T15:35:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/restless-legs-syndrome/</loc>
		<lastmod>2012-10-15T11:10:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/resveratrol/</loc>
		<lastmod>2010-11-30T15:28:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/retaspimycin/</loc>
		<lastmod>2011-08-30T15:36:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/retrovir/</loc>
		<lastmod>2012-09-17T10:50:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/revlimid/</loc>
		<lastmod>2020-09-17T06:59:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/rezidiv/</loc>
		<lastmod>2014-03-19T16:16:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/rezidiviertes-multiples-myelom/</loc>
		<lastmod>2019-10-03T11:14:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ricolinostat/</loc>
		<lastmod>2015-12-07T10:00:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/right-to-try/</loc>
		<lastmod>2018-05-30T13:15:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/risikofaktoren/</loc>
		<lastmod>2013-09-24T16:06:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/risikoklassifikation/</loc>
		<lastmod>2013-09-24T16:06:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/risk-factors/</loc>
		<lastmod>2016-05-23T11:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/risk-stratification/</loc>
		<lastmod>2009-04-15T18:26:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/roche-group/</loc>
		<lastmod>2009-09-12T01:07:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/romidepsin/</loc>
		<lastmod>2011-10-19T12:55:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/roneparstat/</loc>
		<lastmod>2016-03-28T12:17:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/roxithromycin/</loc>
		<lastmod>2018-06-13T22:04:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ruxolitinib/</loc>
		<lastmod>2014-12-05T07:41:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/rvd/</loc>
		<lastmod>2019-07-08T15:24:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sagent-pharma/</loc>
		<lastmod>2010-01-25T14:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/salubrinal/</loc>
		<lastmod>2009-04-07T23:03:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/salvage-therapy/</loc>
		<lastmod>2015-03-23T17:27:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sar650984/</loc>
		<lastmod>2020-06-02T06:47:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/saracatinib/</loc>
		<lastmod>2016-04-17T15:51:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sarclisa/</loc>
		<lastmod>2020-07-08T07:15:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/scar-tissue/</loc>
		<lastmod>2014-03-20T13:55:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/scd105/</loc>
		<lastmod>2012-05-14T12:58:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sch727965/</loc>
		<lastmod>2013-11-04T13:03:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/schwelendes-myelom/</loc>
		<lastmod>2016-07-14T15:04:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sclerostin/</loc>
		<lastmod>2011-11-18T12:14:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/scottish-medicines-consortium/</loc>
		<lastmod>2009-11-13T15:54:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sea-bcma/</loc>
		<lastmod>2018-11-14T08:00:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/seans-burgundy-thread/</loc>
		<lastmod>2016-12-24T10:04:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/second-opinion/</loc>
		<lastmod>2012-03-05T11:06:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/secondary-cancer/</loc>
		<lastmod>2016-10-11T07:44:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/selective-digestive-decontamination/</loc>
		<lastmod>2018-09-23T00:23:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/selektive-dekontamination-des-verdauungstraktes/</loc>
		<lastmod>2019-08-22T14:27:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/selinexor/</loc>
		<lastmod>2020-07-20T07:00:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sendai-virus/</loc>
		<lastmod>2016-07-01T17:40:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/series-on-management-of-side-effects/</loc>
		<lastmod>2011-09-12T17:54:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/serum-albumin/</loc>
		<lastmod>2010-01-12T14:07:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sexual-dysfunction/</loc>
		<lastmod>2011-09-19T10:43:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sf1126/</loc>
		<lastmod>2013-02-04T10:52:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/shingles/</loc>
		<lastmod>2019-10-04T12:20:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/shortness-of-breath/</loc>
		<lastmod>2017-01-24T12:44:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/side-effects/</loc>
		<lastmod>2019-05-23T17:03:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/siltuximab/</loc>
		<lastmod>2014-04-28T11:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sirolimus/</loc>
		<lastmod>2012-10-01T11:25:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sistema-inmunologico/</loc>
		<lastmod>2013-11-04T16:35:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sl-401/</loc>
		<lastmod>2020-06-10T08:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/slamf7-targeted-therapies/</loc>
		<lastmod>2020-11-17T20:00:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/smoking/</loc>
		<lastmod>2012-10-22T11:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/smoldering-multiple-myeloma/</loc>
		<lastmod>2020-10-21T19:10:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/snake-venom/</loc>
		<lastmod>2013-09-09T15:17:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sns01-t/</loc>
		<lastmod>2012-06-04T20:23:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/snx5422/</loc>
		<lastmod>2013-06-24T15:20:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/soliris/</loc>
		<lastmod>2016-04-12T14:44:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/solitares-knochenplasmozytom/</loc>
		<lastmod>2012-05-08T21:06:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/solitary-bone-plasmacytoma/</loc>
		<lastmod>2012-05-04T12:32:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sorafenib/</loc>
		<lastmod>2016-03-23T11:18:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sotatercept/</loc>
		<lastmod>2011-09-23T15:46:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/spanish-translations/</loc>
		<lastmod>2013-02-11T12:58:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/spectrum-pharmaceuticals/</loc>
		<lastmod>2013-03-25T12:02:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/spender-lymphozyten-infusionen/</loc>
		<lastmod>2012-02-28T10:08:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/spender-transplantation/</loc>
		<lastmod>2014-05-14T11:37:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/spinal-fracture/</loc>
		<lastmod>2013-06-24T15:20:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sporanox/</loc>
		<lastmod>2012-12-05T11:59:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/spry2/</loc>
		<lastmod>2016-03-28T12:17:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sprycel/</loc>
		<lastmod>2009-02-27T18:09:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/src-kinases/</loc>
		<lastmod>2011-03-14T17:16:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/srf231/</loc>
		<lastmod>2018-07-30T14:24:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/srt501/</loc>
		<lastmod>2010-11-30T15:28:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sst0001/</loc>
		<lastmod>2016-03-28T12:17:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stammzellmobilisierung/</loc>
		<lastmod>2016-04-19T14:58:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stammzelltransplantation/</loc>
		<lastmod>2019-08-22T14:27:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/statin/</loc>
		<lastmod>2013-05-06T13:24:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/statins/</loc>
		<lastmod>2010-01-20T09:16:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stem-cell-collection/</loc>
		<lastmod>2016-12-16T09:20:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stem-cell-mobilization/</loc>
		<lastmod>2020-10-30T07:00:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stem-cell-transplant/</loc>
		<lastmod>2019-08-13T17:36:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/steroids/</loc>
		<lastmod>2012-02-23T14:12:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stimuvax/</loc>
		<lastmod>2011-12-12T16:21:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/strahlentherapie/</loc>
		<lastmod>2019-05-15T16:22:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stringent-complete-response/</loc>
		<lastmod>2014-02-26T17:56:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/stro-001/</loc>
		<lastmod>2018-10-12T07:00:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/subcutaneous-administration/</loc>
		<lastmod>2014-01-30T15:21:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/subcutaneous-formulation/</loc>
		<lastmod>2020-11-12T07:00:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/subkutanes-velcade/</loc>
		<lastmod>2015-05-04T21:24:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sucrets/</loc>
		<lastmod>2014-09-03T07:39:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/summer-reading/</loc>
		<lastmod>2014-06-21T09:02:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/supervivencia/</loc>
		<lastmod>2013-11-04T16:35:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/support-group/</loc>
		<lastmod>2013-11-19T14:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/supportive-care/</loc>
		<lastmod>2008-10-15T08:00:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/survival/</loc>
		<lastmod>2019-11-04T16:46:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sweden/</loc>
		<lastmod>2010-03-31T15:56:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/sylvant/</loc>
		<lastmod>2014-04-28T11:41:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/symptome/</loc>
		<lastmod>2013-10-29T14:05:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/t-cell/</loc>
		<lastmod>2013-10-11T17:36:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/t414/</loc>
		<lastmod>2011-02-11T10:54:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tabalumab/</loc>
		<lastmod>2013-05-24T16:23:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tagraxofusp/</loc>
		<lastmod>2020-06-10T08:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tak-169/</loc>
		<lastmod>2020-02-19T07:00:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/talidomid/</loc>
		<lastmod>2011-01-10T16:19:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/talomid/</loc>
		<lastmod>2011-01-10T16:19:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tandemtransplantation/</loc>
		<lastmod>2013-04-04T09:25:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tanespimycin/</loc>
		<lastmod>2010-07-22T23:55:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tasquinimod/</loc>
		<lastmod>2020-08-03T02:30:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tecentriq/</loc>
		<lastmod>2018-05-29T20:08:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/teclistamab/</loc>
		<lastmod>2020-09-14T06:30:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/temsirolimus/</loc>
		<lastmod>2012-09-26T11:37:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tendencias/</loc>
		<lastmod>2013-05-31T22:00:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/terapia-de-mantenimiento/</loc>
		<lastmod>2013-05-04T22:12:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/testosteron/</loc>
		<lastmod>2018-10-19T11:42:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/testosterone/</loc>
		<lastmod>2018-10-16T10:27:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/th-302/</loc>
		<lastmod>2015-06-07T13:15:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/thalidomid/</loc>
		<lastmod>2011-11-15T15:15:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/thalidomide/</loc>
		<lastmod>2019-05-30T17:07:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/thalomid/</loc>
		<lastmod>2016-04-09T14:42:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/the-final-mile/</loc>
		<lastmod>2020-06-10T23:57:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/thiotepa/</loc>
		<lastmod>2013-04-01T12:53:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/thrombose/</loc>
		<lastmod>2013-09-17T17:34:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/thrombotic-microangiopathy/</loc>
		<lastmod>2016-04-12T14:44:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/timing/</loc>
		<lastmod>2013-08-16T15:11:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/timp-1/</loc>
		<lastmod>2009-10-04T14:35:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tinostamustine/</loc>
		<lastmod>2019-03-05T08:30:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tiragolumab/</loc>
		<lastmod>2019-10-08T15:29:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tisagenlecleucel/</loc>
		<lastmod>2015-06-04T13:34:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tisagenlecleucel-t/</loc>
		<lastmod>2015-09-09T17:00:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tissue-typing/</loc>
		<lastmod>2014-03-29T12:03:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tj202/</loc>
		<lastmod>2020-04-27T16:01:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tjp1/</loc>
		<lastmod>2016-05-04T23:54:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tnb-383b/</loc>
		<lastmod>2019-11-06T08:00:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/top-beacon-articles/</loc>
		<lastmod>2014-03-01T17:56:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/top-research/</loc>
		<lastmod>2014-03-01T17:56:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/topotecan/</loc>
		<lastmod>2010-08-20T16:10:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/torisel/</loc>
		<lastmod>2012-09-26T11:37:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/total-therapy/</loc>
		<lastmod>2012-12-04T13:25:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tourmaline-mm1/</loc>
		<lastmod>2016-04-28T16:19:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/traf6/</loc>
		<lastmod>2012-04-04T11:25:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tragara-pharmaceuticals/</loc>
		<lastmod>2010-04-05T11:53:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/trail/</loc>
		<lastmod>2013-03-06T13:42:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/transdermal-formulations/</loc>
		<lastmod>2020-04-30T07:00:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/translations/</loc>
		<lastmod>2010-11-24T17:04:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/trasplante/</loc>
		<lastmod>2013-11-27T11:55:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tratamiento/</loc>
		<lastmod>2013-05-31T22:00:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/travel/</loc>
		<lastmod>2012-11-13T13:06:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/treanda/</loc>
		<lastmod>2016-05-27T17:44:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/treatment/</loc>
		<lastmod>2011-02-21T12:22:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tretinoin/</loc>
		<lastmod>2013-09-09T15:17:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tricor/</loc>
		<lastmod>2013-10-28T14:28:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/trisenox/</loc>
		<lastmod>2013-02-25T12:20:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/trisomy/</loc>
		<lastmod>2012-02-15T12:54:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/trispecific-antibodies/</loc>
		<lastmod>2020-04-27T06:30:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tsk011010/</loc>
		<lastmod>2020-06-08T07:00:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tti-622/</loc>
		<lastmod>2020-09-08T16:05:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tumor-junction-protein-1/</loc>
		<lastmod>2016-05-04T23:54:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tumor-suppressor-gene/</loc>
		<lastmod>2009-03-31T19:45:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/tysabri/</loc>
		<lastmod>2011-10-26T15:37:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/uberlebensrate/</loc>
		<lastmod>2018-05-02T10:33:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ucartcs1/</loc>
		<lastmod>2020-11-17T20:00:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ucartcs1a/</loc>
		<lastmod>2020-11-17T20:00:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ucl67022/</loc>
		<lastmod>2013-08-05T16:23:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ulocuplumab/</loc>
		<lastmod>2014-12-05T07:41:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/united-kingdom/</loc>
		<lastmod>2010-08-30T10:40:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/university-of-chicago-medical-center/</loc>
		<lastmod>2009-02-18T18:24:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/university-of-cincinnati-cancer-institute/</loc>
		<lastmod>2012-03-29T11:21:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/usa/</loc>
		<lastmod>2015-12-02T13:14:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vaccine/</loc>
		<lastmod>2012-08-09T11:30:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/valproic-acid/</loc>
		<lastmod>2012-09-26T11:37:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vcd/</loc>
		<lastmod>2016-03-24T11:30:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vegetarians/</loc>
		<lastmod>2009-07-07T23:16:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vegf/</loc>
		<lastmod>2013-01-28T14:33:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/velcade/</loc>
		<lastmod>2019-07-10T07:00:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/veliparib/</loc>
		<lastmod>2013-12-08T17:16:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/venclexta/</loc>
		<lastmod>2019-06-24T08:45:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/venetoclax/</loc>
		<lastmod>2019-06-24T08:45:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/venous-thromboembolism/</loc>
		<lastmod>2013-06-17T15:36:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/venous-thrombosis/</loc>
		<lastmod>2010-06-14T16:23:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/venous-thromoboembolism/</loc>
		<lastmod>2012-05-09T13:06:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vergleichsstudie/</loc>
		<lastmod>2015-03-10T16:33:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vertebral-compression-fracture/</loc>
		<lastmod>2012-04-06T11:15:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vertebroplasty/</loc>
		<lastmod>2013-06-24T15:20:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vesanoid/</loc>
		<lastmod>2013-09-09T15:17:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vesicular-stomatitis-virus/</loc>
		<lastmod>2013-10-07T16:19:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vesselplasty/</loc>
		<lastmod>2010-10-11T10:38:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vincristine/</loc>
		<lastmod>2011-12-02T11:57:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/viracept/</loc>
		<lastmod>2019-09-25T10:26:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/viral-infection/</loc>
		<lastmod>2013-01-14T11:25:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vitamin-b12/</loc>
		<lastmod>2008-11-16T02:01:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vitamin-b6/</loc>
		<lastmod>2008-11-16T02:01:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vitamin-c/</loc>
		<lastmod>2010-09-02T15:48:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vitamin-d/</loc>
		<lastmod>2011-05-13T16:44:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vitamin-k/</loc>
		<lastmod>2016-12-28T13:24:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vmp/</loc>
		<lastmod>2012-11-14T14:37:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vorinostat/</loc>
		<lastmod>2014-05-31T21:17:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vtd/</loc>
		<lastmod>2016-03-24T11:30:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/vulnerability-score/</loc>
		<lastmod>2012-10-26T12:17:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/warfarin/</loc>
		<lastmod>2016-12-28T13:24:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/wilms-tumor-1-vaccine/</loc>
		<lastmod>2013-04-22T14:16:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/wogonin/</loc>
		<lastmod>2012-11-21T12:37:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/womens-running-magazine/</loc>
		<lastmod>2009-02-09T18:24:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/xbp1/</loc>
		<lastmod>2012-03-29T11:21:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/xgeva/</loc>
		<lastmod>2018-01-05T09:00:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/xgeva-denosumab/</loc>
		<lastmod>2017-06-19T09:00:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/xl184/</loc>
		<lastmod>2016-03-30T12:35:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/xpovio/</loc>
		<lastmod>2020-07-20T07:00:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/xrcc5/</loc>
		<lastmod>2009-06-25T20:51:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/xtl-biopharmaceuticals/</loc>
		<lastmod>2011-04-25T11:19:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/yakult-honsha/</loc>
		<lastmod>2011-03-14T17:16:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ygalo/</loc>
		<lastmod>2020-10-12T02:19:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/ym155/</loc>
		<lastmod>2016-05-06T16:47:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/yoga/</loc>
		<lastmod>2013-04-11T13:43:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zalypsis/</loc>
		<lastmod>2012-12-12T14:57:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zarnestra/</loc>
		<lastmod>2009-03-07T23:30:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zarxio/</loc>
		<lastmod>2016-03-25T11:50:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zellbasierter-impfstoff/</loc>
		<lastmod>2013-06-14T15:17:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zidovudine/</loc>
		<lastmod>2012-09-17T10:50:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zofran/</loc>
		<lastmod>2011-09-26T16:59:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zoledronic-acid/</loc>
		<lastmod>2013-06-26T17:50:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zolinza/</loc>
		<lastmod>2014-05-31T21:17:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zometa/</loc>
		<lastmod>2013-06-26T17:50:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zukunft/</loc>
		<lastmod>2011-02-28T11:40:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zulassung/</loc>
		<lastmod>2018-05-15T12:44:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zweitmalignom/</loc>
		<lastmod>2014-03-13T10:34:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/tag/zytogenetik/</loc>
		<lastmod>2016-04-07T16:34:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>https://myelomabeacon.org/forum/</loc>
		<lastmod>2010-03-22T00:00:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.0</priority>
	</url>
</urlset>